assay_type,curated_by,src_id,cell_id,assay_subcellular_fraction,assay_organism,assay_test_type,assay_category,assay_tax_id,description,variant_id,assay_id,confidence_score,src_assay_id,assay_strain,doc_id,assay_cell_type,assay_tissue,relationship_type,tid,chembl_id,bao_format,tissue_id
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7524,1,,,9866,,Kidney,N,50597,CHEMBL618647,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,7525,1,,,9866,,Kidney,N,50597,CHEMBL618648,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,7526,1,,,9866,,Kidney,N,50597,CHEMBL618649,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7527,1,,,9866,,Liver,N,50597,CHEMBL618650,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,7528,1,,,9866,,Liver,N,50597,CHEMBL618651,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,7529,1,,,9866,,Liver,N,50597,CHEMBL876497,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7530,1,,,9866,,Lung,N,50597,CHEMBL618652,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,7531,1,,,9866,,Lung,N,50597,CHEMBL618653,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,7532,1,,,9866,,Lung,N,50597,CHEMBL618654,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,7533,1,,,6351,,,N,50597,CHEMBL618655,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for solubility in water,,7534,1,,,1465,,,N,50597,CHEMBL618656,BAO_0000218,
P,Intermediate,1,,,,,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,7535,0,,,5182,,,U,22229,CHEMBL618657,BAO_0000100,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Solubility was determined,,7536,1,,,17847,,,N,50597,CHEMBL618658,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,solubility in water (ug/mL) at 37 degree C.,,7537,1,,,15339,,,N,50597,CHEMBL618659,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,7538,1,,,5202,,,N,50597,CHEMBL618660,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,7539,1,,,1088,,,N,50597,CHEMBL618661,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rats,,7540,1,,,3169,,,N,50597,CHEMBL873807,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in Dawley rat,,7541,1,,,5353,,,N,50597,CHEMBL618662,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after 3 mg/kg iv administration,,7542,1,,,2864,,,N,50597,CHEMBL618663,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after 3 mg/kg iv administration in rat,,7543,1,,,2864,,,N,50597,CHEMBL618664,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after 3 mg/kg iv administration in the rat,,7544,1,,,2864,,,N,50597,CHEMBL618665,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in female Sprague-Dawley rats,,7545,1,,,6362,,,N,50597,CHEMBL876498,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat,,7546,1,,,6249,,,N,50597,CHEMBL618666,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rats was determined,,7547,1,,,3169,,,N,50597,CHEMBL620440,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rats with metabolic oxidation,,7548,1,,,3169,,,N,50597,CHEMBL620441,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rats,,7549,1,,,3169,,,N,50597,CHEMBL620442,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7550,1,,,17260,,,N,50597,CHEMBL620443,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,7551,1,,,17260,,,N,50597,CHEMBL620444,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7552,1,,,17260,,,N,50597,CHEMBL620445,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,7553,1,,,17260,,,N,50597,CHEMBL620446,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biological half-life measured in plasma of rat,,7554,1,,,2879,,Plasma,N,50597,CHEMBL620447,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biological half-life measured in plasma of rat; 22-25,,7555,1,,,2879,,Plasma,N,50597,CHEMBL621129,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biological half-life measured in plasma of rat; 9-16,,7556,1,,,2879,,Plasma,N,50597,CHEMBL621130,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for its half life when administered intravenously in rat,,7557,1,,,3184,,,N,50597,CHEMBL873808,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,7558,1,,,4891,,,N,50597,CHEMBL876598,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,7559,1,,,429,,,N,50597,CHEMBL621131,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life (T1/2) after oral administration in rat,,7560,1,,,5656,,,N,50597,CHEMBL621132,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound after iv administration of 20 mg/kg dose in rat,,7561,1,,,4413,,,N,50597,CHEMBL621133,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,7562,1,,,3598,,,N,50597,CHEMBL621312,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life of compound was determined in rat,,7563,1,,,17267,,,N,50597,CHEMBL621313,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life of compound was determined in rat blood,,7564,1,,,4727,,Blood,N,50597,CHEMBL621314,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life at 1 mg/kg was determined in rat,,7565,1,,,17651,,,N,50597,CHEMBL621315,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life at 10 mg/kg was determined in rat,,7566,1,,,17651,,,N,50597,CHEMBL621316,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rats,,7567,1,,,401,,,N,50597,CHEMBL621317,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rats in hours,,7568,1,,,4942,,,N,50597,CHEMBL621318,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,7569,1,,,17735,,,N,50597,CHEMBL621319,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,7570,1,,,6056,,,N,50597,CHEMBL621377,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was determined,,7571,1,,,5213,,,N,50597,CHEMBL621378,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after i.v. administration,,7572,1,,,6616,,,N,50597,CHEMBL876599,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,7573,1,,,5937,,,N,50597,CHEMBL621379,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat plasma,,7574,1,,,5819,,Plasma,N,50597,CHEMBL621380,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat plasma; Not detected,,7575,1,,,5819,,Plasma,N,50597,CHEMBL621381,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rats,,7576,1,,,6803,,,N,50597,CHEMBL618515,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period of compound was determined after peroral administration,,7577,1,,,17804,,,N,50597,CHEMBL618516,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,7578,1,,,17804,,,N,50597,CHEMBL618517,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat,,7579,1,,,5948,,,N,50597,CHEMBL618518,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,7580,1,,,1916,,,N,50597,CHEMBL618519,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,7581,1,,,1916,,,N,50597,CHEMBL618698,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,7582,1,,,1916,,,N,50597,CHEMBL618862,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,7583,1,,,4890,,,N,50597,CHEMBL618863,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,7584,1,,,17764,,,N,50597,CHEMBL618864,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life time in rat the dose of 2 mg/kg,,7585,1,,,4727,,,N,50597,CHEMBL618865,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life 24 hr after 10 mg/kg iv administration in rats,,7586,1,,,17509,,,N,50597,CHEMBL618866,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life 24 hr after 2 mg/kg iv administration in rats,,7587,1,,,17509,,,N,50597,CHEMBL618867,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life consistent with the observed metabolic steady state in rats,,7588,1,,,6597,,,N,50597,CHEMBL875828,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,7589,1,,,17735,,,N,50597,CHEMBL618868,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life for oxidative metabolic stability was determined using male human,,7590,1,,,6597,,,N,50597,CHEMBL618869,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,7591,1,,,17670,,,N,50597,CHEMBL618870,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat plasma,,7592,1,,,1696,,Plasma,N,50597,CHEMBL618871,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat plasma was determined,,7593,1,,,1742,,Plasma,N,50597,CHEMBL618872,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rats was determined,,7594,1,,,17800,,,N,50597,CHEMBL873816,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,7595,0,,,12923,,,U,22224,CHEMBL618873,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve after oral dose of 0.1 mg//kg,,7596,0,,,11954,,,U,22224,CHEMBL621602,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve after oral dose of 0.3 mg/kg,,7597,0,,,11954,,,U,22224,CHEMBL621603,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve after oral dose of 1 mg/kg,,7598,0,,,11954,,,U,22224,CHEMBL621604,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve after oral dose of 10 mg/kg,,7599,0,,,11954,,,U,22224,CHEMBL621605,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve after oral dose of 23.4 mg/kg,,7600,0,,,11954,,,U,22224,CHEMBL621606,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve after oral dose of 3 mg/kg,,7601,0,,,11954,,,U,22224,CHEMBL621607,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve after oral dose of 3.87 mg/kg,,7602,0,,,11954,,,U,22224,CHEMBL621608,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve was determined,,7603,0,,,5237,,,U,22224,CHEMBL621609,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve at a dose of 10 mg/kg,,7604,0,,,4026,,,U,22224,CHEMBL621610,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined; ND=No data,,7605,1,,,5237,,,N,50597,CHEMBL621611,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,7606,1,,,14793,,,N,50597,CHEMBL621612,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,7607,1,,,14793,,,N,50597,CHEMBL622308,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,7608,1,,,14793,,,N,50597,CHEMBL622309,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,7609,1,,,14793,,,N,50597,CHEMBL622310,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,7610,1,,,14793,,,N,50597,CHEMBL622311,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,7611,1,,,14793,,,N,50597,CHEMBL622312,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,7612,1,,,14793,,,N,50597,CHEMBL622931,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,7613,1,,,14793,,,N,50597,CHEMBL622932,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,7614,1,,,14793,,Plasma,N,50597,CHEMBL622736,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,7615,1,,,14793,,Plasma,N,50597,CHEMBL622737,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,7616,1,,,14793,,Plasma,N,50597,CHEMBL622738,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,7617,1,,,14793,,Plasma,N,50597,CHEMBL622739,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,7618,1,,,14793,,Plasma,N,50597,CHEMBL622740,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,7619,1,,,14793,,Plasma,N,50597,CHEMBL622741,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,7620,1,,,14793,,Plasma,N,50597,CHEMBL622742,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,7621,1,,,14793,,Plasma,N,50597,CHEMBL622743,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,AUC in mice,,7622,1,,,11637,,Plasma,N,50594,CHEMBL622744,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Area under curve was measured from the graph obtained from concentration Vs time,,7623,0,,,11149,,,U,22224,CHEMBL624134,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve value of compound per hour after oral administration,,7624,0,,,10016,,,U,22224,CHEMBL624135,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined after oral administration in rats,,7625,1,,,17796,,,N,50597,CHEMBL624136,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined after oral administration in rats; No data,,7626,1,,,17796,,,N,50597,CHEMBL624137,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined after oral administration in rats;No data,,7627,1,,,17796,,,N,50597,CHEMBL624320,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,7628,1,,,12923,,,N,50588,CHEMBL624321,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,7629,1,,,15372,,,N,50597,CHEMBL624322,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound after iv dose of 5.06 in rats,,7630,1,,,15372,,,N,50597,CHEMBL624323,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,7631,1,,,15372,,,N,50597,CHEMBL624324,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,7632,1,,,15372,,,N,50597,CHEMBL624325,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,7633,1,,,15372,,,N,50597,CHEMBL624326,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,7634,1,,,15372,,,N,50597,CHEMBL624327,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,7635,1,,,15372,,,N,50597,CHEMBL624328,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve was determined in Dogs after peroral administration,,7636,1,,,14169,,,N,50588,CHEMBL627848,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in Rats after peroral administration,,7637,1,,,14169,,,N,50597,CHEMBL627849,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in carotid blood of rat when administered intradermally,,7638,1,,,14258,,,N,50597,CHEMBL627850,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in portal blood of rat when administered intradermally,,7639,1,,,14258,,,N,50597,CHEMBL627851,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,7640,1,,,15011,,,N,50594,CHEMBL627852,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,7641,1,,,15011,,,N,50594,CHEMBL627853,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,7642,1,,,15011,,,N,50594,CHEMBL627854,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,7643,1,,,15011,,,N,50594,CHEMBL627855,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,7644,1,,,15011,,,N,50594,CHEMBL627856,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,7645,1,,,15011,,,N,50594,CHEMBL875339,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,7646,1,,,15011,,,N,50594,CHEMBL627857,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,7647,1,,,11195,,Spleen,N,50597,CHEMBL627858,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,7648,1,,,10130,,Blood,N,50597,CHEMBL627859,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,7649,1,,,10130,,Brain,N,50597,CHEMBL627860,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,7650,1,,,10130,,Heart,N,50597,CHEMBL627019,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,7651,1,,,10130,,Liver,N,50597,CHEMBL627020,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,7652,1,,,10130,,Lung,N,50597,CHEMBL627021,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,7653,1,,,10130,,Muscle tissue,N,50597,CHEMBL627022,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,7654,1,,,10130,,,N,50597,CHEMBL627023,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,7655,1,,,10130,,Spleen,N,50597,CHEMBL627024,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,7656,1,,,10130,,Thyroid gland,N,50597,CHEMBL627025,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,7657,1,,,10130,,Kidney,N,50597,CHEMBL627026,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,7658,1,,,10130,,Blood,N,50597,CHEMBL627027,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,7659,1,,,10130,,Brain,N,50597,CHEMBL627028,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,7660,1,,,10130,,Heart,N,50597,CHEMBL627029,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,7661,1,,,10130,,Kidney,N,50597,CHEMBL627030,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,7662,1,,,10130,,Liver,N,50597,CHEMBL627031,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,7663,1,,,10130,,Lung,N,50597,CHEMBL627032,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,7664,1,,,10130,,Muscle tissue,N,50597,CHEMBL627033,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,7665,1,,,10130,,,N,50597,CHEMBL627034,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,7666,1,,,10130,,Spleen,N,50597,CHEMBL627035,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,7667,1,,,10130,,Thyroid gland,N,50597,CHEMBL627036,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,7668,1,,,10130,,Blood,N,50597,CHEMBL875340,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,7669,1,,,10130,,Heart,N,50597,CHEMBL627037,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,7670,1,,,10130,,Kidney,N,50597,CHEMBL627038,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,7671,1,,,10130,,Liver,N,50597,CHEMBL627039,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,7672,1,,,10130,,Muscle tissue,N,50597,CHEMBL627040,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,7673,1,,,10130,,Spleen,N,50597,CHEMBL624663,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,7674,1,,,10130,,Thyroid gland,N,50597,CHEMBL625963,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,7675,1,,,10130,,Brain,N,50597,CHEMBL876799,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,7676,1,,,10130,,Lung,N,50597,CHEMBL626133,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,7677,1,,,10130,,,N,50597,CHEMBL626134,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,7678,1,,,6295,,,N,50597,CHEMBL626135,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,7679,1,,,6296,,,N,50597,CHEMBL626136,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,7680,1,,,6296,,,N,50597,CHEMBL626137,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,7681,1,,,6295,,,N,50597,CHEMBL626138,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,7682,1,,,6296,,,N,50597,CHEMBL626139,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7683,1,,,17260,,,N,50597,CHEMBL626140,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,7684,1,,,17260,,,N,50597,CHEMBL626141,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,C24h in rat p.o. at 20 mg/kg concentration,,7685,1,,,17686,,,N,50597,CHEMBL626142,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7686,1,,,9866,,Muscle tissue,N,50597,CHEMBL627930,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,7687,1,,,9866,,Muscle tissue,N,50597,CHEMBL627931,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,7688,1,,,9866,,Muscle tissue,N,50597,CHEMBL627932,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,7689,1,,,9866,,Spleen,N,50597,CHEMBL627933,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,7690,1,,,9866,,Spleen,N,50597,CHEMBL627934,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,7691,1,,,9866,,Spleen,N,50597,CHEMBL627935,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,7692,1,,,9866,,Blood,N,50597,CHEMBL627936,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,7693,1,,,9866,,Blood,N,50597,CHEMBL627937,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7694,1,,,9866,,Blood,N,50597,CHEMBL627938,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,7695,1,,,9866,,Blood,N,50597,CHEMBL627939,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,7696,1,,,9866,,Blood,N,50597,CHEMBL627940,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7697,1,,,9866,,Blood,N,50597,CHEMBL627941,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7698,1,,,9866,,Blood,N,50597,CHEMBL876800,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,7699,1,,,9866,,Blood,N,50597,CHEMBL627942,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,7700,1,,,9866,,Blood,N,50597,CHEMBL627943,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,7701,1,,,9866,,Blood,N,50597,CHEMBL627944,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,7702,1,,,9866,,Blood,N,50597,CHEMBL627945,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,7703,1,,,9866,,Blood,N,50597,CHEMBL628584,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,7704,1,,,9866,,Blood,N,50597,CHEMBL628585,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,7705,1,,,9866,,Blood,N,50597,CHEMBL628586,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,7706,1,,,9866,,Blood,N,50597,CHEMBL628587,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,7707,1,,,9866,,Blood,N,50597,CHEMBL628588,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,7708,1,,,9866,,Blood,N,50597,CHEMBL628589,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,7709,1,,,9866,,Blood,N,50597,CHEMBL625304,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,7710,1,,,9866,,Blood,N,50597,CHEMBL625305,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,7711,1,,,9866,,Blood,N,50597,CHEMBL625306,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,7712,1,,,9866,,Blood,N,50597,CHEMBL625307,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,7713,1,,,9866,,Blood,N,50597,CHEMBL625308,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,7714,1,,,9866,,Blood,N,50597,CHEMBL627740,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,7715,1,,,9866,,Blood,N,50597,CHEMBL627741,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7716,1,,,9866,,Blood,N,50597,CHEMBL627742,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,7717,1,,,9866,,Blood,N,50597,CHEMBL627743,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,7718,1,,,9866,,Blood,N,50597,CHEMBL627744,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,7719,1,,,9866,,Bone,N,50597,CHEMBL627745,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7720,1,,,9866,,Bone,N,50597,CHEMBL627746,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,7721,1,,,9866,,Bone,N,50597,CHEMBL627747,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,7722,1,,,9866,,Bone,N,50597,CHEMBL876810,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,7723,1,,,9866,,Bone,N,50597,CHEMBL627748,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7724,1,,,9866,,Bone,N,50597,CHEMBL627749,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7725,1,,,9866,,Bone,N,50597,CHEMBL627750,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,7726,1,,,9866,,Bone,N,50597,CHEMBL618728,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,7727,1,,,9866,,Bone,N,50597,CHEMBL618729,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,7728,1,,,9866,,Bone,N,50597,CHEMBL618730,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,7729,1,,,9866,,Bone,N,50597,CHEMBL618731,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,7730,1,,,9866,,Bone,N,50597,CHEMBL618732,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,7731,1,,,9866,,Bone,N,50597,CHEMBL618733,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,7732,1,,,9866,,Bone,N,50597,CHEMBL618734,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,7733,1,,,9866,,Bone,N,50597,CHEMBL618735,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,7734,1,,,9866,,Bone,N,50597,CHEMBL876602,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,7735,1,,,9866,,Bone,N,50597,CHEMBL618736,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,7736,1,,,9866,,Bone,N,50597,CHEMBL618737,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,7737,1,,,9866,,Bone,N,50597,CHEMBL618738,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,7738,1,,,9866,,Bone,N,50597,CHEMBL618739,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,7739,1,,,9866,,Bone,N,50597,CHEMBL618740,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7740,1,,,9866,,Bone,N,50597,CHEMBL618741,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,7741,1,,,9866,,Bone,N,50597,CHEMBL618742,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,7742,1,,,9866,,Bone,N,50597,CHEMBL618743,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life from rat plasma at a single oral dose of 25 mg/kg,,7743,1,,,17752,,Plasma,N,50597,CHEMBL618744,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in male rat,,7744,1,,,5610,,,N,50597,CHEMBL618745,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in rat after peroral administration at 10 mg/kg concentration,,7745,1,,,5939,,,N,50597,CHEMBL620479,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in rat after peroral administration at 5 mg/kg concentration,,7746,1,,,5939,,,N,50597,CHEMBL620480,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in rat at a dose of 3 mg/kg,,7747,1,,,17771,,,N,50597,CHEMBL620481,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was evaluated in rats,,7748,1,,,1974,,,N,50597,CHEMBL620482,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was measured in rat,,7749,1,,,4239,,,N,50597,CHEMBL876603,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period for the compound was determined in rats at 50 mg/kg dose,,7750,1,,,6681,,,N,50597,CHEMBL620483,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period in rats after intravenous administration at 5 mg/kg,,7751,1,,,17752,,,N,50597,CHEMBL620484,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period in rat at 10 mg/kg,,7752,1,,,6046,,,N,50597,CHEMBL620485,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,7753,1,,,6685,,,N,50597,CHEMBL620486,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,7754,1,,,6685,,,N,50597,CHEMBL620487,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,7755,1,,,6685,,,N,50597,CHEMBL620488,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life time in rat the dose of 2 mg/kg,,7756,1,,,4727,,,N,50597,CHEMBL620489,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,7757,1,,,1088,,,N,50597,CHEMBL620490,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,7758,1,,,5610,,,N,50597,CHEMBL620491,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,7759,1,,,3032,,Plasma,N,50597,CHEMBL876604,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral half life was determined,,7760,1,,,5199,,,N,50597,CHEMBL620492,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,7761,1,,,14941,,,N,50597,CHEMBL620493,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (t1/2) in rat,,7762,1,,,4408,,,N,50597,CHEMBL620494,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma elimination half-life was determined,,7763,1,,,2552,,Plasma,N,50597,CHEMBL620495,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,7764,1,,,5199,,Plasma,N,50597,CHEMBL620496,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma half life was observed after intravenous administration in rat,,7765,1,,,15662,,Plasma,N,50597,CHEMBL620497,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life was determined,,7766,1,,,1465,,Plasma,N,50597,CHEMBL620498,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma half-life following oral administration in Fisher rats,,7767,1,,,1446,,Plasma,N,50597,CHEMBL620499,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life in rat,,7768,1,,,6824,,Plasma,N,50597,CHEMBL620500,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasmatic Half-life after intravenous administration to rat,,7769,1,,,17533,,Plasma,N,50597,CHEMBL873809,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,7770,1,,,5979,,,N,50597,CHEMBL620501,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Terminal half life after intravenous administration (1 mg/kg) in rat,,7771,1,,,4689,,,N,50597,CHEMBL620502,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Terminal half life in Rat at a oral dose of 5 mg/kg,,7772,1,,,4689,,,N,50597,CHEMBL620503,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,7773,1,,,2463,,,N,50597,CHEMBL620504,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,7774,1,,,4883,,,N,50597,CHEMBL876605,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,7775,1,,,4883,,,N,50597,CHEMBL620505,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,plasma half life was observed after intravenous administration in rat,,7776,1,,,15662,,Plasma,N,50597,CHEMBL873811,BAO_0000218,1969.0
A,Expert,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,7777,1,,,3598,,,N,50597,CHEMBL624016,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life of compound determined in rat,,7778,1,,,4576,,,N,50597,CHEMBL624017,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean residence time determined in rat,,7779,1,,,4576,,,N,50597,CHEMBL624018,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half life determined in rat,,7780,1,,,4576,,,N,50597,CHEMBL624019,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,7781,1,,,4910,,Brain,N,50597,CHEMBL624020,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for pharmacokinetic parameter maximum time period,,7782,1,,,4891,,,N,50597,CHEMBL624201,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,7783,1,,,429,,,N,50597,CHEMBL872528,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,7784,1,,,5974,,,N,50597,CHEMBL624202,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,7785,1,,,5974,,,N,50597,CHEMBL624203,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,7786,1,,,5974,,,N,50597,CHEMBL624350,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,7787,1,,,5974,,,N,50597,CHEMBL621320,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,7788,1,,,17582,,,N,50597,CHEMBL621321,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Maximum time (Tmax) required to reach Cmax in rats,,7789,1,,,4026,,,N,50597,CHEMBL621322,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,7790,1,,,4890,,,N,50597,CHEMBL621323,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum time of clearance of compound in rats after peroral administration,,7791,1,,,6571,,,N,50597,CHEMBL621324,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Maximum time at the dose of 2 mg/kg in rat,,7792,1,,,4727,,,N,50597,CHEMBL621325,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,7793,1,,,17651,,Plasma,N,50597,CHEMBL875837,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,7794,1,,,17651,,Plasma,N,50597,CHEMBL621326,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax in Guinea pig (PO dose),,7795,1,,,14465,,,N,50597,CHEMBL621327,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,7796,1,,,14941,,,N,50597,CHEMBL621328,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (Tmax) in rat,,7797,1,,,5960,,,N,50597,CHEMBL621329,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (Tmax) was estimated,,7798,1,,,5022,,,N,50597,CHEMBL621330,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Tmax) in rat,,7799,1,,,4408,,,N,50597,CHEMBL621331,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,7800,1,,,5983,,,N,50597,CHEMBL621332,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T max in Rat at a oral dose of 5 mg/kg,,7801,1,,,4689,,,N,50597,CHEMBL621333,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T max was determined at 10 mg/kg po dose in rats,,7802,1,,,2792,,,N,50597,CHEMBL621334,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,7803,1,,,15011,,,N,50594,CHEMBL621335,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,7804,1,,,14180,,,N,50588,CHEMBL621336,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,7805,1,,,14180,,,N,50597,CHEMBL621337,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve was measured after i.v. administration into Beagle dog.,,7806,1,,,14599,,,N,50588,CHEMBL621338,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve was measured after iv administration into Beagle dog,,7807,1,,,14599,,,N,50588,CHEMBL875838,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve was measured after po administration into Beagle dog,,7808,1,,,14599,,,N,50588,CHEMBL621339,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve was measured after po administration into Beagle dog.,,7809,1,,,14599,,,N,50588,CHEMBL621340,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve was measured at peroral dose of 3 mg/kg,,7810,0,,,15675,,,U,22224,CHEMBL621341,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve was measured by using concentration Vs time,,7811,0,,,12706,,,U,22224,CHEMBL621342,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve was measured by using concentration Vs time; not tested,,7812,0,,,12706,,,U,22224,CHEMBL621343,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,7813,1,,,9750,,,N,50594,CHEMBL621344,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve(AUC) was measured in mice after oral administration.,,7814,1,,,9750,,,N,50594,CHEMBL621345,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve(AUC) value of the compound,,7815,0,,,14691,,,U,22224,CHEMBL621346,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,7816,0,,,14691,,,U,22224,CHEMBL621347,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,7817,1,,,14691,,,N,50588,CHEMBL621348,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve(carotid artery) was determined by the availability in blood,,7818,0,,,2939,,Blood,U,22224,CHEMBL621349,BAO_0000019,178.0
A,Autocuration,1,,,,,,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,7819,0,,,2939,,Blood,U,22224,CHEMBL621350,BAO_0000019,178.0
A,Autocuration,1,,,,,,,Area under curve(carotid artery) was determined by the availability in blood; No data,,7820,0,,,2939,,Blood,U,22224,CHEMBL875839,BAO_0000019,178.0
A,Autocuration,1,,,,,,,Area under curve(portal vein) was determined by the availability in blood,,7821,0,,,2939,,Blood,U,22224,CHEMBL620211,BAO_0000019,178.0
A,Autocuration,1,,,,,,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,7822,0,,,2939,,Blood,U,22224,CHEMBL620212,BAO_0000019,178.0
A,Autocuration,1,,,,,,,Area under curve(portal vein) was determined by the availability in blood; No data,,7823,0,,,2939,,Blood,U,22224,CHEMBL620213,BAO_0000019,178.0
A,Intermediate,1,,,Macaca mulatta,,,9544.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,7824,1,,,9552,,Plasma,N,50797,CHEMBL620214,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca mulatta,,,9544.0,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,7825,1,,,9552,,Plasma,N,50797,CHEMBL620215,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca mulatta,,,9544.0,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,7826,1,,,9552,,Plasma,N,50797,CHEMBL620216,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,7827,1,,,9552,,Plasma,N,50588,CHEMBL620888,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,7828,1,,,9552,,Plasma,N,50588,CHEMBL620889,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,7829,0,,,9552,,Plasma,U,22224,CHEMBL620890,BAO_0000019,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under plasma time curve determined in male rat,,7830,1,,,11911,,Plasma,N,50597,CHEMBL620891,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Area under the MAP curve measured over 5 min.,,7831,0,,,16618,,,U,22224,CHEMBL620892,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,7832,1,,,14387,,,N,50594,CHEMBL621079,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,7833,1,,,14387,,,N,50594,CHEMBL621080,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,7834,1,,,12836,,,N,50588,CHEMBL621081,BAO_0000218,
A,Intermediate,1,,,Cricetinae,,,10026.0,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,7835,1,,,12836,,,N,100712,CHEMBL621082,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,7836,1,,,12836,,,N,50597,CHEMBL621083,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,7837,1,,,14339,,,N,50588,CHEMBL621084,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,7838,1,,,14339,,,N,50588,CHEMBL621085,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,7839,1,,,14339,,,N,50588,CHEMBL621086,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,7840,1,,,10524,,,N,50588,CHEMBL621087,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,7841,1,,,9994,,,N,50588,CHEMBL622607,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Serum AUC in marmosets (IV dose),,7842,1,,,11325,,,N,50588,CHEMBL622608,BAO_0000218,
A,Autocuration,1,,,,,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,7843,0,,,12536,,,U,22224,CHEMBL624481,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,7844,0,,,12536,,,U,22224,CHEMBL624482,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,7845,0,,,12536,,,U,22224,CHEMBL624483,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,7846,0,,,12536,,,U,22224,CHEMBL624484,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,7847,0,,,12536,,,U,22224,CHEMBL624485,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve for fumarate salt was evaluated in F344 Rats.,,7848,1,,,15556,,,N,50597,CHEMBL624486,BAO_0000218,
A,Autocuration,1,,,,,,,Area under the curve for the compound was calculated.,,7849,0,,,2809,,,U,22224,CHEMBL624487,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve in concentration/ time,,7850,0,,,9511,,,U,22224,CHEMBL624488,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve administered intraintestinal in rats.,,7851,1,,,12818,,,N,50597,CHEMBL624489,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve administered intravenously in rats.,,7852,1,,,12818,,,N,50597,CHEMBL625184,BAO_0000218,
A,Autocuration,1,,,,,,,Area under the curve during intravenous administration,,7853,0,,,15118,,,U,22224,CHEMBL625185,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve during intravenous administration; Not determined,,7854,0,,,15118,,,U,22224,CHEMBL875954,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve during systemic administration,,7855,0,,,15118,,,U,22224,CHEMBL625186,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve during systemic administration; Not determined,,7856,0,,,15118,,,U,22224,CHEMBL625187,BAO_0000019,
A,Autocuration,1,,,,,,,Area under the curve was calculated for the compound.,,7857,0,,,2632,,,U,22224,CHEMBL625188,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,7858,1,,,14346,,,N,50588,CHEMBL625189,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,7859,1,,,14346,,,N,50588,CHEMBL625190,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,7860,1,,,14346,,,N,50597,CHEMBL621733,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,7861,1,,,14346,,,N,50597,CHEMBL621734,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,7862,1,,,11149,,,N,50597,CHEMBL621735,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Clearance of the drug was measured in the plasma of rat; No data,,7863,1,,,17796,,Plasma,N,50597,CHEMBL621736,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The pharmacokinetic parameter plasma clearance in vivo in rats,,7864,1,,,5247,,Plasma,N,50597,CHEMBL621737,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma clearance at the dose of 2 mg/kg in rat,,7865,1,,,4727,,,N,50597,CHEMBL621738,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,7866,1,,,5654,,,N,50597,CHEMBL622806,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,7867,1,,,5654,,,N,50597,CHEMBL623519,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,7868,1,,,17260,,,N,50597,CHEMBL623520,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,7869,1,,,17065,,,N,50597,CHEMBL623521,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,7870,1,,,17671,,,N,50597,CHEMBL623522,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate in rat,,7871,1,,,6672,,,N,50597,CHEMBL623523,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate in rat,,7872,1,,,6673,,,N,50597,CHEMBL623690,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7873,1,,,5978,,,N,50597,CHEMBL623691,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7874,1,,,5978,,,N,50597,CHEMBL623692,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7875,1,,,5978,,,N,50597,CHEMBL623693,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,7876,1,,,5978,,,N,50597,CHEMBL623694,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance of compound after iv administration of 20 mg/kg dose in rat,,7877,1,,,4413,,,N,50597,CHEMBL623695,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,7878,1,,,2661,,,N,50597,CHEMBL623696,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,7879,1,,,2661,,,N,50597,CHEMBL623697,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,7880,0,,,5005,,Plasma,U,22224,CHEMBL623698,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,7881,0,,,5005,,Plasma,U,22224,CHEMBL623699,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Mean (%CV) PK parameters for CL(mL/min/kg).,,7882,1,,,15765,,,N,50597,CHEMBL623700,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,7883,1,,,3747,,,N,50597,CHEMBL623701,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,7884,1,,,16366,,Plasma,N,50597,CHEMBL623702,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,7885,1,,,4199,,,N,50597,CHEMBL623703,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat was determined,,7886,1,,,17267,,,N,50597,CHEMBL623704,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat after administration of 2 mg/kg iv,,7887,1,,,6535,,,N,50597,CHEMBL623705,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat after administration of 2 mg/kg iv,,7888,1,,,6535,,,N,50597,CHEMBL623706,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined,,7889,1,,,5041,,,N,50597,CHEMBL623707,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,7890,1,,,5960,,,N,50597,CHEMBL623708,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,7891,1,,,5937,,,N,50597,CHEMBL623709,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat by iv administration,,7892,1,,,5871,,,N,50597,CHEMBL623710,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,7893,1,,,5874,,,N,50597,CHEMBL623711,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat p.o.,,7894,1,,,6504,,,N,50597,CHEMBL623712,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rats,,7895,1,,,6803,,,N,50597,CHEMBL623713,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined; ND denotes no data,,7896,1,,,5041,,,N,50597,CHEMBL623714,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined; ND denotes not determined,,7897,1,,,5041,,,N,50597,CHEMBL623715,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,7898,1,,,1916,,,N,50597,CHEMBL623716,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,7899,1,,,5199,,,N,50597,CHEMBL622980,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma administration to rats,,7900,1,,,16367,,,N,50597,CHEMBL622981,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance of the compound in female Sprague-Dawley rats,,7901,1,,,6362,,,N,50597,CHEMBL622982,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was observed after intravenous administration in rat,,7902,1,,,15662,,,N,50597,CHEMBL622983,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,7903,1,,,6215,,,N,50597,CHEMBL622984,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,7904,1,,,1466,,,N,50597,CHEMBL622985,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,plasma clearance was observed after intravenous administration in rat,,7905,1,,,15662,,Plasma,N,50597,CHEMBL623631,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo CL/F determined,,7906,1,,,4723,,,N,50597,CHEMBL623632,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,7907,1,,,2792,,Plasma,N,50597,CHEMBL623633,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,7908,1,,,2792,,Plasma,N,50597,CHEMBL623634,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for the lower blood clearance in rat,,7909,1,,,5213,,,N,50597,CHEMBL623635,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for the low clearance in rat (in vivo),,7910,1,,,4687,,,N,50597,CHEMBL621195,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (CLb)of the compound was determined in rat,,7911,1,,,3371,,,N,50597,CHEMBL621196,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Rapid clearance after intravenous administration in rat was determined,,7912,1,,,4690,,,N,50597,CHEMBL875287,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance measured in rat,,7913,1,,,5702,,,N,50597,CHEMBL621197,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for plasma clearance in rat,,7914,1,,,740,,Plasma,N,50597,CHEMBL621198,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Low plasma clearance was calculated in rat,,7915,1,,,4853,,Plasma,N,50597,CHEMBL621199,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Clp) in rat,,7916,1,,,5789,,,N,50597,CHEMBL621200,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,7917,1,,,4527,,,N,50597,CHEMBL621201,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,7918,1,,,4527,,,N,50597,CHEMBL621202,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,7919,1,,,6518,,,N,50597,CHEMBL621203,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after IV dosing at 1 mg/kg in rat,,7920,1,,,6518,,,N,50597,CHEMBL621204,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,7921,1,,,9866,,Heart,N,50597,CHEMBL621205,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,7922,1,,,9866,,Heart,N,50597,CHEMBL621206,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,7923,1,,,9866,,Heart,N,50597,CHEMBL621207,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,7924,1,,,9866,,Heart,N,50597,CHEMBL621208,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,7925,1,,,9866,,Heart,N,50597,CHEMBL621209,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,7926,1,,,9866,,Heart,N,50597,CHEMBL876484,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7927,1,,,9866,,Heart,N,50597,CHEMBL621210,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,7928,1,,,9866,,Heart,N,50597,CHEMBL621211,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,7929,1,,,9866,,Heart,N,50597,CHEMBL621212,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,7930,1,,,9866,,Heart,N,50597,CHEMBL621213,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,7931,1,,,9866,,Heart,N,50597,CHEMBL621214,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,7932,1,,,9866,,Heart,N,50597,CHEMBL621215,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,7933,1,,,9866,,Heart,N,50597,CHEMBL621216,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,7934,1,,,9866,,Heart,N,50597,CHEMBL621217,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,7935,1,,,9866,,Heart,N,50597,CHEMBL621218,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,7936,1,,,9866,,Heart,N,50597,CHEMBL621219,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,7937,1,,,9866,,Heart,N,50597,CHEMBL621220,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,7938,1,,,9866,,Heart,N,50597,CHEMBL621221,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,7939,1,,,9866,,Heart,N,50597,CHEMBL621222,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,7940,1,,,9866,,Heart,N,50597,CHEMBL621223,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,7941,1,,,9866,,Heart,N,50597,CHEMBL876485,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7942,1,,,9866,,Heart,N,50597,CHEMBL621224,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,7943,1,,,9866,,Heart,N,50597,CHEMBL621225,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,7944,1,,,9866,,Heart,N,50597,CHEMBL621226,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,7945,1,,,9866,,Kidney,N,50597,CHEMBL621227,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7946,1,,,9866,,Kidney,N,50597,CHEMBL621228,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,7947,1,,,9866,,Kidney,N,50597,CHEMBL621229,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,7948,1,,,9866,,Kidney,N,50597,CHEMBL621230,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,7949,1,,,9866,,Kidney,N,50597,CHEMBL621231,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7950,1,,,9866,,Kidney,N,50597,CHEMBL621232,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7951,1,,,9866,,Kidney,N,50597,CHEMBL621233,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,7952,1,,,9866,,Kidney,N,50597,CHEMBL621234,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,7953,1,,,9866,,Kidney,N,50597,CHEMBL621235,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,7954,1,,,9866,,Kidney,N,50597,CHEMBL621236,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,7955,1,,,9866,,Kidney,N,50597,CHEMBL621237,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,7956,1,,,9866,,Kidney,N,50597,CHEMBL876486,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,7957,1,,,9866,,Intestine,N,50597,CHEMBL622436,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,7958,1,,,9866,,Intestine,N,50597,CHEMBL622437,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,7959,1,,,9866,,Intestine,N,50597,CHEMBL622438,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,7960,1,,,9866,,Liver,N,50597,CHEMBL622439,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,7961,1,,,9866,,Liver,N,50597,CHEMBL622440,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,7962,1,,,9866,,Liver,N,50597,CHEMBL622441,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,7963,1,,,9866,,Liver,N,50597,CHEMBL622442,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,7964,1,,,9866,,Liver,N,50597,CHEMBL622443,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,7965,1,,,9866,,Liver,N,50597,CHEMBL622444,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,7966,1,,,9866,,Liver,N,50597,CHEMBL622445,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,7967,1,,,9866,,Liver,N,50597,CHEMBL622446,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,7968,1,,,9866,,Liver,N,50597,CHEMBL622447,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,7969,1,,,9866,,Liver,N,50597,CHEMBL622448,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,7970,1,,,9866,,Liver,N,50597,CHEMBL622449,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,7971,1,,,9866,,Liver,N,50597,CHEMBL622450,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,7972,1,,,9866,,Liver,N,50597,CHEMBL622451,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,7973,1,,,9866,,Liver,N,50597,CHEMBL622452,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,7974,1,,,9866,,Liver,N,50597,CHEMBL622453,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,7975,1,,,9866,,Liver,N,50597,CHEMBL622454,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,7976,1,,,9866,,Liver,N,50597,CHEMBL622455,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,7977,1,,,9866,,Liver,N,50597,CHEMBL876024,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,T max was determined at 3 mg/kg po dose in rats,,7978,1,,,2792,,,N,50597,CHEMBL622456,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,7979,1,,,15078,,,N,50597,CHEMBL622457,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,7980,1,,,15078,,,N,50597,CHEMBL622458,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,7981,1,,,15022,,,N,50597,CHEMBL622459,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,7982,1,,,15022,,,N,50597,CHEMBL873343,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,7983,1,,,15022,,,N,50597,CHEMBL622460,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Time for maximum plasma concentration determined in rat,,7984,1,,,4576,,Plasma,N,50597,CHEMBL622461,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,7985,1,,,6681,,Plasma,N,50597,CHEMBL622462,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,7986,1,,,16365,,,N,50597,CHEMBL622463,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,7987,1,,,16365,,,N,50597,CHEMBL622464,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,7988,1,,,16365,,,N,50597,CHEMBL622465,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,7989,1,,,16365,,,N,50597,CHEMBL622466,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,7990,1,,,16365,,,N,50597,CHEMBL622467,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Time of maximum plasma concentration in rat,,7991,1,,,6824,,Plasma,N,50597,CHEMBL622468,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,7992,1,,,6685,,Plasma,N,50597,CHEMBL876025,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,7993,1,,,6685,,Plasma,N,50597,CHEMBL622469,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,7994,1,,,6685,,Plasma,N,50597,CHEMBL622470,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time required to reach maximum concentration (Cmax) after oral administration in rat,,7995,1,,,15662,,,N,50597,CHEMBL622471,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Time required to reach maximum concentration in rat plasma,,7996,1,,,1742,,Plasma,N,50597,CHEMBL622472,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,7997,1,,,2774,,Plasma,N,50597,CHEMBL622473,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,7998,1,,,5199,,Plasma,N,50597,CHEMBL624282,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,7999,1,,,12873,,Plasma,N,50597,CHEMBL624283,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,8000,1,,,12873,,Plasma,N,50597,CHEMBL624284,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,8001,1,,,1916,,Plasma,N,50597,CHEMBL624285,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time to reach Cmax after oral administration to rats,,8002,1,,,16367,,,N,50597,CHEMBL624286,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,8003,1,,,16366,,,N,50597,CHEMBL624287,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,8004,1,,,216,,,N,50597,CHEMBL624288,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,8005,1,,,6410,,Plasma,N,50597,CHEMBL624289,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,8006,1,,,6410,,Plasma,N,50597,CHEMBL873344,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax after peroral administration (10 mg/kg) was determined in rat,,8007,1,,,6215,,,N,50597,CHEMBL619623,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,8008,1,,,3598,,,N,50597,CHEMBL621399,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,8009,1,,,4527,,,N,50597,CHEMBL621400,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,8010,1,,,17670,,,N,50597,CHEMBL621401,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tmax was determined,,8011,1,,,1465,,,N,50597,CHEMBL621402,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tmax was determined,,8012,1,,,2552,,,N,50597,CHEMBL621403,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax after oral administration in rat,,8013,1,,,5656,,,N,50597,CHEMBL621121,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax after peroral administration in rats at 2.4 uM/kg,,8014,1,,,17764,,,N,50597,CHEMBL872525,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tmax in male rat,,8015,1,,,5610,,,N,50597,CHEMBL621122,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax in rat at 10 mg/kg,,8016,1,,,6046,,,N,50597,CHEMBL621123,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax in rat by po administration at a dose of 40 mg/kg,,8017,1,,,5874,,,N,50597,CHEMBL621124,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tmax in rats,,8018,1,,,17596,,,N,50597,CHEMBL621125,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax was measured in rats after peroral administration at 5 mg/kg,,8019,1,,,17804,,,N,50597,CHEMBL621126,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,8020,1,,,1908,,,N,50597,CHEMBL621127,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax value after administration of 20 mg/Kg oral dose in rat,,8021,1,,,2959,,,N,50597,CHEMBL621128,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax value at a dose of 10 mg/kg in male SD rats,,8022,1,,,6757,,,N,50597,CHEMBL618263,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax value at a dose of 100 mg/kg in male SD rats,,8023,1,,,6757,,,N,50597,CHEMBL618264,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax value at a dose of 50 mg/kg in male SD rats,,8024,1,,,6757,,,N,50597,CHEMBL618265,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,8025,1,,,4186,,Plasma,N,50597,CHEMBL618266,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,time required to reach maximum concentration (Cmax) after oral administration in rat,,8026,1,,,15662,,,N,50597,CHEMBL618267,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,8027,1,,,429,,Urine,N,50597,CHEMBL618450,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,8028,1,,,429,,Urine,N,50597,CHEMBL618451,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,8029,1,,,5546,,,N,50597,CHEMBL618452,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,8030,1,,,3173,,Urine,N,50597,CHEMBL618453,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,8031,1,,,3173,,Urine,N,50597,CHEMBL618454,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,8032,1,,,3173,,Urine,N,50597,CHEMBL618455,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,8033,1,,,4257,,,N,50597,CHEMBL618456,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound distribution in rat tissues was determined,,8034,1,,,6011,,,N,50597,CHEMBL618457,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was evaluated in rat,,8035,1,,,5472,,,N,50597,CHEMBL618458,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,8036,1,,,14346,,,N,50597,CHEMBL618459,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,8037,1,,,14346,,,N,50597,CHEMBL876733,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,8038,1,,,14346,,,N,50588,CHEMBL618460,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,8039,1,,,14346,,,N,50597,CHEMBL618461,BAO_0000218,
A,Autocuration,1,,,,,,,Area under the curve was determined after oral administration (300 uM/Kg),,8040,0,,,15469,,,U,22224,CHEMBL618462,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,8041,1,,,14346,,,N,50597,CHEMBL618463,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,8042,1,,,14346,,,N,50597,CHEMBL618464,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,8043,1,,,14346,,,N,50597,CHEMBL618465,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,8044,1,,,14346,,,N,50597,CHEMBL618466,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,8045,1,,,14346,,,N,50597,CHEMBL618467,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,8046,1,,,15372,,,N,50597,CHEMBL618468,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,8047,1,,,12935,,Plasma,N,50588,CHEMBL618469,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,8048,1,,,12935,,Plasma,N,50588,CHEMBL618470,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Plasma drug AUC in rat (PO dose),,8049,0,,,14813,,,U,22224,CHEMBL618471,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,8050,1,,,15792,,,N,50594,CHEMBL618472,BAO_0000218,
A,Autocuration,1,,,,,,,Area under was determined at a dose of 30 mg/kg,,8051,0,,,3579,,,U,22224,CHEMBL618473,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,8052,1,,,12487,,,N,50506,CHEMBL621699,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,8053,1,,,12487,,,N,50597,CHEMBL621700,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,8054,1,,,12487,,,N,50597,CHEMBL621701,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,8055,1,,,12487,,,N,50506,CHEMBL621702,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,8056,1,,,12487,,,N,50588,CHEMBL621703,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,8057,1,,,12487,,,N,50588,CHEMBL621704,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,8058,1,,,12902,,,N,50597,CHEMBL624259,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,8059,1,,,12902,,,N,50597,CHEMBL624260,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,8060,1,,,12902,,,N,50597,CHEMBL624430,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,8061,1,,,12902,,,N,50597,CHEMBL624431,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,8062,1,,,12902,,,N,50597,CHEMBL624432,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,8063,1,,,12902,,,N,50597,CHEMBL624433,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,8064,1,,,12902,,,N,50597,CHEMBL624434,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,8065,1,,,12902,,,N,50597,CHEMBL624435,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,8066,1,,,12745,,,N,50594,CHEMBL618570,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8067,1,,,12745,,,N,50594,CHEMBL618571,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,8068,1,,,12745,,,N,50594,CHEMBL618572,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8069,1,,,12745,,,N,50594,CHEMBL618573,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,8070,1,,,12745,,,N,50594,CHEMBL619267,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8071,1,,,12745,,,N,50594,CHEMBL619431,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,8072,1,,,12745,,,N,50594,CHEMBL619432,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,8073,1,,,12745,,,N,50594,CHEMBL619433,BAO_0000218,
A,Autocuration,1,,,,,,,AUC in mice after oral dose (50 mg/kg),,8074,0,,,13298,,Plasma,U,22224,CHEMBL619434,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,8075,1,,,12226,,Serum,N,50594,CHEMBL619435,BAO_0000218,1977.0
A,Autocuration,1,,,,,,,AUC (0-4 hr) ug/ml/h,,8076,0,,,12634,,Plasma,U,22224,CHEMBL619436,BAO_0000019,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,8077,1,,,14810,,,N,50597,CHEMBL619437,BAO_0000218,
A,Autocuration,1,,,,,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,8078,0,,,13889,,,U,22224,CHEMBL619438,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated for Area under curve in mice,,8079,1,,,10018,,,N,50594,CHEMBL619439,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8080,1,,,8758,,,N,50597,CHEMBL619440,BAO_0000218,
F,Autocuration,1,,,,,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8081,0,,,8758,,,U,22224,CHEMBL619441,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8082,1,,,8758,,,N,50597,CHEMBL619442,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,8083,0,,,2249,,,U,22224,CHEMBL875156,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,8084,0,,,2249,,,U,22224,CHEMBL619443,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,8085,0,,,2249,,,U,22224,CHEMBL619444,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,8086,0,,,2249,,,U,22224,CHEMBL623464,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated for area under curve when administered through oral route in mouse,,8087,1,,,15115,,,N,50594,CHEMBL623465,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,8088,1,,,6518,,,N,50597,CHEMBL623466,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,8089,1,,,6518,,,N,50597,CHEMBL623467,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,8090,1,,,6249,,,N,50597,CHEMBL623468,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,8091,1,,,2463,,,N,50597,CHEMBL622660,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance rate in Sprague-Dawley rats,,8092,1,,,4969,,,N,50597,CHEMBL622661,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,8093,1,,,17720,,,N,50597,CHEMBL622662,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (total body clearance) in rat,,8094,1,,,3457,,,N,50597,CHEMBL622663,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,8095,1,,,5983,,,N,50597,CHEMBL622664,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,8096,1,,,6295,,,N,50597,CHEMBL622665,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,8097,1,,,6296,,,N,50597,CHEMBL622666,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cl in rat i.v. at 2 mg/kg concentration,,8098,1,,,17686,,,N,50597,CHEMBL621615,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance of compound after intravenous administration in rats at 24 uM/kg,,8099,1,,,17764,,,N,50597,CHEMBL621616,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance was determined,,8100,1,,,5503,,,N,50597,CHEMBL621617,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance by intravenous administration of 3.4 mg/kg in rat,,8101,1,,,4368,,,N,50597,CHEMBL621618,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,8102,1,,,6005,,,N,50597,CHEMBL621619,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate after i.v. administration in rats,,8103,1,,,5031,,,N,50597,CHEMBL621620,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,8104,1,,,4890,,,N,50597,CHEMBL621786,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,8105,1,,,5182,,,N,50597,CHEMBL621787,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,8106,1,,,5979,,,N,50597,CHEMBL621788,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance (Cl) after oral administration in rat,,8107,1,,,5656,,,N,50597,CHEMBL621789,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,8108,1,,,17804,,,N,50597,CHEMBL621790,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for plasma clearance in rat,,8109,1,,,4839,,Plasma,N,50597,CHEMBL621791,BAO_0000218,1969.0
A,Intermediate,1,,Microsomes,Rattus norvegicus,In vitro,,10116.0,In vitro microsome metabolism clearance in rat was determined,,8110,1,,,5041,,,N,50597,CHEMBL621792,BAO_0000218,
A,Intermediate,1,,Microsomes,Rattus norvegicus,In vitro,,10116.0,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,8111,1,,,5041,,,N,50597,CHEMBL621793,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,8112,1,,,5974,,,N,50597,CHEMBL621794,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo plasma clearance was determined,,8113,1,,,5496,,Plasma,N,50597,CHEMBL621795,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,8114,1,,,5739,,,N,50597,CHEMBL621796,BAO_0000218,
A,Intermediate,1,401.0,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,8115,1,,,5676,Hepatocyte,Liver,N,50597,CHEMBL621797,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Plasma clearance) was measured in rat,,8116,1,,,4239,,,N,50597,CHEMBL621798,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (clearance) in rat i.v.,,8117,1,,,5676,,,N,50597,CHEMBL621799,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Plasma Clearance was evaluated in rats, iv",,8118,1,,,1918,,,N,50597,CHEMBL621800,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance (in vivo) in rats was determined,,8119,1,,,17800,,,N,50597,CHEMBL621801,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,8120,1,,,6056,,,N,50597,CHEMBL621802,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined,,8121,1,,,5496,,,N,50597,CHEMBL618596,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,8122,1,,,5939,,,N,50597,CHEMBL618597,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,8123,1,,,5939,,,N,50597,CHEMBL618598,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rats,,8124,1,,,17752,,,N,50597,CHEMBL618599,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance rate determined in rat,,8125,1,,,4576,,,N,50597,CHEMBL618600,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined in rat,,8126,1,,,6011,,,N,50597,CHEMBL618601,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined,,8127,1,,,5510,,,N,50597,CHEMBL618602,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance value in rat,,8128,1,,,5948,,,N,50597,CHEMBL618603,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,Ex vivo,,10116.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,8129,1,,,6125,,Liver,N,50597,CHEMBL618604,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in rat,,8130,1,,,4839,,,N,50597,CHEMBL618605,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total body clearance in rat i.v. at 2 mg/kg concentration,,8131,1,,,17686,,,N,50597,CHEMBL618606,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance of compound in rats after intravenous administration,,8132,1,,,6571,,,N,50597,CHEMBL618607,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance after iv administration to rats,,8133,1,,,3364,,,N,50597,CHEMBL618608,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,8134,1,,,13569,,,N,50597,CHEMBL618609,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,8135,1,,,13569,,,N,50597,CHEMBL618610,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,8136,1,,,13569,,,N,50597,CHEMBL618611,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,8137,1,,,13569,,,N,50597,CHEMBL618612,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,8138,1,,,13569,,,N,50597,CHEMBL618613,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,8139,1,,,13569,,,N,50597,CHEMBL621076,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,8140,1,,,13569,,,N,50597,CHEMBL621077,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,8141,1,,,17670,,,N,50597,CHEMBL621078,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in rat,,8142,1,,,5970,,,N,50597,CHEMBL621251,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in rat after oral administration at 10 mg/kg,,8143,1,,,6495,,,N,50597,CHEMBL621252,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in rat.,,8144,1,,,4590,,,N,50597,CHEMBL621253,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate following an oral dose of 20 mg/kg in rats,,8145,1,,,6193,,,N,50597,CHEMBL621254,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,8146,1,,,2832,,,N,50597,CHEMBL621255,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,8147,1,,,1052,,Plasma,N,50597,CHEMBL621256,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,8148,1,,,9866,,Liver,N,50597,CHEMBL621257,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,8149,1,,,9866,,Liver,N,50597,CHEMBL621258,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,8150,1,,,9866,,Liver,N,50597,CHEMBL621259,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,8151,1,,,9866,,Liver,N,50597,CHEMBL621260,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,8152,1,,,9866,,Liver,N,50597,CHEMBL876494,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,8153,1,,,9866,,Liver,N,50597,CHEMBL621261,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,8154,1,,,9866,,Liver,N,50597,CHEMBL621262,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,8155,1,,,9866,,Liver,N,50597,CHEMBL621263,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,8156,1,,,9866,,Liver,N,50597,CHEMBL621264,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,8157,1,,,9866,,Muscle tissue,N,50597,CHEMBL621265,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,8158,1,,,9866,,Muscle tissue,N,50597,CHEMBL621266,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,8159,1,,,9866,,Muscle tissue,N,50597,CHEMBL621267,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,8160,1,,,9866,,Muscle tissue,N,50597,CHEMBL621268,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,8161,1,,,9866,,Muscle tissue,N,50597,CHEMBL621269,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,8162,1,,,9866,,Muscle tissue,N,50597,CHEMBL621270,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,8163,1,,,9866,,Muscle tissue,N,50597,CHEMBL621271,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,8164,1,,,9866,,Muscle tissue,N,50597,CHEMBL621272,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,8165,1,,,9866,,Muscle tissue,N,50597,CHEMBL621273,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,8166,1,,,9866,,Muscle tissue,N,50597,CHEMBL621274,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,8167,1,,,9866,,Muscle tissue,N,50597,CHEMBL876495,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,8168,1,,,9866,,Muscle tissue,N,50597,CHEMBL621275,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,8169,1,,,9866,,Muscle tissue,N,50597,CHEMBL621276,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,8170,1,,,9866,,Muscle tissue,N,50597,CHEMBL621277,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,8171,1,,,9866,,Intestine,N,50597,CHEMBL621278,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,8172,1,,,9866,,Intestine,N,50597,CHEMBL621279,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,8173,1,,,9866,,Intestine,N,50597,CHEMBL621280,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,8174,1,,,9866,,Spleen,N,50597,CHEMBL621281,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,8175,1,,,9866,,Spleen,N,50597,CHEMBL621282,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,8176,1,,,9866,,Spleen,N,50597,CHEMBL621283,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,8177,1,,,9866,,Spleen,N,50597,CHEMBL621284,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,8178,1,,,9866,,Spleen,N,50597,CHEMBL621285,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,8179,1,,,9866,,Spleen,N,50597,CHEMBL621286,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,8180,1,,,9866,,Spleen,N,50597,CHEMBL623220,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,8181,1,,,9866,,Spleen,N,50597,CHEMBL623221,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,8182,1,,,9866,,Spleen,N,50597,CHEMBL876029,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,8183,1,,,9866,,Stomach,N,50597,CHEMBL623222,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,8184,1,,,9866,,Stomach,N,50597,CHEMBL623223,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,8185,1,,,9866,,Stomach,N,50597,CHEMBL621445,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8186,1,,,13950,,Blood,N,50597,CHEMBL621446,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8187,1,,,13950,,Blood,N,50597,CHEMBL621447,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8188,1,,,13950,,Blood,N,50597,CHEMBL619681,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8189,1,,,13950,,Blood,N,50597,CHEMBL619682,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8190,1,,,13950,,Blood,N,50597,CHEMBL619683,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8191,1,,,13950,,Brain,N,50597,CHEMBL619684,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8192,1,,,13950,,Brain,N,50597,CHEMBL619685,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8193,1,,,13950,,Brain,N,50597,CHEMBL619686,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8194,1,,,13950,,Brain,N,50597,CHEMBL619687,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8195,1,,,13950,,Brain,N,50597,CHEMBL619688,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8196,1,,,13950,,Heart,N,50597,CHEMBL619689,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8197,1,,,13950,,Heart,N,50597,CHEMBL619690,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8198,1,,,13950,,Heart,N,50597,CHEMBL619691,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,8199,1,,,6062,,,N,50597,CHEMBL619692,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,,,10116.0,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,8200,1,,,3598,,,N,50597,CHEMBL619693,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vc value after IV dose at a dose of 5 mg/kg in rats.,,8201,1,,,1908,,,N,50597,CHEMBL619694,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,8202,1,,,17596,,,N,50597,CHEMBL619695,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for pharmacokinetic parameter volume of distribution,,8203,1,,,4891,,,N,50597,CHEMBL619696,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for volume of distribution in rat,,8204,1,,,740,,,N,50597,CHEMBL619697,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume distribution was determined; steady state(ss),,8205,1,,,16366,,,N,50597,CHEMBL619698,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume of distribution after iv administration to rats,,8206,1,,,3364,,,N,50597,CHEMBL619699,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume of distribution dosing at 3 mg/kg iv,,8207,1,,,2552,,,N,50597,CHEMBL619700,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was evaluated for volume of distribution in rat,,8208,1,,,406,,,N,50597,CHEMBL619701,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for volume of distribution in rat,,8209,1,,,12500,,,N,50597,CHEMBL619702,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,8210,1,,,12500,,,N,50597,CHEMBL620335,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution (VD) after oral administration in rat,,8211,1,,,5656,,,N,50597,CHEMBL620336,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,8212,1,,,17671,,,N,50597,CHEMBL620337,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat,,8213,1,,,1094,,,N,50597,CHEMBL620520,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat,,8214,1,,,5833,,,N,50597,CHEMBL620521,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat after peroral administration at 10 mg/kg,,8215,1,,,5939,,,N,50597,CHEMBL875825,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat after peroral administration at 5 mg/kg,,8216,1,,,5939,,,N,50597,CHEMBL620522,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,8217,1,,,6005,,,N,50597,CHEMBL620523,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rat.,,8218,1,,,1696,,,N,50597,CHEMBL620524,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rat,,8219,1,,,6672,,,N,50597,CHEMBL620525,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rat,,8220,1,,,6673,,,N,50597,CHEMBL620526,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rat by iv administration,,8221,1,,,5871,,,N,50597,CHEMBL620527,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rats,,8222,1,,,6803,,,N,50597,CHEMBL620528,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,8223,1,,,5199,,,N,50597,CHEMBL620529,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Volume distribution at the dose of 2 mg/kg in rat,,8224,1,,,4727,,,N,50597,CHEMBL620530,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume of distribution was determined,,8225,1,,,16367,,,N,50597,CHEMBL620531,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,8226,0,,,5005,,,U,22224,CHEMBL620532,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,8227,0,,,5005,,,U,22224,CHEMBL620533,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,8228,0,,,5005,,,U,22224,CHEMBL620534,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Mean (%CV) PK parameters for Vdss(mL/kg).,,8229,1,,,15765,,,N,50597,CHEMBL620535,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,8230,1,,,2792,,,N,50597,CHEMBL875826,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,8231,1,,,2792,,,N,50597,CHEMBL620536,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,8232,1,,,5334,,,N,50597,CHEMBL620537,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,8233,1,,,5334,,,N,50597,CHEMBL618526,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,8234,1,,,5739,,,N,50597,CHEMBL618527,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Vdss) in rat,,8235,1,,,5789,,,N,50597,CHEMBL618528,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (vdss) was measured in rat,,8236,1,,,4239,,,N,50597,CHEMBL618529,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,8237,1,,,4709,,,N,50597,CHEMBL618530,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rat,,8238,1,,,6642,,,N,50597,CHEMBL618531,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The pharmacokinetic parameter volume of distribution in vivo in rats,,8239,1,,,5247,,,N,50597,CHEMBL618532,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,8240,1,,,17720,,,N,50597,CHEMBL618533,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vdss in rat i.v. at 2 mg/kg concentration,,8241,1,,,17686,,,N,50597,CHEMBL618534,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution after intravenous administration (1 mg/kg) in rat,,8242,1,,,4689,,,N,50597,CHEMBL618535,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,8243,1,,,5654,,,N,50597,CHEMBL618536,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,8244,1,,,5654,,,N,50597,CHEMBL618537,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution at a dose of 10 uM/kg in rat was determined,,8245,1,,,4527,,,N,50597,CHEMBL618538,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,8246,1,,,4521,,,N,50597,CHEMBL618539,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution was calculated in rat,,8247,1,,,6057,,,N,50597,CHEMBL618540,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution was determined,,8248,1,,,5510,,,N,50597,CHEMBL618541,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution after intravenous administration was evaluated in rat,,8249,1,,,2938,,,N,50597,CHEMBL618542,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,8250,1,,,6679,,,N,50597,CHEMBL622544,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,8251,1,,,6685,,,N,50597,CHEMBL622545,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,8252,1,,,6685,,,N,50597,CHEMBL622546,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,8253,1,,,6685,,,N,50597,CHEMBL622547,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in steady state was determined in rat,,8254,1,,,5145,,,N,50597,CHEMBL622548,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,8255,1,,,6467,,,N,50597,CHEMBL622549,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,8256,1,,,6467,,,N,50597,CHEMBL622550,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated for area under curve when administered through oral route to mouse,,8257,1,,,15115,,,N,50594,CHEMBL622551,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8258,1,,,8758,,,N,50597,CHEMBL622552,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8259,1,,,8758,,,N,50597,CHEMBL622553,BAO_0000218,
F,Autocuration,1,,,,In vivo,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,8260,0,,,8267,,,U,22224,CHEMBL622554,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,8261,1,,,8267,,,N,50588,CHEMBL622555,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,8262,1,,,14239,,,N,50594,CHEMBL622556,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,8263,1,,,14239,,,N,50594,CHEMBL622557,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,8264,1,,,10754,,Blood,N,50594,CHEMBL622558,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,8265,1,,,10754,,Blood,N,50594,CHEMBL622559,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,8266,1,,,10754,,,N,50588,CHEMBL622560,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,8267,1,,,14681,,,N,50597,CHEMBL622561,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,8268,1,,,14681,,,N,50597,CHEMBL622562,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,8269,1,,,14681,,,N,50597,CHEMBL622563,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of compound in Central nervous system,,8270,0,,,13118,,,U,22224,CHEMBL622564,BAO_0000019,
A,Autocuration,1,,,,,,,Concentration of compound in Central nervous system; Not detectable,,8271,0,,,13118,,,U,22224,CHEMBL622565,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Concentration of diester in the blood, following oral administration in mice",,8272,1,,,13318,,,N,50594,CHEMBL622566,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Concentration of monoester in the blood, following oral administration in mice",,8273,1,,,13318,,,N,50594,CHEMBL624515,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,8274,1,,,13318,,,N,50594,CHEMBL624516,BAO_0000218,
A,Autocuration,1,,,,,,,Evaluated for Pharmacokinetic property: Area under the curve,,8275,0,,,15692,,,U,22224,CHEMBL624517,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,8276,1,,,14839,,,N,50594,CHEMBL624518,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,8277,1,,,14839,,,N,100710,CHEMBL624519,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,8278,1,,,14839,,,N,100710,CHEMBL624520,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,8279,1,,,14839,,,N,100710,CHEMBL624521,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,8280,1,,,14839,,,N,100710,CHEMBL624522,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,8281,1,,,14839,,,N,100710,CHEMBL624523,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,8282,1,,,14839,,,N,100710,CHEMBL624409,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,8283,1,,,14839,,,N,100710,CHEMBL624410,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,8284,1,,,14839,,,N,100710,CHEMBL624411,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,8285,1,,,14839,,,N,100710,CHEMBL623531,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,8286,1,,,14839,,,N,100710,CHEMBL623532,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,8287,1,,,14839,,,N,100710,CHEMBL623533,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,8288,1,,,14839,,,N,100710,CHEMBL623534,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,8289,1,,,14839,,,N,50594,CHEMBL623535,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,8290,1,,,14839,,,N,50594,CHEMBL623536,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,8291,1,,,14839,,,N,50594,CHEMBL623537,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,8292,1,,,14839,,,N,50594,CHEMBL623538,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,8293,1,,,14839,,,N,50594,CHEMBL623539,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,8294,1,,,14839,,,N,50594,CHEMBL623540,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,8295,1,,,14839,,,N,50594,CHEMBL623541,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,8296,1,,,14839,,,N,50594,CHEMBL623542,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,8297,1,,,14839,,,N,50594,CHEMBL623543,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,8298,1,,,14839,,,N,50594,CHEMBL623544,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,8299,1,,,14839,,,N,50594,CHEMBL623545,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,8300,1,,,14839,,,N,50594,CHEMBL623546,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,8301,1,,,5408,,Plasma,N,50597,CHEMBL623547,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,High i.v. clearance in Dawley rats,,8302,1,,,6827,,,N,50597,CHEMBL623548,BAO_0000218,
A,Intermediate,1,,Microsomes,Rattus norvegicus,In vitro,,10116.0,In vitro clearance in rat liver microsomes,,8303,1,,,17538,,Liver,N,50597,CHEMBL623549,BAO_0000218,2107.0
A,Intermediate,1,,Microsomes,Rattus norvegicus,In vitro,,10116.0,Intrinsic clearance in rat liver microsomes was determined,,8304,1,,,6331,,Liver,N,50597,CHEMBL623550,BAO_0000218,2107.0
A,Intermediate,1,401.0,,Rattus norvegicus,In vitro,,10116.0,Intrinsic clearance in rat hepatocytes was determined,,8305,1,,,5948,Hepatocyte,Liver,N,50597,CHEMBL875276,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma Clearance was determined,,8306,1,,,4026,,,N,50597,CHEMBL621872,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,8307,1,,,6647,,,N,50597,CHEMBL621873,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat.,,8308,1,,,1696,,,N,50597,CHEMBL621874,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rats,,8309,1,,,6597,,,N,50597,CHEMBL621875,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,8310,1,,,347,,,N,50597,CHEMBL621876,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,8311,1,,,16423,,,N,50597,CHEMBL621877,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was measured in rat,,8312,1,,,2879,,,N,50597,CHEMBL621878,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,8313,1,,,4883,,,N,50597,CHEMBL621879,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,8314,1,,,5328,,Plasma,N,50597,CHEMBL621880,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,8315,1,,,5160,,,N,50597,CHEMBL621881,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,8316,1,,,17582,,,N,50597,CHEMBL621882,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total clearance at 1 mg/kg was determined in rat,,8317,1,,,17651,,,N,50597,CHEMBL875283,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total clearance at 10 mg/kg was determined in rat,,8318,1,,,17651,,,N,50597,CHEMBL621883,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in rat,,8319,1,,,6596,,,N,50597,CHEMBL621884,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance rate determined in rats,,8320,1,,,4796,,,N,50597,CHEMBL621885,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance of compound in rat was evaluated,,8321,1,,,6850,,,N,50597,CHEMBL621886,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,8322,1,,,5932,,Plasma,N,50597,CHEMBL621887,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (blood clearance) in rat,,8323,1,,,3371,,,N,50597,CHEMBL621888,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,8324,1,,,2083,,,N,50597,CHEMBL621889,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rats,,8325,1,,,4942,,,N,50597,CHEMBL621890,BAO_0000218,
A,Intermediate,1,,Microsomes,Rattus norvegicus,In vitro,,10116.0,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,8326,1,,,6838,,Liver,N,50597,CHEMBL621891,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in Dawley rat,,8327,1,,,5353,,,N,50597,CHEMBL621892,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rat,,8328,1,,,6641,,,N,50597,CHEMBL621893,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,8329,1,,,6641,,,N,50597,CHEMBL621894,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rat; Not determined,,8330,1,,,6641,,,N,50597,CHEMBL621895,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,8331,1,,,6444,,,N,50597,CHEMBL875284,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,8332,1,,,6444,,,N,50597,CHEMBL618699,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,8333,1,,,6444,,,N,50597,CHEMBL618700,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,8334,1,,,6211,,,N,50597,CHEMBL618701,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,8335,1,,,12873,,Plasma,N,50597,CHEMBL876600,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance of compound in rat after 1 mg/kg i.v. administration,,8336,1,,,6570,,,N,50597,CHEMBL618702,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for Hepatic clearance in rat,,8337,1,,,3341,,,N,50597,CHEMBL618703,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo clearance after 5 mg/kg dose,,8338,1,,,4891,,,N,50597,CHEMBL618704,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for plasma clearance in rats,,8339,1,,,1094,,Plasma,N,50597,CHEMBL618705,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Hepatic clearance after intravenous administration was evaluated in rat,,8340,1,,,2938,,,N,50597,CHEMBL618706,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Lower clearance in rat (i.v.) at 0.5 mpk,,8341,1,,,17853,,,N,50597,CHEMBL618707,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter expressed as plasma clearance in rat,,8342,1,,,6049,,Plasma,N,50597,CHEMBL618708,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Clp) in rat,,8343,1,,,5789,,,N,50597,CHEMBL618709,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in Sprague-Dawley rats,,8344,1,,,4514,,,N,50597,CHEMBL618710,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance (Clp) in rat,,8345,1,,,6448,,,N,50597,CHEMBL618711,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,8346,1,,,6062,,,N,50597,CHEMBL618712,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,8347,1,,,5710,,,N,50597,CHEMBL618713,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after intravenous administration of 1 mg/kg in rat,,8348,1,,,4709,,,N,50597,CHEMBL618714,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,8349,1,,,4521,,,N,50597,CHEMBL618715,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat was determined,,8350,1,,,1742,,,N,50597,CHEMBL618716,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance measured in rat,,8351,1,,,6057,,,N,50597,CHEMBL876601,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was calculated in rat,,8352,1,,,6057,,,N,50597,CHEMBL618717,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,8353,1,,,5145,,,N,50597,CHEMBL618718,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,8354,1,,,5833,,,N,50597,CHEMBL618719,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,8355,1,,,6453,,,N,50597,CHEMBL618720,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,8356,1,,,6640,,,N,50597,CHEMBL618721,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rats,,8357,1,,,6305,,,N,50597,CHEMBL621477,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,8358,1,,,6642,,,N,50597,CHEMBL621478,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was evaluated in rat,,8359,1,,,5472,,,N,50597,CHEMBL621479,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was evaluated in rat; Not tested,,8360,1,,,5472,,,N,50597,CHEMBL621480,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance rate was determined for the compound in rat,,8361,1,,,5144,,,N,50597,CHEMBL621481,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,8362,1,,,6685,,,N,50597,CHEMBL621482,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,8363,1,,,6685,,,N,50597,CHEMBL621483,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,8364,1,,,6685,,,N,50597,CHEMBL621484,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8365,1,,,13950,,Heart,N,50597,CHEMBL621485,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8366,1,,,13950,,Heart,N,50597,CHEMBL621486,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8367,1,,,13950,,Intestine,N,50597,CHEMBL621487,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8368,1,,,13950,,Intestine,N,50597,CHEMBL621488,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8369,1,,,13950,,Intestine,N,50597,CHEMBL621489,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8370,1,,,13950,,Intestine,N,50597,CHEMBL621490,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8371,1,,,13950,,Intestine,N,50597,CHEMBL621491,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8372,1,,,13950,,Kidney,N,50597,CHEMBL621492,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,8373,1,,,13950,,Kidney,N,50597,CHEMBL621493,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8374,1,,,13950,,Kidney,N,50597,CHEMBL621494,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8375,1,,,13950,,Kidney,N,50597,CHEMBL621495,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8376,1,,,13950,,Kidney,N,50597,CHEMBL621496,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8377,1,,,13950,,Liver,N,50597,CHEMBL621497,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8378,1,,,13950,,Liver,N,50597,CHEMBL621498,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8379,1,,,13950,,Liver,N,50597,CHEMBL621499,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,8380,1,,,13950,,Liver,N,50597,CHEMBL618634,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8381,1,,,13950,,Liver,N,50597,CHEMBL618635,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8382,1,,,13950,,Lung,N,50597,CHEMBL618636,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8383,1,,,13950,,Lung,N,50597,CHEMBL619737,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8384,1,,,13950,,Lung,N,50597,CHEMBL619738,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8385,1,,,13950,,Lung,N,50597,CHEMBL624329,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8386,1,,,13950,,Lung,N,50597,CHEMBL624330,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8387,1,,,13950,,Muscle tissue,N,50597,CHEMBL624331,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8388,1,,,13950,,Muscle tissue,N,50597,CHEMBL624332,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8389,1,,,13950,,Muscle tissue,N,50597,CHEMBL624333,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8390,1,,,13950,,Muscle tissue,N,50597,CHEMBL624334,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8391,1,,,13950,,Muscle tissue,N,50597,CHEMBL624335,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8392,1,,,13950,,Spleen,N,50597,CHEMBL620016,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,8393,1,,,13950,,Spleen,N,50597,CHEMBL620169,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8394,1,,,13950,,Spleen,N,50597,CHEMBL620170,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,8395,1,,,13950,,Spleen,N,50597,CHEMBL620171,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8396,1,,,13950,,Spleen,N,50597,CHEMBL620172,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,8397,1,,,13950,,Stomach,N,50597,CHEMBL620173,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,8398,1,,,13950,,Stomach,N,50597,CHEMBL620174,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,8399,1,,,13950,,Stomach,N,50597,CHEMBL620175,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,8400,1,,,13950,,Stomach,N,50597,CHEMBL620176,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,8401,1,,,13950,,Stomach,N,50597,CHEMBL620177,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8402,1,,,13950,,Cerebellum,N,50597,CHEMBL620178,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8403,1,,,13950,,Cerebellum,N,50597,CHEMBL620179,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8404,1,,,13950,,,N,50597,CHEMBL620180,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,8405,1,,,6570,,,N,50597,CHEMBL620181,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution of compound in rats after intravenous administration,,8406,1,,,6571,,,N,50597,CHEMBL620182,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rat,,8407,1,,,6453,,,N,50597,CHEMBL620183,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,8408,1,,,6444,,,N,50597,CHEMBL620184,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,8409,1,,,6444,,,N,50597,CHEMBL620185,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,8410,1,,,6444,,,N,50597,CHEMBL620186,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was determined in Dawley rat,,8411,1,,,5353,,,N,50597,CHEMBL620187,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,8412,1,,,5334,,,N,50597,CHEMBL620188,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was reported in Sprague-Dawley rat,,8413,1,,,5334,,,N,50597,CHEMBL620189,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volumes of distribution in rat after peroral administration,,8414,1,,,6641,,,N,50597,CHEMBL620190,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volumes of distribution in rat after po administration,,8415,1,,,6641,,,N,50597,CHEMBL620191,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volumes of distribution in rat after po administration; Not determined,,8416,1,,,6641,,,N,50597,CHEMBL620192,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Volume) in rat i.v.,,8417,1,,,5676,,,N,50597,CHEMBL620193,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,8418,1,,,6410,,,N,50597,CHEMBL620194,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,8419,1,,,17670,,,N,50597,CHEMBL876730,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat after oral administration at 10 mg/kg,,8420,1,,,6495,,,N,50597,CHEMBL620195,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,8421,1,,,5408,,,N,50597,CHEMBL620196,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,8422,1,,,4883,,,N,50597,CHEMBL620197,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,8423,1,,,6647,,,N,50597,CHEMBL620198,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rats,,8424,1,,,6495,,,N,50597,CHEMBL620199,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,8425,1,,,2661,,,N,50597,CHEMBL620200,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,8426,1,,,2661,,,N,50597,CHEMBL620201,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,8427,1,,,5974,,,N,50597,CHEMBL620202,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,8428,1,,,5974,,,N,50597,CHEMBL620203,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,8429,1,,,5974,,,N,50597,CHEMBL620204,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,8430,1,,,5974,,,N,50597,CHEMBL620205,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (Vss) in rat,,8431,1,,,5960,,,N,50597,CHEMBL624664,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Volume) in rat i.v.,,8432,1,,,5676,,,N,50597,CHEMBL624665,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property (Vss) in rat,,8433,1,,,5948,,,N,50597,CHEMBL624666,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,8434,1,,,5979,,,N,50597,CHEMBL624667,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,8435,1,,,5978,,,N,50597,CHEMBL624668,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,8436,1,,,5978,,,N,50597,CHEMBL624669,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,8437,1,,,5978,,,N,50597,CHEMBL624670,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,8438,1,,,5978,,,N,50597,CHEMBL624671,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume distribution in rat,,8439,1,,,6448,,,N,50597,CHEMBL624672,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,8440,1,,,12873,,Plasma,N,50597,CHEMBL624673,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady state volume of distribution determined in rat,,8441,1,,,4576,,,N,50597,CHEMBL624674,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,8442,1,,,17582,,,N,50597,CHEMBL624675,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,8443,1,,,1466,,,N,50597,CHEMBL621728,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,8444,1,,,5182,,,N,50597,CHEMBL621729,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,8445,1,,,5182,,,N,50597,CHEMBL621730,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat after administration of 2 mg/kg iv,,8446,1,,,6535,,,N,50597,CHEMBL621731,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rat after administration of 2 mg/kg iv,,8447,1,,,6535,,,N,50597,CHEMBL621732,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume in steady state distribution value was determined,,8448,1,,,5041,,,N,50597,CHEMBL621908,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume in steady state distribution value was determined; ND denotes no data,,8449,1,,,5041,,,N,50597,CHEMBL875347,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume in steady state distribution value was determined; ND denotes not determined,,8450,1,,,5041,,,N,50597,CHEMBL621909,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,8451,1,,,17065,,,N,50597,CHEMBL621910,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution at steady state was evaluated in rats,,8452,1,,,6597,,,N,50597,CHEMBL621911,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution at steady state was observed after intravenous administration in rat,,8453,1,,,15662,,,N,50597,CHEMBL621912,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in steady state was determined in rat,,8454,1,,,6485,,,N,50597,CHEMBL621913,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in steady state was determined in rat,,8455,1,,,17655,,,N,50597,CHEMBL621914,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution after i.v. administration,,8456,1,,,6616,,,N,50597,CHEMBL621915,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,8457,1,,,1916,,,N,50597,CHEMBL621916,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,8458,1,,,16438,,Liver,N,50594,CHEMBL621917,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,8459,1,,,16438,,Liver,N,50594,CHEMBL621918,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of compound (oxidized form) in spleen tissue,,8460,1,,,16438,,Spleen,N,50594,CHEMBL621919,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,8461,1,,,16438,,Spleen,N,50594,CHEMBL621920,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,8462,1,,,16438,,Spleen,N,50594,CHEMBL621921,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8463,1,,,16438,,Spleen,N,50594,CHEMBL622401,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,8464,1,,,16438,,Spleen,N,50594,CHEMBL875348,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,8465,1,,,16438,,Spleen,N,50594,CHEMBL622402,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,8466,1,,,16438,,Blood,N,50594,CHEMBL622403,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8467,1,,,16438,,Blood,N,50594,CHEMBL622404,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,8468,1,,,16438,,Brain,N,50594,CHEMBL622405,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,8469,1,,,16438,,Brain,N,50594,CHEMBL622406,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8470,1,,,16438,,Brain,N,50594,CHEMBL622407,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,8471,1,,,16438,,Heart,N,50594,CHEMBL622408,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,8472,1,,,16438,,Heart,N,50594,CHEMBL622409,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8473,1,,,16438,,Heart,N,50594,CHEMBL622410,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,8474,1,,,16438,,Kidney,N,50594,CHEMBL622411,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,8475,1,,,16438,,Kidney,N,50594,CHEMBL627864,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8476,1,,,16438,,Kidney,N,50594,CHEMBL627865,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,8477,1,,,16438,,Liver,N,50594,CHEMBL627866,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8478,1,,,16438,,Liver,N,50594,CHEMBL627751,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,8479,1,,,16438,,Spleen,N,50594,CHEMBL627752,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,8480,1,,,16438,,Spleen,N,50594,CHEMBL627753,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,8481,1,,,16438,,Spleen,N,50594,CHEMBL627754,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,8482,1,,,12467,,,N,50594,CHEMBL627755,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,8483,1,,,17208,,Brain,N,50594,CHEMBL627756,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,8484,1,,,17208,,Brain,N,50594,CHEMBL627757,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,8485,1,,,17208,,Brain,N,50594,CHEMBL627758,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,8486,1,,,17208,,Brain,N,50594,CHEMBL627759,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,8487,1,,,17208,,Brain,N,50594,CHEMBL627760,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,8488,1,,,17208,,Brain,N,50594,CHEMBL627761,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,8489,1,,,17208,,Heart,N,50594,CHEMBL876811,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,8490,1,,,17208,,Heart,N,50594,CHEMBL627762,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,8491,1,,,17208,,Heart,N,50594,CHEMBL627763,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,8492,1,,,17208,,Heart,N,50594,CHEMBL627764,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,8493,1,,,17208,,Heart,N,50594,CHEMBL627765,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,8494,1,,,17208,,Heart,N,50594,CHEMBL627766,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,8495,1,,,17208,,Kidney,N,50594,CHEMBL627767,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,8496,1,,,17208,,Kidney,N,50594,CHEMBL627768,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,8497,1,,,17208,,Kidney,N,50594,CHEMBL628422,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,8498,1,,,17208,,Kidney,N,50594,CHEMBL628423,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,8499,1,,,5089,,,N,50597,CHEMBL628424,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,8500,1,,,5089,,,N,50597,CHEMBL628425,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,8501,1,,,4257,,,N,50597,CHEMBL628426,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,8502,1,,,6679,,,N,50597,CHEMBL628427,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,8503,1,,,5546,,,N,50597,CHEMBL626938,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,8504,1,,,6141,,,N,50597,CHEMBL626939,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,8505,1,,,5334,,,N,50597,CHEMBL626940,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,8506,1,,,5334,,,N,50597,CHEMBL626941,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was reported in Sprague-Dawley rat,,8507,1,,,5334,,,N,50597,CHEMBL626942,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after intravenous administration (1 mg/kg) in rat,,8508,1,,,4689,,,N,50597,CHEMBL876812,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance of compound in rats was evaluated,,8509,1,,,6848,,,N,50597,CHEMBL626943,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,8510,1,,,6848,,,N,50597,CHEMBL626944,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,8511,1,,,6467,,,N,50597,CHEMBL626945,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,8512,1,,,6467,,,N,50597,CHEMBL626946,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance rate in Sprague-Dawley rats,,8513,1,,,4956,,,N,50597,CHEMBL626856,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,8514,1,,,5529,,,N,50597,CHEMBL626857,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was evaluated for plasma clearance in rat,,8515,1,,,406,,Plasma,N,50597,CHEMBL626858,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance in rat,,8516,1,,,17655,,Plasma,N,50597,CHEMBL627018,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,8517,1,,,3293,,Blood,N,50597,CHEMBL625331,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,8518,1,,,4075,,Blood,N,50597,CHEMBL625332,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,C max was determined at 10 mg/kg po dose in rats,,8519,1,,,2792,,,N,50597,CHEMBL877590,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,C max was determined at 3 mg/kg po dose in rats,,8520,1,,,2792,,,N,50597,CHEMBL625333,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,8521,1,,,17594,,,N,50597,CHEMBL625334,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after single intravenous bolus of 1 mg/kg in rats,,8522,1,,,17594,,,N,50597,CHEMBL625335,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax of compound at 5 mg/kg after po administration was determined in rat,,8523,1,,,4762,,,N,50597,CHEMBL625336,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax 24 hr after 10 mg/kg oral administration in rats,,8524,1,,,17509,,,N,50597,CHEMBL625337,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax 24 hr after 2 mg/kg oral administration in rats,,8525,1,,,17509,,,N,50597,CHEMBL625338,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,8526,1,,,1466,,Plasma,N,50597,CHEMBL625339,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat after administration of 2 mg/kg iv,,8527,1,,,6535,,,N,50597,CHEMBL625340,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat after administration of 2 mg/kg iv,,8528,1,,,6535,,,N,50597,CHEMBL625341,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,8529,1,,,3169,,,N,50597,CHEMBL622687,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,8530,1,,,6515,,Plasma,N,50597,CHEMBL622688,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,8531,1,,,11149,,Blood,N,50597,CHEMBL622689,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,8532,1,,,11149,,Blood,N,50597,CHEMBL620295,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after 10 mg/kg oral administration in rat,,8533,1,,,17858,,,N,50597,CHEMBL620296,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,8534,1,,,6518,,,N,50597,CHEMBL620297,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after IV dosing at 1 mg/kg in rat; no data,,8535,1,,,6518,,,N,50597,CHEMBL620298,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after oral administration at 20 mpk in rats,,8536,1,,,4426,,,N,50597,CHEMBL620299,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after oral administration at 20 mpk in rats; Not performed.,,8537,1,,,4426,,,N,50597,CHEMBL620300,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after oral administration at 20 mpk in rats d; Not performed.,,8538,1,,,4426,,,N,50597,CHEMBL620301,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after oral administration in rat,,8539,1,,,5656,,,N,50597,CHEMBL620302,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after oral administration at a dose of 2 mg/kg in rat,,8540,1,,,6518,,,N,50597,CHEMBL620303,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after oral administration at a dose of 4 mg/kg in rat,,8541,1,,,6518,,,N,50597,CHEMBL620304,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rats after 20 mg/kg oral dose,,8542,1,,,6113,,,N,50597,CHEMBL620305,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after peroral administration in rats at 2.4 uM/kg,,8543,1,,,17764,,,N,50597,CHEMBL620306,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax at the dose of 2 mg/Kg administered perorally in rats,,8544,1,,,4756,,,N,50597,CHEMBL620307,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax at the dose of 5 mg/Kg administered perorally in rats,,8545,1,,,4756,,,N,50597,CHEMBL620308,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax by administering at 20 mg/kg p.o. in rats,,8546,1,,,6402,,,N,50597,CHEMBL620309,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in male rat,,8547,1,,,5610,,,N,50597,CHEMBL620310,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat,,8548,1,,,5207,,,N,50597,CHEMBL620311,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat,,8549,1,,,6011,,,N,50597,CHEMBL620312,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat,,8550,1,,,6504,,,N,50597,CHEMBL620313,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat at 10 mg/kg,,8551,1,,,6046,,,N,50597,CHEMBL620314,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat at the dose of 1 mg/kg i.v.,,8552,1,,,6504,,,N,50597,CHEMBL620315,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat by po administration at a dose of 40 mg/kg,,8553,1,,,5874,,,N,50597,CHEMBL620316,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat p.o. at 20 mg/kg concentration,,8554,1,,,17686,,,N,50597,CHEMBL620317,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rats,,8555,1,,,5836,,,N,50597,CHEMBL620318,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rats,,8556,1,,,17596,,,N,50597,CHEMBL620319,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was evaluated after 20 uM/kg of peroral administration,,8557,1,,,16423,,,N,50597,CHEMBL620320,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was measured in rats after peroral administration at 3 mg/kg,,8558,1,,,17804,,,N,50597,CHEMBL620321,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,8559,1,,,1908,,,N,50597,CHEMBL620322,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8560,1,,,13950,,,N,50597,CHEMBL620323,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8561,1,,,13950,,Frontal cortex,N,50597,CHEMBL620324,BAO_0000218,1870.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8562,1,,,13950,,Frontal cortex,N,50597,CHEMBL620325,BAO_0000218,1870.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8563,1,,,13950,,Hippocampus,N,50597,CHEMBL620326,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8564,1,,,13950,,Hippocampus,N,50597,CHEMBL620327,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8565,1,,,13950,,,N,50597,CHEMBL620328,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8566,1,,,13950,,,N,50597,CHEMBL620329,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8567,1,,,13950,,Midbrain,N,50597,CHEMBL620330,BAO_0000218,1891.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8568,1,,,13950,,Midbrain,N,50597,CHEMBL875286,BAO_0000218,1891.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8569,1,,,13950,,,N,50597,CHEMBL620331,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8570,1,,,13950,,,N,50597,CHEMBL620332,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,8571,1,,,13950,,Striatum,N,50597,CHEMBL620333,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,8572,1,,,13950,,Striatum,N,50597,CHEMBL620334,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8573,1,,,16434,,Blood,N,50597,CHEMBL621015,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8574,1,,,16434,,Blood,N,50597,CHEMBL621016,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8575,1,,,16434,,Blood,N,50597,CHEMBL621191,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8576,1,,,16434,,Blood,N,50597,CHEMBL621192,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8577,1,,,16434,,Blood,N,50597,CHEMBL621193,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8578,1,,,16434,,Blood,N,50597,CHEMBL621194,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8579,1,,,16434,,Blood,N,50597,CHEMBL624204,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8580,1,,,16434,,Blood,N,50597,CHEMBL624205,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8581,1,,,16435,,Blood,N,50597,CHEMBL624206,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8582,1,,,16435,,Blood,N,50597,CHEMBL624207,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8583,1,,,16435,,Blood,N,50597,CHEMBL624208,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8584,1,,,16435,,Blood,N,50597,CHEMBL624209,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8585,1,,,16435,,Blood,N,50597,CHEMBL624210,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8586,1,,,16435,,Blood,N,50597,CHEMBL624211,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8587,1,,,16435,,Blood,N,50597,CHEMBL624212,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8588,1,,,16435,,Blood,N,50597,CHEMBL624213,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8589,1,,,16434,,Blood,N,50597,CHEMBL876611,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8590,1,,,16434,,Blood,N,50597,CHEMBL624214,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8591,1,,,16434,,Blood,N,50597,CHEMBL624215,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8592,1,,,16435,,Blood,N,50597,CHEMBL624216,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8593,1,,,16435,,Blood,N,50597,CHEMBL624217,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8594,1,,,16435,,Blood,N,50597,CHEMBL624218,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8595,1,,,16435,,Blood,N,50597,CHEMBL624219,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8596,1,,,16435,,Blood,N,50597,CHEMBL624220,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8597,1,,,16435,,Blood,N,50597,CHEMBL624221,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8598,1,,,16434,,,N,50597,CHEMBL624222,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8599,1,,,16434,,,N,50597,CHEMBL624223,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8600,1,,,16434,,,N,50597,CHEMBL624224,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8601,1,,,16434,,,N,50597,CHEMBL624225,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,8602,1,,,17764,,,N,50597,CHEMBL622420,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of steady state distribution after i.v. administration in rats,,8603,1,,,5031,,,N,50597,CHEMBL622421,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,8604,1,,,6215,,,N,50597,CHEMBL622422,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,8605,1,,,17671,,,N,50597,CHEMBL622423,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vss was determined,,8606,1,,,17752,,,N,50597,CHEMBL622424,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vss in rat,,8607,1,,,6596,,,N,50597,CHEMBL622425,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Vss was evaluated after 10 uM/kg of intra arterial administration,,8608,1,,,16423,,,N,50597,CHEMBL876612,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,volume of distribution at steady state was observed after intravenous administration in rat,,8609,1,,,15662,,,N,50597,CHEMBL622426,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,8610,1,,,6062,,,N,50597,CHEMBL622427,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic (PK) parameter Vz in rat,,8611,1,,,5874,,,N,50597,CHEMBL622428,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume distribution in rats,,8612,1,,,4942,,,N,50597,CHEMBL622429,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in rat; No data,,8613,1,,,17796,,,N,50597,CHEMBL622430,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,8614,1,,,4890,,,N,50597,CHEMBL622431,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% absorption predicted from in vitro rat ileum transport studies,,8615,1,,,15765,,Ileum,N,50597,CHEMBL622432,BAO_0000218,2116.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,8616,1,,,13569,,,N,50597,CHEMBL622433,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,8617,1,,,13569,,,N,50597,CHEMBL622434,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,8618,1,,,13569,,,N,50597,CHEMBL622435,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,8619,1,,,13569,,,N,50597,CHEMBL618748,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,8620,1,,,13569,,,N,50597,CHEMBL618749,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,8621,1,,,13569,,,N,50597,CHEMBL618750,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,8622,1,,,13569,,,N,50597,CHEMBL618751,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,8623,1,,,13569,,,N,50597,CHEMBL618752,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,8624,1,,,4576,,,N,50597,CHEMBL618753,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,8625,1,,,750,,Plasma,N,50597,CHEMBL618754,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,8626,1,,,750,,,N,50597,CHEMBL618755,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,8627,1,,,4590,,,N,50597,CHEMBL618756,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,8628,1,,,1716,,,N,50597,CHEMBL618757,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,8629,1,,,1974,,,N,50597,CHEMBL618758,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 30 mg/kg),,8630,1,,,4502,,,N,50597,CHEMBL621088,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property (cLogP) in rat,,8631,1,,,3371,,,N,50597,CHEMBL621089,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,8632,1,,,9099,,Blood,N,50597,CHEMBL621090,BAO_0000218,178.0
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,8633,1,,,9099,,Blood,N,50597,CHEMBL621091,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in rat.,,8634,1,,,4590,,,N,50597,CHEMBL876731,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for its clearance when administered intravenously in rat,,8635,1,,,3184,,,N,50597,CHEMBL621092,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,8636,1,,,16456,,,N,50597,CHEMBL621093,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Blood: Brain distribution ratio is determined in rat,,8637,1,,,4199,,,N,50597,CHEMBL621094,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,8638,1,,,4199,,,N,50597,CHEMBL621095,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,8639,1,,,4199,,,N,50597,CHEMBL621096,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8640,1,,,8677,,Kidney,N,50597,CHEMBL621097,BAO_0000218,2113.0
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent dose excreted in 0-48 hours administered ip to male rat,,8641,1,,,7449,,,N,50597,CHEMBL621098,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8642,1,,,11977,,Cerebellum,N,50597,CHEMBL621099,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8643,1,,,11977,,Cerebellum,N,50597,CHEMBL621100,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8644,1,,,11977,,Cerebellum,N,50597,CHEMBL621101,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8645,1,,,11977,,Cerebellum,N,50597,CHEMBL621102,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8646,1,,,11977,,Cerebellum,N,50597,CHEMBL876732,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8647,1,,,11977,,,N,50597,CHEMBL621103,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8648,1,,,11977,,,N,50597,CHEMBL621104,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8649,1,,,11977,,,N,50597,CHEMBL621105,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8650,1,,,11977,,,N,50597,CHEMBL621106,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8651,1,,,11977,,,N,50597,CHEMBL621107,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8652,1,,,11977,,,N,50597,CHEMBL621108,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8653,1,,,11977,,,N,50597,CHEMBL621109,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,8654,1,,,17208,,Kidney,N,50594,CHEMBL621110,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,8655,1,,,17208,,Kidney,N,50594,CHEMBL621111,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,8656,1,,,17208,,Liver,N,50594,CHEMBL622541,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,8657,1,,,17208,,Liver,N,50594,CHEMBL622542,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,8658,1,,,17208,,Liver,N,50594,CHEMBL622543,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,8659,1,,,17208,,Liver,N,50594,CHEMBL624412,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,8660,1,,,17208,,Liver,N,50594,CHEMBL624413,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,8661,1,,,17208,,Liver,N,50594,CHEMBL624414,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,8662,1,,,17208,,Lung,N,50594,CHEMBL624415,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,8663,1,,,17208,,Lung,N,50594,CHEMBL624416,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,8664,1,,,17208,,Lung,N,50594,CHEMBL624417,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,8665,1,,,17208,,Lung,N,50594,CHEMBL624418,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,8666,1,,,17208,,Lung,N,50594,CHEMBL624419,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,8667,1,,,17208,,Lung,N,50594,CHEMBL624420,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,8668,1,,,17208,,Muscle tissue,N,50594,CHEMBL624421,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,8669,1,,,17208,,Muscle tissue,N,50594,CHEMBL624422,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,8670,1,,,17208,,Muscle tissue,N,50594,CHEMBL624423,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,8671,1,,,17208,,Muscle tissue,N,50594,CHEMBL625123,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,8672,1,,,17208,,Muscle tissue,N,50594,CHEMBL625124,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,8673,1,,,17208,,Muscle tissue,N,50594,CHEMBL625125,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,8674,1,,,17208,,Zone of skin,N,50594,CHEMBL625126,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,8675,1,,,17208,,Zone of skin,N,50594,CHEMBL626947,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,8676,1,,,17208,,Zone of skin,N,50594,CHEMBL626948,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,8677,1,,,17208,,Zone of skin,N,50594,CHEMBL626949,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,8678,1,,,17208,,Zone of skin,N,50594,CHEMBL626950,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,8679,1,,,17208,,Zone of skin,N,50594,CHEMBL626951,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,8680,1,,,17208,,Spleen,N,50594,CHEMBL626952,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,8681,1,,,17208,,Spleen,N,50594,CHEMBL626953,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,8682,1,,,17208,,Spleen,N,50594,CHEMBL626954,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,8683,1,,,17208,,Spleen,N,50594,CHEMBL626955,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,8684,1,,,17208,,Spleen,N,50594,CHEMBL626956,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,8685,1,,,17208,,Spleen,N,50594,CHEMBL626957,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,8686,1,,,17208,,Blood,N,50594,CHEMBL626958,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,8687,1,,,17208,,Blood,N,50594,CHEMBL626959,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,8688,1,,,17208,,Blood,N,50594,CHEMBL626960,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,8689,1,,,17208,,Blood,N,50594,CHEMBL626961,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,8690,1,,,17208,,Blood,N,50594,CHEMBL627589,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,8691,1,,,17208,,Blood,N,50594,CHEMBL627590,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Time taken for EC90 was determined when tested in mouse,,8692,1,,,3132,,,N,50594,CHEMBL627591,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,8693,1,,,3132,,,N,50594,CHEMBL627592,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,8694,1,,,16597,,,N,50594,CHEMBL627593,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Half life in mice,,8695,1,,,5727,,,N,50594,CHEMBL627594,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life period in mouse after 10 mg/Kg dose,,8696,1,,,5302,,,N,50594,CHEMBL876813,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life period in mouse after 10 mg/kg dose,,8697,1,,,5302,,,N,50594,CHEMBL627595,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,8698,1,,,6348,,,N,50594,CHEMBL627596,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value at 5 mg/kg po was determined in rat,,8699,1,,,5964,,,N,50597,CHEMBL627597,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value evaluated in rat,,8700,1,,,6078,,,N,50597,CHEMBL627598,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,8701,1,,,5206,,Brain,N,50597,CHEMBL627599,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value after administration of 20 mg/Kg oral dose in rat,,8702,1,,,2959,,,N,50597,CHEMBL627600,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value at 1 mg/kg po in rat,,8703,1,,,5964,,,N,50597,CHEMBL627601,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value at 5 mg/kg po in rat,,8704,1,,,5964,,,N,50597,CHEMBL627776,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value at a dose of 10 mg/kg in male SD rats,,8705,1,,,6757,,,N,50597,CHEMBL627777,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value at a dose of 100 mg/kg in male SD rats,,8706,1,,,6757,,,N,50597,CHEMBL627778,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value at a dose of 50 mg/kg in male SD rats,,8707,1,,,6757,,,N,50597,CHEMBL627779,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value in rats at 10 mg/kg,,8708,1,,,17617,,,N,50597,CHEMBL876814,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value was evaluated in rats at a dose of 20 mg/kg,,8709,1,,,1445,,,N,50597,CHEMBL627780,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value was determined after peroral administration of 20 mg/kg in rat,,8710,1,,,6082,,,N,50597,CHEMBL627781,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,8711,1,,,1446,,,N,50597,CHEMBL627782,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,8712,1,,,5407,,Plasma,N,50597,CHEMBL627783,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,8713,1,,,2690,,Plasma,N,50597,CHEMBL627784,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,8714,1,,,2661,,,N,50597,CHEMBL627785,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,8715,1,,,2661,,,N,50597,CHEMBL627786,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,8716,1,,,4891,,Plasma,N,50597,CHEMBL627787,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,8717,1,,,2807,,Plasma,N,50597,CHEMBL627788,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,8718,1,,,2807,,Plasma,N,50597,CHEMBL626579,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,8719,1,,,2807,,Plasma,N,50597,CHEMBL626580,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,8720,1,,,3634,,,N,50597,CHEMBL876815,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,8721,1,,,1881,,Plasma,N,50597,CHEMBL626581,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,8722,1,,,1881,,Plasma,N,50597,CHEMBL626582,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,8723,1,,,429,,,N,50597,CHEMBL626583,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,8724,1,,,5974,,,N,50597,CHEMBL626205,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,8725,1,,,5974,,,N,50597,CHEMBL626206,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,8726,1,,,5974,,,N,50597,CHEMBL626207,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,8727,1,,,5974,,,N,50597,CHEMBL623882,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,8728,1,,,17582,,,N,50597,CHEMBL623883,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,8729,1,,,17582,,,N,50597,CHEMBL623884,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,8730,1,,,3032,,Plasma,N,50597,CHEMBL623885,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,8731,1,,,6295,,Plasma,N,50597,CHEMBL623886,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal concentration in rat was determined,,8732,1,,,6619,,,N,50597,CHEMBL623887,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal concentration after i.v. administration,,8733,1,,,6616,,,N,50597,CHEMBL623888,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,8734,1,,,3249,,Plasma,N,50597,CHEMBL623889,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,8735,1,,,17791,,Plasma,N,50597,CHEMBL623890,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat plasma after oral dose (50 mg/Kg),,8736,1,,,17791,,Plasma,N,50597,CHEMBL623891,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal plasma concentration was determined.,,8737,1,,,1360,,Plasma,N,50597,CHEMBL623892,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal plasma drug concentration was determined,,8738,1,,,2552,,Plasma,N,50597,CHEMBL623893,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal concentration in rats after peroral administration,,8739,1,,,6571,,,N,50597,CHEMBL877616,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rat after 2 mg/kg peroral administration,,8740,1,,,6570,,,N,50597,CHEMBL623894,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,8741,1,,,6567,,Plasma,N,50597,CHEMBL623895,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of compound in rat was evaluated.,,8742,1,,,3031,,,N,50597,CHEMBL623896,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,8743,1,,,3436,,,N,50597,CHEMBL623897,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,8744,1,,,3436,,,N,50597,CHEMBL623898,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,8745,1,,,2083,,,N,50597,CHEMBL623899,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,8746,1,,,3436,,,N,50597,CHEMBL623900,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,8747,1,,,4527,,,N,50597,CHEMBL623901,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration was evaluated in rats,,8748,1,,,1974,,,N,50597,CHEMBL623902,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,8749,1,,,3307,,Cerebrospinal fluid,N,50597,CHEMBL623903,BAO_0000218,1359.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,8750,1,,,3307,,Plasma,N,50597,CHEMBL623904,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,8751,1,,,1916,,Plasma,N,50597,CHEMBL877617,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,8752,1,,,1500,,,N,50597,CHEMBL623905,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,8753,1,,,1500,,,N,50597,CHEMBL623906,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,8754,1,,,4186,,Plasma,N,50597,CHEMBL623907,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8755,1,,,16434,,,N,50597,CHEMBL623908,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,8756,1,,,16434,,,N,50597,CHEMBL623909,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8757,1,,,16434,,,N,50597,CHEMBL623910,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8758,1,,,16434,,,N,50597,CHEMBL623911,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8759,1,,,16435,,,N,50597,CHEMBL623912,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8760,1,,,16435,,,N,50597,CHEMBL624616,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8761,1,,,16435,,,N,50597,CHEMBL624617,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8762,1,,,16435,,,N,50597,CHEMBL624618,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8763,1,,,16435,,,N,50597,CHEMBL624619,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8764,1,,,16435,,,N,50597,CHEMBL624794,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8765,1,,,16435,,,N,50597,CHEMBL624795,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8766,1,,,16435,,,N,50597,CHEMBL623921,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8767,1,,,16434,,,N,50597,CHEMBL623922,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8768,1,,,16434,,,N,50597,CHEMBL623923,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8769,1,,,16434,,,N,50597,CHEMBL623924,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8770,1,,,16435,,,N,50597,CHEMBL623925,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8771,1,,,16435,,,N,50597,CHEMBL623926,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8772,1,,,16435,,,N,50597,CHEMBL623927,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8773,1,,,16435,,,N,50597,CHEMBL623928,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8774,1,,,16435,,,N,50597,CHEMBL623929,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8775,1,,,16435,,,N,50597,CHEMBL623930,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8776,1,,,16434,,Brain,N,50597,CHEMBL623931,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8777,1,,,16434,,Brain,N,50597,CHEMBL622165,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8778,1,,,16434,,Brain,N,50597,CHEMBL621249,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8779,1,,,16434,,Brain,N,50597,CHEMBL621250,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8780,1,,,16434,,Brain,N,50597,CHEMBL621448,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8781,1,,,16434,,Brain,N,50597,CHEMBL621449,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8782,1,,,16434,,Brain,N,50597,CHEMBL621450,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8783,1,,,16434,,Brain,N,50597,CHEMBL621451,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8784,1,,,16435,,Brain,N,50597,CHEMBL621452,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8785,1,,,16435,,Brain,N,50597,CHEMBL621453,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8786,1,,,16435,,Brain,N,50597,CHEMBL621454,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8787,1,,,16435,,Brain,N,50597,CHEMBL621455,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8788,1,,,16435,,Brain,N,50597,CHEMBL621456,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8789,1,,,16435,,Brain,N,50597,CHEMBL625145,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8790,1,,,16435,,Brain,N,50597,CHEMBL875847,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8791,1,,,16435,,Brain,N,50597,CHEMBL625146,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8792,1,,,16434,,Brain,N,50597,CHEMBL625147,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8793,1,,,16434,,Brain,N,50597,CHEMBL625148,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8794,1,,,16434,,Brain,N,50597,CHEMBL625149,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8795,1,,,16435,,Brain,N,50597,CHEMBL625150,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8796,1,,,16435,,Brain,N,50597,CHEMBL625151,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8797,1,,,16435,,Brain,N,50597,CHEMBL625152,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8798,1,,,16435,,Brain,N,50597,CHEMBL625153,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8799,1,,,16435,,Brain,N,50597,CHEMBL625154,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8800,1,,,16435,,Brain,N,50597,CHEMBL625155,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8801,1,,,11977,,,N,50597,CHEMBL625156,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8802,1,,,11977,,,N,50597,CHEMBL624354,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8803,1,,,11977,,Hippocampus,N,50597,CHEMBL624355,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8804,1,,,11977,,Hippocampus,N,50597,CHEMBL624356,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8805,1,,,11977,,Hippocampus,N,50597,CHEMBL624357,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8806,1,,,11977,,Hippocampus,N,50597,CHEMBL624358,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8807,1,,,11977,,Striatum,N,50597,CHEMBL624359,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8808,1,,,11977,,Striatum,N,50597,CHEMBL624360,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8809,1,,,11977,,Striatum,N,50597,CHEMBL624361,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8810,1,,,11977,,Striatum,N,50597,CHEMBL624362,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8811,1,,,11977,,Striatum,N,50597,CHEMBL624363,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8812,1,,,11977,,Blood,N,50597,CHEMBL624364,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8813,1,,,11977,,Blood,N,50597,CHEMBL624365,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8814,1,,,11977,,Blood,N,50597,CHEMBL624366,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8815,1,,,11977,,Blood,N,50597,CHEMBL624367,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8816,1,,,11977,,Brain,N,50597,CHEMBL624368,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8817,1,,,11977,,Brain,N,50597,CHEMBL624369,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8818,1,,,11977,,Brain,N,50597,CHEMBL624370,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8819,1,,,11977,,Brain,N,50597,CHEMBL625069,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8820,1,,,11977,,Brain,N,50597,CHEMBL625070,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8821,1,,,11977,,Heart,N,50597,CHEMBL626051,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8822,1,,,11977,,Heart,N,50597,CHEMBL626052,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8823,1,,,11977,,Heart,N,50597,CHEMBL626053,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8824,1,,,11977,,Heart,N,50597,CHEMBL626054,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8825,1,,,11977,,Heart,N,50597,CHEMBL626055,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8826,1,,,11977,,Kidney,N,50597,CHEMBL626056,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8827,1,,,11977,,Kidney,N,50597,CHEMBL626057,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8828,1,,,11977,,Kidney,N,50597,CHEMBL625193,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8829,1,,,11977,,Kidney,N,50597,CHEMBL625194,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8830,1,,,11977,,Liver,N,50597,CHEMBL625195,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8831,1,,,11977,,Liver,N,50597,CHEMBL625196,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8832,1,,,11977,,Liver,N,50597,CHEMBL625197,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8833,1,,,11977,,Liver,N,50597,CHEMBL625198,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8834,1,,,11977,,Liver,N,50597,CHEMBL627929,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8835,1,,,11977,,Lung,N,50597,CHEMBL627074,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8836,1,,,11977,,Lung,N,50597,CHEMBL627075,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8837,1,,,11977,,Lung,N,50597,CHEMBL627076,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8838,1,,,11977,,Lung,N,50597,CHEMBL627077,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8839,1,,,11977,,Lung,N,50597,CHEMBL627078,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,8840,1,,,11977,,Muscle tissue,N,50597,CHEMBL627079,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,8841,1,,,4573,,,N,50594,CHEMBL873824,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in mouse plasma was determined at dose 25 mg/kg,,8842,1,,,3132,,Plasma,N,50594,CHEMBL627080,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Half life was determined,,8843,1,,,17718,,,N,50594,CHEMBL627081,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,8844,1,,,17728,,,N,50594,CHEMBL627082,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half-life in male mice after 1 mg/kg intravenous dose,,8845,1,,,5961,,,N,50594,CHEMBL627083,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Half life in mice plasma,,8847,1,,,17731,,Plasma,N,50594,CHEMBL627085,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Half life in mouse,,8848,1,,,17592,,,N,50594,CHEMBL627086,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in mouse plasma at dose 25 mg/kg,,8849,1,,,3132,,Plasma,N,50594,CHEMBL627087,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,8850,1,,,17729,,,N,50594,CHEMBL627088,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,8851,1,,,17729,,,N,50594,CHEMBL627089,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,8852,1,,,17729,,,N,50594,CHEMBL627090,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,8853,1,,,3277,,,N,50594,CHEMBL627091,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,8854,1,,,3760,,,N,50594,CHEMBL627092,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,8855,1,,,3760,,,N,50594,CHEMBL876785,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half-life by iv administration in mouse,,8856,1,,,2862,,,N,50594,CHEMBL627093,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half-life by oral administration in mouse,,8857,1,,,2862,,,N,50594,CHEMBL627094,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Half-life in mice,,8858,1,,,5980,,,N,50594,CHEMBL627095,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Half-life using mouse brain homogenate,,8859,1,,,6159,,Brain,N,50594,CHEMBL627096,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Half-life was measured in mice,,8860,1,,,6254,,,N,50594,CHEMBL627097,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half-life was measured in mouse after an iv dose of 1 mg/kg,,8861,1,,,6062,,,N,50594,CHEMBL627098,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Half-life period was determined in mouse blood,,8862,1,,,1574,,Blood,N,50594,CHEMBL627099,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,8863,1,,,56,,Brain,N,50594,CHEMBL627100,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma half life in mouse,,8864,1,,,993,,Plasma,N,50594,CHEMBL627101,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Stability of the peptide in the presence of mouse serum,,8865,1,,,6652,,,N,50594,CHEMBL627102,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Terminal half life of compound was determined in mouse,,8866,1,,,17852,,,N,50594,CHEMBL627103,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Terminal half life was evaluated in mice after intravenous administration,,8867,1,,,2675,,,N,50594,CHEMBL627104,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Terminal half life was evaluated in mice after oral administration,,8868,1,,,2675,,,N,50594,CHEMBL627105,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,8869,1,,,499,,,N,50594,CHEMBL876786,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,8870,1,,,499,,,N,50594,CHEMBL873825,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,8871,1,,,499,,,N,50594,CHEMBL627106,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,8872,1,,,14239,,,N,50594,CHEMBL626336,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,8873,1,,,5506,,,N,50594,CHEMBL877462,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,8874,1,,,5506,,,N,50594,CHEMBL626337,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Half life after intraperitoneal administration of 100 mg/kg in mice,,8875,1,,,17734,,,N,50594,CHEMBL626338,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,8876,1,,,17728,,,N,50594,CHEMBL626339,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,8877,1,,,17728,,,N,50594,CHEMBL626340,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,8878,1,,,17728,,,N,50594,CHEMBL625377,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,8879,1,,,17728,,,N,50594,CHEMBL625378,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,8880,1,,,17728,,,N,50594,CHEMBL625379,BAO_0000218,
A,Autocuration,1,,Microsomes,Sus scrofa,,,9823.0,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,8881,0,,,14294,,,U,22224,CHEMBL625380,BAO_0000251,
A,Autocuration,1,,Microsomes,Sus scrofa,,,9823.0,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,8882,0,,,14294,,,U,22224,CHEMBL625381,BAO_0000251,
A,Autocuration,1,,,Sus scrofa,,,9823.0,Stability to porcine renal DHP-I,,8883,0,,,6056,,,U,22224,CHEMBL625382,BAO_0000019,
A,Autocuration,1,,,Sus scrofa,In vivo,,9823.0,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,8884,0,,,1317,,,U,22224,CHEMBL873828,BAO_0000218,
A,Autocuration,1,,,Sus scrofa,In vivo,,9823.0,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,8885,0,,,1317,,,U,22224,CHEMBL625383,BAO_0000218,
A,Autocuration,1,,,Sus scrofa,,,9823.0,Half-life of the parent prodrug in porcine esterase solution,,8886,0,,,5229,,,U,22224,CHEMBL625384,BAO_0000019,
A,Autocuration,1,,,Sus scrofa,,,9823.0,"First order rate constant, k was determined in in pig liver Esterase",,8887,0,,,4231,,,U,22224,CHEMBL625385,BAO_0000019,
A,Autocuration,1,,,Sus scrofa,,,9823.0,Half life of the in pig liver Esterase,,8888,0,,,4231,,Liver,U,22224,CHEMBL625386,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,8889,0,,,5318,,Liver,U,22224,CHEMBL623571,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,8890,0,,,5318,,Liver,U,22224,CHEMBL623572,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,8891,0,,,5318,,Liver,U,22224,CHEMBL623573,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,8892,0,,,3305,,Liver,U,22224,CHEMBL623574,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,8893,0,,,3305,,Liver,U,22224,CHEMBL623575,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,8894,0,,,2842,,Liver,U,22224,CHEMBL623749,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,8895,0,,,2842,,Liver,U,22224,CHEMBL623750,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,In vitro,,9823.0,Half-life in vitro in pig liver,,8896,0,,,889,,Liver,U,22224,CHEMBL623751,BAO_0000221,2107.0
A,Autocuration,1,,,Sus scrofa,,,9823.0,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,8897,0,,,1904,,Liver,U,22224,CHEMBL623752,BAO_0000221,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,8898,1,,,4186,,Plasma,N,50597,CHEMBL623753,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,8899,1,,,2774,,Plasma,N,50597,CHEMBL623754,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rat plasma was determined,,8900,1,,,1742,,Plasma,N,50597,CHEMBL623755,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rats,,8901,1,,,3169,,,N,50597,CHEMBL623756,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rats at 1-2 hours,,8902,1,,,3169,,,N,50597,CHEMBL623757,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,8903,1,,,2081,,,N,50597,CHEMBL623758,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,8904,1,,,3307,,Brain,N,50597,CHEMBL623759,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at the dose of 2 mg/kg in rat,,8905,1,,,4727,,,N,50597,CHEMBL623760,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration was evaluated in rats,,8906,1,,,6597,,,N,50597,CHEMBL623761,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,8907,1,,,16365,,Plasma,N,50597,CHEMBL623762,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,8908,1,,,16365,,Plasma,N,50597,CHEMBL877594,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,8909,1,,,16365,,Plasma,N,50597,CHEMBL623763,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,8910,1,,,16365,,Plasma,N,50597,CHEMBL623764,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,8911,1,,,16365,,Plasma,N,50597,CHEMBL623765,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,8912,1,,,2591,,Blood,N,50597,CHEMBL623766,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,8913,1,,,2591,,Blood,N,50597,CHEMBL623767,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,8914,1,,,2591,,Blood,N,50597,CHEMBL623768,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,8915,1,,,5978,,Plasma,N,50597,CHEMBL623769,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,8916,1,,,5978,,Plasma,N,50597,CHEMBL623770,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,8917,1,,,5978,,Plasma,N,50597,CHEMBL623771,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,8918,1,,,5978,,Plasma,N,50597,CHEMBL623772,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,8919,1,,,5978,,Plasma,N,50597,CHEMBL623773,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,8920,1,,,5978,,Plasma,N,50597,CHEMBL623774,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,8921,1,,,5978,,Plasma,N,50597,CHEMBL623775,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat (PO dose),,8922,1,,,14465,,,N,50597,CHEMBL623776,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,8923,1,,,4723,,Plasma,N,50597,CHEMBL622191,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,8924,1,,,4723,,Plasma,N,50597,CHEMBL622192,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration determined in rat,,8925,1,,,4576,,Plasma,N,50597,CHEMBL622193,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,8926,1,,,12873,,Plasma,N,50597,CHEMBL622194,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,8927,1,,,12873,,Plasma,N,50597,CHEMBL622195,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration in rat,,8928,1,,,6824,,Plasma,N,50597,CHEMBL622196,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,8929,1,,,17065,,Plasma,N,50597,CHEMBL622197,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,8930,1,,,2932,,Plasma,N,50597,CHEMBL622198,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,8931,1,,,2932,,Plasma,N,50597,CHEMBL622199,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration of compound was measured in rat,,8932,1,,,2879,,Plasma,N,50597,CHEMBL622200,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration after 20 mg/kg oral administration in rat,,8933,1,,,2864,,Plasma,N,50597,CHEMBL622201,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration after oral administration to rats,,8934,1,,,16367,,Plasma,N,50597,CHEMBL623990,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,8935,1,,,17717,,Plasma,N,50597,CHEMBL623991,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,8936,1,,,17717,,Plasma,N,50597,CHEMBL623992,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,8937,1,,,17717,,Plasma,N,50597,CHEMBL623993,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,8938,1,,,17717,,Plasma,N,50597,CHEMBL623994,BAO_0000218,1969.0
F,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,8939,1,,,17720,,Plasma,N,50597,CHEMBL623995,BAO_0000218,1969.0
F,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,8940,1,,,17720,,Plasma,N,50597,CHEMBL623996,BAO_0000218,1969.0
F,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,8941,1,,,17720,,Plasma,N,50597,CHEMBL623997,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration dosed orally in rats,,8942,1,,,4516,,Plasma,N,50597,CHEMBL623998,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration dosed orally in rats after 6 hours,,8943,1,,,4516,,Plasma,N,50597,CHEMBL623999,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,8944,1,,,4516,,Plasma,N,50597,CHEMBL624000,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,8945,1,,,5199,,Plasma,N,50597,CHEMBL624001,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration in rat after po administration,,8946,1,,,17538,,Plasma,N,50597,CHEMBL624002,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,8947,1,,,6685,,Plasma,N,50597,CHEMBL624003,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,8948,1,,,6685,,Plasma,N,50597,CHEMBL624004,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8949,1,,,16434,,Heart,N,50597,CHEMBL624005,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8950,1,,,16434,,Heart,N,50597,CHEMBL624006,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8951,1,,,16434,,Heart,N,50597,CHEMBL624007,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8952,1,,,16434,,Heart,N,50597,CHEMBL624008,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8953,1,,,16434,,Heart,N,50597,CHEMBL624009,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8954,1,,,16434,,Heart,N,50597,CHEMBL874387,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8955,1,,,16434,,Heart,N,50597,CHEMBL624010,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,8956,1,,,16434,,Heart,N,50597,CHEMBL624011,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8957,1,,,16435,,Heart,N,50597,CHEMBL624012,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8958,1,,,16435,,Heart,N,50597,CHEMBL624013,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8959,1,,,16435,,Heart,N,50597,CHEMBL624736,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8960,1,,,16435,,Heart,N,50597,CHEMBL624737,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8961,1,,,16434,,Heart,N,50597,CHEMBL624738,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8962,1,,,16434,,Heart,N,50597,CHEMBL624739,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8963,1,,,16434,,Heart,N,50597,CHEMBL624740,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8964,1,,,16435,,Heart,N,50597,CHEMBL624896,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,8965,1,,,16435,,Heart,N,50597,CHEMBL624897,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,8966,1,,,16435,,Heart,N,50597,CHEMBL624108,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,8967,1,,,16435,,Heart,N,50597,CHEMBL624109,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,8968,1,,,16435,,Heart,N,50597,CHEMBL624110,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,8969,1,,,16435,,Heart,N,50597,CHEMBL624111,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8970,1,,,16435,,Heart,N,50597,CHEMBL624112,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8971,1,,,16435,,Heart,N,50597,CHEMBL624113,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8972,1,,,16435,,Heart,N,50597,CHEMBL619709,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8973,1,,,16435,,Heart,N,50597,CHEMBL619710,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,8974,1,,,16434,,Kidney,N,50597,CHEMBL619711,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,8975,1,,,16434,,Kidney,N,50597,CHEMBL619712,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,8976,1,,,16434,,Kidney,N,50597,CHEMBL619713,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,8977,1,,,16434,,Kidney,N,50597,CHEMBL619714,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,8978,1,,,16434,,Kidney,N,50597,CHEMBL619715,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,8979,1,,,16434,,Kidney,N,50597,CHEMBL619716,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,8980,1,,,16434,,Kidney,N,50597,CHEMBL619717,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,8981,1,,,16434,,Kidney,N,50597,CHEMBL619718,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,8982,1,,,16435,,Kidney,N,50597,CHEMBL619719,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,8983,1,,,16435,,Kidney,N,50597,CHEMBL875329,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,8984,1,,,16435,,Kidney,N,50597,CHEMBL619720,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,8985,1,,,16435,,Kidney,N,50597,CHEMBL619721,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,8986,1,,,16435,,Kidney,N,50597,CHEMBL619722,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,8987,1,,,16435,,Kidney,N,50597,CHEMBL619723,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,8988,1,,,16435,,Kidney,N,50597,CHEMBL619724,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,8989,1,,,16435,,Kidney,N,50597,CHEMBL619725,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,8990,1,,,16434,,Kidney,N,50597,CHEMBL619726,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,8991,1,,,16434,,Kidney,N,50597,CHEMBL619727,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,8992,1,,,16434,,Kidney,N,50597,CHEMBL619728,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,8993,1,,,16435,,Kidney,N,50597,CHEMBL619729,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8994,1,,,11977,,Muscle tissue,N,50597,CHEMBL619730,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,8995,1,,,11977,,Muscle tissue,N,50597,CHEMBL619731,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,8996,1,,,11977,,Muscle tissue,N,50597,CHEMBL619732,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,8997,1,,,11977,,Muscle tissue,N,50597,CHEMBL619733,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,8998,1,,,11977,,Muscle tissue,N,50597,CHEMBL619734,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,8999,1,,,11977,,Zone of skin,N,50597,CHEMBL619735,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9000,1,,,11977,,Zone of skin,N,50597,CHEMBL875330,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,9001,1,,,11977,,Zone of skin,N,50597,CHEMBL628465,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,9002,1,,,11977,,Zone of skin,N,50597,CHEMBL628466,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,9003,1,,,11977,,Zone of skin,N,50597,CHEMBL628467,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,9004,1,,,11977,,Spleen,N,50597,CHEMBL628468,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9005,1,,,11977,,Spleen,N,50597,CHEMBL628469,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,9006,1,,,11977,,Spleen,N,50597,CHEMBL628470,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,9007,1,,,11977,,Spleen,N,50597,CHEMBL628471,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,9008,1,,,11977,,Spleen,N,50597,CHEMBL628472,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,9009,1,,,11977,,Thyroid gland,N,50597,CHEMBL625191,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9010,1,,,11977,,Thyroid gland,N,50597,CHEMBL625192,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,9011,1,,,11977,,Thyroid gland,N,50597,CHEMBL875337,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,9012,1,,,11977,,Thyroid gland,N,50597,CHEMBL626341,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,9013,1,,,11977,,Thyroid gland,N,50597,CHEMBL626342,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,9014,1,,,11977,,Liver,N,50597,CHEMBL621943,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rats,,9015,1,,,3748,,,N,50597,CHEMBL621944,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,9016,1,,,15765,,,N,50597,CHEMBL621945,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,9017,1,,,4871,,,N,50597,CHEMBL621946,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,9018,1,,,4871,,,N,50597,CHEMBL621947,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,9019,1,,,4872,,,N,50597,CHEMBL621948,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,9020,1,,,4872,,,N,50597,CHEMBL621949,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,9021,1,,,5413,,,N,50597,CHEMBL621950,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,9022,1,,,5413,,,N,50597,CHEMBL621951,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,9023,1,,,15272,,Blood,N,50597,CHEMBL621952,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability (%) in rat liver microsomes,,9024,1,,,4689,,Liver,N,50597,CHEMBL621953,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was calculated after intravenous administration,,9025,1,,,6057,,,N,50597,CHEMBL621954,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was calculated after iv administration in rat,,9026,1,,,6057,,,N,50597,CHEMBL621955,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was calculated in rat after peroral administration,,9027,1,,,6057,,,N,50597,CHEMBL621956,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,9028,1,,,6211,,,N,50597,CHEMBL621957,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,9029,1,,,5710,,,N,50597,CHEMBL621958,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,9030,1,,,5710,,,N,50597,CHEMBL621959,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,9031,1,,,17853,,,N,50597,CHEMBL621960,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,9032,1,,,17853,,,N,50597,CHEMBL621961,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,p value of the compound,,9033,1,,,15765,,,N,50597,CHEMBL621962,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,p value of the compound,,9034,1,,,15765,,,N,50597,CHEMBL876787,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,p value of the compound,,9035,1,,,15765,,,N,50597,CHEMBL621963,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9036,1,,,6175,,Stomach,N,50597,CHEMBL622637,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9037,1,,,6175,,Stomach,N,50597,CHEMBL622638,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9038,1,,,6175,,Stomach,N,50597,CHEMBL626561,BAO_0000218,945.0
F,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,9039,0,,,7991,,,U,22224,CHEMBL626562,BAO_0000019,
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,9040,0,,,429,,,U,22224,CHEMBL626563,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,9041,0,,,429,,,U,22224,CHEMBL626564,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,9042,0,,,6253,,,U,22224,CHEMBL626565,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,9043,0,,,6253,,,U,22224,CHEMBL626566,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Clearance rate in rabbits,,9044,0,,,3615,,,U,22224,CHEMBL626567,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,9045,0,,,4059,,,U,22224,CHEMBL626568,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,9046,0,,,5124,,,U,22224,CHEMBL626569,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,9047,0,,,5124,,,U,22224,CHEMBL626570,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,9048,0,,,5124,,,U,22224,CHEMBL626571,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,9049,0,,,429,,,U,22224,CHEMBL626572,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,9050,0,,,4059,,Plasma,U,22224,CHEMBL626573,BAO_0000218,1969.0
A,Autocuration,1,,Microsomes,Oryctolagus cuniculus,,,9986.0,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,9051,0,,,9659,,Liver,U,22224,CHEMBL626574,BAO_0000251,2107.0
A,Autocuration,1,,Microsomes,Oryctolagus cuniculus,,,9986.0,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,9052,0,,,9659,,Liver,U,22224,CHEMBL626575,BAO_0000251,2107.0
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,9053,0,,,3639,,,U,22224,CHEMBL626576,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Dose at which bioavailability of perorally administered compound was tested in rabbit,,9054,0,,,3639,,,U,22224,CHEMBL626577,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,The compound was tested for its bioavailability in rabbit (by oral dosage).,,9055,0,,,3639,,,U,22224,CHEMBL626578,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,9056,0,,,5124,,,U,22224,CHEMBL625263,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,9057,0,,,5124,,,U,22224,CHEMBL625264,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,9058,0,,,5124,,,U,22224,CHEMBL625265,BAO_0000218,
A,Autocuration,1,,Microsomes,Oryctolagus cuniculus,,,9986.0,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,9059,0,,,14294,,,U,22224,CHEMBL625266,BAO_0000251,
A,Autocuration,1,,Microsomes,Oryctolagus cuniculus,,,9986.0,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,9060,0,,,14294,,,U,22224,CHEMBL876796,BAO_0000251,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,9061,0,,,429,,,U,22224,CHEMBL625267,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,9062,0,,,5124,,Plasma,U,22224,CHEMBL625268,BAO_0000218,1969.0
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,9063,0,,,5124,,Plasma,U,22224,CHEMBL625269,BAO_0000218,1969.0
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,9064,0,,,5124,,Plasma,U,22224,CHEMBL624689,BAO_0000218,1969.0
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,9065,0,,,429,,,U,22224,CHEMBL624690,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,9066,0,,,429,,Urine,U,22224,CHEMBL624691,BAO_0000218,1088.0
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,9067,0,,,429,,Urine,U,22224,CHEMBL624692,BAO_0000218,1088.0
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,9068,0,,,4059,,,U,22224,CHEMBL624693,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,9069,0,,,4137,,,U,22224,CHEMBL624694,BAO_0000218,
A,Autocuration,1,,,Oryctolagus cuniculus,In vitro,,9986.0,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,9070,0,,,11672,,,U,22224,CHEMBL877596,BAO_0000221,
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Time within which only 10% of the drug was degraded,,9071,0,,,12886,,,U,22224,CHEMBL624695,BAO_0000019,
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Half life period in rabbit liver homogenate,,9072,0,,,3853,,Liver,U,22224,CHEMBL624696,BAO_0000221,2107.0
A,Autocuration,1,,,Oryctolagus cuniculus,,,9986.0,Half life value in rabbits,,9073,0,,,3615,,,U,22224,CHEMBL624697,BAO_0000019,
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,9074,0,,,6253,,Blood,U,22224,CHEMBL624698,BAO_0000218,178.0
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,9075,0,,,6253,,Blood,U,22224,CHEMBL624699,BAO_0000218,178.0
A,Autocuration,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Half-life period in rabbits following intravenous administration at 2 mg/kg,,9076,0,,,6077,,,U,22224,CHEMBL624700,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC 0-8 hr value in rats at 10 mg/kg,,9077,1,,,17617,,Plasma,N,50597,CHEMBL622903,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC after administration at 2000 mg/kg/day in rats,,9078,1,,,17594,,Plasma,N,50597,CHEMBL622904,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,9079,1,,,6149,,Plasma,N,50597,CHEMBL622905,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,9080,1,,,17260,,Plasma,N,50597,CHEMBL622906,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,9081,1,,,17260,,Plasma,N,50597,CHEMBL622907,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat after oral administration at 10.5 mg/kg dose,,9082,1,,,6644,,Plasma,N,50597,CHEMBL622908,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat after oral administration at 11.2 mg/kg dose,,9083,1,,,6644,,Plasma,N,50597,CHEMBL622909,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat after oral administration at 9.7 mg/kg dose,,9084,1,,,6644,,Plasma,N,50597,CHEMBL622910,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat brain after oral administration at 10 mg/kg,,9085,1,,,6495,,Brain,N,50597,CHEMBL622911,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat p.o.,,9086,1,,,6504,,Plasma,N,50597,CHEMBL622912,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat p.o. at 20 mg/kg concentration,,9087,1,,,17686,,Plasma,N,50597,CHEMBL622913,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat plasma after oral administration at 10 mg/kg,,9088,1,,,6495,,Plasma,N,50597,CHEMBL622914,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rats,,9089,1,,,216,,Plasma,N,50597,CHEMBL622915,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC value after IV dose at a dose of 5 mg/kg in rats.,,9090,1,,,1908,,Plasma,N,50597,CHEMBL622916,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC value after oral dose at a dose of 10 mg/kg in rats.,,9091,1,,,1908,,Plasma,N,50597,CHEMBL622917,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,9092,1,,,6685,,Plasma,N,50597,CHEMBL622918,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,9093,1,,,216,,Plasma,N,50597,CHEMBL622919,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration was evaluated in rat,,9094,1,,,6049,,Plasma,N,50597,CHEMBL622920,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,9095,1,,,2463,,Plasma,N,50597,CHEMBL622921,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,9096,1,,,6679,,Plasma,N,50597,CHEMBL622922,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,9097,1,,,6681,,Plasma,N,50597,CHEMBL622923,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,9098,1,,,4890,,Plasma,N,50597,CHEMBL877604,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,9099,1,,,6410,,Plasma,N,50597,CHEMBL622924,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,9100,1,,,6410,,Plasma,N,50597,CHEMBL622925,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,9101,1,,,16366,,Plasma,N,50597,CHEMBL622926,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,9102,1,,,6227,,Plasma,N,50597,CHEMBL623625,BAO_0000218,1969.0
A,Expert,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,9103,1,,,3598,,Plasma,N,50597,CHEMBL623626,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma drug concentration was determined,,9104,1,,,1465,,Plasma,N,50597,CHEMBL623627,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,9105,1,,,4368,,,N,50597,CHEMBL623628,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Mean peak plasma concentration was observed after intravenous administration in rat,,9106,1,,,15662,,Plasma,N,50597,CHEMBL623629,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Mean peak plasma concentration was observed after oral administration in rat,,9107,1,,,15662,,Plasma,N,50597,CHEMBL623630,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,9108,1,,,5355,,,N,50597,CHEMBL623804,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,9109,1,,,5355,,,N,50597,CHEMBL623805,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak oral plasma concentration was determined in rats by oral administration,,9110,1,,,1567,,Plasma,N,50597,CHEMBL623806,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak plasma concentration (Cmax) was determined,,9111,1,,,4026,,Plasma,N,50597,CHEMBL623807,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,9112,1,,,6193,,Plasma,N,50597,CHEMBL623808,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak plasma concentration (Cmax) in rats,,9113,1,,,4026,,Plasma,N,50597,CHEMBL623809,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak plasma concentration at 1 mg/kg peroral administration,,9114,1,,,6485,,Plasma,N,50597,CHEMBL623810,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak plasma concentration in rat,,9115,1,,,17655,,Plasma,N,50597,CHEMBL623811,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,9116,1,,,14941,,Plasma,N,50597,CHEMBL623812,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,9117,1,,,5394,,,N,50597,CHEMBL877605,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Cmax) in rat,,9118,1,,,4408,,,N,50597,CHEMBL623813,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,9119,1,,,5983,,,N,50597,CHEMBL623814,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat after 3mg/kg oral dose,,9120,1,,,4878,,,N,50597,CHEMBL623815,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,9121,1,,Sprague-Dawley,5862,,,N,50597,CHEMBL623816,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rats after 20 mg/kg oral dose,,9122,1,,,4517,,,N,50597,CHEMBL623145,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat plasma after 30mg/kg oral dose,,9123,1,,,5932,,Plasma,N,50597,CHEMBL623146,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma concentration after oral administration of 100 mg/kg to rats,,9124,1,,,5436,,Plasma,N,50597,CHEMBL623147,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,9125,1,,,4910,,Brain,N,50597,CHEMBL623042,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for the Cmax in rat at 10 mg/kg per orally,,9126,1,,,4950,,,N,50597,CHEMBL623043,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,9127,1,,,15078,,,N,50597,CHEMBL623044,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,9128,1,,,15078,,,N,50597,CHEMBL623045,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability as oral Cmax in rats at 30 mins,,9129,1,,,3360,,,N,50597,CHEMBL623046,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability as oral Cmax in rats at 6hr,,9130,1,,,3360,,,N,50597,CHEMBL623226,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum concentration of compound was measured at the dose of 100 umol/kg,,9131,1,,,15022,,,N,50597,CHEMBL623227,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum concentration of compound was measured at the dose of 300 umol/kg,,9132,1,,,15022,,,N,50597,CHEMBL623228,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum concentration of compound was measured at the dose of 30 umol/kg,,9133,1,,,15022,,,N,50597,CHEMBL623229,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma levels for the compounds were determined by LC-MS.,,9134,1,,,5160,,Plasma,N,50597,CHEMBL623230,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,mean peak plasma concentration was observed after intravenous administration in rat,,9135,1,,,15662,,Plasma,N,50597,CHEMBL623231,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,mean peak plasma concentration was observed after oral administration in rat,,9136,1,,,15662,,Plasma,N,50597,CHEMBL623232,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,9137,1,,,4709,,,N,50597,CHEMBL623233,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,9138,1,,,3535,,,N,50597,CHEMBL623234,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in plasma (portal) following oral dose in rats at 1 hr,,9139,1,,,3535,,,N,50597,CHEMBL623235,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in plasma (portal) following oral dose in rats at 2 hr,,9140,1,,,3535,,,N,50597,CHEMBL623236,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,9141,1,,,3535,,,N,50597,CHEMBL623237,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,9142,1,,,3535,,,N,50597,CHEMBL623238,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,9143,1,,,3535,,,N,50597,CHEMBL623239,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,9144,0,,,5005,,Plasma,U,22224,CHEMBL623240,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,9145,1,,,6326,,Hypothalamus,N,50597,CHEMBL623241,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,9146,1,,,6326,,Hypothalamus,N,50597,CHEMBL623242,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,9147,1,,,6326,,,N,50597,CHEMBL874394,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,9148,1,,,6326,,,N,50597,CHEMBL623243,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9149,1,,,17411,,,N,50597,CHEMBL623244,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9150,1,,,16435,,Kidney,N,50597,CHEMBL623245,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9151,1,,,16435,,Kidney,N,50597,CHEMBL623246,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9152,1,,,16435,,Kidney,N,50597,CHEMBL623247,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9153,1,,,16435,,Kidney,N,50597,CHEMBL623248,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9154,1,,,16435,,Kidney,N,50597,CHEMBL623249,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9155,1,,,16434,,Liver,N,50597,CHEMBL625072,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9156,1,,,16434,,Liver,N,50597,CHEMBL625073,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9157,1,,,16434,,Liver,N,50597,CHEMBL625074,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9158,1,,,16434,,Liver,N,50597,CHEMBL625075,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,9159,1,,,16434,,Liver,N,50597,CHEMBL625076,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9160,1,,,16434,,Liver,N,50597,CHEMBL625077,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9161,1,,,16434,,Liver,N,50597,CHEMBL625078,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9162,1,,,16434,,Liver,N,50597,CHEMBL874395,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9163,1,,,16435,,Liver,N,50597,CHEMBL625079,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9164,1,,,16435,,Liver,N,50597,CHEMBL625080,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9165,1,,,16435,,Liver,N,50597,CHEMBL625081,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9166,1,,,16435,,Liver,N,50597,CHEMBL625082,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9167,1,,,16435,,Liver,N,50597,CHEMBL625083,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9168,1,,,16435,,Liver,N,50597,CHEMBL625084,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9169,1,,,16435,,Liver,N,50597,CHEMBL625085,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9170,1,,,16435,,Liver,N,50597,CHEMBL625086,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9171,1,,,16434,,Liver,N,50597,CHEMBL625087,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9172,1,,,16434,,Liver,N,50597,CHEMBL625088,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9173,1,,,16434,,Liver,N,50597,CHEMBL622205,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9174,1,,,16435,,Liver,N,50597,CHEMBL622206,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9175,1,,,16435,,Liver,N,50597,CHEMBL622207,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9176,1,,,16435,,Liver,N,50597,CHEMBL622366,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9177,1,,,16435,,Liver,N,50597,CHEMBL622367,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9178,1,,,16435,,Liver,N,50597,CHEMBL875331,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9179,1,,,16435,,Liver,N,50597,CHEMBL622368,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9180,1,,,16434,,Lung,N,50597,CHEMBL622369,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9181,1,,,16434,,Lung,N,50597,CHEMBL622370,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9182,1,,,16434,,Lung,N,50597,CHEMBL622371,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9183,1,,,16434,,Lung,N,50597,CHEMBL622372,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9184,1,,,16434,,Lung,N,50597,CHEMBL622373,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9185,1,,,16434,,Lung,N,50597,CHEMBL622374,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9186,1,,,16434,,Lung,N,50597,CHEMBL622375,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,9187,1,,,16434,,Lung,N,50597,CHEMBL622376,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9188,1,,,16435,,Lung,N,50597,CHEMBL622377,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9189,1,,,16435,,Lung,N,50597,CHEMBL622378,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9190,1,,,16435,,Lung,N,50597,CHEMBL622379,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9191,1,,,16435,,Lung,N,50597,CHEMBL622380,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9192,1,,,16435,,Lung,N,50597,CHEMBL622381,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9193,1,,,16435,,Lung,N,50597,CHEMBL622382,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,9194,1,,,16434,,Lung,N,50597,CHEMBL622383,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9195,1,,,6175,,Stomach,N,50597,CHEMBL875332,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9196,1,,,6175,,Stomach,N,50597,CHEMBL622384,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9197,1,,,6175,,Stomach,N,50597,CHEMBL622385,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,9198,1,,,6175,,Stomach,N,50597,CHEMBL622386,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for the plasma binding in rat,,9199,1,,,10839,,,N,50597,CHEMBL622387,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,9200,1,,,16459,,,N,50597,CHEMBL622388,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,9201,1,,,16459,,,N,50597,CHEMBL622389,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,9202,1,,,16459,,,N,50597,CHEMBL622390,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,9203,1,,,16459,,,N,50597,CHEMBL622391,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,9204,1,,,16459,,,N,50597,CHEMBL622392,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,9205,1,,,16459,,,N,50597,CHEMBL622393,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma level at 2 hr after administration of the compound,,9206,1,,,3278,,,N,50597,CHEMBL622394,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,plasma level at 2 hr after administration of the compound,,9207,1,,,3278,,,N,50597,CHEMBL622395,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 1 min,,9208,1,,,4684,,Serum,N,50597,CHEMBL622396,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 10 min,,9209,1,,,4684,,Serum,N,50597,CHEMBL624894,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 10 mins,,9210,1,,,4684,,Serum,N,50597,CHEMBL624895,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 2 hr,,9211,1,,,4684,,Serum,N,50597,CHEMBL624058,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 3 min,,9212,1,,,4684,,Serum,N,50597,CHEMBL624059,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 3 mins,,9213,1,,,4684,,Serum,N,50597,CHEMBL624060,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 5 min,,9214,1,,,4684,,Serum,N,50597,CHEMBL624061,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat serum measured as % recovery at 5 mins,,9215,1,,,4684,,Serum,N,50597,CHEMBL624062,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,9216,1,,,16456,,,N,50597,CHEMBL624063,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,9217,1,,,16456,,,N,50597,CHEMBL624064,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,9218,1,,,723,,Plasma,N,50597,CHEMBL624065,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,9219,1,,,723,,Plasma,N,50597,CHEMBL624066,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life tested in mature male rat at a dose of 30 mg/kg,,9220,1,,,5160,,,N,50597,CHEMBL877490,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after intravenous administration of 1 mg/kg in rat,,9221,1,,,4709,,,N,50597,CHEMBL874442,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after administration (30 mg/kg) in rat,,9222,1,,,5633,,,N,50597,CHEMBL626890,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period in rat after 5 mg/Kg dose,,9223,1,,,5302,,,N,50597,CHEMBL626891,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period in rat after 5 mg/kg dose,,9224,1,,,5302,,,N,50597,CHEMBL626892,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was determined,,9225,1,,,17791,,,N,50597,CHEMBL626893,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was evaluated in rat,,9226,1,,,17791,,,N,50597,CHEMBL626894,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was evaluated in rat; 0.5-1.0,,9227,1,,,17791,,,N,50597,CHEMBL626895,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was evaluated in rat; 5.9-7.5,,9228,1,,,17791,,,N,50597,CHEMBL626896,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat plasma,,9229,1,,,14512,,Plasma,N,50597,CHEMBL626897,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life time in rat was determined,,9230,1,,,6230,,,N,50597,CHEMBL626898,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Terminal half-life after iv administration to rats,,9231,1,,,3364,,,N,50597,CHEMBL626899,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,9232,1,,,6874,,,N,50597,CHEMBL626900,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,9233,1,,,857,,,N,50597,CHEMBL626901,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,9234,1,,,858,,,N,50597,CHEMBL626902,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,9235,1,,,858,,,N,50597,CHEMBL626903,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,9236,1,,,5355,,,N,50597,CHEMBL874443,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,9237,1,,,5355,,,N,50597,CHEMBL626904,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rats,,9238,1,,,6305,,,N,50597,CHEMBL626905,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,9239,1,,,13501,,Plasma,N,50597,CHEMBL873830,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,9240,1,,,17594,,,N,50597,CHEMBL626906,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,9241,1,,,4186,,Plasma,N,50597,CHEMBL631076,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biological half-life was measured in plasma of rats,,9242,1,,,2932,,Plasma,N,50597,CHEMBL631077,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,9243,1,,,17065,,,N,50597,CHEMBL631078,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,9244,1,,,15765,,,N,50597,CHEMBL631079,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,9245,1,,,2713,,,N,50597,CHEMBL631080,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,9246,1,,,2661,,,N,50597,CHEMBL631081,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,9247,1,,,2661,,,N,50597,CHEMBL631239,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for plasma half life in rat,,9248,1,,,740,,Plasma,N,50597,CHEMBL631240,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC value at a dose of 5 mg/kg (p.o.) in rats,,9249,1,,,6597,,Plasma,N,50597,CHEMBL631241,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC value after administration of 20 mg/Kg oral dose in rat,,9250,1,,,2959,,Plasma,N,50597,CHEMBL631242,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,9251,1,,,17594,,Plasma,N,50597,CHEMBL631243,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC0-96 after administration at 50 mg/kg,,9252,1,,,17596,,Plasma,N,50597,CHEMBL874444,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,9253,1,,,17594,,Plasma,N,50597,CHEMBL631244,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,9254,1,,,3293,,,N,50597,CHEMBL631245,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,9255,1,,,6757,,,N,50597,CHEMBL627162,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,9256,1,,,6757,,,N,50597,CHEMBL627163,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,9257,1,,,6757,,,N,50597,CHEMBL627164,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,9258,1,,,5979,,Kidney,N,50597,CHEMBL627165,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,9259,1,,,5979,,,N,50597,CHEMBL627166,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,9260,1,,,5979,,,N,50597,CHEMBL627167,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) at a dose of 30 mg/kg in rats,,9261,1,,,4026,,,N,50597,CHEMBL627822,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,9262,1,,,5355,,,N,50597,CHEMBL627823,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,9263,1,,,5355,,,N,50597,CHEMBL627824,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,9264,1,,,5355,,,N,50597,CHEMBL627825,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,9265,1,,,5633,,,N,50597,CHEMBL627826,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (Pharmacokinetic property) was determined,,9266,1,,,1716,,,N,50597,CHEMBL627827,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (Pharmacokinetic property) of the compound; Not determined,,9267,1,,,1716,,,N,50597,CHEMBL627828,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve after intravenous administration (1 mg/kg) in rat,,9268,1,,,4689,,,N,50597,CHEMBL627829,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,9269,1,,,4527,,,N,50597,CHEMBL627830,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,9270,1,,,4527,,,N,50597,CHEMBL627831,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in male SD rats was observed after oral administration in rat,,9271,1,,,15662,,,N,50597,CHEMBL627832,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,9272,1,,,4413,,,N,50597,CHEMBL627833,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,,,10116.0,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,9273,1,,,3598,,,N,50597,CHEMBL627834,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,,,10116.0,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,9274,1,,,3598,,,N,50597,CHEMBL628004,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve at 5 mg/kg po was determined in rat,,9275,1,,,5964,,,N,50597,CHEMBL628005,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in Rat at a oral dose of 5 mg/kg,,9276,1,,,4689,,,N,50597,CHEMBL628006,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,9277,1,,,4186,,,N,50597,CHEMBL628007,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined,,9278,1,,,5510,,,N,50597,CHEMBL625676,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,9279,1,,,17858,,,N,50597,CHEMBL631309,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve after intravenous administration at 3 mg/kg,,9280,1,,,17804,,,N,50597,CHEMBL631310,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,9281,1,,,6106,,,N,50597,CHEMBL631311,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve at 4 hr in rat,,9282,1,,,5964,,,N,50597,CHEMBL631312,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve at a dose of 30 mg/kg,,9283,1,,,4026,,,N,50597,CHEMBL631313,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,9284,1,,,4756,,,N,50597,CHEMBL631314,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,9285,1,,,4756,,,N,50597,CHEMBL631315,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve for a 2-mpk po dose in SD rats,,9286,1,,,5862,,,N,50597,CHEMBL631316,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in SD rats,,9287,1,,,5862,,,N,50597,CHEMBL631317,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat after oral administration at 13 mg/kg dose,,9288,1,,,6644,,,N,50597,CHEMBL874471,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat by po administration at 0-24 hr,,9289,1,,,5871,,,N,50597,CHEMBL631318,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat plasma,,9290,1,,,5919,,Plasma,N,50597,CHEMBL631319,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,9291,1,,,5939,,,N,50597,CHEMBL631320,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,9292,1,,,5939,,,N,50597,CHEMBL631321,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,9293,1,,,10,,,N,50597,CHEMBL631322,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,9294,1,,,11149,,,N,50597,CHEMBL631323,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve value in rat at a dose of 5 mg/kg,,9295,1,,,5302,,,N,50597,CHEMBL631324,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined after oral administration in rats,,9296,1,,,17796,,,N,50597,CHEMBL631325,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,9297,1,,,4890,,,N,50597,CHEMBL631326,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined after peroral administration in rat,,9298,1,,,6011,,,N,50597,CHEMBL631327,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined at a dose 30 mpk administered orally.,,9299,1,,,5375,,,N,50597,CHEMBL631328,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,9300,1,,,17764,,,N,50597,CHEMBL631329,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,9301,1,,,4368,,,N,50597,CHEMBL627217,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in male rat,,9302,1,,,5610,,,N,50597,CHEMBL626352,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in rat after PO administration,,9303,1,,,5833,,,N,50597,CHEMBL626353,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in rat after a 3 mg/kg of oral dose,,9304,1,,,4257,,,N,50597,CHEMBL626354,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,9305,1,,,5937,,,N,50597,CHEMBL626355,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,9306,1,,,5932,,,N,50597,CHEMBL626356,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,9307,1,,,5932,,,N,50597,CHEMBL626357,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9308,1,,,17411,,,N,50597,CHEMBL626358,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9309,1,,,17411,,,N,50597,CHEMBL626359,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Peak plasma concentration in rat at a dose of 3 mg/kg,,9310,1,,,17771,,Plasma,N,50597,CHEMBL626360,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration at 2 hr in rats was evaluated.,,9311,1,,,1628,,,N,50597,CHEMBL626361,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration at 2 hr in rats was evaluated; Not available,,9312,1,,,1628,,,N,50597,CHEMBL626362,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9313,1,,,17411,,,N,50597,CHEMBL626363,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,9314,1,,,4910,,,N,50597,CHEMBL626970,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,9315,1,,,4910,,,N,50597,CHEMBL626971,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,9316,1,,,4910,,Plasma,N,50597,CHEMBL626972,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,9317,1,,,4910,,Plasma,N,50597,CHEMBL626973,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,9318,1,,,4910,,Plasma,N,50597,CHEMBL626974,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,9319,1,,,4910,,Plasma,N,50597,CHEMBL874592,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,9320,1,,,5510,,,N,50597,CHEMBL626975,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,9321,1,,,5510,,,N,50597,CHEMBL626976,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,9322,1,,,5510,,,N,50597,CHEMBL626977,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,9323,1,,,5510,,,N,50597,CHEMBL626978,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,PK study was carried to determine the relative absorption ranking in rat.,,9324,1,,,16427,,,N,50597,CHEMBL626979,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,9325,1,,,4689,,Plasma,N,50597,CHEMBL626980,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,9326,1,,,11450,,Blood,N,50597,CHEMBL626981,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,9327,1,,,11450,,Blood,N,50597,CHEMBL626982,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,9328,1,,,11450,,Blood,N,50597,CHEMBL626983,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,9329,1,,,11450,,Blood,N,50597,CHEMBL622522,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,9330,1,,,11450,,Blood,N,50597,CHEMBL622523,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,9331,1,,,11450,,Blood,N,50597,CHEMBL622524,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,9332,1,,,11450,,Brain,N,50597,CHEMBL622525,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,9333,1,,,11450,,Brain,N,50597,CHEMBL622526,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,9334,1,,,11450,,Brain,N,50597,CHEMBL619849,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,9335,1,,,11450,,Brain,N,50597,CHEMBL619850,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,9336,1,,,11450,,Brain,N,50597,CHEMBL623864,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,9337,1,,,11450,,Brain,N,50597,CHEMBL623865,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,9338,1,,,11450,,Heart,N,50597,CHEMBL623866,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,9339,1,,,11450,,Heart,N,50597,CHEMBL623867,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,9340,1,,,11450,,Heart,N,50597,CHEMBL877615,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,9341,1,,,11450,,Heart,N,50597,CHEMBL623868,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,9342,1,,,11450,,Heart,N,50597,CHEMBL623869,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,9343,1,,,11450,,Heart,N,50597,CHEMBL623870,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,9344,1,,,16434,,Lung,N,50597,CHEMBL623871,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9345,1,,,16434,,Lung,N,50597,CHEMBL623872,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9346,1,,,16435,,Lung,N,50597,CHEMBL622129,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9347,1,,,16435,,Lung,N,50597,CHEMBL622130,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9348,1,,,16435,,Lung,N,50597,CHEMBL622131,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9349,1,,,16435,,Lung,N,50597,CHEMBL622132,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9350,1,,,16435,,Lung,N,50597,CHEMBL622133,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9351,1,,,16435,,Lung,N,50597,CHEMBL622134,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9352,1,,,16435,,Lung,N,50597,CHEMBL622135,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9353,1,,,16435,,Lung,N,50597,CHEMBL622136,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9354,1,,,16434,,Muscle tissue,N,50597,CHEMBL622137,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9355,1,,,16434,,Muscle tissue,N,50597,CHEMBL622138,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9356,1,,,16434,,Muscle tissue,N,50597,CHEMBL623017,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9357,1,,,16434,,Muscle tissue,N,50597,CHEMBL623018,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9358,1,,,16434,,Muscle tissue,N,50597,CHEMBL623019,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9359,1,,,16434,,Muscle tissue,N,50597,CHEMBL623020,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,9360,1,,,16434,,Muscle tissue,N,50597,CHEMBL623021,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,9361,1,,,16434,,Muscle tissue,N,50597,CHEMBL623022,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9362,1,,,16435,,Muscle tissue,N,50597,CHEMBL623023,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9363,1,,,16435,,Muscle tissue,N,50597,CHEMBL623024,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9364,1,,,16435,,Muscle tissue,N,50597,CHEMBL623025,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9365,1,,,16435,,Muscle tissue,N,50597,CHEMBL620545,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9366,1,,,16435,,Muscle tissue,N,50597,CHEMBL620546,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9367,1,,,16435,,Muscle tissue,N,50597,CHEMBL620547,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9368,1,,,16435,,Muscle tissue,N,50597,CHEMBL620548,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9369,1,,,16435,,Muscle tissue,N,50597,CHEMBL620549,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9370,1,,,16434,,Muscle tissue,N,50597,CHEMBL620550,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,9371,1,,,16434,,Muscle tissue,N,50597,CHEMBL620551,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9372,1,,,16434,,Muscle tissue,N,50597,CHEMBL620552,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9373,1,,,16435,,Muscle tissue,N,50597,CHEMBL620553,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9374,1,,,16435,,Muscle tissue,N,50597,CHEMBL620554,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9375,1,,,16435,,Muscle tissue,N,50597,CHEMBL875845,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9376,1,,,16435,,Muscle tissue,N,50597,CHEMBL620555,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9377,1,,,16435,,Muscle tissue,N,50597,CHEMBL620556,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9378,1,,,16435,,Muscle tissue,N,50597,CHEMBL620557,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9379,1,,,16434,,,N,50597,CHEMBL620558,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9380,1,,,16434,,,N,50597,CHEMBL620559,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9381,1,,,16434,,,N,50597,CHEMBL622939,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9382,1,,,16434,,,N,50597,CHEMBL622940,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9383,1,,,16434,,,N,50597,CHEMBL622941,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9384,1,,,16434,,,N,50597,CHEMBL622942,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9385,1,,,16434,,,N,50597,CHEMBL622943,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9386,1,,,16434,,,N,50597,CHEMBL622944,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9387,1,,,16435,,,N,50597,CHEMBL622945,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9388,1,,,16435,,,N,50597,CHEMBL622946,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for terminal half life in rat,,9389,1,,,3341,,,N,50597,CHEMBL622947,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,9390,1,,,3634,,Plasma,N,50597,CHEMBL622948,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,9391,1,,,3634,,Plasma,N,50597,CHEMBL622949,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for its half life in rat,,9392,1,,,4839,,,N,50597,CHEMBL622950,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,9393,0,,,5005,,Plasma,U,22224,CHEMBL622951,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for its plasma half life in Sprague Dawley rats,,9394,0,,,5005,,Plasma,U,22224,CHEMBL622952,BAO_0000366,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,9395,0,,,5005,,Plasma,U,22224,CHEMBL622953,BAO_0000366,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for plasma half-life period in rat,,9396,1,,,1094,,Plasma,N,50597,CHEMBL873818,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Elimination half life after i.v. administration of compound in rats,,9397,1,,,5031,,,N,50597,CHEMBL622954,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,9398,1,,,6518,,,N,50597,CHEMBL622955,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Elimination half-life after IV dosing at 1 mg/kg in rat,,9399,1,,,6518,,,N,50597,CHEMBL875229,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,9400,1,,,6518,,,N,50597,CHEMBL622956,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,9401,1,,,6518,,,N,50597,CHEMBL622957,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,9402,1,,,5408,,Brain,N,50597,CHEMBL622958,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,9403,1,,,5408,,Plasma,N,50597,CHEMBL622959,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,9404,1,,,5408,,Brain,N,50597,CHEMBL622960,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,9405,1,,,5408,,Plasma,N,50597,CHEMBL622961,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for the half life in rat (in vivo),,9406,1,,,4687,,,N,50597,CHEMBL622962,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hafl life in rat,,9407,1,,,6640,,,N,50597,CHEMBL622963,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hafl life rat,,9408,1,,,6640,,,N,50597,CHEMBL622964,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hafl life rat,,9409,1,,,6641,,,N,50597,CHEMBL622965,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hafl life rat; Not determined,,9410,1,,,6640,,,N,50597,CHEMBL622966,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hafl life rat; Not determined,,9411,1,,,6641,,,N,50597,CHEMBL622967,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9412,1,,,17411,,Kidney,N,50597,CHEMBL622968,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9413,1,,,17411,,Liver,N,50597,CHEMBL622969,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9414,1,,,17411,,Lung,N,50597,CHEMBL875327,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after 1 mg/kg i.v. administration,,9415,1,,,6570,,,N,50597,CHEMBL628638,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after 2 mg/kg peroral administration,,9416,1,,,6570,,,N,50597,CHEMBL628639,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,9417,1,,,17411,,,N,50597,CHEMBL625840,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of 10 mg/kg oral dose determined in rats,,9418,1,,,4722,,,N,50597,CHEMBL625841,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9419,1,,,5978,,,N,50597,CHEMBL625842,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,9420,1,,,5978,,,N,50597,CHEMBL625843,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,9421,1,,,5978,,,N,50597,CHEMBL625844,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,9422,1,,,5978,,,N,50597,CHEMBL873822,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9423,1,,,5978,,,N,50597,CHEMBL625845,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9424,1,,,5978,,,N,50597,CHEMBL627059,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,9425,1,,,5978,,,N,50597,CHEMBL627060,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,9426,1,,,5978,,,N,50597,CHEMBL627061,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound at 5 mg/kg after po administration was determined in rat,,9427,1,,,4762,,,N,50597,CHEMBL627709,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life of compound determined after intravenous administration to rat,,9428,1,,,5327,,,N,50597,CHEMBL627710,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life of compound was determined in rat,,9429,1,,,4847,,,N,50597,CHEMBL627711,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,9430,1,,,17720,,Plasma,N,50597,CHEMBL627712,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9431,1,,,4723,,,N,50597,CHEMBL627713,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9432,1,,,4723,,,N,50597,CHEMBL627714,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,9433,0,,,4256,,,U,22224,CHEMBL627889,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life determined in rat by intravenous administration,,9434,0,,,4256,,,U,22224,CHEMBL627890,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life determined in rats after iv administration,,9435,1,,,4722,,,N,50597,CHEMBL627891,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat plasma after administration of 2 mg/kg iv,,9436,1,,,6535,,Plasma,N,50597,CHEMBL627892,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat plasma after administration of 2 mg/kg iv,,9437,1,,,6535,,Plasma,N,50597,CHEMBL627893,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat plasma was determined,,9438,1,,,1435,,Plasma,N,50597,CHEMBL627894,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat plasma was determined; NA means not applicable,,9439,1,,,1435,,Plasma,N,50597,CHEMBL627895,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat was tested,,9440,1,,,5206,,,N,50597,CHEMBL627896,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life measured in rat plasma,,9441,1,,,6080,,Plasma,N,50597,CHEMBL627897,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life recorded in rats,,9442,1,,,4449,,,N,50597,CHEMBL627898,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was calculated,,9443,1,,,6057,,,N,50597,CHEMBL627899,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was calculated in rat,,9444,1,,,6057,,,N,50597,CHEMBL873823,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was determined,,9445,1,,,3747,,,N,50597,CHEMBL627900,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after 10 mg/kg oral administration in rat,,9446,1,,,17858,,,N,50597,CHEMBL627901,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,9447,1,,,16365,,,N,50597,CHEMBL627902,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after administering orally a dose of 30 mg/kg,,9448,1,,,16365,,,N,50597,CHEMBL627903,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,9449,1,,,5031,,,N,50597,CHEMBL627904,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,9450,1,,,4722,,,N,50597,CHEMBL627905,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,9451,1,,,6078,,,N,50597,CHEMBL627906,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,9452,1,,,6078,,,N,50597,CHEMBL627907,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,9453,1,,,6078,,,N,50597,CHEMBL876783,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,9454,1,,,6078,,,N,50597,CHEMBL627908,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,9455,1,,,17065,,,N,50597,CHEMBL627909,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,9456,1,,,1353,,,N,50597,CHEMBL627910,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,9457,1,,,1353,,,N,50597,CHEMBL627911,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,9458,1,,,1353,,,N,50597,CHEMBL627912,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,9459,1,,,1353,,,N,50597,CHEMBL627913,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,9460,1,,,1353,,,N,50597,CHEMBL627914,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,9461,1,,,16423,,,N,50597,CHEMBL627915,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was evaluated after 20 uM/kg of peroral administration,,9462,1,,,16423,,,N,50597,CHEMBL627916,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,9463,1,,,6062,,,N,50597,CHEMBL627917,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,9464,1,,,6056,,,N,50597,CHEMBL627918,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,9465,1,,,5182,,,N,50597,CHEMBL627919,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,9466,1,,,6410,,,N,50597,CHEMBL627920,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve was evaluated at an oral dose of 30 mg/kg,,9467,1,,,6410,,,N,50597,CHEMBL627921,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9468,1,,,4723,,,N,50597,CHEMBL627922,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9469,1,,,4723,,,N,50597,CHEMBL876784,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9470,1,,,4723,,,N,50597,CHEMBL627923,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9471,1,,,4723,,,N,50597,CHEMBL626208,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,9472,1,,,4723,,,N,50597,CHEMBL626209,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,9473,1,,,4723,,,N,50597,CHEMBL626210,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,9474,1,,,2463,,Plasma,N,50597,CHEMBL627994,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,9475,1,,,4709,,,N,50597,CHEMBL627995,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,9476,1,,,4075,,,N,50597,CHEMBL627996,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,9477,1,,,5394,,,N,50597,CHEMBL627997,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,9478,1,,,2661,,,N,50597,CHEMBL627998,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,9479,1,,,2661,,,N,50597,CHEMBL628640,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,9480,1,,,2661,,,N,50597,CHEMBL628641,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,9481,1,,,2661,,,N,50597,CHEMBL628642,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for area under the curve expressed as (h*ug/ml),,9482,1,,,17791,,,N,50597,CHEMBL628643,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for area under curve in rat,,9483,1,,,2591,,,N,50597,CHEMBL628644,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,9484,1,,,6567,,,N,50597,CHEMBL628645,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,9485,1,,,6211,,,N,50597,CHEMBL628646,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,9486,1,,,5529,,,N,50597,CHEMBL628647,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,9487,1,,,5408,,,N,50597,CHEMBL628648,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,9488,1,,,5408,,,N,50597,CHEMBL625358,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,9489,1,,,5408,,,N,50597,CHEMBL625359,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,9490,1,,,5408,,,N,50597,CHEMBL625360,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,9491,1,,,429,,,N,50597,CHEMBL625361,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,9492,1,,,429,,,N,50597,CHEMBL625362,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,9493,1,,,429,,,N,50597,CHEMBL625363,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,9494,1,,,4796,,,N,50597,CHEMBL625364,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,9495,1,,,5974,,,N,50597,CHEMBL625365,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,9496,1,,,5974,,,N,50597,CHEMBL625366,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,9497,1,,,5974,,,N,50597,CHEMBL625367,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,9498,1,,,11450,,Kidney,N,50597,CHEMBL625368,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,9499,1,,,11450,,Kidney,N,50597,CHEMBL625369,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,9500,1,,,11450,,Kidney,N,50597,CHEMBL625370,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,9501,1,,,11450,,Kidney,N,50597,CHEMBL625371,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,9502,1,,,11450,,Kidney,N,50597,CHEMBL625372,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,9503,1,,,11450,,Kidney,N,50597,CHEMBL625373,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,9504,1,,,11450,,Liver,N,50597,CHEMBL625374,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,9505,1,,,11450,,Liver,N,50597,CHEMBL877593,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,9506,1,,,11450,,Liver,N,50597,CHEMBL625375,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,9507,1,,,11450,,Liver,N,50597,CHEMBL625376,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,9508,1,,,11450,,Liver,N,50597,CHEMBL621973,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,9509,1,,,11450,,Liver,N,50597,CHEMBL621974,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,9510,1,,,11450,,Lung,N,50597,CHEMBL621975,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,9511,1,,,11450,,Lung,N,50597,CHEMBL622166,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,9512,1,,,11450,,Lung,N,50597,CHEMBL622167,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,9513,1,,,11450,,Lung,N,50597,CHEMBL622168,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,9514,1,,,11450,,Lung,N,50597,CHEMBL622169,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,9515,1,,,11450,,Lung,N,50597,CHEMBL622170,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,9516,1,,,11450,,Thyroid gland,N,50597,CHEMBL622171,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,9517,1,,,11450,,Thyroid gland,N,50597,CHEMBL622172,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,9518,1,,,11450,,Thyroid gland,N,50597,CHEMBL622173,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,9519,1,,,11450,,Thyroid gland,N,50597,CHEMBL622174,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,9520,1,,,11450,,Thyroid gland,N,50597,CHEMBL622175,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,9521,1,,,11450,,Thyroid gland,N,50597,CHEMBL622176,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,9522,1,,,11450,,Thyroid gland,N,50597,CHEMBL622177,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,9523,1,,,11450,,Thyroid gland,N,50597,CHEMBL622178,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,9524,1,,,11450,,Thyroid gland,N,50597,CHEMBL622179,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,9525,1,,,11450,,Thyroid gland,N,50597,CHEMBL622180,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9526,1,,,16435,,,N,50597,CHEMBL622181,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9527,1,,,16435,,,N,50597,CHEMBL622182,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9528,1,,,16435,,,N,50597,CHEMBL622183,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9529,1,,,16435,,,N,50597,CHEMBL622184,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9530,1,,,16435,,,N,50597,CHEMBL622185,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9531,1,,,16435,,,N,50597,CHEMBL622186,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9532,1,,,16434,,,N,50597,CHEMBL622187,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,9533,1,,,16434,,,N,50597,CHEMBL625002,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,9534,1,,,16434,,,N,50597,CHEMBL622090,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9535,1,,,16435,,,N,50597,CHEMBL622091,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9536,1,,,16435,,,N,50597,CHEMBL622092,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9537,1,,,16435,,,N,50597,CHEMBL622093,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9538,1,,,16435,,,N,50597,CHEMBL622094,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9539,1,,,16435,,,N,50597,CHEMBL622095,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9540,1,,,16435,,,N,50597,CHEMBL622264,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9541,1,,,16434,,Spleen,N,50597,CHEMBL622265,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9542,1,,,16434,,Spleen,N,50597,CHEMBL622266,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9543,1,,,16434,,Spleen,N,50597,CHEMBL622267,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9544,1,,,16434,,Spleen,N,50597,CHEMBL622268,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9545,1,,,16434,,Spleen,N,50597,CHEMBL622269,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9546,1,,,16434,,Spleen,N,50597,CHEMBL625071,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9547,1,,,16434,,Spleen,N,50597,CHEMBL621621,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9548,1,,,16434,,Spleen,N,50597,CHEMBL621622,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9549,1,,,16435,,Spleen,N,50597,CHEMBL621623,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9550,1,,,16435,,Spleen,N,50597,CHEMBL621624,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9551,1,,,16435,,Spleen,N,50597,CHEMBL621625,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9552,1,,,16435,,Spleen,N,50597,CHEMBL621626,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9553,1,,,16435,,Spleen,N,50597,CHEMBL621627,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9554,1,,,16435,,Spleen,N,50597,CHEMBL621628,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9555,1,,,16435,,Spleen,N,50597,CHEMBL875328,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9556,1,,,16435,,Spleen,N,50597,CHEMBL621629,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9557,1,,,16434,,Spleen,N,50597,CHEMBL621630,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9558,1,,,16434,,Spleen,N,50597,CHEMBL621631,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9559,1,,,16434,,Spleen,N,50597,CHEMBL621632,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9560,1,,,16435,,Spleen,N,50597,CHEMBL621633,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9561,1,,,16435,,Spleen,N,50597,CHEMBL621634,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9562,1,,,16435,,Spleen,N,50597,CHEMBL621635,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9563,1,,,16435,,Spleen,N,50597,CHEMBL621636,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9564,1,,,16435,,Spleen,N,50597,CHEMBL621637,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9565,1,,,16435,,Spleen,N,50597,CHEMBL621638,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9566,1,,,16434,,,N,50597,CHEMBL618883,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,9567,1,,,16434,,,N,50597,CHEMBL618884,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9568,1,,,16434,,,N,50597,CHEMBL628627,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9569,1,,,16434,,,N,50597,CHEMBL628628,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,9570,1,,,16434,,,N,50597,CHEMBL628629,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after administering orally a dose of 3 mg/kg,,9571,1,,,16365,,,N,50597,CHEMBL628630,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,9572,1,,,16365,,,N,50597,CHEMBL628631,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after administering intravenously a dose of 1 mg/kg,,9573,1,,,16365,,,N,50597,CHEMBL628632,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after oral dosing in rats,,9574,1,,,526,,,N,50597,CHEMBL628633,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,9575,1,,,16365,,,N,50597,CHEMBL628634,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life by intravenous administration of 3.4 mg/kg in rat,,9576,1,,,4368,,,N,50597,CHEMBL627789,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat,,9577,1,,,3371,,,N,50597,CHEMBL627790,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat,,9578,1,,,6448,,,N,50597,CHEMBL627791,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat,,9579,1,,,6453,,,N,50597,CHEMBL627792,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after intravenous administration of the compound,,9580,1,,,4353,,,N,50597,CHEMBL627793,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,9581,1,,,4353,,Plasma,N,50597,CHEMBL627794,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after po administration of the compound,,9582,1,,,4353,,,N,50597,CHEMBL627795,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after po administration of the compound; ND means Not determined,,9583,1,,,4353,,,N,50597,CHEMBL627796,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,9584,1,,,4353,,Plasma,N,50597,CHEMBL875335,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,9585,1,,,4353,,Plasma,N,50597,CHEMBL627797,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat i.v.,,9586,1,,,5789,,,N,50597,CHEMBL627798,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rat i.v. at 2 mg/kg concentration,,9587,1,,,17686,,,N,50597,CHEMBL627799,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rats,,9588,1,,,6495,,,N,50597,CHEMBL627800,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rats after intravenous administration,,9589,1,,,484,,,N,50597,CHEMBL627801,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life in rats at the dose of 1.0 mpk by i.v. administration,,9590,1,,,6467,,,N,50597,CHEMBL627802,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,,,10116.0,Half life in rat,,9591,1,,,6642,,,N,50597,CHEMBL627803,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was evaluated after intravenous administration to rats,,9592,1,,,16367,,,N,50597,CHEMBL873820,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,9593,1,,,1369,,,N,50597,CHEMBL627804,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was evaluated in rat,,9594,1,,,5472,,,N,50597,CHEMBL627805,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was evaluated in rat,,9595,1,,,6049,,,N,50597,CHEMBL627806,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was evaluated in rat; Not tested,,9596,1,,,5472,,,N,50597,CHEMBL627107,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,9597,1,,,16366,,,N,50597,CHEMBL627108,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,9598,1,,,11149,,,N,50597,CHEMBL627109,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,9599,1,,,11149,,Blood,N,50597,CHEMBL627110,BAO_0000218,178.0
A,Intermediate,1,,,Primates,In vivo,,9443.0,Half life was measured in monkey at dose of 10 mg/kg by po administration,,9600,0,,,2891,,,U,22224,CHEMBL627111,BAO_0000218,
A,Intermediate,1,,,Primates,In vivo,,9443.0,Half life was measured in monkey at dose of 10 mg/kg by po administration,,9601,0,,,2891,,,U,22224,CHEMBL627112,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was measured in rat at dose of 30 mg/kg by iv administration,,9602,0,,,2891,,,U,22224,CHEMBL627113,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was measured in rat at dose of 30 mg/kg by po administration,,9603,0,,,2891,,,U,22224,CHEMBL627114,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life (t1/2) was determined,,9604,1,,,4026,,,N,50597,CHEMBL627115,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period at a dose of 10 uM/kg in rat was determined,,9605,1,,,4527,,,N,50597,CHEMBL627116,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,9606,1,,,4527,,,N,50597,CHEMBL627117,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was determined,,9607,1,,,5503,,,N,50597,CHEMBL627118,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after intravenous administration at 20 mpk in rats,,9608,1,,,4426,,,N,50597,CHEMBL627119,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,9609,1,,,4426,,,N,50597,CHEMBL627120,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after intravenous administration in rat,,9610,1,,,6109,,,N,50597,CHEMBL626922,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,9611,1,,,5654,,,N,50597,CHEMBL626923,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,9612,1,,,5654,,,N,50597,CHEMBL626924,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in 80% rat plasma at 37 degree Centigrade,,9613,1,,,4755,,Plasma,N,50597,CHEMBL626925,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in SD rats,,9614,1,,,5862,,,N,50597,CHEMBL626926,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,9615,1,,,1515,,Plasma,N,50597,CHEMBL626927,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,9616,1,,,1515,,Plasma,N,50597,CHEMBL626928,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9617,1,,,1515,,Plasma,N,50597,CHEMBL626929,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9618,1,,,1515,,Plasma,N,50597,CHEMBL626930,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat,,9619,1,,,5960,,,N,50597,CHEMBL626931,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat,,9620,1,,,6103,,,N,50597,CHEMBL626932,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat,,9621,1,,,6317,,,N,50597,CHEMBL626933,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period in rat after oral administration at 10.5 mg/kg dose,,9622,1,,,6644,,,N,50597,CHEMBL873826,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period in rat after oral administration at 11.2 mg/kg dose,,9623,1,,,6644,,,N,50597,CHEMBL626934,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period in rat after oral administration at 13 mg/kg dose,,9624,1,,,6644,,,N,50597,CHEMBL626935,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period in rat after oral administration at 9.7 mg/kg dose,,9625,1,,,6644,,,N,50597,CHEMBL626936,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,9626,1,,,5974,,,N,50597,CHEMBL626937,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,9627,1,,,6295,,,N,50597,CHEMBL625906,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,9628,1,,,6296,,,N,50597,CHEMBL625907,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,PK study was carried to determine AUC (area under curve) value in rat,,9629,1,,,16427,,,N,50597,CHEMBL625908,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC after intravenous administration to rats,,9630,1,,,16367,,,N,50597,CHEMBL625909,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC after oral administration to rats,,9631,1,,,16367,,,N,50597,CHEMBL625910,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,9632,1,,,16365,,,N,50597,CHEMBL625911,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,9633,1,,,16365,,,N,50597,CHEMBL625912,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,9634,1,,,16365,,,N,50597,CHEMBL626538,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,9635,1,,,16365,,,N,50597,CHEMBL876794,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,9636,1,,,16365,,,N,50597,CHEMBL626539,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,9637,1,,,16365,,,N,50597,CHEMBL626540,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,9638,1,,,5394,,,N,50597,CHEMBL626541,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,9639,1,,,5394,,,N,50597,CHEMBL626542,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,9640,1,,,2792,,,N,50597,CHEMBL626543,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,9641,1,,,2792,,,N,50597,CHEMBL626544,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,9642,1,,,2792,,,N,50597,CHEMBL626545,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,9643,1,,,2792,,,N,50597,CHEMBL626546,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter area under curve was reported,,9644,1,,,5334,,,N,50597,CHEMBL626547,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property (AUC) in rat,,9645,1,,,4408,,,N,50597,CHEMBL626548,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,9646,1,,,5983,,,N,50597,CHEMBL626549,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,9647,1,,,4397,,,N,50597,CHEMBL626550,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,9648,1,,,4397,,,N,50597,CHEMBL626551,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property was determined,,9649,1,,,5491,,,N,50597,CHEMBL623777,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,9650,1,,,5491,,,N,50597,CHEMBL623778,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,9651,1,,,5491,,,N,50597,CHEMBL623779,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,9652,1,,,4199,,Plasma,N,50597,CHEMBL623780,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,9653,1,,,4199,,Plasma,N,50597,CHEMBL622015,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,9654,1,,,4199,,Plasma,N,50597,CHEMBL622016,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,9655,1,,,5173,,,N,50597,CHEMBL622017,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,9656,1,,,5173,,,N,50597,CHEMBL622018,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,9657,1,,,5173,,,N,50597,CHEMBL622019,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,9658,1,,,5173,,,N,50597,CHEMBL622020,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,9659,1,,,16366,,,N,50597,CHEMBL622021,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,9660,1,,,16366,,,N,50597,CHEMBL622022,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,9661,1,,,5327,,,N,50597,CHEMBL622023,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,9662,1,,,6681,,,N,50597,CHEMBL622024,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,9663,1,,,12873,,,N,50597,CHEMBL622693,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,9664,1,,,12873,,,N,50597,CHEMBL622694,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,9665,1,,,6685,,,N,50597,CHEMBL622695,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,9666,1,,,6685,,,N,50597,CHEMBL622696,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,9667,1,,,6685,,,N,50597,CHEMBL622697,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,9668,1,,,6619,,,N,50597,CHEMBL622874,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,9669,1,,,6619,,,N,50597,CHEMBL622875,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,9670,1,,,10363,,,N,50597,CHEMBL622876,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,9671,1,,,4796,,,N,50597,CHEMBL622877,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,9672,1,,,4910,,,N,50597,CHEMBL622878,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,9673,1,,,4910,,Plasma,N,50597,CHEMBL622879,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,9674,1,,,4839,,,N,50597,CHEMBL877602,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,9675,1,,,15078,,,N,50597,CHEMBL622880,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,9676,1,,,15078,,,N,50597,CHEMBL622881,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,9677,1,,,15078,,,N,50597,CHEMBL622882,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,9678,1,,,15078,,,N,50597,CHEMBL622883,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,9679,1,,,11450,,Thyroid gland,N,50597,CHEMBL622884,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,9680,1,,,11450,,Thyroid gland,N,50597,CHEMBL622885,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,9681,1,,,8151,,,N,50597,CHEMBL622886,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,9682,1,,,8151,,,N,50597,CHEMBL622887,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,9683,1,,,8151,,Urine,N,50597,CHEMBL622888,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9684,1,,,8677,,Blood,N,50597,CHEMBL622889,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9685,1,,,8677,,Blood,N,50597,CHEMBL622890,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9686,1,,,8677,,Blood,N,50597,CHEMBL622891,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9687,1,,,8677,,Blood,N,50597,CHEMBL877603,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9688,1,,,8677,,Brain,N,50597,CHEMBL622892,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9689,1,,,8677,,Brain,N,50597,CHEMBL622893,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9690,1,,,8677,,Brain,N,50597,CHEMBL622894,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9691,1,,,8677,,Brain,N,50597,CHEMBL622895,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,9692,1,,,8677,,Brain,N,50597,CHEMBL622896,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9693,1,,,8677,,Heart,N,50597,CHEMBL622897,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9694,1,,,8677,,Heart,N,50597,CHEMBL622898,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9695,1,,,8677,,Heart,N,50597,CHEMBL622899,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9696,1,,,8677,,Kidney,N,50597,CHEMBL622900,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9697,1,,,8677,,Kidney,N,50597,CHEMBL624114,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9698,1,,,8677,,Kidney,N,50597,CHEMBL624115,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9699,1,,,8677,,Kidney,N,50597,CHEMBL624116,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9700,1,,,8677,,Liver,N,50597,CHEMBL624117,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9701,1,,,8677,,Liver,N,50597,CHEMBL624118,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9702,1,,,8677,,Liver,N,50597,CHEMBL624119,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9703,1,,,8677,,Liver,N,50597,CHEMBL624120,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9704,1,,,8677,,Lung,N,50597,CHEMBL624121,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9705,1,,,8677,,Lung,N,50597,CHEMBL624122,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9706,1,,,8677,,Lung,N,50597,CHEMBL624123,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9707,1,,,8677,,Lung,N,50597,CHEMBL624124,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9708,1,,,8677,,Muscle tissue,N,50597,CHEMBL624125,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9709,1,,,8677,,Muscle tissue,N,50597,CHEMBL624126,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9710,1,,,8677,,Muscle tissue,N,50597,CHEMBL624127,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9711,1,,,8677,,Muscle tissue,N,50597,CHEMBL624128,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9712,1,,,8677,,Zone of skin,N,50597,CHEMBL624129,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9713,1,,,8677,,Zone of skin,N,50597,CHEMBL624130,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9714,1,,,8677,,Zone of skin,N,50597,CHEMBL622340,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9715,1,,,8677,,Zone of skin,N,50597,CHEMBL622341,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9716,1,,,8677,,Intestine,N,50597,CHEMBL622342,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9717,1,,,8677,,Intestine,N,50597,CHEMBL622343,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9718,1,,,8677,,Intestine,N,50597,CHEMBL622344,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9719,1,,,8677,,Intestine,N,50597,CHEMBL622345,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9720,1,,,8677,,Spleen,N,50597,CHEMBL622346,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9721,1,,,8677,,Spleen,N,50597,CHEMBL622347,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9722,1,,,8677,,Spleen,N,50597,CHEMBL622348,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9723,1,,,8677,,Spleen,N,50597,CHEMBL622349,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,9724,1,,,16434,,,N,50597,CHEMBL622350,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,9725,1,,,16434,,,N,50597,CHEMBL622351,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,9726,1,,,16434,,,N,50597,CHEMBL622352,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,9727,1,,,16435,,,N,50597,CHEMBL622353,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,9728,1,,,16435,,,N,50597,CHEMBL622354,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,9729,1,,,16435,,,N,50597,CHEMBL622355,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,9730,1,,,16435,,,N,50597,CHEMBL622356,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,9731,1,,,16435,,,N,50597,CHEMBL622357,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,9732,1,,,16435,,,N,50597,CHEMBL622358,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,9733,1,,,16435,,,N,50597,CHEMBL622359,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,9734,1,,,16435,,,N,50597,CHEMBL874393,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9735,1,,,16434,,,N,50597,CHEMBL622872,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9736,1,,,16434,,,N,50597,CHEMBL622873,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9737,1,,,16434,,,N,50597,CHEMBL623047,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9738,1,,,16435,,,N,50597,CHEMBL623048,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9739,1,,,16435,,,N,50597,CHEMBL623049,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9740,1,,,16435,,,N,50597,CHEMBL623050,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9741,1,,,16435,,,N,50597,CHEMBL623051,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9742,1,,,16435,,,N,50597,CHEMBL623052,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9743,1,,,16435,,,N,50597,CHEMBL626343,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,9744,1,,,16434,,,N,50597,CHEMBL626344,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,9745,1,,,16434,,,N,50597,CHEMBL626345,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,9746,1,,,16434,,,N,50597,CHEMBL626346,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,9747,1,,,16434,,,N,50597,CHEMBL626347,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,9748,1,,,16434,,,N,50597,CHEMBL626348,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,9749,1,,,16434,,,N,50597,CHEMBL626349,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,9750,1,,,16435,,,N,50597,CHEMBL626350,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,9751,1,,,16435,,,N,50597,CHEMBL626351,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,9752,1,,,16435,,,N,50597,CHEMBL627650,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,9753,1,,,16435,,,N,50597,CHEMBL627651,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,9754,1,,,16435,,,N,50597,CHEMBL627652,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,9755,1,,,16435,,,N,50597,CHEMBL627653,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,9756,1,,,13091,,,N,50597,CHEMBL627654,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,9757,1,,,13091,,,N,50597,CHEMBL627835,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,9758,1,,,13091,,,N,50597,CHEMBL627836,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,9759,1,,,13091,,,N,50597,CHEMBL627837,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,9760,1,,,13091,,,N,50597,CHEMBL627838,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,9761,1,,,13091,,,N,50597,CHEMBL875338,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,9762,1,,,13091,,,N,50597,CHEMBL627839,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,9763,1,,,13091,,,N,50597,CHEMBL627840,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,9764,1,,,13091,,,N,50597,CHEMBL627841,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,9765,1,,,13091,,,N,50597,CHEMBL627842,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,9766,1,,,13091,,,N,50597,CHEMBL627843,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,9767,1,,,13091,,,N,50597,CHEMBL627844,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,9768,1,,,13091,,,N,50597,CHEMBL627845,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period in rat by iv administration at a dose of 3 mg/kg,,9769,1,,,5874,,,N,50597,CHEMBL627846,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,9770,1,,,1515,,Plasma,N,50597,CHEMBL627847,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,9771,1,,,1515,,Plasma,N,50597,CHEMBL873821,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9772,1,,,1515,,Plasma,N,50597,CHEMBL626079,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,9773,1,,,1515,,Plasma,N,50597,CHEMBL626080,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was evaluated in rat plasma,,9774,1,,,5491,,Plasma,N,50597,CHEMBL626081,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was evaluated in rat plasma; Not tested,,9775,1,,,5491,,Plasma,N,50597,CHEMBL875344,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life period was evaluated in rats,,9776,1,,,1918,,,N,50597,CHEMBL626082,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half life period was evaluated in rats, iv",,9777,1,,,1918,,,N,50597,CHEMBL626250,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period after intravenous administration at 5 mg/kg in rat,,9778,1,,,6113,,,N,50597,CHEMBL626251,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,9779,1,,,5546,,,N,50597,CHEMBL626252,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,9780,1,,,5553,,,N,50597,CHEMBL626253,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life stability of compound was evaluated in rat plasma,,9781,1,,,4188,,Plasma,N,50597,CHEMBL626254,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,9782,1,,,6215,,,N,50597,CHEMBL626255,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,9783,1,,,6141,,,N,50597,CHEMBL626256,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,9784,1,,,5182,,,N,50597,CHEMBL626257,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,9785,1,,,5182,,,N,50597,CHEMBL626258,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,9786,1,,,5710,,,N,50597,CHEMBL626259,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half in rat i.v.,,9787,1,,,5789,,,N,50597,CHEMBL626260,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half period in rat after intravenous administration,,9788,1,,,6011,,,N,50597,CHEMBL875345,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,9789,1,,,17594,,,N,50597,CHEMBL626261,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Half-life measured in in vitro Cathepsin B assay in rat liver,,9790,1,,,12357,,Liver,N,50597,CHEMBL626262,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life of compound was determined in rats,,9791,1,,,5210,,,N,50597,CHEMBL626263,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life at 10 mg/kg in rat upon intravenous administration,,9792,1,,,17596,,,N,50597,CHEMBL625270,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life determined in rat,,9793,1,,,6672,,,N,50597,CHEMBL625271,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life determined in rat,,9794,1,,,6673,,,N,50597,CHEMBL625272,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,9795,1,,,4910,,Brain,N,50597,CHEMBL625273,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,9796,1,,,3741,,Plasma,N,50597,CHEMBL625274,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,9797,1,,,17671,,,N,50597,CHEMBL625275,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,9798,1,,,4910,,Plasma,N,50597,CHEMBL625276,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat plasma,,9799,1,,,17537,,Plasma,N,50597,CHEMBL625277,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat plasma was determined,,9800,1,,,4965,,Plasma,N,50597,CHEMBL625278,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat plasma; Not tested,,9801,1,,,17537,,Plasma,N,50597,CHEMBL625279,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat serum,,9802,1,,,6124,,Serum,N,50597,CHEMBL625280,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat serum; na is not available,,9803,1,,,6124,,Serum,N,50597,CHEMBL876797,BAO_0000218,1977.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was calculated in rat,,9804,1,,,6078,,,N,50597,CHEMBL625281,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was calculated in rat plasma,,9805,1,,,17668,,Plasma,N,50597,CHEMBL873827,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was determined,,9806,1,,,3185,,,N,50597,CHEMBL625282,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was determined,,9807,1,,,4883,,,N,50597,CHEMBL625283,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life after administration of 20 mg/Kg oral dose in rat,,9808,1,,,2959,,,N,50597,CHEMBL625284,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life after administration of 3.2 mg/kg intravenously in male rat,,9809,1,,,4029,,,N,50597,CHEMBL625285,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life after intravenous administration in female rat,,9810,1,,,4029,,,N,50597,CHEMBL625286,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life after intravenous administration in male rat,,9811,1,,,4029,,,N,50597,CHEMBL625287,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life after intravenous dose in rat,,9812,1,,,6180,,,N,50597,CHEMBL625288,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in a rat liver homogenate preparation,,9813,1,,,1557,,Liver,N,50597,CHEMBL625289,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in plasma of rat,,9814,1,,,12500,,Plasma,N,50597,CHEMBL625290,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in plasma of rat at dose of 3-10 mgkg,,9815,1,,,12500,,Plasma,N,50597,CHEMBL876798,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat,,9816,1,,,5064,,,N,50597,CHEMBL625291,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat,,9817,1,,,5145,,,N,50597,CHEMBL625292,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat,,9818,1,,,5147,,,N,50597,CHEMBL625293,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat,,9819,1,,,5833,,,N,50597,CHEMBL622832,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat,,9820,1,,,6596,,,N,50597,CHEMBL622833,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat,,9821,1,,,17655,,,N,50597,CHEMBL622834,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in rat after oral administration at 10 mg/kg,,9822,1,,,6495,,,N,50597,CHEMBL622835,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in rat after po administration at a dose of 10 mg/kg,,9823,1,,,17538,,,N,50597,CHEMBL622836,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,9824,1,,,17538,,,N,50597,CHEMBL622837,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life in rat at 3 mg/kg dose administered intravenously,,9825,1,,,10,,,N,50597,CHEMBL622838,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat brain homogenate,,9826,1,,,17669,,Brain,N,50597,CHEMBL622839,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat plasma,,9827,1,,,17065,,Plasma,N,50597,CHEMBL622840,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rats,,9828,1,,,4333,,,N,50597,CHEMBL622841,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in Dawley rats,,9829,1,,,6827,,,N,50597,CHEMBL622842,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Half-life in vitro in rat plasma,,9830,1,,,889,,Plasma,N,50597,CHEMBL622843,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,9831,1,,,889,,Plasma,N,50597,CHEMBL622844,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,9832,1,,,3747,,,N,50597,CHEMBL622845,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The area under the curve of compound was measured at the dose of 100 umol/kg,,9833,1,,,15022,,,N,50597,CHEMBL622846,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The area under the curve of compound was measured at the dose of 300 umol/kg,,9834,1,,,15022,,,N,50597,CHEMBL622847,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The area under the curve of compound was measured at the dose of 30 umol/kg,,9835,1,,,15022,,,N,50597,CHEMBL622848,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability as oral AUC in rats,,9836,1,,,3360,,,N,50597,CHEMBL622849,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The plasma concentration versus time curve (AUC) was determined,,9837,1,,,5334,,Plasma,N,50597,CHEMBL622850,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9838,1,,,17411,,,N,50597,CHEMBL876807,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9839,1,,,17411,,,N,50597,CHEMBL622851,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9840,1,,,17411,,,N,50597,CHEMBL622852,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,9841,1,,,6570,,,N,50597,CHEMBL622853,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,9842,1,,,6570,,,N,50597,CHEMBL622854,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,9843,1,,,17411,,,N,50597,CHEMBL622855,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,9844,1,,,14941,,Plasma,N,50597,CHEMBL622856,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,9845,1,,,14941,,Plasma,N,50597,CHEMBL622857,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rat after po administration at a dose of 10 mg/kg,,9846,1,,,17538,,Plasma,N,50597,CHEMBL622858,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,9847,1,,,17752,,Plasma,N,50597,CHEMBL622859,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,9848,1,,,17509,,,N,50597,CHEMBL622860,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,9849,1,,,17509,,,N,50597,CHEMBL622861,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,9850,1,,,17509,,,N,50597,CHEMBL622862,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,9851,1,,,17509,,,N,50597,CHEMBL622863,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve value 6 hr after po administration in rat,,9852,1,,,17509,,,N,50597,CHEMBL623817,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,9853,1,,,17717,,,N,50597,CHEMBL623818,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,9854,1,,,17717,,,N,50597,CHEMBL623819,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,9855,1,,,17717,,,N,50597,CHEMBL623820,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,9856,1,,,17717,,,N,50597,CHEMBL623821,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC normalized for dose (AUCN) in rat,,9857,1,,,6642,,Plasma,N,50597,CHEMBL623822,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat after p.o. administration,,9858,1,,,6640,,,N,50597,CHEMBL623823,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat after p.o. administration,,9859,1,,,6641,,,N,50597,CHEMBL623824,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat after p.o. administration; Not determined,,9860,1,,,6641,,,N,50597,CHEMBL623825,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in rat after peroral administration,,9861,1,,,6641,,,N,50597,CHEMBL622070,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (carotid artery) value of the compound,,9862,1,,,3603,,,N,50597,CHEMBL622071,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Bioavailability expressed as the area under curve of rat carotid artery,,9863,1,,,3550,,,N,50597,CHEMBL622072,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve in male SD rats was observed after intravenous administration in rat,,9864,1,,,15662,,,N,50597,CHEMBL622073,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve of the compound was determined,,9865,1,,,17720,,,N,50597,CHEMBL622074,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,9866,1,,,5407,,,N,50597,CHEMBL622075,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,9867,1,,,17752,,Plasma,N,50597,CHEMBL622076,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,9868,1,,,17752,,Plasma,N,50597,CHEMBL622077,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (portal vein) value of the compound,,9869,1,,,3603,,,N,50597,CHEMBL622078,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Bioavailability expressed as the area under curve of rat portal vein,,9870,1,,,3550,,,N,50597,CHEMBL622079,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area Under plasma concentration time curve in rat upon peroral administration,,9871,1,,,17655,,Plasma,N,50597,CHEMBL622080,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,9872,1,,,17582,,,N,50597,CHEMBL877612,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,9873,1,,,17582,,,N,50597,CHEMBL622081,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for oral bioavailability in rats,,9874,1,,,17791,,,N,50597,CHEMBL622082,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for oral bioavailability in rats after iv administration,,9875,1,,,17791,,,N,50597,CHEMBL622083,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for oral bioavailability in rats; 30-80,,9876,1,,,17791,,,N,50597,CHEMBL622084,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for oral bioavailability in rats; 50-60,,9877,1,,,17791,,,N,50597,CHEMBL622085,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for oral bioavailability in rats; no data,,9878,1,,,17791,,,N,50597,CHEMBL622086,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for oral bioavailability in rats; peptide,,9879,1,,,17791,,,N,50597,CHEMBL622087,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,9880,1,,,7768,,Blood,N,50597,CHEMBL622088,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,9881,1,,,7768,,Blood,N,50597,CHEMBL622089,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,9882,1,,,7768,,Blood,N,50597,CHEMBL623685,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,9883,1,,,7768,,Blood,N,50597,CHEMBL623686,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9884,1,,,8677,,Stomach,N,50597,CHEMBL623687,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9885,1,,,8677,,Stomach,N,50597,CHEMBL623688,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9886,1,,,8677,,Stomach,N,50597,CHEMBL623689,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9887,1,,,8677,,Stomach,N,50597,CHEMBL622485,BAO_0000218,945.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9888,1,,,8677,,Thyroid gland,N,50597,CHEMBL622486,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9889,1,,,8677,,Thyroid gland,N,50597,CHEMBL877613,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9890,1,,,8677,,Thyroid gland,N,50597,CHEMBL622487,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9891,1,,,8677,,Thyroid gland,N,50597,CHEMBL622488,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,9892,1,,,8677,,Heart,N,50597,CHEMBL622489,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,9893,1,,,6899,,Urine,N,50597,CHEMBL622490,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,9894,1,,,6899,,Urine,N,50597,CHEMBL622491,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,9895,1,,,6899,,Liver,N,50597,CHEMBL622492,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,9896,1,,,6899,,Urine,N,50597,CHEMBL622493,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,9897,1,,,6899,,Urine,N,50597,CHEMBL622494,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,9898,1,,,8677,,Muscle tissue,N,50597,CHEMBL622495,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,9899,1,,,6899,,,N,50597,CHEMBL622496,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,9900,1,,,6899,,Urine,N,50597,CHEMBL622497,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,9901,1,,,2189,,,N,50597,CHEMBL622498,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,9902,1,,,2189,,Urine,N,50597,CHEMBL624918,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,9903,1,,,2189,,Urine,N,50597,CHEMBL624919,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat blood after 5 min of administration,,9904,1,,,10839,,Blood,N,50597,CHEMBL624920,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat blood after 5 min of administration.,,9905,1,,,10839,,Blood,N,50597,CHEMBL624921,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat brain after 5 min of administration,,9906,1,,,10839,,Brain,N,50597,CHEMBL624922,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat heart after 5 min of administration,,9907,1,,,10839,,Heart,N,50597,CHEMBL624923,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat heart after 5 min of administration.,,9908,1,,,10839,,Heart,N,50597,CHEMBL624924,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat kidney after 5 min of administration,,9909,1,,,10839,,Kidney,N,50597,CHEMBL624925,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat kidney after 5 min of administration.,,9910,1,,,10839,,Kidney,N,50597,CHEMBL624926,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat liver after 5 min of administration,,9911,1,,,10839,,Liver,N,50597,CHEMBL624927,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat liver after 5 min of administration.,,9912,1,,,10839,,Liver,N,50597,CHEMBL874402,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat lung after 5 min of administration,,9913,1,,,10839,,Lung,N,50597,CHEMBL624928,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat lung after 5 min of administration.,,9914,1,,,10839,,Lung,N,50597,CHEMBL624929,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat muscle after 5 min of administration,,9915,1,,,10839,,Muscle tissue,N,50597,CHEMBL624930,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of compound in rat muscle after 5 min of administration.,,9916,1,,,10839,,Muscle tissue,N,50597,CHEMBL624931,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9917,1,,,4043,,Heart,N,50597,CHEMBL624932,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9918,1,,,4043,,Heart,N,50597,CHEMBL624933,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9919,1,,,4043,,Liver,N,50597,CHEMBL624934,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9920,1,,,4043,,Liver,N,50597,CHEMBL624935,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9921,1,,,4043,,,N,50597,CHEMBL624936,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9922,1,,,4043,,,N,50597,CHEMBL624937,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9923,1,,,4043,,Spleen,N,50597,CHEMBL624938,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9924,1,,,4043,,Spleen,N,50597,CHEMBL624939,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9925,1,,,4043,,,N,50597,CHEMBL624940,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,9926,1,,,4043,,,N,50597,CHEMBL874403,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,9927,1,,,1446,,,N,50597,CHEMBL624941,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,9928,1,,,9971,,Urine,N,50597,CHEMBL624942,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,9929,1,,,9971,,Urine,N,50597,CHEMBL624943,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,% Bioavailability after 1 day of the drug administration in rats,,9930,1,,,5765,,,N,50597,CHEMBL624944,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,% Bioavailability after 4 day of the drug administration in rats,,9931,1,,,5765,,,N,50597,CHEMBL624945,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Absolute bioavailability was evaluated in rat,,9932,1,,,4257,,,N,50597,CHEMBL624946,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,9933,1,,,13091,,,N,50597,CHEMBL624947,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,9934,1,,,13091,,,N,50597,CHEMBL624948,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,9935,1,,,13091,,,N,50597,CHEMBL624949,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,9936,1,,,13091,,Kidney,N,50597,CHEMBL622025,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,9937,1,,,13091,,Kidney,N,50597,CHEMBL622026,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,9938,1,,,13091,,Kidney,N,50597,CHEMBL622027,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,9939,1,,,13091,,Kidney,N,50597,CHEMBL622028,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,9940,1,,,13091,,Liver,N,50597,CHEMBL622029,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,9941,1,,,13091,,Liver,N,50597,CHEMBL622208,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,9942,1,,,13091,,Liver,N,50597,CHEMBL622209,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,9943,1,,,13091,,Liver,N,50597,CHEMBL622210,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,9944,1,,,13091,,,N,50597,CHEMBL622211,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,9945,1,,,13091,,,N,50597,CHEMBL622212,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,9946,1,,,13091,,,N,50597,CHEMBL622213,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,9947,1,,,13091,,,N,50597,CHEMBL874404,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,9948,1,,,13091,,Muscle tissue,N,50597,CHEMBL620452,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,9949,1,,,13091,,Muscle tissue,N,50597,CHEMBL620453,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,9950,1,,,13091,,Muscle tissue,N,50597,CHEMBL620454,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,9951,1,,,13091,,Muscle tissue,N,50597,CHEMBL624067,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,9952,1,,,13091,,,N,50597,CHEMBL624068,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,9953,1,,,13091,,Female gonad,N,50597,CHEMBL624069,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,9954,1,,,13091,,Female gonad,N,50597,CHEMBL624070,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,9955,1,,,13091,,Female gonad,N,50597,CHEMBL624071,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,9956,1,,,13091,,Uterus,N,50597,CHEMBL624072,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,9957,1,,,13091,,Uterus,N,50597,CHEMBL624073,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,9958,1,,,13091,,Uterus,N,50597,CHEMBL624788,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,9959,1,,,13091,,Uterus,N,50597,CHEMBL624789,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,9960,1,,,13091,,,N,50597,CHEMBL624790,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,9961,1,,,13091,,,N,50597,CHEMBL624791,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,9962,1,,,13091,,,N,50597,CHEMBL624792,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,9963,1,,,13091,,,N,50597,CHEMBL624793,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,9964,1,,,13091,,Muscle tissue,N,50597,CHEMBL877491,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,9965,1,,,13091,,Muscle tissue,N,50597,CHEMBL624957,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,9966,1,,,13091,,Muscle tissue,N,50597,CHEMBL624958,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,9967,1,,,13091,,Muscle tissue,N,50597,CHEMBL624959,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dissociation constant was determined,,9968,1,,,11977,,,N,50597,CHEMBL624960,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,9969,1,,,14941,,,N,50597,CHEMBL624961,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,9970,1,,,15078,,,N,50597,CHEMBL624962,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,9971,1,,,15078,,,N,50597,CHEMBL624963,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,9972,1,,,4755,,,N,50597,CHEMBL624964,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,LogP value was evaluated in the in situ rat gut perfusion assay,,9973,1,,,589,,,N,50597,CHEMBL624965,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,9974,1,,,17582,,,N,50597,CHEMBL624966,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,9975,1,,,5031,,,N,50597,CHEMBL624967,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,9976,1,,,17764,,,N,50597,CHEMBL624968,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,9977,1,,,17720,,,N,50597,CHEMBL624969,BAO_0000218,
F,Expert,1,,,Rattus norvegicus,,,10116.0,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,9978,1,,,2862,,,N,50597,CHEMBL624970,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was evaluated after 10 uM/kg of intra arterial administration,,9979,1,,,16423,,,N,50597,CHEMBL624971,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was evaluated after 20 uM/kg of peroral administration,,9980,1,,,16423,,,N,50597,CHEMBL624972,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,9981,1,,,6005,,,N,50597,CHEMBL624973,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life was evaluated in plasma of rat,,9982,1,,,2938,,Plasma,N,50597,CHEMBL624974,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,9983,1,,,6410,,,N,50597,CHEMBL624975,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,9984,1,,,6410,,,N,50597,CHEMBL877492,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was measured in rat after an iv dose of 1 mg/kg,,9985,1,,,6062,,,N,50597,CHEMBL624976,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period of compound in rats after peroral administration,,9986,1,,,6571,,,N,50597,CHEMBL624977,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life period of compound was measured in rat plasma.,,9987,1,,,3136,,Plasma,N,50597,CHEMBL626848,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life period of compound was measured in rat plasma; ND is not determined,,9988,1,,,3136,,Plasma,N,50597,CHEMBL626849,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life period of compound was measured in rat plasma; not determined,,9989,1,,,3136,,Plasma,N,50597,CHEMBL626850,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,9990,1,,,4521,,,N,50597,CHEMBL626851,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period in rat by iv administration,,9991,1,,,5871,,,N,50597,CHEMBL626852,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period in rats following intravenous administration at 2 mg/kg,,9992,1,,,6077,,,N,50597,CHEMBL626853,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,9993,1,,,6679,,,N,50597,CHEMBL626854,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life period was determined for the compound in rat,,9994,1,,,5144,,,N,50597,CHEMBL627486,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,9995,1,,,4498,,,N,50597,CHEMBL627487,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,9996,1,,,4498,,,N,50597,CHEMBL627488,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,9997,1,,,1908,,,N,50597,CHEMBL627489,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,9998,1,,,6211,,,N,50597,CHEMBL627490,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,9999,1,,,5529,,,N,50597,CHEMBL873829,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was determined in rat at a dose of 1 mpk i.v.,,10000,1,,,6444,,,N,50597,CHEMBL627655,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,10001,1,,,6444,,,N,50597,CHEMBL625994,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,10002,1,,,6444,,,N,50597,CHEMBL625995,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life in rat,,10003,1,,,5207,,,N,50597,CHEMBL625996,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,In vitro half life in rat plasma,,10004,1,,,530,,Plasma,N,50597,CHEMBL625850,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,10005,1,,,1116,,Plasma,N,50597,CHEMBL625851,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,In vitro half life in rat,,10006,1,,,3219,,,N,50597,CHEMBL625852,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo half life period after intravenous administration in rat,,10007,1,,,6109,,,N,50597,CHEMBL625853,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,10008,1,,,17582,,,N,50597,CHEMBL625854,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,10009,1,,,17582,,,N,50597,CHEMBL874450,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,10010,1,,,5974,,,N,50597,CHEMBL625855,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,10011,1,,,5974,,,N,50597,CHEMBL625856,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,10012,1,,,5974,,,N,50597,CHEMBL625857,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,10013,1,,,5974,,,N,50597,CHEMBL873831,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Longer half-life in rat (i.v.) at 0.5 mpk,,10014,1,,,17853,,,N,50597,CHEMBL625858,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Longer half-life in rat (p.o.) at 2.0 mpk,,10015,1,,,17853,,,N,50597,CHEMBL625859,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic property (half life) in rat,,10016,1,,,3457,,,N,50597,CHEMBL625860,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,10017,1,,,2792,,,N,50597,CHEMBL625861,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,10018,1,,,2792,,,N,50597,CHEMBL625862,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,10019,1,,,2792,,,N,50597,CHEMBL625863,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,10020,1,,,2792,,,N,50597,CHEMBL625864,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,10021,1,,,5739,,,N,50597,CHEMBL625865,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic half time was determined intravenously in rats.,,10022,1,,,15765,,,N,50597,CHEMBL625866,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,10023,1,,,6567,,Plasma,N,50597,CHEMBL625867,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half life of hydrolysis of the compound,,10024,1,,,2448,,Plasma,N,50597,CHEMBL625868,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,10025,1,,,5423,,Plasma,N,50597,CHEMBL625869,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half life period was calculated in rat,,10026,1,,,4853,,Plasma,N,50597,CHEMBL874451,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life in Sprague-Dawley rats,,10027,1,,,4514,,Plasma,N,50597,CHEMBL625870,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life in Sprague-Dawley rats; Not determined,,10028,1,,,4514,,Plasma,N,50597,CHEMBL625871,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life in rats,,10029,1,,,1500,,Plasma,N,50597,CHEMBL625872,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life in rats; <MQL,,10030,1,,,1500,,Plasma,N,50597,CHEMBL625873,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life period (0-8 h) was determined,,10031,1,,,5334,,Plasma,N,50597,CHEMBL625874,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,10032,1,,,5334,,Plasma,N,50597,CHEMBL625875,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,10033,1,,,5334,,Plasma,N,50597,CHEMBL625876,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,10034,1,,,5334,,Plasma,N,50597,CHEMBL631258,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,10035,1,,,4956,,Plasma,N,50597,CHEMBL631259,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,10036,1,,,4956,,Plasma,N,50597,CHEMBL631260,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,10037,1,,,7768,,Blood,N,50597,CHEMBL631261,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,10038,1,,,7768,,Blood,N,50597,CHEMBL631262,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,10039,1,,,7768,,Blood,N,50597,CHEMBL631263,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,10040,1,,,7768,,,N,50597,CHEMBL631264,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,10041,1,,,7768,,,N,50597,CHEMBL631265,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,10042,1,,,7768,,,N,50597,CHEMBL631266,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,10043,1,,,7768,,,N,50597,CHEMBL631267,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,10044,1,,,7768,,,N,50597,CHEMBL631268,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,10045,1,,,7768,,,N,50597,CHEMBL631269,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,10046,1,,,7768,,,N,50597,CHEMBL631270,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,10047,1,,,7768,,Heart,N,50597,CHEMBL631271,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,10048,1,,,7768,,Heart,N,50597,CHEMBL631272,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,10049,1,,,7768,,Heart,N,50597,CHEMBL631273,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,10050,1,,,7768,,Heart,N,50597,CHEMBL631274,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,10051,1,,,7768,,Heart,N,50597,CHEMBL631275,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,10052,1,,,7768,,Heart,N,50597,CHEMBL626984,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,10053,1,,,7768,,Heart,N,50597,CHEMBL626985,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,10054,1,,,7768,,Liver,N,50597,CHEMBL626986,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,10055,1,,,7768,,Liver,N,50597,CHEMBL626987,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,10056,1,,,7768,,Liver,N,50597,CHEMBL626988,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,10057,1,,,7768,,Liver,N,50597,CHEMBL626989,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,10058,1,,,7768,,Liver,N,50597,CHEMBL626990,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,10059,1,,,7768,,Liver,N,50597,CHEMBL626991,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,10060,1,,,7768,,Liver,N,50597,CHEMBL626992,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,10061,1,,,7768,,Lung,N,50597,CHEMBL626993,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,10062,1,,,7768,,Lung,N,50597,CHEMBL874593,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,10063,1,,,7768,,Lung,N,50597,CHEMBL626994,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,10064,1,,,7768,,Lung,N,50597,CHEMBL626995,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,10065,1,,,7768,,Lung,N,50597,CHEMBL626190,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,10066,1,,,7768,,Lung,N,50597,CHEMBL626191,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,10067,1,,,7768,,Lung,N,50597,CHEMBL626364,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,10068,1,,,7768,,Thyroid gland,N,50597,CHEMBL626365,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,10069,1,,,7768,,Thyroid gland,N,50597,CHEMBL626366,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,10070,1,,,7768,,Thyroid gland,N,50597,CHEMBL626367,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,10071,1,,,7768,,Thyroid gland,N,50597,CHEMBL626368,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,10072,1,,,7768,,Thyroid gland,N,50597,CHEMBL626369,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,10073,1,,,7768,,Thyroid gland,N,50597,CHEMBL626370,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,10074,1,,,4498,,,N,50597,CHEMBL626371,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,10075,1,,,4498,,,N,50597,CHEMBL626372,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after a dose of 10 mg/kg p.o.,,10076,1,,,3603,,,N,50597,CHEMBL626373,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,10077,1,,,6215,,,N,50597,CHEMBL626374,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,10078,1,,,5710,,,N,50597,CHEMBL626375,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,10079,1,,,5710,,,N,50597,CHEMBL626376,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat po was determined,,10080,1,,,5676,,,N,50597,CHEMBL626377,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability of compound at 10 mg/kg in rat after oral administration,,10081,1,,,17667,,,N,50597,CHEMBL626378,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,10082,1,,,17667,,,N,50597,CHEMBL626379,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10083,1,,,6848,,,N,50597,CHEMBL626380,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10084,1,,,6848,,,N,50597,CHEMBL626381,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10085,1,,,17267,,,N,50597,CHEMBL626382,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Sprague-Dawley) (female),,10086,1,,,6362,,,N,50597,CHEMBL626383,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,10087,1,,,17671,,,N,50597,CHEMBL874652,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,10088,1,,,17671,,,N,50597,CHEMBL626384,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,10089,1,,,4333,,,N,50597,CHEMBL626385,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat at an oral dose of 2 mg/kg,,10090,1,,,6077,,,N,50597,CHEMBL626386,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10091,1,,,3278,,,N,50597,CHEMBL626387,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10092,1,,,5964,,,N,50597,CHEMBL626388,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10093,1,,,4884,,,N,50597,CHEMBL626389,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10094,1,,,4905,,,N,50597,CHEMBL626390,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,10095,1,,,4884,,,N,50597,CHEMBL626391,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10096,1,,,6850,,,N,50597,CHEMBL626392,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10097,1,,,2864,,,N,50597,CHEMBL626393,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was determined in rat,,10098,1,,,5780,,,N,50597,CHEMBL623026,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability,,10099,1,,,1465,,,N,50597,CHEMBL623027,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability,,10100,1,,,5199,,,N,50597,CHEMBL623028,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after 1 day dosing,,10101,1,,,5765,,,N,50597,CHEMBL623029,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after 4 day dosing,,10102,1,,,5765,,,N,50597,CHEMBL623030,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,10103,1,,,6518,,,N,50597,CHEMBL623031,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,10104,1,,,6518,,,N,50597,CHEMBL623032,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,10105,1,,,6518,,,N,50597,CHEMBL623033,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,10106,1,,,6518,,,N,50597,CHEMBL623034,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,10107,1,,,2083,,,N,50597,CHEMBL623035,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,10108,1,,,17260,,,N,50597,CHEMBL623036,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10109,1,,,4956,,,N,50597,CHEMBL623037,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,10110,1,,,4368,,,N,50597,CHEMBL623038,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,10111,1,,,17752,,Plasma,N,50597,CHEMBL874385,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Fisher) (fasted),,10112,1,,,1446,,,N,50597,CHEMBL623039,BAO_0000218,
A,Intermediate,1,,,Primates,In vivo,,9443.0,Bioavailability in monkey after po administration of 10 mg/kg dose,,10113,0,,,2891,,,U,22224,CHEMBL623040,BAO_0000218,
A,Intermediate,1,,,Primates,In vivo,,9443.0,Oral bioavailability in monkey (dose 10 mg/kg),,10114,0,,,2891,,,U,22224,CHEMBL623041,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10115,1,,,6672,,,N,50597,CHEMBL623741,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10116,1,,,6673,,,N,50597,CHEMBL623742,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10117,1,,,17655,,,N,50597,CHEMBL623743,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10118,1,,,17796,,,N,50597,CHEMBL623744,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 2.0 mg/kg p.o.),,10119,1,,,17853,,,N,50597,CHEMBL623745,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,10120,1,,,4521,,,N,50597,CHEMBL623746,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 5 mg/kg p.o.),,10121,1,,,4940,,,N,50597,CHEMBL623747,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after po administration of 30 mg/kg dose,,10122,0,,,2891,,,U,22224,CHEMBL623748,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after po administration of 30 mg/kg dose,,10123,0,,,2891,,,U,22224,CHEMBL623916,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,10124,1,,,4521,,,N,50597,CHEMBL623917,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 2 mg/kg i.v.),,10125,1,,,17686,,,N,50597,CHEMBL623918,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10126,1,,,17796,,,N,50597,CHEMBL874386,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat; Only traces detected in rat plasma,,10127,1,,,17796,,Plasma,N,50597,CHEMBL623919,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10128,1,,,5064,,,N,50597,CHEMBL623920,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability upon oral administration of compound,,10129,1,,,5147,,,N,50597,CHEMBL623148,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,10130,1,,,1916,,,N,50597,CHEMBL623149,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10131,1,,,6049,,,N,50597,CHEMBL623150,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,10132,1,,,1445,,,N,50597,CHEMBL623151,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,10133,1,,,1445,,,N,50597,CHEMBL623152,BAO_0000218,
F,Expert,1,,,Rattus norvegicus,,,10116.0,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,10134,1,,,2862,,,N,50597,CHEMBL623153,BAO_0000218,
F,Expert,1,,,Rattus norvegicus,,,10116.0,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,10135,1,,,2862,,,N,50597,CHEMBL623154,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro and metabolic stability was determined,,10136,1,,,4194,,,N,50597,CHEMBL623155,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro metabolic stability in rat hepatocytes,,10137,1,,,4194,,,N,50597,CHEMBL623156,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,10138,1,,,5486,,,N,50597,CHEMBL623157,BAO_0000218,
A,Intermediate,1,401.0,,Rattus norvegicus,In vitro,,10116.0,Metabolic rate for compound was observed in rat hepatocytes,,10139,1,,,17582,Hepatocyte,Liver,N,50597,CHEMBL623158,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,10140,1,,,5600,,,N,50597,CHEMBL623159,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,10141,1,,,14294,,,N,50597,CHEMBL874390,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,10142,1,,,14294,,,N,50597,CHEMBL623160,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Metabolism of compound in rat S9 microsomes; Trace,,10143,1,,,14294,,,N,50597,CHEMBL623161,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,10144,1,,,17847,,,N,50597,CHEMBL623162,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,10145,1,,,11020,,,N,50597,CHEMBL623163,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,10146,1,,,11020,,,N,50597,CHEMBL623164,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,10147,1,,,11020,,,N,50597,CHEMBL623165,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,10148,1,,,11020,,,N,50597,CHEMBL623166,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,10149,1,,,11020,,,N,50597,CHEMBL624983,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,10150,1,,,11020,,,N,50597,CHEMBL624984,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,10151,1,,,11020,,,N,50597,CHEMBL624985,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,10152,1,,,11020,,,N,50597,CHEMBL622970,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,10153,1,,,11020,,,N,50597,CHEMBL622971,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,10154,1,,,11020,,,N,50597,CHEMBL622972,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,10155,1,,,11020,,,N,50597,CHEMBL622973,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,10156,1,,,11020,,,N,50597,CHEMBL622974,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,10157,1,,,11020,,,N,50597,CHEMBL622975,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,10158,1,,,11020,,,N,50597,CHEMBL622976,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,10159,1,,,11020,,,N,50597,CHEMBL622977,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,10160,1,,,11020,,,N,50597,CHEMBL624351,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,10161,1,,,11020,,,N,50597,CHEMBL624352,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,10162,1,,,11020,,,N,50597,CHEMBL624353,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,10163,1,,,11020,,,N,50597,CHEMBL622397,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,10164,1,,,11020,,,N,50597,CHEMBL622398,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,10165,1,,,11020,,,N,50597,CHEMBL622399,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,10166,1,,,11020,,,N,50597,CHEMBL622400,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,10167,1,,,11020,,,N,50597,CHEMBL628428,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,10168,1,,,11020,,,N,50597,CHEMBL628590,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,10169,1,,,11020,,,N,50597,CHEMBL628591,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,10170,1,,,11020,,,N,50597,CHEMBL628592,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,10171,1,,,11020,,,N,50597,CHEMBL628593,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,10172,1,,,11020,,,N,50597,CHEMBL875333,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,10173,1,,,11020,,,N,50597,CHEMBL628594,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,10174,1,,,4969,,Plasma,N,50597,CHEMBL628595,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat plasma was determined,,10175,1,,,6737,,Plasma,N,50597,CHEMBL628596,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Stability in rat plasma was determined; ND= no data,,10176,1,,,6737,,Plasma,N,50597,CHEMBL628597,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for plasma half life period in rat (0-8 hr),,10177,1,,,5089,,Plasma,N,50597,CHEMBL628598,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for plasma half life period in rat (0-8 hr); Not determined,,10178,1,,,5089,,Plasma,N,50597,CHEMBL628599,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,10179,1,,,1466,,,N,50597,CHEMBL628600,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,10180,1,,,1466,,,N,50597,CHEMBL628601,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for the half life in rat,,10181,1,,,4950,,,N,50597,CHEMBL628602,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,10182,1,,,2412,,,N,50597,CHEMBL628603,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,10183,1,,,2412,,,N,50597,CHEMBL628604,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,10184,1,,,2412,,,N,50597,CHEMBL628605,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,10185,1,,,2412,,,N,50597,CHEMBL628606,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,10186,1,,,2412,,,N,50597,CHEMBL628607,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The biological half life the compound was measured at the dose of 100 umol/kg,,10187,1,,,15022,,,N,50597,CHEMBL628608,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The biological half life the compound was measured at the dose of 30 umol/kg,,10188,1,,,15022,,,N,50597,CHEMBL628609,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was evaluated for plasma half life period in rat,,10189,1,,,406,,Plasma,N,50597,CHEMBL628610,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,10190,1,,,15078,,,N,50597,CHEMBL873819,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,10191,1,,,15078,,,N,50597,CHEMBL628611,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The pharmacokinetic parameter half-life period in vivo in rats,,10192,1,,,5247,,,N,50597,CHEMBL628612,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The pharmacokinetic property, Half-life was determined",,10193,1,,,5041,,,N,50597,CHEMBL628613,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The pharmacokinetic property, Half-life in rat in vivo",,10194,1,,,5041,,,N,50597,CHEMBL628614,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,10195,1,,,5041,,,N,50597,CHEMBL628615,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,10196,1,,,5041,,,N,50597,CHEMBL628616,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The plasma half life period in rats,,10197,1,,,3918,,Plasma,N,50597,CHEMBL627924,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,10198,1,,,2906,,Liver,N,50597,CHEMBL627925,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,10199,1,,,6467,,,N,50597,CHEMBL627926,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,t1/2 (apparent elimination)of the compound was determined,,10200,1,,,5510,,,N,50597,CHEMBL627927,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,t1/2 value in rat,,10201,1,,,3788,,,N,50597,CHEMBL627928,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life in rat,,10202,1,,,17796,,,N,50597,CHEMBL627539,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,10203,1,,,12873,,Plasma,N,50597,CHEMBL876790,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,10204,1,,,5983,,,N,50597,CHEMBL858186,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half-life period in fasted rats,,10205,1,,,15765,,,N,50597,CHEMBL627540,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,10206,1,,,2661,,,N,50597,CHEMBL627541,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,10207,1,,,2661,,,N,50597,CHEMBL627715,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,10208,1,,,429,,,N,50597,CHEMBL627716,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Maximum time required to achieve Cmax was determined in rat,,10209,1,,,17655,,,N,50597,CHEMBL627717,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,10210,1,,,17717,,,N,50597,CHEMBL627718,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,10211,1,,,17717,,,N,50597,CHEMBL627719,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,10212,1,,,17717,,,N,50597,CHEMBL627720,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,10213,1,,,6570,,,N,50597,CHEMBL627721,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,10214,1,,,6570,,,N,50597,CHEMBL627722,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,10215,1,,,5978,,,N,50597,CHEMBL627723,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,10216,1,,,5978,,,N,50597,CHEMBL626058,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,10217,1,,,5978,,,N,50597,CHEMBL626059,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,10218,1,,,5978,,,N,50597,CHEMBL626060,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,10219,1,,,17720,,Plasma,N,50597,CHEMBL626061,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,10220,1,,,4723,,,N,50597,CHEMBL876791,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,10221,1,,,4723,,,N,50597,CHEMBL626062,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax at the dose of 2 mg/Kg administered perorally in rats,,10222,1,,,4756,,,N,50597,CHEMBL626063,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tmax at the dose of 5 mg/Kg administered perorally in rats,,10223,1,,,4756,,,N,50597,CHEMBL626064,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,10224,1,,,17720,,Plasma,N,50597,CHEMBL626065,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,10225,1,,,17720,,Plasma,N,50597,CHEMBL626066,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,10226,1,,,1466,,,N,50597,CHEMBL626067,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,10227,1,,,7449,,,N,50597,CHEMBL626068,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,10228,1,,,7449,,,N,50597,CHEMBL626069,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of 3-methoxyacetaminophen glucuronide,,10229,1,,,7449,,,N,50597,CHEMBL626070,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of N-methoxyacetaminophen glucuronide,,10230,1,,,7449,,,N,50597,CHEMBL626071,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of N-methoxyacetaminophen sulfate,,10231,1,,,7449,,,N,50597,CHEMBL626072,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of acetaminophen,,10232,1,,,7449,,,N,50597,CHEMBL626073,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,10233,1,,,7768,,Thyroid gland,N,50597,CHEMBL626741,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,10234,1,,,17655,,,N,50597,CHEMBL626742,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,10235,1,,,17735,,,N,50597,CHEMBL626743,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,10236,1,,,5960,,,N,50597,CHEMBL876792,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,10237,1,,,17735,,,N,50597,CHEMBL626744,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for antidiuretic activity in rats,,10238,1,,,7116,,,N,50597,CHEMBL626745,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,AUC in rat after 3mg/kg oral dose,,10239,1,,,4878,,Plasma,N,50597,CHEMBL626746,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,10240,1,,,5939,,,N,50597,CHEMBL626747,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,10241,1,,,5939,,,N,50597,CHEMBL626748,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Bioavailability administered orally at a dose of 10 mg/kg to rats,,10242,1,,,16367,,,N,50597,CHEMBL626749,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral Bioavailability was determined,,10243,1,,,16366,,,N,50597,CHEMBL626750,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral bioavailability in rat,,10244,1,,,4426,,,N,50597,CHEMBL626751,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral bioavailability in rat; Not performed.,,10245,1,,,4426,,,N,50597,CHEMBL626913,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Bioavailability,,10246,1,,,5041,,,N,50597,CHEMBL626914,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Bioavailability was determined; ND denotes no data,,10247,1,,,5041,,,N,50597,CHEMBL626915,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,10248,1,,,1500,,,N,50597,CHEMBL626916,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,10249,1,,,1500,,,N,50597,CHEMBL626917,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Binding towards rat plasma protein at 10 uM,,10250,1,,,17409,,,N,50597,CHEMBL626918,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Binding towards rat plasma protein at 100 uM,,10251,1,,,17409,,,N,50597,CHEMBL626919,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 20 mg/kg p.o.),,10252,1,,,2959,,,N,50597,CHEMBL626920,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,10253,1,,,13501,,,N,50597,CHEMBL621976,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after 5 mg/kg oral gavage,,10254,1,,,6567,,,N,50597,CHEMBL877599,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10255,1,,,6571,,,N,50597,CHEMBL621977,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 1 mg/kg i.v.),,10256,1,,,6715,,,N,50597,CHEMBL621978,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 3 mg/kg p.o.),,10257,1,,,6715,,,N,50597,CHEMBL621979,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10258,1,,,2932,,,N,50597,CHEMBL621980,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability of the compound in rats after administration of 30 mg/kg,,10259,1,,,4171,,,N,50597,CHEMBL621981,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after administration of 10 mg/kg in rats,,10260,1,,,17509,,,N,50597,CHEMBL621982,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability after administration of 2 mg/kg in rats,,10261,1,,,17509,,,N,50597,CHEMBL882953,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,10262,1,,,4527,,,N,50597,CHEMBL621983,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in dogs was determined; high,,10263,1,,,4026,,,N,50597,CHEMBL621984,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in monkey after intravenous administration at 1 mpk,,10264,1,,,6659,,,N,50597,CHEMBL621985,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in monkey after peroral administration at 10 mpk,,10265,1,,,6659,,,N,50597,CHEMBL621986,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after intravenous administration at 1 mpk,,10266,1,,,6659,,,N,50597,CHEMBL621987,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after intravenous administration at 2 mpk,,10267,1,,,6659,,,N,50597,CHEMBL877600,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after peroral administration at 30 mpk,,10268,1,,,6659,,,N,50597,CHEMBL621988,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after peroral administration at at 100 mpk,,10269,1,,,6659,,,N,50597,CHEMBL621989,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rats was evaluated,,10270,1,,,6597,,,N,50597,CHEMBL621990,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,10271,1,,,1202,,,N,50597,CHEMBL621991,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,10272,1,,,1202,,,N,50597,CHEMBL621992,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,10273,1,,,1202,,,N,50597,CHEMBL621993,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,10274,1,,,1202,,,N,50597,CHEMBL621994,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10275,1,,,5207,,,N,50597,CHEMBL621995,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10276,1,,,5970,,,N,50597,CHEMBL621996,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg),,10277,1,,,17538,,,N,50597,CHEMBL621997,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,10278,1,,,17538,,,N,50597,CHEMBL621998,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,10279,1,,,1466,,,N,50597,CHEMBL621999,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10280,1,,,2879,,,N,50597,CHEMBL622000,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was measured in rat after oral administration; 2-4,,10281,1,,,2879,,,N,50597,CHEMBL622001,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was measured in rat after oral administration; 3-7,,10282,1,,,2879,,,N,50597,CHEMBL622002,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (intraduodenal administration),,10283,1,,,3777,,,N,50597,CHEMBL622003,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (intraduodenal administration),,10284,1,,,3777,,,N,50597,CHEMBL877601,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10285,1,,,3777,,,N,50597,CHEMBL624871,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10286,1,,,3777,,,N,50597,CHEMBL622004,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,10287,1,,,5423,,,N,50597,CHEMBL882954,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,10288,1,,,16365,,,N,50597,CHEMBL622005,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,10289,1,,,16365,,,N,50597,CHEMBL622006,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was measured in rat,,10290,1,,,4239,,,N,50597,CHEMBL622007,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was reported,,10291,1,,,5438,,,N,50597,CHEMBL622008,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10292,1,,,5334,,,N,50597,CHEMBL622009,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10293,1,,,5334,,,N,50597,CHEMBL622010,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,10294,1,,,4199,,,N,50597,CHEMBL622011,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,10295,1,,,4199,,,N,50597,CHEMBL622012,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,10296,1,,,4199,,,N,50597,CHEMBL622013,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,10297,1,,,4890,,,N,50597,CHEMBL622014,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was determined at 3 mg/kg po dose in rats,,10298,1,,,2792,,,N,50597,CHEMBL624749,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 2 mg/kg),,10299,1,,,5529,,,N,50597,CHEMBL624750,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,10300,1,,,6685,,,N,50597,CHEMBL624751,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,10301,1,,,6685,,,N,50597,CHEMBL624752,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,10302,1,,,6685,,,N,50597,CHEMBL624753,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,10303,1,,,6005,,,N,50597,CHEMBL624754,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,10304,1,,,6410,,,N,50597,CHEMBL624755,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,10305,1,,,6410,,,N,50597,CHEMBL624756,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10306,1,,,6103,,,N,50597,CHEMBL624757,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,10307,1,,,6410,,,N,50597,CHEMBL624758,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,10308,1,,,6410,,,N,50597,CHEMBL622270,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Sprague-Dawley),,10309,1,,,5353,,,N,50597,CHEMBL622271,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat at the dose of 2 mg/kg,,10310,1,,,4727,,,N,50597,CHEMBL622272,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10311,1,,,17804,,,N,50597,CHEMBL622273,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (cannulated) (dose 2 mg/kg),,10312,1,,,5809,,,N,50597,CHEMBL622274,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability value of compound in rats was determined after peroral administration,,10313,1,,,17804,,,N,50597,CHEMBL622275,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 20 mg/kg),,10314,1,,,3634,,,N,50597,CHEMBL622276,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10315,1,,,3341,,,N,50597,CHEMBL622277,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 5 mg/kg),,10316,1,,,2690,,,N,50597,CHEMBL622278,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10317,1,,,3184,,,N,50597,CHEMBL622279,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10318,1,,,740,,,N,50597,CHEMBL622280,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for oral bioavailability in rats; 15-27 %,,10319,1,,,1806,,,N,50597,CHEMBL624083,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,10320,1,,,4891,,,N,50597,CHEMBL624084,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,10321,1,,,3634,,,N,50597,CHEMBL624085,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for bioavailability in rats,,10322,1,,,64,,,N,50597,CHEMBL624086,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10323,1,,,4839,,,N,50597,CHEMBL624087,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10324,1,,,1094,,,N,50597,CHEMBL624088,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,10325,0,,,5005,,,U,22224,CHEMBL624089,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,10326,0,,,5005,,,U,22224,CHEMBL624090,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Evaluated for the bioavailability in rat (in vivo),,10327,1,,,4687,,,N,50597,CHEMBL624091,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,F value of compound in rats was determined after peroral administration,,10328,1,,,17804,,,N,50597,CHEMBL624092,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,10329,1,,,5974,,,N,50597,CHEMBL624093,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,10330,1,,,5974,,,N,50597,CHEMBL624094,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,10331,1,,,5974,,,N,50597,CHEMBL624095,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,10332,1,,,5974,,,N,50597,CHEMBL624096,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,10333,1,,,1088,,,N,50597,CHEMBL624097,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum fall in carotid flow in rat,,10334,1,,,1742,,,N,50597,CHEMBL624098,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,10335,1,,,4689,,,N,50597,CHEMBL874392,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 5 mg/kg),,10336,1,,,2463,,,N,50597,CHEMBL624099,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,10337,1,,,5654,,,N,50597,CHEMBL624100,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,10338,1,,,5654,,,N,50597,CHEMBL624101,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (male Wistar),,10339,1,,,6874,,,N,50597,CHEMBL624102,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability after administration (30 mg/kg) in rat; good,,10340,1,,,5633,,,N,50597,CHEMBL624103,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability at the dose of 2 mg/kg in rat,,10341,1,,,5496,,,N,50597,CHEMBL624104,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability determined in rats,,10342,1,,,2358,,,N,50597,CHEMBL624105,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,10343,1,,,16456,,,N,50597,CHEMBL624106,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose single 10 mg/kg),,10344,1,,,5302,,,N,50597,CHEMBL624107,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose single 10 mg/kg),,10345,1,,,5302,,,N,50597,CHEMBL623943,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 5 mg/kg,,10346,1,,,5302,,,N,50597,CHEMBL623944,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,10347,1,,,11020,,,N,50597,CHEMBL623945,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,10348,1,,,11020,,,N,50597,CHEMBL623946,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,10349,1,,,11020,,,N,50597,CHEMBL623947,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,10350,1,,,11020,,,N,50597,CHEMBL623948,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,10351,1,,,11020,,,N,50597,CHEMBL623949,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,10352,1,,,11020,,,N,50597,CHEMBL623950,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,10353,1,,,11020,,,N,50597,CHEMBL874398,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,10354,1,,,11020,,,N,50597,CHEMBL623951,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,10355,1,,,11020,,,N,50597,CHEMBL623952,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,10356,1,,,11020,,,N,50597,CHEMBL623953,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,10357,1,,,11020,,,N,50597,CHEMBL623954,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,10358,1,,,11020,,,N,50597,CHEMBL623955,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,10359,1,,,11020,,,N,50597,CHEMBL623956,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,10360,1,,,11020,,,N,50597,CHEMBL627807,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,10361,1,,,11020,,,N,50597,CHEMBL627808,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,10362,1,,,11020,,,N,50597,CHEMBL627809,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,10363,1,,,11020,,,N,50597,CHEMBL627810,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,10364,1,,,11020,,,N,50597,CHEMBL627811,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,10365,1,,,11020,,,N,50597,CHEMBL627812,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,10366,1,,,11020,,,N,50597,CHEMBL627813,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,10367,1,,,11020,,,N,50597,CHEMBL627814,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,10368,1,,,11020,,,N,50597,CHEMBL875336,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,10369,1,,,11020,,,N,50597,CHEMBL627815,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,10370,1,,,11020,,,N,50597,CHEMBL627816,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,10371,1,,,11020,,,N,50597,CHEMBL627817,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,10372,1,,,11020,,,N,50597,CHEMBL627818,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,10373,1,,,11020,,,N,50597,CHEMBL627819,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,10374,1,,,11020,,,N,50597,CHEMBL627820,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,10375,1,,,11020,,,N,50597,CHEMBL627821,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,10376,1,,,11020,,,N,50597,CHEMBL628464,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,10377,1,,,11020,,,N,50597,CHEMBL626239,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,10378,1,,,11020,,,N,50597,CHEMBL626240,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,10379,1,,,11020,,,N,50597,CHEMBL626241,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,10380,1,,,11020,,,N,50597,CHEMBL626242,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,10381,1,,,11020,,,N,50597,CHEMBL626243,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,10382,1,,,11020,,,N,50597,CHEMBL626244,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,10383,1,,,11020,,,N,50597,CHEMBL626907,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,10384,1,,,11020,,,N,50597,CHEMBL626908,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,10385,1,,,11020,,,N,50597,CHEMBL626909,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,10386,1,,,11020,,,N,50597,CHEMBL626910,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of acetaminophen cysteine conjugate,,10387,1,,,7449,,,N,50597,CHEMBL875342,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of acetaminophen glucuronide,,10388,1,,,7449,,,N,50597,CHEMBL626911,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of acetaminophen sulfate,,10389,1,,,7449,,,N,50597,CHEMBL626912,BAO_0000218,
F,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent total excretion of acetaminophen-mercapturic acid,,10390,1,,,7449,,,N,50597,CHEMBL627065,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,10391,1,,,3172,,Urine,N,50597,CHEMBL627066,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,10392,1,,,16456,,,N,50597,CHEMBL627067,BAO_0000218,
A,Autocuration,1,,,ratrat,In vivo,,8656.0,Biodistribution of compound in rat muscle after 5 min of administration,,10393,0,,,10839,,Muscle tissue,U,22224,CHEMBL627068,BAO_0000218,2385.0
A,Autocuration,1,,,ratrat,In vivo,,8656.0,Biodistribution of compound in rat muscle after 5 min of administration.,,10394,0,,,10839,,Muscle tissue,U,22224,CHEMBL627069,BAO_0000218,2385.0
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10395,0,,,5334,,,U,22224,CHEMBL627070,BAO_0000218,
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10396,0,,,5334,,,U,22224,CHEMBL627071,BAO_0000218,
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10397,0,,,5334,,,U,22224,CHEMBL627072,BAO_0000218,
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10398,0,,,5334,,,U,22224,CHEMBL627073,BAO_0000218,
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10399,0,,,5334,,,U,22224,CHEMBL625387,BAO_0000218,
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10400,0,,,5334,,,U,22224,CHEMBL625388,BAO_0000218,
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,10401,0,,,5334,,Plasma,U,22224,CHEMBL625389,BAO_0000218,1969.0
A,Autocuration,1,,,Ovis aries,In vivo,,9940.0,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,10402,0,,,5334,,Plasma,U,22224,CHEMBL875343,BAO_0000218,1969.0
A,Intermediate,1,,,Serpentes,,,8570.0,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,10403,1,,,1735,,,N,50497,CHEMBL876795,BAO_0000218,
A,Intermediate,1,,,Serpentes,,,8570.0,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,10404,1,,,1469,,,N,50497,CHEMBL626552,BAO_0000218,
A,Intermediate,1,,,Serpentes,,,8570.0,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,10405,1,,,1336,,,N,50497,CHEMBL626553,BAO_0000218,
A,Autocuration,1,,,Homo sapiens,,,9606.0,The human biological plasma half life of the compound,,10406,0,,,12403,,Plasma,U,22224,CHEMBL626554,BAO_0000366,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,10407,1,,,8151,,Urine,N,50597,CHEMBL626555,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,10408,1,,,8004,,,N,50597,CHEMBL626556,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,10409,1,,,8004,,,N,50597,CHEMBL626557,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,10410,1,,,8004,,,N,50597,CHEMBL626558,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,10411,1,,,8004,,,N,50597,CHEMBL626559,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,10412,1,,,8004,,,N,50597,CHEMBL626560,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,10413,1,,,8004,,,N,50597,CHEMBL876803,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,10414,1,,,8004,,,N,50597,CHEMBL627964,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,10415,1,,,8004,,,N,50597,CHEMBL627965,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,10416,1,,,8004,,,N,50597,CHEMBL627966,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,10417,1,,,8004,,,N,50597,CHEMBL627967,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,10418,1,,,8004,,,N,50597,CHEMBL627968,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,10419,1,,,8004,,,N,50597,CHEMBL627969,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,10420,1,,,8004,,,N,50597,CHEMBL627970,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,10421,1,,,8004,,Blood,N,50597,CHEMBL627971,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,10422,1,,,8004,,Blood,N,50597,CHEMBL627972,BAO_0000218,178.0
B,Expert,1,,,Homo sapiens,,,9606.0,Dissociation constant against binding to human cyclophilin A,,10423,9,,,15917,,,D,180,CHEMBL856029,BAO_0000357,
B,Expert,1,,,Bos taurus,,,9913.0,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,10424,8,,,12396,,,H,11591,CHEMBL627973,BAO_0000019,
A,Autocuration,1,,,,,,,-Log C was determined by performing the electroshock minimum test,,10425,0,,,7065,,,U,22224,CHEMBL627974,BAO_0000019,
A,Autocuration,1,,,,,,,-Log C was determined by performing the foot shock test,,10426,0,,,7065,,,U,22224,CHEMBL627975,BAO_0000019,
A,Autocuration,1,,,,,,,-Log C was determined by performing the incl screen test,,10427,0,,,7065,,,U,22224,CHEMBL627976,BAO_0000019,
A,Autocuration,1,,,,,,,-Log C was determined by performing the maximum electroshock test,,10428,0,,,7065,,,U,22224,CHEMBL627977,BAO_0000019,
A,Autocuration,1,,,,,,,-Log C was determined by performing the pentylenetetrazole test,,10429,0,,,7065,,,U,22224,CHEMBL627978,BAO_0000019,
A,Autocuration,1,,,,,,,Tested for experimental arotinoid inhibitory dose,,10430,0,,,12415,,,U,22224,CHEMBL627979,BAO_0000019,
A,Autocuration,1,,,,,,,Negative log transformed activity,,10431,0,,,10256,,,U,22224,CHEMBL876804,BAO_0000019,
A,Autocuration,1,,,,,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,10432,0,,,7991,,,U,22224,CHEMBL627980,BAO_0000019,
A,Intermediate,1,,,Cavia porcellus,,,10141.0,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,10433,1,,,14342,,,N,50512,CHEMBL627981,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,,,10141.0,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,10434,1,,,14342,,,N,50512,CHEMBL627982,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,,,10141.0,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,10435,1,,,14342,,,N,50512,CHEMBL627983,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,,,10141.0,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,10436,1,,,14342,,Ileum,N,50512,CHEMBL627984,BAO_0000218,2116.0
P,Autocuration,1,,,,,,,Solubility in water was determined; values expressed as -log,,10437,0,,,6047,,,U,22229,CHEMBL627985,BAO_0000100,
A,Autocuration,1,,,,,,,Ratio of Kcat to that of Km was determined,,10438,0,,,17269,,,U,22224,CHEMBL627986,BAO_0000019,
A,Autocuration,1,,,,,,,Observed first order rate constant,,10439,0,,,10026,,,U,22224,CHEMBL627987,BAO_0000019,
A,Autocuration,1,,,,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,10440,0,,,14583,,,U,22224,CHEMBL627988,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,10441,1,,,2661,,,N,50597,CHEMBL627989,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,10442,1,,,2661,,,N,50597,CHEMBL627990,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral Bioavailability after administration of 10 mg/kg in male rat,,10443,1,,,4029,,,N,50597,CHEMBL876805,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,10444,1,,,17735,,,N,50597,CHEMBL627991,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10445,1,,,4576,,,N,50597,CHEMBL627992,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,10446,1,,,17582,,,N,50597,CHEMBL627993,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability at 1 mg/kg was determined in rat,,10447,1,,,17651,,,N,50597,CHEMBL622817,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability at 10 mg/kg was determined in rat,,10448,1,,,17651,,,N,50597,CHEMBL622818,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,10449,1,,,17670,,,N,50597,CHEMBL622819,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10450,1,,,5045,,,N,50597,CHEMBL872267,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10451,1,,,1696,,,N,50597,CHEMBL622820,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,10452,1,,,17764,,,N,50597,CHEMBL622821,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10453,1,,,6448,,,N,50597,CHEMBL622822,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10454,1,,,6596,,,N,50597,CHEMBL622823,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10455,1,,,17547,,,N,50597,CHEMBL622824,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat at a dose of 3 mg/kg,,10456,1,,,17771,,,N,50597,CHEMBL622825,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after oral administration at 10 mg/kg,,10457,1,,,6495,,,N,50597,CHEMBL622901,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10458,1,,,4558,,,N,50597,CHEMBL622902,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10459,1,,,17596,,,N,50597,CHEMBL621844,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in Dawley rats,,10460,1,,,6827,,,N,50597,CHEMBL621845,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10461,1,,,4026,,,N,50597,CHEMBL621846,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 30 mg/kg),,10462,1,,,10,,,N,50597,CHEMBL621847,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,10463,1,,,17717,,,N,50597,CHEMBL877609,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 3 mg/kg i.v.),,10464,1,,,17717,,,N,50597,CHEMBL621848,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,10465,1,,,17717,,,N,50597,CHEMBL621849,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 60 mg/kg p.o.),,10466,1,,,17717,,,N,50597,CHEMBL622030,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Percent oral bioavailability determined in rats,,10467,1,,,4796,,,N,50597,CHEMBL622031,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,10468,1,,,4883,,,N,50597,CHEMBL622032,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was evaluated for bioavailability in rats; 32-51,,10469,1,,,2137,,,N,50597,CHEMBL622033,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 20 mg/kg p.o.),,10470,1,,,2959,,,N,50597,CHEMBL622034,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10471,1,,,1361,,,N,50597,CHEMBL622035,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability percent in rat at the dose of 2 mg/kg,,10472,1,,,4727,,,N,50597,CHEMBL882966,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated after 20 uM/kg of peroral administration,,10473,1,,,16423,,,N,50597,CHEMBL622036,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10474,1,,,5206,,,N,50597,CHEMBL622037,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10475,1,,,6448,,,N,50597,CHEMBL622038,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rats,,10476,1,,,17723,,,N,50597,CHEMBL622039,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,10477,1,,,17738,,Blood,N,50597,CHEMBL622040,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,10478,1,,,17738,,Blood,N,50597,CHEMBL622041,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,10479,1,,,17738,,Blood,N,50597,CHEMBL622042,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,10480,1,,,17738,,Blood,N,50597,CHEMBL622043,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,10481,1,,,17738,,Blood,N,50597,CHEMBL622044,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,10482,1,,,17738,,Bone,N,50597,CHEMBL622045,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,10483,1,,,17738,,Bone,N,50597,CHEMBL622046,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,10484,1,,,17738,,Bone,N,50597,CHEMBL622047,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,10485,1,,,17738,,Bone,N,50597,CHEMBL877610,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,10486,1,,,17738,,Brain,N,50597,CHEMBL622048,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,10487,1,,,17738,,Brain,N,50597,CHEMBL622049,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,10488,1,,,17738,,Brain,N,50597,CHEMBL622050,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,10489,1,,,17738,,Brain,N,50597,CHEMBL622051,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,10490,1,,,17738,,,N,50597,CHEMBL622052,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,10491,1,,,17738,,,N,50597,CHEMBL622053,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,10492,1,,,17738,,,N,50597,CHEMBL622054,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,10493,1,,,17738,,,N,50597,CHEMBL622055,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rats was determined; High,,10494,1,,,5237,,,N,50597,CHEMBL622056,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in the rat was determined,,10495,1,,,5503,,,N,50597,CHEMBL622057,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,10496,1,,,15765,,,N,50597,CHEMBL628008,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,10497,1,,,15660,,,N,50597,CHEMBL622058,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,10498,1,,,5978,,,N,50597,CHEMBL622059,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,10499,1,,,5978,,,N,50597,CHEMBL622060,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,10500,1,,,5978,,,N,50597,CHEMBL622061,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,10501,1,,,5978,,,N,50597,CHEMBL622062,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,10502,1,,,5656,,,N,50597,CHEMBL622063,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,10503,1,,,3598,,,N,50597,CHEMBL877611,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound in Sprague Dawley rats,,10504,1,,,4216,,,N,50597,CHEMBL622064,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound in rat,,10505,1,,,17839,,,N,50597,CHEMBL622065,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 2 mg/kg),,10506,1,,,6570,,,N,50597,CHEMBL622066,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound in rat was determined,,10507,1,,,5334,,,N,50597,CHEMBL622067,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound in rats,,10508,1,,,6886,,,N,50597,CHEMBL622068,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound was determined in rats,,10509,1,,,5210,,,N,50597,CHEMBL622069,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability at a dose of 30 mg/kg in rats,,10510,1,,,4170,,,N,50597,CHEMBL624796,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg),,10511,1,,,6028,,,N,50597,CHEMBL624797,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg),,10512,1,,,6028,,,N,50597,CHEMBL623053,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability evaluated in rat,,10513,1,,,6078,,,N,50597,CHEMBL623054,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in fasted rat,,10514,1,,,6168,,,N,50597,CHEMBL623055,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in fed rat,,10515,1,,,6168,,,N,50597,CHEMBL623056,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,10516,1,,,5160,,,N,50597,CHEMBL623057,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10517,1,,,6057,,,N,50597,CHEMBL623058,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg p.o.),,10518,1,,,6535,,,N,50597,CHEMBL623059,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after administration of 10 mg/kg po,,10519,1,,,6535,,,N,50597,CHEMBL623060,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10520,1,,,4194,,,N,50597,CHEMBL623061,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10521,1,,,6230,,,N,50597,CHEMBL623062,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10522,1,,,6619,,,N,50597,CHEMBL623063,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10523,1,,,17607,,,N,50597,CHEMBL623064,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in ratrs,,10524,1,,,4942,,,N,50597,CHEMBL623065,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10525,1,,,4942,,,N,50597,CHEMBL623066,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10526,1,,,6646,,,N,50597,CHEMBL623067,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rats was determined; High,,10527,1,,,5237,,,N,50597,CHEMBL623068,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10528,1,,,6646,,,N,50597,CHEMBL623069,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10529,1,,,4449,,,N,50597,CHEMBL623070,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was calculated in rat,,10530,1,,,6057,,,N,50597,CHEMBL623071,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10531,1,,,2552,,,N,50597,CHEMBL623072,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10532,1,,,5496,,,N,50597,CHEMBL623073,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10533,1,,,6484,,,N,50597,CHEMBL623074,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10534,1,,,6485,,,N,50597,CHEMBL623075,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability after i.v. administration,,10535,1,,,6616,,,N,50597,CHEMBL623076,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10536,1,,,4969,,,N,50597,CHEMBL623077,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley),,10537,1,,,5862,,,N,50597,CHEMBL623078,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in Sprague-Dawley rats,,10538,1,,,4514,,,N,50597,CHEMBL623079,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10539,1,,,4514,,,N,50597,CHEMBL623080,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10540,1,,,4514,,,N,50597,CHEMBL623081,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,10541,1,,,5546,,,N,50597,CHEMBL623082,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in fasted rat,,10542,1,,,6168,,,N,50597,CHEMBL874400,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in fed rat,,10543,1,,,6168,,,N,50597,CHEMBL623083,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10544,1,,,3624,,,N,50597,CHEMBL623084,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10545,1,,,5213,,,N,50597,CHEMBL623085,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10546,1,,,5496,,,N,50597,CHEMBL623086,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10547,1,,,5553,,,N,50597,CHEMBL623087,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10548,1,,,5833,,,N,50597,CHEMBL623088,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10549,1,,,5836,,,N,50597,CHEMBL623089,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10550,1,,,5865,,,N,50597,CHEMBL623090,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10551,1,,,5960,,,N,50597,CHEMBL623091,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10552,1,,,6249,,,N,50597,CHEMBL623092,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10553,1,,,6448,,,N,50597,CHEMBL623093,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10554,1,,,6453,,,N,50597,CHEMBL874401,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10555,1,,,6640,,,N,50597,CHEMBL623094,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10556,1,,,17607,,,N,50597,CHEMBL623095,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after peroral administration at 10 mg/kg,,10557,1,,,5939,,,N,50597,CHEMBL623096,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after peroral administration at 5 mg/kg,,10558,1,,,5939,,,N,50597,CHEMBL624913,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,10559,1,,,6281,,,N,50597,CHEMBL624914,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,10560,1,,,5874,,,N,50597,CHEMBL624915,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat; Not measured,,10561,1,,,5213,,,N,50597,CHEMBL624916,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10562,1,,,4964,,,N,50597,CHEMBL624917,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,10563,1,,,11020,,,N,50597,CHEMBL625157,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro metabolic potential in rat liver microsomes,,10564,1,,,6251,,Liver,N,50597,CHEMBL625158,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,10565,1,,,1568,,,N,50597,CHEMBL625159,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,10566,1,,,3032,,,N,50597,CHEMBL625160,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,10567,1,,,3748,,,N,50597,CHEMBL625161,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10568,1,,,401,,,N,50597,CHEMBL625162,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10569,1,,,6512,,,N,50597,CHEMBL625163,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rats at 10 mg/kg,,10570,1,,,17617,,,N,50597,CHEMBL625164,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,10571,1,,,6679,,,N,50597,CHEMBL625165,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10572,1,,,6742,,,N,50597,CHEMBL625166,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,10573,1,,,589,,,N,50597,CHEMBL625167,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,10574,1,,,589,,,N,50597,CHEMBL625168,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance of the compound,,10575,1,,,3185,,,N,50597,CHEMBL625169,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,10576,1,,,17596,,,N,50597,CHEMBL626264,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,10577,1,,,2713,,,N,50597,CHEMBL626265,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for plasma clearance in rat,,10578,1,,,12500,,Plasma,N,50597,CHEMBL626266,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,10579,1,,,12500,,Plasma,N,50597,CHEMBL626267,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration upon oral administration of 1 mg/Kg in rats,,10580,1,,,2713,,,N,50597,CHEMBL626268,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,10581,1,,,1446,,,N,50597,CHEMBL626269,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,10582,1,,,6227,,,N,50597,CHEMBL626270,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,10583,1,,,4709,,,N,50597,CHEMBL626271,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,10584,1,,,5510,,,N,50597,CHEMBL626272,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,10585,1,,,5510,,,N,50597,CHEMBL626273,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,10586,1,,,5510,,,N,50597,CHEMBL875346,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,10587,1,,,5510,,,N,50597,CHEMBL626274,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for protein binding in rat plasma,,10588,1,,,4514,,,N,50597,CHEMBL626275,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,10589,1,,,2713,,,N,50597,CHEMBL624646,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,10590,1,,,2713,,,N,50597,CHEMBL624647,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,10591,1,,,5340,,Liver,N,50597,CHEMBL624648,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve ratio was determined (po/iv) in rat,,10592,1,,,12058,,,N,50597,CHEMBL624649,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,10593,1,,,11195,,,N,50597,CHEMBL624650,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,10594,1,,,11195,,,N,50597,CHEMBL624651,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,10595,1,,,11195,,,N,50597,CHEMBL624652,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,10596,1,,,6495,,,N,50597,CHEMBL624653,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Ratio of AUCbrain to AUCplasma,,10597,1,,,6078,,,N,50597,CHEMBL624654,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Ratio of brain to plasma,,10598,1,,,5656,,,N,50597,CHEMBL624655,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,10599,1,,,4910,,,N,50597,CHEMBL624656,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,10600,1,,,4910,,,N,50597,CHEMBL624657,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,10601,1,,,4910,,,N,50597,CHEMBL624658,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,10602,1,,,10130,,,N,50597,CHEMBL624659,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,10603,1,,,10130,,,N,50597,CHEMBL624660,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,10604,1,,,10130,,,N,50597,CHEMBL624661,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Steady state brain :blood ratio was determined,,10605,1,,,5213,,,N,50597,CHEMBL624662,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,10606,1,,,4910,,,N,50597,CHEMBL625199,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,10607,1,,,4910,,,N,50597,CHEMBL625200,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,10608,1,,,4910,,,N,50597,CHEMBL625201,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,10609,1,,,4910,,,N,50597,CHEMBL625202,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage recovery after 3h incubation with rat hapatocytes was determined,,10610,1,,,2083,,,N,50597,CHEMBL625203,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,10611,1,,,2082,,,N,50597,CHEMBL625204,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,10612,1,,,2082,,,N,50597,CHEMBL625205,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,10613,1,,,6351,,,N,50597,CHEMBL625206,BAO_0000218,
A,Autocuration,1,,,,,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,10614,0,,,14583,,,U,22224,CHEMBL625207,BAO_0000019,
A,Autocuration,1,,,,,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,10615,0,,,14583,,,U,22224,CHEMBL625208,BAO_0000019,
A,Intermediate,1,495.0,,Homo sapiens,,,9606.0,In vivo absorption in Caco-2 cell line monolayers was determined,,10616,1,,,4608,Caco-2,,N,50587,CHEMBL625209,BAO_0000218,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,10617,0,,,13668,,,U,22229,CHEMBL625210,BAO_0000100,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determine after peroral administration at 10 mpk in Rat,,10618,1,,,5669,,,N,50597,CHEMBL625211,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,,,9544.0,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,10619,1,,,5669,,,N,50797,CHEMBL625212,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determine after peroral administration at 160 mpk in Rat,,10620,1,,,5669,,,N,50597,CHEMBL625213,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determine after peroral administration at 20 mpk in Rat,,10621,1,,,5669,,,N,50597,CHEMBL625214,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve was determine after peroral administration at 50 mpk in Rat,,10622,1,,,5669,,,N,50597,CHEMBL874542,BAO_0000218,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (AlogP),,10623,0,,,6472,,,U,22229,CHEMBL625215,BAO_0000100,
A,Autocuration,1,,,,,,,Activated partial thromboplastin time measured,,10624,0,,,15106,,,U,22224,CHEMBL625216,BAO_0000019,
P,Autocuration,1,,,,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,10625,0,,,15207,,,U,22224,CHEMBL625217,BAO_0000100,
P,Autocuration,1,,,,,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,10626,0,,,15207,,,U,22224,CHEMBL625218,BAO_0000100,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,10627,1,,,13941,,Plasma,N,50588,CHEMBL622864,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,10628,1,,,13941,,Plasma,N,50597,CHEMBL622865,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,10629,1,,,13941,,Plasma,N,50597,CHEMBL622866,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,10630,1,,,13941,,Plasma,N,50588,CHEMBL622867,BAO_0000218,1969.0
A,Intermediate,1,,,Cavia porcellus,,,10141.0,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,10631,1,,,15240,,Plasma,N,50512,CHEMBL876808,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,AUC in brain,,10632,0,,,10655,,Brain,U,22224,CHEMBL627725,BAO_0000019,955.0
A,Autocuration,1,,,,,,,AUC in serum,,10633,0,,,10655,,Serum,U,22224,CHEMBL627726,BAO_0000019,1977.0
A,Autocuration,1,,,,,,,AUC was determined,,10634,0,,,6504,,Plasma,U,22224,CHEMBL627727,BAO_0000019,1969.0
A,Autocuration,1,,,,,,,AUC of the compound.,,10635,0,,,10615,,Plasma,U,22224,CHEMBL627728,BAO_0000019,1969.0
A,Autocuration,1,,,,,,,AUC value (0-4 hr),,10636,0,,,10353,,Plasma,U,22224,CHEMBL627729,BAO_0000019,1969.0
A,Autocuration,1,,,,,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,10637,0,,,14907,,Plasma,U,22224,CHEMBL627730,BAO_0000019,1969.0
A,Autocuration,1,,,,,,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,10638,0,,,14907,,Plasma,U,22224,CHEMBL627731,BAO_0000019,1969.0
A,Autocuration,1,,,,,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,10639,0,,,14907,,Plasma,U,22224,CHEMBL627732,BAO_0000019,1969.0
A,Autocuration,1,,,,,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,10640,0,,,14907,,Plasma,U,22224,CHEMBL627733,BAO_0000019,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC(area under curve) was determined after intravenous administration in rats,,10641,1,,,16359,,Plasma,N,50597,CHEMBL627734,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC(area under curve) was determined after oral administration in rats,,10642,1,,,16359,,Plasma,N,50597,CHEMBL627735,BAO_0000218,1969.0
A,Intermediate,1,,,Cavia porcellus,,,10141.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,10643,1,,,15240,,Plasma,N,50512,CHEMBL627736,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,10644,1,,,15240,,Plasma,N,50597,CHEMBL876809,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Area Under Curve after oral dosing of 100 uM/Kg,,10645,0,,,15469,,,U,22224,CHEMBL627737,BAO_0000019,
A,Autocuration,1,,,,,,,Area Under Curve after oral dosing of 30 uM/Kg,,10646,0,,,15469,,,U,22224,CHEMBL627738,BAO_0000019,
A,Autocuration,1,,,,,,,Area Under Curve was measured by ploting the graph between concentration verses time,,10647,0,,,13520,,,U,22224,CHEMBL627739,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,10648,1,,,17025,,,N,50588,CHEMBL626143,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,10649,0,,,17025,,,U,22224,CHEMBL626144,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,10650,1,,,17025,,,N,50592,CHEMBL626145,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,10651,1,,,17025,,,N,50597,CHEMBL626146,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,10652,1,,,12032,,Blood,N,50597,CHEMBL626147,BAO_0000218,178.0
A,Autocuration,1,,,,,,,Area under curve (AUC) was determined,,10653,0,,,10291,,,U,22224,CHEMBL626148,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve (AUC) following ip administration at 1 mg/kg,,10654,0,,,5767,,,U,22224,CHEMBL626149,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve (AUC) was determined; ND is Not determined,,10655,0,,,1434,,,U,22224,CHEMBL626150,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,10656,1,,,14925,,,N,50588,CHEMBL626151,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,10657,1,,,14925,,,N,50588,CHEMBL626152,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,10658,1,,,14925,,,N,50588,CHEMBL626153,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve (AUR) was determined,,10659,0,,,1434,,,U,22224,CHEMBL626154,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve at 1 uM/dg administered intravenously,,10660,0,,,11883,,,U,22224,CHEMBL626155,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve at 10 uM/dg administered perorally,,10661,0,,,11883,,,U,22224,CHEMBL626156,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve at 2 uM/dg administered intravenously,,10662,0,,,11883,,,U,22224,CHEMBL626157,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve at 20 uM/dg administered perorally,,10663,0,,,11883,,,U,22224,CHEMBL626158,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve at a peroral dose of 3 mg/kg in dog,,10664,1,,,15233,,,N,50588,CHEMBL626159,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve at a peroral dose of 3 mg/kg in rat,,10665,1,,,15233,,,N,50597,CHEMBL626160,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve at an iv dose of 1 mg/kg in dog,,10666,1,,,15233,,,N,50588,CHEMBL626161,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under curve at an iv dose of 1 mg/kg in rat,,10667,1,,,15233,,,N,50597,CHEMBL626162,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,10668,0,,,12978,,,U,22224,CHEMBL626163,BAO_0000019,
A,Autocuration,1,,,,,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,10669,0,,,12978,,,U,22224,CHEMBL626164,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve measured as conc vs time after intravenous administration to mice.,,10670,1,,,11355,,,N,50594,CHEMBL626165,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Area under curve measured as conc vs time after peroral administration to mice.,,10671,1,,,11355,,,N,50594,CHEMBL626166,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,10672,1,,,12923,,,N,50588,CHEMBL626167,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,10673,1,,,12923,,,N,50588,CHEMBL626168,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,10674,1,,,12923,,,N,50588,CHEMBL877463,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,10675,1,,,12923,,,N,50588,CHEMBL626169,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,10676,1,,,17738,,Heart,N,50597,CHEMBL626170,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,10677,1,,,17738,,Heart,N,50597,CHEMBL626171,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,10678,1,,,17738,,Heart,N,50597,CHEMBL626172,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,10679,1,,,17738,,Heart,N,50597,CHEMBL626173,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,10680,1,,,17738,,Kidney,N,50597,CHEMBL626174,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,10681,1,,,17738,,Kidney,N,50597,CHEMBL626175,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,10682,1,,,17738,,Kidney,N,50597,CHEMBL626176,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,10683,1,,,17738,,Kidney,N,50597,CHEMBL626177,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,10684,1,,,17738,,Kidney,N,50597,CHEMBL622499,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,10685,1,,,17738,,Liver,N,50597,CHEMBL622500,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,10686,1,,,17738,,Liver,N,50597,CHEMBL622501,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,10687,1,,,17738,,Liver,N,50597,CHEMBL622502,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,10688,1,,,17738,,Liver,N,50597,CHEMBL622503,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,10689,1,,,17738,,Liver,N,50597,CHEMBL877614,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,10690,1,,,17738,,Lung,N,50597,CHEMBL624839,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,10691,1,,,17738,,Lung,N,50597,CHEMBL624840,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,10692,1,,,17738,,Lung,N,50597,CHEMBL624841,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,10693,1,,,17738,,Lung,N,50597,CHEMBL624842,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,10694,1,,,17738,,Muscle tissue,N,50597,CHEMBL624843,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,10695,1,,,17738,,Muscle tissue,N,50597,CHEMBL624844,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,10696,1,,,17738,,Muscle tissue,N,50597,CHEMBL624845,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,10697,1,,,17738,,Muscle tissue,N,50597,CHEMBL621904,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,10698,1,,,11195,,Blood,N,50597,CHEMBL621905,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,10699,1,,,11195,,Blood,N,50597,CHEMBL874382,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,10700,1,,,11195,,Blood,N,50597,CHEMBL621906,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,10701,1,,,11195,,Brain,N,50597,CHEMBL621907,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,10702,1,,,11195,,Brain,N,50597,CHEMBL622096,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,10703,1,,,11195,,Brain,N,50597,CHEMBL622097,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,10704,1,,,11195,,Heart,N,50597,CHEMBL622098,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,10705,1,,,11195,,Heart,N,50597,CHEMBL622099,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,10706,1,,,11195,,Heart,N,50597,CHEMBL622100,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,10707,1,,,11195,,Kidney,N,50597,CHEMBL622101,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,10708,1,,,11195,,Kidney,N,50597,CHEMBL622102,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,10709,1,,,11195,,Kidney,N,50597,CHEMBL622103,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,10710,1,,,11195,,Liver,N,50597,CHEMBL622104,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,10711,1,,,11195,,Liver,N,50597,CHEMBL622105,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,10712,1,,,11195,,Liver,N,50597,CHEMBL622106,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,10713,1,,,11195,,Lung,N,50597,CHEMBL622107,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,10714,1,,,11195,,Lung,N,50597,CHEMBL622108,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,10715,1,,,11195,,Lung,N,50597,CHEMBL622109,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,10716,1,,,11195,,Muscle tissue,N,50597,CHEMBL622110,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,10717,1,,,11195,,Muscle tissue,N,50597,CHEMBL622111,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,10718,1,,,11195,,Muscle tissue,N,50597,CHEMBL874383,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,10719,1,,,11195,,Zone of skin,N,50597,CHEMBL622112,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,10720,1,,,11195,,Zone of skin,N,50597,CHEMBL622113,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,10721,1,,,11195,,Zone of skin,N,50597,CHEMBL622114,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,10722,1,,,11195,,Spleen,N,50597,CHEMBL622115,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,10723,1,,,11195,,Spleen,N,50597,CHEMBL622116,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10724,1,,,6193,,,N,50597,CHEMBL622117,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10725,1,,,6803,,,N,50597,CHEMBL622118,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rats at 6 mg/kg,,10726,1,,,6647,,,N,50597,CHEMBL622119,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 6 mg/kg),,10727,1,,,6647,,,N,50597,CHEMBL622120,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,10728,1,,,6647,,,N,50597,CHEMBL622121,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10729,1,,,6640,,,N,50597,CHEMBL622122,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10730,1,,,6641,,,N,50597,CHEMBL622123,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10731,1,,,6641,,,N,50597,CHEMBL622124,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10732,1,,,6642,,,N,50597,CHEMBL622125,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10733,1,,,5472,,,N,50597,CHEMBL622126,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10734,1,,,6141,,,N,50597,CHEMBL620455,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10735,1,,,4390,,,N,50597,CHEMBL620456,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10736,1,,,5472,,,N,50597,CHEMBL620457,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was evaluated; Not tested,,10737,1,,,5472,,,N,50597,CHEMBL620458,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10738,1,,,5438,,,N,50597,CHEMBL620459,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat by oral dosing,,10739,1,,,4883,,,N,50597,CHEMBL620460,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg p.o.),,10740,1,,,1908,,,N,50597,CHEMBL620461,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley),,10741,1,,,4853,,,N,50597,CHEMBL620462,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10742,1,,,4853,,,N,50597,CHEMBL620463,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,10743,1,,,4853,,,N,50597,CHEMBL620464,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,10744,1,,,4853,,,N,50597,CHEMBL620465,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,10745,1,,,4853,,,N,50597,CHEMBL620466,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,10746,1,,,4853,,,N,50597,CHEMBL620467,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,10747,1,,,4853,,,N,50597,CHEMBL620468,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,10748,1,,,12873,,,N,50597,CHEMBL620469,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,10749,1,,,12873,,,N,50597,CHEMBL620470,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10750,1,,,3169,,,N,50597,CHEMBL620471,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10751,1,,,6305,,,N,50597,CHEMBL620472,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,10752,1,,,4762,,,N,50597,CHEMBL620473,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10753,1,,,17847,,,N,50597,CHEMBL620474,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,10754,1,,,6211,,,N,50597,CHEMBL620475,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10755,1,,,6011,,,N,50597,CHEMBL620476,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10756,1,,,6317,,,N,50597,CHEMBL620477,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,10757,1,,,6644,,,N,50597,CHEMBL620478,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,10758,1,,,6644,,,N,50597,CHEMBL618768,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,10759,1,,,6644,,,N,50597,CHEMBL618769,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,10760,1,,,6644,,,N,50597,CHEMBL618770,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability (dose 20 mg/kg p.o.),,10761,1,,,6113,,,N,50597,CHEMBL618771,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,10762,1,,,5937,,,N,50597,CHEMBL618772,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat at 10 mg/kg of the compound,,10763,1,,,5711,,,N,50597,CHEMBL618773,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,10764,1,,,17717,,,N,50597,CHEMBL875842,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 3 mg/kg i.v.),,10765,1,,,17717,,,N,50597,CHEMBL618774,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,10766,1,,,17717,,,N,50597,CHEMBL618775,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 60 mg/kg p.o.),,10767,1,,,17717,,,N,50597,CHEMBL618776,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Percent bioavailability (F) in rats after iv administration,,10768,1,,,4722,,,N,50597,CHEMBL618777,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,10769,1,,,4722,,,N,50597,CHEMBL618778,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 5 uM/kg p.o.),,10770,1,,,4353,,,N,50597,CHEMBL618779,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability,,10771,1,,,15662,,,N,50597,CHEMBL618780,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 2 mg/kg p.o.),,10772,1,,,4756,,,N,50597,CHEMBL618781,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,10773,1,,,4756,,,N,50597,CHEMBL618782,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 20 mg/kg),,10774,1,,,3436,,,N,50597,CHEMBL618783,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10775,1,,,17800,,,N,50597,CHEMBL618784,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Percent oral bioavailability evaluated in rat,,10776,1,,,15762,,,N,50597,CHEMBL618785,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10777,1,,,5089,,,N,50597,CHEMBL618786,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Percent oral bioavailability in rat; Not determined,,10778,1,,,5089,,,N,50597,CHEMBL618787,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,10779,1,,,3185,,,N,50597,CHEMBL618788,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10780,1,,,5145,,,N,50597,CHEMBL618789,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,10781,1,,,3457,,,N,50597,CHEMBL618790,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,10782,1,,,3457,,,N,50597,CHEMBL618791,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,10783,1,,,5983,,,N,50597,CHEMBL875843,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 20 mg/kg p.o.),,10784,1,,,5739,,,N,50597,CHEMBL618792,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax at a dose of 30 mg/kg in rat,,10785,1,,,3579,,,N,50597,CHEMBL623395,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Cmax in monkeys at a dose of 1 mg/kg,,10786,0,,,17788,,,U,22224,CHEMBL623396,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat,,10787,1,,,14956,,,N,50597,CHEMBL623397,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rats at a dose of 1 mg/kg,,10788,1,,,17788,,,N,50597,CHEMBL623398,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Cmax was measured in mice after an oral dose of 50 mg/kg.,,10789,1,,,9750,,,N,50594,CHEMBL623399,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,"Cmax value at a dose of 12.7 uM/kg, po",,10790,0,,,12767,,,U,22224,CHEMBL623400,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,"Cmax value at a dose of 6.3 uM/kg, iv",,10791,0,,,12767,,,U,22224,CHEMBL623401,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,"Cmax value at a dose of 7.1 uM/kg, iv",,10792,0,,,12767,,,U,22224,CHEMBL623402,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value of compound was determined after 1 hr,,10793,0,,,12703,,,U,22224,CHEMBL623403,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value of the compound,,10794,0,,,15778,,,U,22224,CHEMBL623404,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value administered intraintestinal in rats.,,10795,1,,,12818,,,N,50597,CHEMBL625997,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value administered perorally was determined in rat; Not determined,,10796,1,,,14964,,,N,50597,CHEMBL625998,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value at the dose of 2.3 mg/kg,,10797,0,,,15808,,,U,22224,CHEMBL625999,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value at the dose of 5 mg/kg,,10798,0,,,15808,,,U,22224,CHEMBL626000,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value in the period of 8 hr after dosing. ,,10799,0,,,15778,,,U,22224,CHEMBL626001,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value at a oral dose of 20 mg/kg; Not tested,,10800,0,,,3715,,,U,22224,CHEMBL626002,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value at a oral dose of 20 mg/kg,,10801,0,,,3715,,,U,22224,CHEMBL626003,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,10802,1,,,1446,,,N,50597,CHEMBL626004,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,10803,1,,,15240,,,N,50512,CHEMBL626005,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,10804,1,,,15240,,,N,50597,CHEMBL626006,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,10805,1,,,14810,,Plasma,N,50597,CHEMBL626007,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,10806,1,,,14239,,Plasma,N,50594,CHEMBL626008,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,10807,1,,,12555,,Liver,N,50588,CHEMBL626009,BAO_0000218,2107.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,10808,1,,,10754,,,N,50588,CHEMBL626010,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,10809,1,,,10754,,Blood,N,50594,CHEMBL626011,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,10810,1,,,10754,,Blood,N,50594,CHEMBL626012,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,10811,1,,,10754,,Blood,N,50594,CHEMBL626013,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,10812,1,,,10754,,Blood,N,50594,CHEMBL626014,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,10813,1,,,10754,,Blood,N,50594,CHEMBL877496,BAO_0000218,178.0
F,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,10814,1,,,14600,,,N,50588,CHEMBL626015,BAO_0000218,
F,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,10815,1,,,14600,,,N,50588,CHEMBL626016,BAO_0000218,
F,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,10816,1,,,14600,,,N,50588,CHEMBL626017,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability as maximal plasma concentration in dogs,,10817,1,,,13543,,Plasma,N,50588,CHEMBL626018,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability as maximal plasma concentration in dogs,,10818,1,,,13543,,Plasma,N,50588,CHEMBL626692,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability as maximal plasma concentration in rats,,10819,1,,,13543,,Plasma,N,50597,CHEMBL626693,BAO_0000218,1969.0
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability as maximal plasma concentration in rats,,10820,0,,,13543,,Plasma,U,22224,CHEMBL626694,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10821,1,,,14600,,Blood,N,50588,CHEMBL626695,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10822,1,,,14600,,Blood,N,50588,CHEMBL626696,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10823,1,,,14600,,Blood,N,50588,CHEMBL626697,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,10824,1,,,14600,,Blood,N,50588,CHEMBL626859,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10825,1,,,14600,,Blood,N,50588,CHEMBL626860,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,10826,1,,,14600,,Blood,N,50588,CHEMBL626861,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,10827,1,,,14681,,,N,50597,CHEMBL626296,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,10828,0,,,15905,,,U,22224,CHEMBL626297,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,10829,0,,,15905,,Plasma,U,22224,CHEMBL626298,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,10830,1,,,13304,,Plasma,N,50597,CHEMBL626299,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,10831,1,,,15137,,Plasma,N,50597,CHEMBL626300,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,10832,1,,,15137,,Plasma,N,50597,CHEMBL626301,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,10833,1,,,15137,,Plasma,N,50597,CHEMBL626962,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,10834,1,,,15137,,Plasma,N,50597,CHEMBL626963,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,10835,1,,,15137,,Plasma,N,50597,CHEMBL626964,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,10836,1,,,14839,,Plasma,N,100710,CHEMBL626965,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10837,1,,,14839,,Plasma,N,50594,CHEMBL626966,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10838,1,,,14839,,Plasma,N,50594,CHEMBL626967,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,10839,1,,,14839,,Plasma,N,100710,CHEMBL626968,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,10840,1,,,8418,,Heart,N,50597,CHEMBL626969,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,10841,1,,,8418,,Heart,N,50597,CHEMBL627126,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,10842,1,,,8418,,Heart,N,50597,CHEMBL631276,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,10843,1,,,8418,,Heart,N,50597,CHEMBL631277,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,10844,1,,,8418,,Heart,N,50597,CHEMBL631278,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,10845,1,,,8418,,Heart,N,50597,CHEMBL874457,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,10846,1,,,8418,,Heart,N,50597,CHEMBL631279,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,10847,1,,,8418,,Heart,N,50597,CHEMBL631280,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,10848,1,,,8418,,Heart,N,50597,CHEMBL631281,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,10849,1,,,8418,,Heart,N,50597,CHEMBL631968,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,10850,1,,,8418,,Heart,N,50597,CHEMBL631969,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,10851,1,,,8418,,Heart,N,50597,CHEMBL631970,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,10852,1,,,8418,,Heart,N,50597,CHEMBL631971,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,10853,1,,,8418,,Heart,N,50597,CHEMBL631972,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,10854,1,,,8418,,Heart,N,50597,CHEMBL630435,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,10855,1,,,8418,,Heart,N,50597,CHEMBL630436,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,10856,1,,,8418,,Heart,N,50597,CHEMBL630437,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,10857,1,,,8418,,Heart,N,50597,CHEMBL630438,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,10858,1,,,8418,,Heart,N,50597,CHEMBL630439,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,10859,1,,,8418,,Kidney,N,50597,CHEMBL630440,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,10860,1,,,8418,,Kidney,N,50597,CHEMBL630441,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,10861,1,,,8418,,Kidney,N,50597,CHEMBL630442,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,10862,1,,,8418,,Kidney,N,50597,CHEMBL625234,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,10863,1,,,8418,,Kidney,N,50597,CHEMBL625235,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,10864,1,,,8418,,Kidney,N,50597,CHEMBL625236,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,10865,1,,,8418,,Kidney,N,50597,CHEMBL625237,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,10866,1,,,8418,,Kidney,N,50597,CHEMBL626125,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,10867,1,,,8418,,Kidney,N,50597,CHEMBL626126,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,10868,1,,,8418,,Kidney,N,50597,CHEMBL626127,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,10869,1,,,8418,,Kidney,N,50597,CHEMBL626128,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,10870,1,,,8418,,Kidney,N,50597,CHEMBL626129,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,10871,1,,,8418,,Kidney,N,50597,CHEMBL626130,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,10872,1,,,8418,,Kidney,N,50597,CHEMBL626131,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,10873,1,,,8418,,Kidney,N,50597,CHEMBL626132,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,10874,1,,,8418,,Kidney,N,50597,CHEMBL626752,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,10875,1,,,8418,,Kidney,N,50597,CHEMBL626753,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,10876,1,,,8418,,Kidney,N,50597,CHEMBL626754,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,10877,1,,,8418,,Kidney,N,50597,CHEMBL626755,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,10878,1,,,8418,,Liver,N,50597,CHEMBL626756,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,10879,1,,,8418,,Liver,N,50597,CHEMBL626757,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,10880,1,,,8418,,Liver,N,50597,CHEMBL626758,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,10881,1,,,8418,,Liver,N,50597,CHEMBL626759,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,10882,1,,,8418,,Liver,N,50597,CHEMBL626760,BAO_0000218,2107.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,10883,1,,,6996,,,N,50588,CHEMBL626394,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,10884,1,,,6996,,,N,50588,CHEMBL626395,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,10885,1,,,6996,,,N,50588,CHEMBL626396,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,10886,1,,,6996,,,N,50588,CHEMBL626397,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,10887,1,,,6996,,,N,50588,CHEMBL626398,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,10888,1,,,6996,,,N,50588,CHEMBL626399,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,10889,1,,,6996,,,N,50597,CHEMBL874653,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,10890,1,,,6996,,,N,50597,CHEMBL626400,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,10891,1,,,6996,,,N,50597,CHEMBL626401,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,10892,1,,,6996,,,N,50597,CHEMBL626402,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,10893,1,,,6996,,,N,50597,CHEMBL626403,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,10894,1,,,6996,,,N,50597,CHEMBL626404,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,10895,1,,,6996,,,N,50597,CHEMBL626405,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,10896,1,,,6996,,,N,50597,CHEMBL625529,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,10897,1,,,6996,,,N,50597,CHEMBL625530,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,10898,1,,,6996,,,N,50597,CHEMBL625531,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,10899,1,,,6996,,,N,50597,CHEMBL625532,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,10900,1,,,6996,,,N,50597,CHEMBL625533,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,10901,1,,,6996,,,N,50597,CHEMBL875474,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,10902,1,,,6996,,,N,50597,CHEMBL625534,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,10903,1,,,6996,,,N,50597,CHEMBL625535,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,10904,1,,,6996,,,N,50597,CHEMBL625536,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,10905,1,,,6996,,,N,50597,CHEMBL625537,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,10906,1,,,6996,,,N,50597,CHEMBL625538,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,10907,1,,,6996,,,N,50597,CHEMBL625539,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,10908,1,,,6996,,,N,50597,CHEMBL625540,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,10909,1,,,6996,,,N,50597,CHEMBL625541,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,10910,1,,,6996,,,N,50597,CHEMBL625542,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,10911,1,,,6996,,,N,50597,CHEMBL625543,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,10912,1,,,6996,,,N,50597,CHEMBL625544,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,10913,1,,,6996,,,N,50588,CHEMBL625545,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,10914,1,,,6996,,,N,50588,CHEMBL625546,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,10915,1,,,6996,,,N,50588,CHEMBL625547,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,10916,1,,,6996,,,N,50588,CHEMBL625548,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,10917,1,,,6996,,,N,50588,CHEMBL625549,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,10918,1,,,6996,,,N,50588,CHEMBL625550,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,10919,1,,,6996,,,N,50588,CHEMBL625551,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,10920,1,,,6996,,,N,50588,CHEMBL875475,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,10921,1,,,6996,,,N,50588,CHEMBL625552,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,10922,1,,,6996,,,N,50588,CHEMBL625553,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,10923,1,,,6996,,,N,50588,CHEMBL625554,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,10924,1,,,6996,,,N,50588,CHEMBL625555,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,10925,1,,,6996,,,N,50588,CHEMBL625556,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,10926,1,,,6996,,,N,50588,CHEMBL624986,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,10927,1,,,6996,,,N,50588,CHEMBL624987,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,10928,1,,,6996,,,N,50588,CHEMBL624988,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,10929,1,,,9025,,Artery,N,50588,CHEMBL624989,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,10930,1,,,9025,,Artery,N,50588,CHEMBL624990,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,10931,1,,,9025,,Artery,N,50588,CHEMBL874391,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,10932,1,,,9025,,Artery,N,50588,CHEMBL624991,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,10933,1,,,9025,,Artery,N,50588,CHEMBL624992,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,10934,1,,,9025,,Artery,N,50588,CHEMBL624993,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,10935,1,,,9025,,Artery,N,50588,CHEMBL624994,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,10936,1,,,9025,,Artery,N,50588,CHEMBL624995,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,10937,1,,,9025,,Artery,N,50588,CHEMBL624996,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,10938,1,,,9025,,Artery,N,50588,CHEMBL624997,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,10939,1,,,9025,,Artery,N,50588,CHEMBL624998,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,10940,1,,,9025,,Artery,N,50588,CHEMBL624999,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,10941,1,,,9025,,Artery,N,50588,CHEMBL882955,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,10942,1,,,9025,,Artery,N,50588,CHEMBL625000,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,10943,1,,,9025,,Artery,N,50588,CHEMBL625001,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,10944,1,,,9025,,Artery,N,50588,CHEMBL625089,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,10945,1,,,9025,,Artery,N,50588,CHEMBL625090,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,10946,1,,,9025,,Artery,N,50588,CHEMBL625091,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,10947,1,,,9025,,Artery,N,50588,CHEMBL625092,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,10948,1,,,9025,,Artery,N,50588,CHEMBL625093,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,10949,1,,,9025,,Artery,N,50588,CHEMBL625094,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,10950,1,,,9025,,Artery,N,50588,CHEMBL625095,BAO_0000218,1637.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for its bioavailability in the dogs,,10951,1,,,2249,,,N,50588,CHEMBL625096,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for its bioavailability in the rats,,10952,1,,,2249,,,N,50597,CHEMBL625097,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Compound was evaluated for oral bioavailability,,10953,0,,,17515,,,U,22224,CHEMBL882956,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for percentage of Oral bioavailability in rats,,10954,1,,,14541,,,N,50597,CHEMBL625098,BAO_0000218,
A,Autocuration,1,,,Cavia porcellus,In vivo,,10141.0,Bioavailability in guinea pig,,10955,0,,,12797,,,U,22224,CHEMBL625099,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for the oral bioavailability in rat,,10956,1,,,12797,,,N,50597,CHEMBL625100,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for the oral bioavailability in dog,,10957,1,,,12797,,,N,50588,CHEMBL625101,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for the oral bioavailability in rat,,10958,1,,,12797,,,N,50597,CHEMBL874396,BAO_0000218,
F,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability in dog (dosed i.v.),,10959,0,,,11727,,,U,22224,CHEMBL625102,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was tested for in vivo bioavailability in dog,,10960,1,,,13249,,,N,50588,CHEMBL625103,BAO_0000218,
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Compound was tested for in vivo bioavailability in hamsters,,10961,1,,,13249,,,N,100712,CHEMBL625104,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Compound was tested for in vivo bioavailability in monkey,,10962,0,,,13249,,,U,22224,CHEMBL625105,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for in vivo bioavailability in rat,,10963,1,,,13249,,,N,50597,CHEMBL625106,BAO_0000218,
A,Autocuration,1,,,Mus musculus,In vivo,,10090.0,Oral bioavailability in mouse,,10964,0,,,9552,,,U,22224,CHEMBL625107,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was tested for percent of oral bioavailability in mice; 56-74,,10965,1,,,9552,,,N,50594,CHEMBL625108,BAO_0000218,
A,Autocuration,1,,,Mus musculus,In vivo,,10090.0,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,10966,0,,,14839,,,U,22224,CHEMBL625109,BAO_0000218,
A,Autocuration,1,,,Macaca fascicularis,In vivo,,9541.0,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,10967,0,,,14839,,,U,22224,CHEMBL625110,BAO_0000218,
A,Autocuration,1,,,Macaca fascicularis,In vivo,,9541.0,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,10968,0,,,14839,,,U,22224,CHEMBL625111,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,10969,1,,,14839,,,N,50594,CHEMBL625112,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Oral bioavailability in nude mice,,10970,1,,,14839,,,N,50594,CHEMBL875334,BAO_0000218,
A,Autocuration,1,,,Primates,In vivo,,9443.0,Bioavailability in monkey (i.d. dosing),,10971,0,,,11219,,,U,22224,CHEMBL628617,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,10972,0,,,9552,,,U,22224,CHEMBL628618,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,10973,0,,,11732,,,U,22224,CHEMBL628619,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,10974,0,,,11732,,,U,22224,CHEMBL628620,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,10975,1,,,14839,,,N,100710,CHEMBL628621,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,10976,1,,,14839,,,N,100710,CHEMBL628622,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,10977,1,,,14839,,,N,100710,CHEMBL628623,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,10978,1,,,14839,,Plasma,N,100710,CHEMBL628624,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10979,1,,,14839,,Plasma,N,50594,CHEMBL628625,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,10980,1,,,14839,,Plasma,N,100710,CHEMBL628626,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10981,1,,,14839,,Plasma,N,50594,CHEMBL627041,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10982,1,,,14839,,Plasma,N,50594,CHEMBL627042,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,10983,1,,,14839,,Plasma,N,50594,CHEMBL627043,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,10984,0,,,13932,,Plasma,U,22224,CHEMBL627044,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Cmax in mouse plasma,,10985,1,,,11637,,Plasma,N,50594,CHEMBL627045,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,10986,0,,,11637,,Plasma,U,22224,CHEMBL627046,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal plasma concentration in rat,,10987,1,,,13960,,Plasma,N,50597,CHEMBL627047,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,10988,1,,,15905,,Plasma,N,50597,CHEMBL627048,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,10989,1,,,14062,,,N,50597,CHEMBL627049,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,10990,1,,,14062,,,N,50597,CHEMBL627050,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,10991,1,,,14062,,,N,50597,CHEMBL627051,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,10992,1,,,14062,,,N,50597,CHEMBL627052,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,10993,1,,,14062,,,N,50597,CHEMBL627053,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,10994,1,,,14062,,,N,50597,CHEMBL627054,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,10995,1,,,15011,,,N,50594,CHEMBL627055,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,10996,1,,,15011,,,N,50594,CHEMBL627056,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,10997,1,,,15011,,,N,50594,CHEMBL627057,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,10998,1,,,15011,,,N,50594,CHEMBL627058,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,10999,1,,,15011,,,N,50594,CHEMBL626211,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum Concentration of the compound.,,11000,0,,,10291,,,U,22224,CHEMBL626212,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum Concentration was measured after iv administration into Beagle dog,,11001,1,,,14599,,,N,50588,CHEMBL626213,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum Concentration was measured after iv administration into Beagle dog.,,11002,1,,,14599,,,N,50588,CHEMBL626214,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum Concentration was measured after po administration into Beagle dog,,11003,1,,,14599,,,N,50588,CHEMBL626215,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum Concentration was measured after po administration into Beagle dog.,,11004,1,,,14599,,,N,50588,CHEMBL626216,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,11005,0,,,12767,,Blood,U,22224,CHEMBL626217,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,11006,0,,,12767,,Blood,U,22224,CHEMBL626218,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,11007,0,,,12767,,Blood,U,22224,CHEMBL626219,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,11008,0,,,12767,,Blood,U,22224,CHEMBL626220,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,11009,0,,,12767,,Blood,U,22224,CHEMBL626221,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Maximum blood level reached at dose of 10.6 uM/kg orally,,11010,0,,,12767,,Blood,U,22224,CHEMBL626222,BAO_0000218,178.0
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,11011,1,,,14706,,,N,50512,CHEMBL626223,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,11012,1,,,14706,,,N,50512,CHEMBL626224,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,11013,1,,,14793,,Brain,N,50597,CHEMBL626225,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,11014,1,,,14793,,Brain,N,50597,CHEMBL626226,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,11015,1,,,14793,,Brain,N,50597,CHEMBL626227,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,11016,1,,,14793,,Brain,N,50597,CHEMBL626228,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,11017,1,,,14793,,,N,50597,CHEMBL626229,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,11018,1,,,14793,,,N,50597,CHEMBL626921,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,11019,1,,,14793,,,N,50597,CHEMBL876793,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,11020,1,,,14793,,,N,50597,CHEMBL625309,BAO_0000218,
A,Intermediate,1,,,Bacillus subtilis,In vivo,,1423.0,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,11021,1,,,10524,,,N,50278,CHEMBL625310,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,11022,0,,,11871,,,U,22224,CHEMBL625311,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,11023,1,,,11871,,,N,50597,CHEMBL625312,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,11024,0,,,3437,,,U,22224,CHEMBL625313,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,11025,1,,,12038,,,N,50594,CHEMBL625314,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in male rats after iv administration of 20 mg/kg,,11026,1,,,12038,,,N,50597,CHEMBL625315,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,11027,1,,,8418,,Liver,N,50597,CHEMBL625316,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,11028,1,,,8418,,Liver,N,50597,CHEMBL625317,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,11029,1,,,8418,,Liver,N,50597,CHEMBL625318,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,11030,1,,,8418,,Liver,N,50597,CHEMBL625319,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,11031,1,,,8418,,Liver,N,50597,CHEMBL625320,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,11032,1,,,8418,,Liver,N,50597,CHEMBL625321,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,11033,1,,,8418,,Liver,N,50597,CHEMBL625322,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,11034,1,,,8418,,Liver,N,50597,CHEMBL876801,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,11035,1,,,8418,,Liver,N,50597,CHEMBL625323,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,11036,1,,,8418,,Liver,N,50597,CHEMBL625324,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,11037,1,,,8418,,Liver,N,50597,CHEMBL625325,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,11038,1,,,8418,,Liver,N,50597,CHEMBL625326,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,11039,1,,,8418,,Liver,N,50597,CHEMBL625327,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,11040,1,,,8418,,Liver,N,50597,CHEMBL625328,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,11041,1,,,8418,,Lung,N,50597,CHEMBL625329,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,11042,1,,,8418,,Lung,N,50597,CHEMBL625330,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,11043,1,,,8418,,Lung,N,50597,CHEMBL627774,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,11044,1,,,8418,,Lung,N,50597,CHEMBL627775,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,11045,1,,,8418,,Lung,N,50597,CHEMBL627949,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,11046,1,,,8418,,Lung,N,50597,CHEMBL627950,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,11047,1,,,8418,,Lung,N,50597,CHEMBL627951,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,11048,1,,,8418,,Lung,N,50597,CHEMBL627952,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,11049,1,,,8418,,Lung,N,50597,CHEMBL627953,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,11050,1,,,8418,,Lung,N,50597,CHEMBL627954,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,11051,1,,,8418,,Lung,N,50597,CHEMBL627955,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,11052,1,,,8418,,Lung,N,50597,CHEMBL627956,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,11053,1,,,8418,,Lung,N,50597,CHEMBL876802,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,11054,1,,,8418,,Lung,N,50597,CHEMBL627957,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,11055,1,,,8418,,Lung,N,50597,CHEMBL627958,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,11056,1,,,8418,,Lung,N,50597,CHEMBL627959,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,11057,1,,,8418,,Lung,N,50597,CHEMBL627960,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,11058,1,,,8418,,Lung,N,50597,CHEMBL627961,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,11059,1,,,8418,,Lung,N,50597,CHEMBL627962,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11060,1,,,9796,,,N,50597,CHEMBL627963,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,11061,1,,,9796,,,N,50597,CHEMBL624759,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11062,1,,,9796,,,N,50597,CHEMBL624760,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11063,1,,,9796,,,N,50597,CHEMBL624761,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11064,1,,,9796,,,N,50597,CHEMBL877607,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11065,1,,,9796,,Liver,N,50597,CHEMBL624762,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,11066,1,,,9796,,Liver,N,50597,CHEMBL624763,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11067,1,,,9796,,Liver,N,50597,CHEMBL624764,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11068,1,,,9796,,Liver,N,50597,CHEMBL624765,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11069,1,,,9796,,Liver,N,50597,CHEMBL624766,BAO_0000218,2107.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,11070,1,,,6996,,,N,50588,CHEMBL624767,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,11071,1,,,6996,,,N,50588,CHEMBL624768,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,11072,1,,,6996,,,N,50588,CHEMBL624769,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,11073,1,,,6996,,,N,50588,CHEMBL624770,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,11074,1,,,6996,,,N,50588,CHEMBL624771,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,11075,1,,,6996,,,N,50588,CHEMBL624772,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,11076,1,,,6996,,,N,50597,CHEMBL624773,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,11077,1,,,6996,,,N,50597,CHEMBL624774,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,11078,1,,,6996,,,N,50597,CHEMBL624775,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,11079,1,,,6996,,,N,50597,CHEMBL624776,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,11080,1,,,6996,,,N,50597,CHEMBL624777,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,11081,1,,,6996,,,N,50597,CHEMBL624778,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,11082,1,,,6996,,,N,50597,CHEMBL624779,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,11083,1,,,6996,,,N,50597,CHEMBL624780,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,11084,1,,,6996,,,N,50597,CHEMBL624781,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,11085,1,,,6996,,,N,50597,CHEMBL877608,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,11086,1,,,6996,,,N,50597,CHEMBL624782,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,11087,1,,,6996,,,N,50597,CHEMBL624783,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,11088,1,,,6996,,,N,50597,CHEMBL624784,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,11089,1,,,6996,,,N,50597,CHEMBL624785,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,11090,1,,,6996,,,N,50597,CHEMBL624786,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,11091,1,,,6996,,,N,50597,CHEMBL624787,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,11092,1,,,6996,,,N,50597,CHEMBL628676,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,11093,1,,,6996,,,N,50597,CHEMBL621842,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,11094,1,,,6996,,,N,50597,CHEMBL621843,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,11095,1,,,6996,,,N,50597,CHEMBL623873,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,11096,1,,,6996,,,N,50597,CHEMBL623874,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,11097,1,,,6996,,,N,50597,CHEMBL623875,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,11098,1,,,6996,,,N,50597,CHEMBL623876,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,11099,1,,,6996,,,N,50588,CHEMBL623877,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,11100,1,,,6996,,,N,50588,CHEMBL623878,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,11101,1,,,6996,,,N,50588,CHEMBL623879,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,11102,1,,,6996,,,N,50588,CHEMBL623880,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,11103,1,,,6996,,,N,50588,CHEMBL623881,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,11104,1,,,6996,,,N,50588,CHEMBL623957,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,11105,1,,,6996,,,N,50588,CHEMBL623958,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,11106,1,,,6996,,,N,50588,CHEMBL623959,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,11107,1,,,6996,,,N,50588,CHEMBL623960,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,11108,1,,,6996,,,N,50588,CHEMBL623961,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,11109,1,,,6996,,,N,50588,CHEMBL623962,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,11110,1,,,6996,,,N,50588,CHEMBL624676,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,11111,1,,,6996,,,N,50588,CHEMBL624677,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,11112,1,,,6996,,,N,50588,CHEMBL624678,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,11113,1,,,6996,,,N,50588,CHEMBL624679,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,11114,1,,,6996,,,N,50588,CHEMBL624680,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,11115,0,,,11732,,,U,22224,CHEMBL624849,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,11116,0,,,11732,,,U,22224,CHEMBL624850,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,11117,0,,,11732,,,U,22224,CHEMBL874399,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,11118,0,,,11732,,,U,22224,CHEMBL624851,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,11119,0,,,11732,,,U,22224,CHEMBL624852,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (dose 10 mg/kg),,11120,0,,,13359,,,U,22224,CHEMBL624853,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley),,11121,0,,,16618,,,U,22224,CHEMBL624854,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,11122,0,,,13960,,,U,22224,CHEMBL624855,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rats was determined in vivo,,11123,0,,,13917,,,U,22224,CHEMBL624856,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Oral bioavailability in dog,,11124,0,,,14266,,,U,22224,CHEMBL882957,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Oral bioavailability of compound in monkey,,11125,0,,,12359,,,U,22224,CHEMBL624857,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound in rat,,11126,1,,,12359,,,N,50597,CHEMBL622202,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat of PMEA prodrug,,11127,0,,,12359,,,U,22224,CHEMBL622203,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,11128,1,,,12359,,,N,50597,CHEMBL625522,BAO_0000218,
A,Autocuration,1,,,Macaca mulatta,In vivo,,9544.0,Serum conc at 3 hours following 25 mg/kg dose,,11129,0,,,10791,,,U,22224,CHEMBL622868,BAO_0000218,
A,Autocuration,1,,,Macaca mulatta,In vivo,,9544.0,Urine conc 0-5 hours following 25 mg/kg dose,,11130,0,,,10791,,Urine,U,22224,CHEMBL622869,BAO_0000218,1088.0
A,Autocuration,1,,,Macaca mulatta,In vivo,,9544.0,Urine conc 0-24 hours following 25 mg/kg dose,,11131,0,,,10791,,Urine,U,22224,CHEMBL622870,BAO_0000218,1088.0
A,Autocuration,1,,,Chlorocebus aethiops,In vivo,,9534.0,Oral bioavailability in African green monkeys; 20-25,,11132,0,,,138,,,U,22224,CHEMBL622871,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Oral bioavailability in cynomolgus monkey.,,11133,1,,,14521,,,N,100710,CHEMBL620560,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Oral bioavailability in dog,,11134,0,,,13953,,,U,22224,CHEMBL620561,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Oral bioavailability in dog at 10 mg/kg oral dose,,11135,1,,,12836,,,N,50588,CHEMBL620562,BAO_0000218,
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Oral bioavailability in hamster at 10 mg/kg oral dose,,11136,1,,,12836,,,N,100712,CHEMBL620563,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat at 10 mg/kg oral dose,,11137,1,,,12836,,,N,50597,CHEMBL620564,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,11138,0,,,14521,,,U,22224,CHEMBL872265,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,11139,0,,,13953,,,U,22224,CHEMBL620565,BAO_0000218,
A,Autocuration,1,,,Eutheria,In vivo,,9347.0,Oral bioavailability,,11140,0,,,6799,,,U,22224,CHEMBL620566,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Oral bioavailability was determined; range 49-102%,,11141,0,,,11311,,,U,22224,CHEMBL620567,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Oral bioavailability was determined in dogs,,11142,1,,,4013,,,N,50588,CHEMBL620568,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat,,11143,0,,,4013,,,U,22224,CHEMBL620569,BAO_0000218,
A,Autocuration,1,,,Eutheria,In vivo,,9347.0,Oral bioavailability,,11144,0,,,17591,,,U,22224,CHEMBL620570,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Oral bioavailability was determined; Not orally available,,11145,0,,,17591,,,U,22224,CHEMBL620571,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,11146,1,,,15011,,,N,50594,CHEMBL620572,BAO_0000218,
A,Autocuration,1,,,Mus musculus,In vivo,,10090.0,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,11147,0,,,15011,,,U,22224,CHEMBL620573,BAO_0000218,
A,Autocuration,1,,,Mus musculus,In vivo,,10090.0,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,11148,0,,,15011,,,U,22224,CHEMBL620574,BAO_0000218,
A,Autocuration,1,,,Macaca mulatta,In vivo,,9544.0,Oral bioavailability in Rhesus monkey,,11149,0,,,9552,,,U,22224,CHEMBL620575,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Oral bioavailability in dog (female mongrel),,11150,0,,,9552,,,U,22224,CHEMBL620576,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,11151,0,,,3639,,,U,22224,CHEMBL875846,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Oral bioavailability in dog,,11152,0,,,13397,,,U,22224,CHEMBL620577,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage Bioavailability was evaluated.,,11153,0,,,3031,,,U,22224,CHEMBL620578,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat administered i.d.,,11154,0,,,12818,,,U,22224,CHEMBL620579,BAO_0000218,
A,Autocuration,1,,,Eutheria,In vivo,,9347.0,Bioavailability,,11155,0,,,4847,,,U,22224,CHEMBL621248,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability in dog (male Beagle) i.v. administration,,11156,0,,,12421,,,U,22224,CHEMBL625390,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,11157,0,,,11966,,,U,22224,CHEMBL625391,BAO_0000218,
A,Autocuration,1,,,Primates,In vivo,,9443.0,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,11158,0,,,11218,,,U,22224,CHEMBL872266,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability in rat (Sprague-Dawley) (male),,11159,0,,,13129,,,U,22224,CHEMBL625392,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The oral bioavailability was measured on rats after oral administration,,11160,1,,,12350,,,N,50597,CHEMBL625393,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,11161,1,,,2231,,,N,50597,CHEMBL625394,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,11162,1,,,2231,,,N,50797,CHEMBL625395,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 10 mg/kg i.d.),,11163,0,,,12187,,,U,22224,CHEMBL625396,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability in dog (male Beagle) i.v. administration,,11164,0,,,12421,,,U,22224,CHEMBL625397,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11165,1,,,13256,,,N,50594,CHEMBL625398,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,11166,1,,,13256,,Blood,N,50594,CHEMBL625399,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11167,1,,,13256,,Cerebellum,N,50594,CHEMBL626074,BAO_0000218,2037.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,11168,1,,,13256,,,N,50594,CHEMBL626075,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,11169,1,,,2231,,Plasma,N,50597,CHEMBL626076,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,11170,1,,,2231,,Plasma,N,50797,CHEMBL626077,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,11171,1,,,12178,,Blood,N,50597,CHEMBL626078,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,11172,0,,,12178,,Blood,U,22224,CHEMBL625846,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,11173,0,,,12178,,Blood,U,22224,CHEMBL625847,BAO_0000218,178.0
A,Expert,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,11174,1,,,15633,,,N,50597,CHEMBL625848,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of compound in plasma administered orally to rats,,11175,1,,,14258,,Plasma,N,50597,CHEMBL625849,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,11176,1,,,14224,,Plasma,N,50588,CHEMBL626023,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,11177,1,,,14224,,Plasma,N,50588,CHEMBL626024,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,11178,1,,,14224,,Plasma,N,50588,CHEMBL626025,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration after 10 mg/kg by oral administration,,11179,0,,,5566,,,U,22224,CHEMBL626026,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration at a dose of 1.5 mg/kg,,11180,0,,,16935,,,U,22224,CHEMBL626027,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration at a dose of 2.0 mg/kg,,11181,0,,,16935,,,U,22224,CHEMBL626028,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum concentration in dog plasma,,11182,1,,,14224,,Plasma,N,50588,CHEMBL626029,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,11183,0,,,12536,,Plasma,U,22224,CHEMBL626030,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,11184,0,,,12536,,Plasma,U,22224,CHEMBL626031,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,11185,0,,,12536,,Plasma,U,22224,CHEMBL626032,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,11186,0,,,12536,,Plasma,U,22224,CHEMBL626033,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,11187,0,,,12536,,Plasma,U,22224,CHEMBL626034,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,11188,1,,,9994,,Plasma,N,50588,CHEMBL626035,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma at Tmax,,11189,0,,,1434,,Plasma,U,22224,CHEMBL626036,BAO_0000218,1969.0
A,Expert,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,11190,1,,,12836,,Plasma,N,50588,CHEMBL626037,BAO_0000218,1969.0
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,11191,1,,,12836,,Plasma,N,100712,CHEMBL626038,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,11192,1,,,12836,,Plasma,N,50597,CHEMBL626039,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,11193,1,,,12545,,Plasma,N,50597,CHEMBL626040,BAO_0000218,1969.0
A,Intermediate,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,11194,1,,,13856,,Plasma,N,50592,CHEMBL626041,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration was calculated,,11195,0,,,3550,,,U,22224,CHEMBL626042,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration was calculated.,,11196,0,,,2632,,,U,22224,CHEMBL626043,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration at a peroral dose of 10 mg/kg,,11197,0,,,5566,,,U,22224,CHEMBL626044,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration of the drug at 10 uM/dg administered perorally,,11198,0,,,11883,,,U,22224,CHEMBL626045,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,11199,0,,,11883,,,U,22224,CHEMBL626046,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,11200,1,,,14122,,Plasma,N,50588,CHEMBL626047,BAO_0000218,1969.0
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,11201,1,,,14122,,Plasma,N,100712,CHEMBL626048,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,11202,1,,,14122,,Plasma,N,50597,CHEMBL626049,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,11203,1,,,12542,,Plasma,N,50597,CHEMBL626050,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,11204,1,,,12542,,Plasma,N,50588,CHEMBL874541,BAO_0000218,1969.0
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,11205,1,,,12542,,Plasma,N,100712,CHEMBL622826,BAO_0000218,1969.0
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,11206,1,,,12542,,Plasma,N,100712,CHEMBL622827,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,11207,1,,,12542,,Plasma,N,50597,CHEMBL622828,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,11208,1,,,14080,,Plasma,N,50597,CHEMBL622829,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration reached following intravenous administration in male rat,,11209,1,,,11911,,,N,50597,CHEMBL876806,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,11210,1,,,13204,,,N,50588,CHEMBL622830,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,11211,1,,,13204,,,N,50597,CHEMBL622831,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,11212,1,,,14346,,,N,50588,CHEMBL626794,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,11213,1,,,14346,,,N,50597,CHEMBL626795,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,11214,1,,,14346,,,N,50597,CHEMBL626796,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,11215,1,,,14346,,,N,50597,CHEMBL626797,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum drug concentration is determined after oral dosing in rats.,,11216,1,,,14127,,,N,50597,CHEMBL626798,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,11217,1,,,14339,,,N,50588,CHEMBL626799,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum observed concentration in oral (5 mg/kg) fed dogs,,11218,1,,,14339,,,N,50588,CHEMBL626800,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration,,11219,0,,,13494,,Plasma,U,22224,CHEMBL626801,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,11220,1,,,14925,,Plasma,N,50597,CHEMBL876816,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,11221,1,,,14474,,Plasma,N,50597,CHEMBL626802,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,11222,1,,,14474,,Plasma,N,50588,CHEMBL626803,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration following oral administration of 30 umol/kg,,11223,0,,,13917,,Plasma,U,22224,CHEMBL626804,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,11224,1,,,9796,,Plasma,N,50597,CHEMBL626805,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11225,1,,,9796,,Plasma,N,50597,CHEMBL626309,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11226,1,,,9796,,Plasma,N,50597,CHEMBL626310,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11227,1,,,9796,,Plasma,N,50597,CHEMBL626311,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11228,1,,,9796,,Plasma,N,50597,CHEMBL626312,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,11229,1,,,9796,,Uterus,N,50597,CHEMBL626313,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,11230,1,,,9796,,Uterus,N,50597,CHEMBL626314,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,11231,1,,,9796,,Uterus,N,50597,CHEMBL626315,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,11232,1,,,9796,,Uterus,N,50597,CHEMBL626316,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,11233,1,,,9796,,Uterus,N,50597,CHEMBL626317,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,11234,1,,,8363,,,N,50597,CHEMBL626318,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,11235,1,,,8363,,,N,50597,CHEMBL626319,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,11236,1,,,8363,,,N,50597,CHEMBL626320,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,11237,1,,,8363,,,N,50597,CHEMBL875053,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,11238,1,,,8363,,,N,50597,CHEMBL626321,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,11239,1,,,8363,,,N,50597,CHEMBL626322,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,11240,1,,,8363,,,N,50597,CHEMBL626323,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,11241,1,,,8363,,,N,50597,CHEMBL626324,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,11242,1,,,8363,,,N,50597,CHEMBL626325,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,11243,1,,,8363,,,N,50597,CHEMBL626326,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,11244,1,,,8363,,,N,50597,CHEMBL626327,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,11245,1,,,8363,,,N,50597,CHEMBL626328,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,11246,1,,,8684,,Blood,N,50597,CHEMBL626329,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,11247,1,,,8684,,Blood,N,50597,CHEMBL626330,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,11248,1,,,8684,,Blood,N,50597,CHEMBL626331,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,11249,1,,,8684,,Blood,N,50597,CHEMBL626332,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,11250,1,,,8684,,Blood,N,50597,CHEMBL626333,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,11251,1,,,8684,,Blood,N,50597,CHEMBL626334,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,11252,1,,,8684,,Blood,N,50597,CHEMBL626335,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,11253,1,,,8684,,Blood,N,50597,CHEMBL624798,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,11254,1,,,8684,,Brain,N,50597,CHEMBL624799,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,11255,1,,,8684,,Brain,N,50597,CHEMBL624800,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,11256,1,,,8684,,Brain,N,50597,CHEMBL624801,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,11257,1,,,8684,,Brain,N,50597,CHEMBL624802,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,11258,1,,,8684,,Brain,N,50597,CHEMBL624803,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,11259,1,,,8684,,Brain,N,50597,CHEMBL624804,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,11260,1,,,8684,,Brain,N,50597,CHEMBL624805,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,11261,1,,,8684,,Brain,N,50597,CHEMBL624806,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,11262,1,,,8684,,,N,50597,CHEMBL624807,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,11263,1,,,8684,,,N,50597,CHEMBL624808,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,11264,1,,,8684,,,N,50597,CHEMBL624809,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,11265,1,,,8684,,,N,50597,CHEMBL624810,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,11266,1,,,8684,,,N,50597,CHEMBL877618,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,11267,1,,,8684,,,N,50597,CHEMBL624811,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,11268,1,,,8684,,,N,50597,CHEMBL624812,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,11269,1,,,8684,,,N,50597,CHEMBL624813,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,11270,1,,,8684,,,N,50597,CHEMBL624814,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,11271,1,,,8684,,,N,50597,CHEMBL624815,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,11272,1,,,8684,,,N,50597,CHEMBL624816,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,11273,1,,,8684,,,N,50597,CHEMBL624817,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,11274,1,,,6996,,,N,50588,CHEMBL624818,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,11275,1,,,6996,,,N,50588,CHEMBL624819,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,11276,1,,,6996,,,N,50588,CHEMBL624820,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,11277,1,,,6996,,,N,50588,CHEMBL624821,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,11278,1,,,6996,,,N,50588,CHEMBL624822,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,11279,1,,,6996,,,N,50588,CHEMBL624823,BAO_0000218,
A,Intermediate,1,,,Escherichia coli,,,562.0,Observed diffusion coefficient in organic solvent for Escherichia coli,,11280,1,,,15599,,,N,50212,CHEMBL624824,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11281,1,,,9614,,Blood,N,50597,CHEMBL624825,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11282,1,,,9614,,Blood,N,50597,CHEMBL624826,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11283,1,,,9614,,Cardiac atrium,N,50597,CHEMBL876817,BAO_0000218,2081.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11284,1,,,9614,,Cardiac atrium,N,50597,CHEMBL624827,BAO_0000218,2081.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11285,1,,,9614,,,N,50597,CHEMBL624828,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11286,1,,,9614,,,N,50597,CHEMBL624829,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11287,1,,,9614,,Liver,N,50597,CHEMBL624830,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11288,1,,,9614,,Liver,N,50597,CHEMBL624831,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11289,1,,,9614,,Cardiac atrium,N,50597,CHEMBL624832,BAO_0000218,2081.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11290,1,,,9614,,Cardiac atrium,N,50597,CHEMBL624833,BAO_0000218,2081.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11291,1,,,9614,,,N,50597,CHEMBL624834,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11292,1,,,9614,,,N,50597,CHEMBL624835,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,11293,1,,,9614,,Spleen,N,50597,CHEMBL624836,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,11294,1,,,9614,,Spleen,N,50597,CHEMBL624837,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,11295,1,,,9071,,Blood,N,50597,CHEMBL624838,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,11296,1,,,9071,,Blood,N,50597,CHEMBL622188,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,11297,1,,,9071,,Heart,N,50597,CHEMBL622189,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,11298,1,,,9071,,Heart,N,50597,CHEMBL622190,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,11299,1,,,9071,,Heart,N,50597,CHEMBL625170,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,11300,1,,,9071,,Kidney,N,50597,CHEMBL625171,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,11301,1,,,9071,,Kidney,N,50597,CHEMBL625172,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,11302,1,,,9071,,Kidney,N,50597,CHEMBL625173,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,11303,1,,,9071,,Liver,N,50597,CHEMBL625174,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,11304,1,,,9071,,Liver,N,50597,CHEMBL625175,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,11305,1,,,9071,,Liver,N,50597,CHEMBL625176,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,11306,1,,,9071,,Lung,N,50597,CHEMBL625177,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,11307,1,,,9071,,Lung,N,50597,CHEMBL625178,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,11308,1,,,9071,,Lung,N,50597,CHEMBL625179,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,11309,1,,,9071,,Lung,N,50597,CHEMBL625180,BAO_0000218,2048.0
A,Autocuration,1,,,,,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,11310,0,,,10677,,,U,22224,CHEMBL625181,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,11311,1,,,9750,,Urine,N,50594,CHEMBL625182,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11312,1,,,8319,,,N,50597,CHEMBL625183,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,11313,1,,,8319,,,N,50597,CHEMBL875848,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11314,1,,,8319,,,N,50597,CHEMBL622260,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,11315,1,,,8319,,,N,50597,CHEMBL622261,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11316,1,,,8319,,,N,50597,CHEMBL622262,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11317,1,,,8319,,Kidney,N,50597,CHEMBL622263,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11318,1,,,8319,,Kidney,N,50597,CHEMBL622418,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,11319,1,,,8319,,Liver,N,50597,CHEMBL622419,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,11320,1,,,13256,,,N,50594,CHEMBL623388,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,11321,1,,,13256,,Liver,N,50594,CHEMBL623389,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,11322,1,,,13256,,,N,50594,CHEMBL623390,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11323,1,,,13256,,,N,50594,CHEMBL623391,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,11324,1,,,13256,,Blood,N,50594,CHEMBL623392,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11325,1,,,13256,,Cerebellum,N,50594,CHEMBL623393,BAO_0000218,2037.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,11326,1,,,13256,,,N,50594,CHEMBL623394,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,11327,1,,,13256,,,N,50594,CHEMBL618885,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,11328,1,,,13256,,Liver,N,50594,CHEMBL618886,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,11329,1,,,13256,,,N,50594,CHEMBL618887,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,11330,1,,,13256,,,N,50594,CHEMBL619535,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,11331,1,,,13256,,Blood,N,50594,CHEMBL619536,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,11332,1,,,13256,,Cerebellum,N,50594,CHEMBL619537,BAO_0000218,2037.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,11333,1,,,13256,,,N,50594,CHEMBL619705,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,11334,1,,,13256,,,N,50594,CHEMBL619706,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,11335,1,,,13256,,Liver,N,50594,CHEMBL619707,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,11336,1,,,13256,,,N,50594,CHEMBL619708,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11337,1,,,13256,,,N,50594,CHEMBL625219,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,11338,1,,,13256,,Blood,N,50594,CHEMBL625220,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,11339,1,,,13256,,Cerebellum,N,50594,CHEMBL625221,BAO_0000218,2037.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,11340,1,,,13256,,,N,50594,CHEMBL625222,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,11341,1,,,13256,,,N,50594,CHEMBL625223,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,11342,1,,,13256,,Liver,N,50594,CHEMBL625224,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,11343,1,,,13256,,,N,50594,CHEMBL625225,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat blood after 24 hours of iv administration,,11344,1,,,8829,,Blood,N,50597,CHEMBL625226,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,11345,1,,,8829,,Blood,N,50597,CHEMBL625227,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat blood after 30 minutes of iv administration,,11346,1,,,8829,,Blood,N,50597,CHEMBL625228,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,11347,1,,,8829,,Blood,N,50597,CHEMBL875354,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat blood after 5 minutes of iv administration,,11348,1,,,8829,,Blood,N,50597,CHEMBL625229,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,11349,1,,,8829,,Blood,N,50597,CHEMBL625230,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat heart after 24 hours of iv administration,,11350,1,,,8829,,Heart,N,50597,CHEMBL625231,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,11351,1,,,8829,,Heart,N,50597,CHEMBL625900,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat heart after 30 minutes of iv administration,,11352,1,,,8829,,Heart,N,50597,CHEMBL625901,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,11353,1,,,8829,,Heart,N,50597,CHEMBL625902,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat heart after 5 minutes of iv administration,,11354,1,,,8829,,Heart,N,50597,CHEMBL625903,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,11355,1,,,8829,,Heart,N,50597,CHEMBL625904,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 24 hours of iv administration,,11356,1,,,8829,,Liver,N,50597,CHEMBL625905,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,11357,1,,,8829,,Liver,N,50597,CHEMBL627861,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration,,11358,1,,,8829,,Liver,N,50597,CHEMBL627862,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,11359,1,,,8829,,Liver,N,50597,CHEMBL627863,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration,,11360,1,,,8829,,Liver,N,50597,CHEMBL627769,BAO_0000218,2107.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,11361,1,,,13249,,Plasma,N,50588,CHEMBL627770,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Cmax in cynomolgus monkey (PO dose),,11362,1,,,13622,,,N,100710,CHEMBL627771,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat (PO dose),,11363,1,,,13622,,,N,50597,CHEMBL627772,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat (PO dose),,11364,1,,,13622,,,N,50597,CHEMBL627773,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,11365,1,,,13494,,Plasma,N,50597,CHEMBL621922,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat plasma after oral dose (10 mg/kg),,11366,1,,,12170,,Plasma,N,50597,CHEMBL621923,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Cmax in plasma after oral dose (10 mg/kg),,11367,0,,,12170,,Plasma,U,22224,CHEMBL621924,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,11368,1,,,17025,,Plasma,N,50588,CHEMBL621925,BAO_0000218,1969.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,11369,0,,,17025,,Plasma,U,22224,CHEMBL621926,BAO_0000218,1969.0
A,Intermediate,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,11370,1,,,17025,,Plasma,N,50592,CHEMBL621927,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,11371,1,,,17025,,Plasma,N,50597,CHEMBL621928,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,11372,1,,,14187,,Plasma,N,50597,CHEMBL621929,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,11373,1,,,14816,,Plasma,N,50594,CHEMBL621930,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration after oral dosing in rat,,11374,1,,,17820,,Plasma,N,50597,CHEMBL621931,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,11375,0,,,14380,,Plasma,U,22224,CHEMBL621932,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,11376,0,,,14380,,Plasma,U,22224,CHEMBL621933,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,11377,1,,,14691,,Plasma,N,50588,CHEMBL621934,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,11378,1,,,14691,,Plasma,N,50588,CHEMBL621935,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,11379,1,,,13375,,Plasma,N,50597,CHEMBL621936,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was determined,,11380,0,,,6236,,Plasma,U,22224,CHEMBL621937,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11381,0,,,14380,,Plasma,U,22224,CHEMBL621938,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11382,0,,,14380,,Plasma,U,22224,CHEMBL621939,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,11383,0,,,14380,,Plasma,U,22224,CHEMBL621940,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,11384,0,,,14380,,Plasma,U,22224,CHEMBL621941,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,11385,0,,,14380,,Plasma,U,22224,CHEMBL621942,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,11386,0,,,14380,,Plasma,U,22224,CHEMBL626178,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,11387,0,,,14380,,Plasma,U,22224,CHEMBL626179,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,11388,0,,,14380,,Plasma,U,22224,CHEMBL626180,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma Cmax in rat (PO dose),,11389,1,,,13622,,Plasma,N,50597,CHEMBL626181,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,11390,1,,,15372,,,N,50597,CHEMBL626182,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,11391,1,,,15372,,,N,50597,CHEMBL626183,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,11392,1,,,15372,,,N,50597,CHEMBL626184,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,11393,1,,,15372,,,N,50597,CHEMBL626185,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,11394,1,,,14925,,Plasma,N,50588,CHEMBL626186,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,11395,1,,,14925,,Plasma,N,50588,CHEMBL877589,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,11396,0,,,11883,,,U,22224,CHEMBL626187,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration of the drug at 20 uM/dg administered perorally,,11397,0,,,11883,,,U,22224,CHEMBL626188,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,11398,0,,,13391,,,U,22224,CHEMBL626189,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,11399,0,,,13391,,Blood,U,22224,CHEMBL626855,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,11400,0,,,13391,,Blood,U,22224,CHEMBL623781,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,11401,0,,,13391,,Blood,U,22224,CHEMBL623782,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,11402,1,,,16360,,Plasma,N,50597,CHEMBL623783,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Cmax in dog plasma after 1mg/kg oral dose,,11403,1,,,3673,,Plasma,N,50588,CHEMBL623784,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,11404,1,,,14431,,Plasma,N,50588,CHEMBL623785,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,11405,1,,,14431,,Plasma,N,50597,CHEMBL623786,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral maximum concentration in rat,,11406,1,,,14964,,,N,50597,CHEMBL623787,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral maximum concentration in rat,,11407,1,,,14964,,,N,50597,CHEMBL623788,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,11408,1,,,14209,,Plasma,N,50594,CHEMBL623789,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Peak concentration in blood after intravenous administration to mice,,11409,1,,,11355,,Blood,N,50594,CHEMBL623790,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Peak concentration in blood after peroral administration to mice,,11410,1,,,11355,,Blood,N,50594,CHEMBL623791,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak concentration in rat plasma was determined,,11411,1,,,11966,,Plasma,N,50597,CHEMBL623792,BAO_0000218,1969.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,11412,0,,,8918,,Plasma,U,22224,CHEMBL623793,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,11413,1,,,8918,,Plasma,N,50594,CHEMBL623794,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,11414,1,,,8918,,Plasma,N,50597,CHEMBL623795,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,11415,1,,,8684,,,N,50597,CHEMBL623796,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,11416,1,,,8684,,,N,50597,CHEMBL623797,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,11417,1,,,8684,,,N,50597,CHEMBL623798,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,11418,1,,,8684,,,N,50597,CHEMBL623799,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,11419,1,,,8684,,Intestine,N,50597,CHEMBL624490,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,11420,1,,,8684,,Intestine,N,50597,CHEMBL624491,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,11421,1,,,8684,,Intestine,N,50597,CHEMBL624492,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,11422,1,,,8684,,Intestine,N,50597,CHEMBL624493,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,11423,1,,,8684,,Intestine,N,50597,CHEMBL877595,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,11424,1,,,8684,,Intestine,N,50597,CHEMBL624494,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,11425,1,,,8684,,Intestine,N,50597,CHEMBL624495,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,11426,1,,,8684,,Intestine,N,50597,CHEMBL624681,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,11427,1,,,8684,,,N,50597,CHEMBL624682,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,11428,1,,,8684,,,N,50597,CHEMBL624683,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,11429,1,,,8684,,,N,50597,CHEMBL624684,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,11430,1,,,8684,,,N,50597,CHEMBL624685,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,11431,1,,,8684,,,N,50597,CHEMBL624686,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,11432,1,,,8684,,,N,50597,CHEMBL624687,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,11433,1,,,8684,,,N,50597,CHEMBL624688,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,11434,1,,,8684,,,N,50597,CHEMBL627161,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,11435,1,,,8684,,,N,50597,CHEMBL622127,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,11436,1,,,8684,,,N,50597,CHEMBL622128,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,11437,1,,,8684,,,N,50597,CHEMBL874384,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,11438,1,,,8684,,,N,50597,CHEMBL624898,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,11439,1,,,8684,,,N,50597,CHEMBL624899,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,11440,1,,,8684,,,N,50597,CHEMBL624900,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,11441,1,,,8684,,,N,50597,CHEMBL624901,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,11442,1,,,8684,,,N,50597,CHEMBL624902,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,11443,1,,,8684,,,N,50597,CHEMBL624903,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,11444,1,,,8684,,,N,50597,CHEMBL624904,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,11445,1,,,8684,,,N,50597,CHEMBL624905,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,11446,1,,,8684,,,N,50597,CHEMBL624906,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,11447,1,,,8684,,,N,50597,CHEMBL624907,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,11448,1,,,8684,,,N,50597,CHEMBL624908,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,11449,1,,,8684,,,N,50597,CHEMBL624909,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,11450,1,,,8684,,,N,50597,CHEMBL624910,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,11451,1,,,8684,,Muscle tissue,N,50597,CHEMBL624911,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,11452,1,,,8684,,Muscle tissue,N,50597,CHEMBL874388,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,11453,1,,,8684,,Muscle tissue,N,50597,CHEMBL624912,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,11454,1,,,8684,,Muscle tissue,N,50597,CHEMBL622930,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,11455,1,,,8684,,Muscle tissue,N,50597,CHEMBL623121,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,11456,1,,,8684,,Muscle tissue,N,50597,CHEMBL623122,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,11457,1,,,8684,,Muscle tissue,N,50597,CHEMBL623123,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,11458,1,,,8684,,Muscle tissue,N,50597,CHEMBL623124,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,11459,1,,,8684,,,N,50597,CHEMBL623125,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,11460,1,,,8684,,,N,50597,CHEMBL623126,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,11461,1,,,8684,,,N,50597,CHEMBL623127,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,11462,1,,,8684,,,N,50597,CHEMBL623128,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,11463,1,,,8684,,,N,50597,CHEMBL623129,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,11464,1,,,8684,,,N,50597,CHEMBL623130,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,11465,1,,,8684,,,N,50597,CHEMBL623131,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,11466,1,,,8684,,,N,50597,CHEMBL623132,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11467,1,,,8319,,Liver,N,50597,CHEMBL623133,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11468,1,,,8319,,,N,50597,CHEMBL623134,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11469,1,,,8319,,,N,50597,CHEMBL874389,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,11470,1,,,8319,,,N,50597,CHEMBL623135,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11471,1,,,8319,,,N,50597,CHEMBL623136,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,11472,1,,,8319,,,N,50597,CHEMBL623137,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11473,1,,,8319,,,N,50597,CHEMBL623138,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11474,1,,,8319,,Kidney,N,50597,CHEMBL623139,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11475,1,,,8319,,Kidney,N,50597,CHEMBL623140,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,11476,1,,,8319,,Liver,N,50597,CHEMBL623141,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11477,1,,,8319,,Liver,N,50597,CHEMBL623142,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11478,1,,,8319,,,N,50597,CHEMBL623143,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,11479,1,,,14571,,Urine,N,50594,CHEMBL623144,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,11480,1,,,14571,,Urine,N,50597,CHEMBL623405,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11481,1,,,8319,,,N,50597,CHEMBL624074,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,11482,1,,,8319,,,N,50597,CHEMBL624075,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11483,1,,,8319,,,N,50597,CHEMBL624076,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,11484,1,,,8319,,,N,50597,CHEMBL624077,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11485,1,,,8319,,,N,50597,CHEMBL624078,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11486,1,,,8319,,Kidney,N,50597,CHEMBL624079,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11487,1,,,8319,,Kidney,N,50597,CHEMBL624261,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,11488,1,,,8319,,,N,50597,CHEMBL624262,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11489,1,,,8319,,,N,50597,CHEMBL624263,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11490,1,,,8319,,,N,50597,CHEMBL624264,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,11491,1,,,8319,,,N,50597,CHEMBL624265,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,11492,1,,,8319,,,N,50597,CHEMBL624266,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,11493,1,,,8319,,,N,50597,CHEMBL624267,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,11494,1,,,8319,,,N,50597,CHEMBL624268,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,11495,1,,,8319,,,N,50597,CHEMBL875227,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,11496,1,,,8319,,Kidney,N,50597,CHEMBL624269,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,11497,1,,,8319,,Kidney,N,50597,CHEMBL624270,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,11498,1,,,8319,,,N,50597,CHEMBL624271,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,11499,1,,,8319,,,N,50597,CHEMBL624272,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,11500,1,,,8319,,,N,50597,CHEMBL624273,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,11501,1,,,12064,,Urine,N,50597,CHEMBL624274,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,11502,1,,,12064,,Urine,N,50597,CHEMBL624275,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,11503,1,,,12064,,Urine,N,50597,CHEMBL624276,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,11504,1,,,12038,,Urine,N,50597,CHEMBL624277,BAO_0000218,1088.0
A,Autocuration,1,,,,,,,% dose converted to 2-amino-5-chlorophenyl sulfate,,11505,0,,,14314,,,U,22224,CHEMBL624278,BAO_0000019,
A,Autocuration,1,,,,,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,11506,0,,,14314,,,U,22224,CHEMBL624279,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,11507,1,,,11488,,Feces,N,50597,CHEMBL624280,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,11508,1,,,11488,,Feces,N,50597,CHEMBL624281,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,11509,1,,,11488,,Feces,N,50597,CHEMBL622933,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,11510,1,,,11488,,Feces,N,50597,CHEMBL622934,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,11511,1,,,8829,,Liver,N,50597,CHEMBL622935,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 5 minutes of iv administration,,11512,1,,,8829,,Liver,N,50597,CHEMBL622936,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,11513,1,,,8829,,Liver,N,50597,CHEMBL875228,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat lung after 24 hours of iv administration,,11514,1,,,8829,,Lung,N,50597,CHEMBL622937,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,11515,1,,,8829,,Lung,N,50597,CHEMBL622938,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat lung after 30 minutes of iv administration,,11516,1,,,8829,,Lung,N,50597,CHEMBL619736,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,11517,1,,,8829,,Lung,N,50597,CHEMBL625117,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat lung after 5 minutes of iv administration,,11518,1,,,8829,,Lung,N,50597,CHEMBL625118,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,11519,1,,,8829,,Lung,N,50597,CHEMBL625119,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,11520,1,,,14972,,Cerebellum,N,50597,CHEMBL625120,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,11521,1,,,14972,,,N,50597,CHEMBL625121,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,11522,1,,,14972,,Thalamus,N,50597,CHEMBL625122,BAO_0000218,10000006.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11523,1,,,14608,,Blood,N,50597,CHEMBL622204,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11524,1,,,14608,,Blood,N,50597,CHEMBL877503,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11525,1,,,14608,,Blood,N,50597,CHEMBL627127,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11526,0,,,14608,,Hippocampus,U,22224,CHEMBL627128,BAO_0000218,10000000.0
A,Autocuration,1,,,,In vivo,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11527,0,,,14608,,Hippocampus,U,22224,CHEMBL627129,BAO_0000218,10000000.0
A,Autocuration,1,,,,In vivo,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11528,0,,,14608,,Hippocampus,U,22224,CHEMBL627130,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11529,1,,,14608,,Brain,N,50597,CHEMBL627131,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11530,1,,,14608,,Brain,N,50597,CHEMBL627132,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11531,1,,,14608,,Brain,N,50597,CHEMBL627133,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11532,1,,,14608,,Cerebellum,N,50597,CHEMBL627134,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11533,1,,,14608,,Cerebellum,N,50597,CHEMBL627135,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11534,1,,,14608,,Cerebellum,N,50597,CHEMBL627136,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11535,1,,,14608,,,N,50597,CHEMBL628435,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11536,1,,,14608,,,N,50597,CHEMBL628436,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11537,1,,,14608,,,N,50597,CHEMBL628437,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11538,1,,,14608,,Heart,N,50597,CHEMBL628438,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11539,1,,,14608,,Heart,N,50597,CHEMBL628439,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11540,1,,,14608,,Heart,N,50597,CHEMBL628440,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11541,1,,,14608,,Hippocampus,N,50597,CHEMBL628441,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11542,1,,,14608,,Hippocampus,N,50597,CHEMBL628442,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11543,1,,,14608,,Hippocampus,N,50597,CHEMBL628443,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11544,1,,,14608,,Kidney,N,50597,CHEMBL628444,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11545,1,,,14608,,Kidney,N,50597,CHEMBL628445,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11546,1,,,14608,,Kidney,N,50597,CHEMBL877504,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11547,1,,,14608,,Liver,N,50597,CHEMBL628446,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11548,1,,,14608,,Liver,N,50597,CHEMBL626874,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11549,1,,,14608,,Liver,N,50597,CHEMBL626875,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11550,1,,,14608,,Lung,N,50597,CHEMBL626876,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11551,1,,,14608,,Lung,N,50597,CHEMBL626877,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11552,1,,,14608,,Lung,N,50597,CHEMBL626878,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11553,1,,,14608,,Muscle tissue,N,50597,CHEMBL626879,BAO_0000218,2385.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,11554,0,,,8918,,Plasma,U,22224,CHEMBL626880,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,11555,1,,,8918,,Plasma,N,50594,CHEMBL626881,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,11556,1,,,8918,,Plasma,N,50597,CHEMBL626882,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Peak plasma concentration was measured in dogs,,11557,1,,,14470,,Plasma,N,50588,CHEMBL626883,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11558,1,,,14393,,,N,50597,CHEMBL626884,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,11559,1,,,14886,,,N,50597,CHEMBL626885,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,11560,1,,,14886,,,N,50597,CHEMBL626886,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,11561,1,,,14886,,,N,50597,CHEMBL626887,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11562,1,,,14393,,,N,50597,CHEMBL626888,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,11563,1,,,13465,,,N,50588,CHEMBL626889,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,11564,0,,,13465,,,U,22224,CHEMBL626761,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,11565,1,,,13465,,,N,50588,CHEMBL626762,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,11566,1,,,13465,,,N,50588,CHEMBL626763,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,11567,1,,,13465,,,N,50597,CHEMBL626764,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,11568,1,,,13465,,,N,50597,CHEMBL626765,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,11569,1,,,13465,,,N,50588,CHEMBL626766,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,11570,1,,,13465,,,N,50597,CHEMBL626767,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,11571,1,,,13465,,,N,50597,CHEMBL626768,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,11572,1,,,13465,,,N,50588,CHEMBL626769,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,11573,1,,,13465,,,N,50588,CHEMBL874463,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,11574,0,,,13465,,,U,22224,CHEMBL626770,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,11575,0,,,13465,,,U,22224,CHEMBL626771,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,11576,1,,,13465,,,N,50597,CHEMBL626772,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,11577,1,,,14731,,,N,100710,CHEMBL626773,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,11578,1,,,14731,,,N,50594,CHEMBL626774,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,11579,1,,,13376,,,N,50588,CHEMBL626775,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,11580,1,,,13376,,,N,50588,CHEMBL626776,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Maximum concentration (Cmax) in rat when administered orally,,11581,1,,,14443,,,N,50597,CHEMBL626777,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,11582,0,,,13465,,Plasma,U,22224,CHEMBL626778,BAO_0000218,1969.0
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,11583,0,,,16359,,,U,22224,CHEMBL626779,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,11584,0,,,16359,,,U,22224,CHEMBL626780,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,11585,0,,,15618,,Plasma,U,22224,CHEMBL626781,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic profile Cmax was evaluated in rats,,11586,1,,,14554,,,N,50597,CHEMBL632164,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,11587,1,,,11537,,,N,50588,CHEMBL632165,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,11588,1,,,11537,,,N,50594,CHEMBL632166,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,11589,1,,,11537,,,N,50588,CHEMBL632167,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,11590,1,,,11537,,,N,50594,CHEMBL632168,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat plasma,,11591,0,,,2021,,Plasma,U,22224,CHEMBL632169,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Cmax in dog plasma after 30mg/kg oral dose,,11592,1,,,5932,,Plasma,N,50588,CHEMBL632170,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax in rat plasma after 30mg/kg oral dose,,11593,1,,,5932,,Plasma,N,50597,CHEMBL632171,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma level in rats at 30 mg/kg,,11594,1,,,17320,,Plasma,N,50597,CHEMBL632172,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Tested for maximum plasma concentration in mice,,11595,1,,,15831,,Plasma,N,50594,CHEMBL632173,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,11596,1,,,15078,,,N,50597,CHEMBL632174,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The Cmax values in female wistar rats.,,11597,1,,,14941,,,N,50597,CHEMBL632175,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,11598,1,,,15343,,Plasma,N,50588,CHEMBL632176,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,11599,1,,,15343,,Plasma,N,50597,CHEMBL632177,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,11600,1,,,14856,,Plasma,N,50597,CHEMBL632178,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,11601,1,,,13129,,,N,50597,CHEMBL632179,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,11602,1,,,13098,,Blood,N,50597,CHEMBL632180,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,11603,1,,,13098,,Blood,N,50597,CHEMBL632181,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,11604,1,,,13098,,Blood,N,50597,CHEMBL632182,BAO_0000218,178.0
A,Autocuration,1,,,Mus musculus,In vivo,,10090.0,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,11605,0,,,15478,,Blood,U,22224,CHEMBL632183,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,11606,1,,,15341,,,N,50588,CHEMBL632184,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,11607,1,,,15341,,,N,50597,CHEMBL874470,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,11608,1,,,8684,,,N,50597,CHEMBL631302,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,11609,1,,,8684,,,N,50597,CHEMBL631303,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,11610,1,,,8684,,,N,50597,CHEMBL631304,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,11611,1,,,8684,,,N,50597,CHEMBL631305,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,11612,1,,,8684,,,N,50597,CHEMBL631306,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,11613,1,,,8684,,,N,50597,CHEMBL631307,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,11614,1,,,8684,,,N,50597,CHEMBL631308,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,11615,1,,,8684,,,N,50597,CHEMBL625557,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,11616,1,,,8684,,Spleen,N,50597,CHEMBL625558,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,11617,1,,,8684,,Spleen,N,50597,CHEMBL625559,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,11618,1,,,8684,,Spleen,N,50597,CHEMBL625560,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,11619,1,,,8684,,Spleen,N,50597,CHEMBL625561,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,11620,1,,,8684,,Spleen,N,50597,CHEMBL625562,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,11621,1,,,8684,,Spleen,N,50597,CHEMBL875320,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,11622,1,,,8684,,Spleen,N,50597,CHEMBL625563,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,11623,1,,,8684,,Spleen,N,50597,CHEMBL625564,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,11624,1,,,8684,,Uterus,N,50597,CHEMBL625565,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,11625,1,,,8684,,Uterus,N,50597,CHEMBL625566,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,11626,1,,,8684,,Uterus,N,50597,CHEMBL625567,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,11627,1,,,8684,,Uterus,N,50597,CHEMBL625568,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,11628,1,,,8684,,Uterus,N,50597,CHEMBL628217,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,11629,1,,,8684,,Uterus,N,50597,CHEMBL628218,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,11630,1,,,8684,,Uterus,N,50597,CHEMBL628219,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,11631,1,,,8684,,Uterus,N,50597,CHEMBL628220,BAO_0000218,995.0
A,Autocuration,1,,,,,,,Distribution in the blood after 120 min of intravenous administration,,11632,0,,,8926,,,U,22224,CHEMBL628221,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the blood after 15 min of intravenous administration,,11633,0,,,8926,,,U,22224,CHEMBL628222,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the blood after 30 min of intravenous administration,,11634,0,,,8926,,,U,22224,CHEMBL628223,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the blood after 5 min of intravenous administration,,11635,0,,,8926,,,U,22224,CHEMBL628224,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the blood after 60 min of intravenous administration,,11636,0,,,8926,,,U,22224,CHEMBL628225,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the blood after 90 min of intravenous administration,,11637,0,,,8926,,,U,22224,CHEMBL628226,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the bone after 120 min of intravenous administration,,11638,0,,,8926,,,U,22224,CHEMBL628227,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the bone after 15 min of intravenous administration,,11639,0,,,8926,,,U,22224,CHEMBL875481,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the bone after 30 min of intravenous administration,,11640,0,,,8926,,,U,22224,CHEMBL628228,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the bone after 5 min of intravenous administration,,11641,0,,,8926,,,U,22224,CHEMBL628229,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the bone after 60 min of intravenous administration,,11642,0,,,8926,,,U,22224,CHEMBL628230,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the bone after 90 min of intravenous administration,,11643,0,,,8926,,,U,22224,CHEMBL628231,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the heart after 120 min of intravenous administration,,11644,0,,,8926,,,U,22224,CHEMBL628232,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the heart after 15 min of intravenous administration,,11645,0,,,8926,,,U,22224,CHEMBL628233,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the heart after 30 min of intravenous administration,,11646,0,,,8926,,,U,22224,CHEMBL628234,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the heart after 5 min of intravenous administration,,11647,0,,,8926,,,U,22224,CHEMBL628235,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the heart after 60 min of intravenous administration,,11648,0,,,8926,,,U,22224,CHEMBL628236,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the heart after 90 min of intravenous administration,,11649,0,,,8926,,,U,22224,CHEMBL628237,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the kidneys after 120 min of intravenous administration,,11650,0,,,8926,,,U,22224,CHEMBL628238,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the kidneys after 15 min of intravenous administration,,11651,0,,,8926,,,U,22224,CHEMBL628239,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the kidneys after 30 min of intravenous administration,,11652,0,,,8926,,,U,22224,CHEMBL628240,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the kidneys after 5 min of intravenous administration,,11653,0,,,8926,,,U,22224,CHEMBL628241,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the kidneys after 60 min of intravenous administration,,11654,0,,,8926,,,U,22224,CHEMBL628242,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the kidneys after 90 min of intravenous administration,,11655,0,,,8926,,,U,22224,CHEMBL875482,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the liver after 120 min of intravenous administration,,11656,0,,,8926,,,U,22224,CHEMBL628243,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the liver after 15 min of intravenous administration,,11657,0,,,8926,,,U,22224,CHEMBL628244,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the liver after 30 min of intravenous administration,,11658,0,,,8926,,,U,22224,CHEMBL628245,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the liver after 5 min of intravenous administration,,11659,0,,,8926,,,U,22224,CHEMBL628246,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the liver after 60 min of intravenous administration,,11660,0,,,8926,,,U,22224,CHEMBL628247,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the liver after 90 min of intravenous administration,,11661,0,,,8926,,,U,22224,CHEMBL628248,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the lung after 120 min of intravenous administration,,11662,0,,,8926,,,U,22224,CHEMBL628249,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,11663,1,,,14839,,,N,50594,CHEMBL625452,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,11664,1,,,14839,,,N,50594,CHEMBL625453,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,11665,1,,,14839,,,N,50594,CHEMBL625454,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,11666,1,,,14839,,,N,50594,CHEMBL623844,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,11667,1,,,12178,,,N,50597,CHEMBL623845,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,11668,1,,,12178,,,N,50597,CHEMBL623846,BAO_0000218,
A,Autocuration,1,,,,,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,11669,0,,,12178,,,U,22224,CHEMBL623847,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,11670,1,,,12186,,,N,100710,CHEMBL623848,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,11671,1,,,12186,,,N,100710,CHEMBL623849,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,11672,1,,,12186,,,N,100710,CHEMBL623850,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,11673,1,,,12186,,,N,100710,CHEMBL623851,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,11674,0,,,12187,,,U,22224,CHEMBL623852,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,11675,1,,,12187,,,N,50506,CHEMBL624551,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,11676,1,,,12187,,,N,50506,CHEMBL624552,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,11677,0,,,12187,,,U,22224,CHEMBL624553,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,11678,0,,,12187,,,U,22224,CHEMBL624554,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,11679,1,,,12187,,,N,50597,CHEMBL624555,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,11680,1,,,12187,,,N,50597,CHEMBL624741,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,11681,1,,,14122,,,N,50588,CHEMBL624742,BAO_0000218,
A,Intermediate,1,,,Cricetinae,,,10026.0,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,11682,1,,,14122,,,N,100712,CHEMBL624743,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,11683,1,,,14122,,,N,50597,CHEMBL877606,BAO_0000218,
A,Autocuration,1,,,,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,11684,0,,,13391,,,U,22224,CHEMBL624744,BAO_0000218,
A,Autocuration,1,,,,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,11685,0,,,13391,,Blood,U,22224,CHEMBL624745,BAO_0000218,178.0
A,Autocuration,1,,,,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,11686,0,,,13391,,Blood,U,22224,CHEMBL624746,BAO_0000218,178.0
A,Autocuration,1,,,,,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,11687,0,,,13391,,Blood,U,22224,CHEMBL624747,BAO_0000218,178.0
A,Autocuration,1,,,,,,,Oral absorption expressed as Area under curve was determined,,11688,0,,,16360,,,U,22224,CHEMBL624748,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,11689,1,,,3673,,,N,50588,CHEMBL622504,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,11690,1,,,14122,,,N,50588,CHEMBL622505,BAO_0000218,
A,Intermediate,1,,,Cricetinae,,,10026.0,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,11691,1,,,14122,,,N,100712,CHEMBL622506,BAO_0000218,
A,Intermediate,1,,,Cricetinae,,,10026.0,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,11692,1,,,14122,,,N,100712,CHEMBL622507,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,11693,1,,,14122,,,N,50597,CHEMBL622508,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,11694,0,,,13889,,,U,22224,CHEMBL622509,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11695,1,,,14393,,,N,50597,CHEMBL622510,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,11696,1,,,17279,,,N,50597,CHEMBL622511,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,11697,1,,,14548,,,N,100710,CHEMBL622512,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,11698,1,,,14548,,,N,100710,CHEMBL622513,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,11699,1,,,14548,,,N,100710,CHEMBL622514,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,11700,1,,,14548,,,N,50588,CHEMBL622515,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,11701,1,,,14548,,,N,50588,CHEMBL622516,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,11702,1,,,14548,,,N,50597,CHEMBL622517,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,11703,1,,,14548,,,N,50597,CHEMBL622518,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,11704,1,,,14548,,,N,50597,CHEMBL622519,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11705,1,,,14608,,Muscle tissue,N,50597,CHEMBL622520,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11706,1,,,14608,,Muscle tissue,N,50597,CHEMBL622521,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11707,1,,,14608,,Zone of skin,N,50594,CHEMBL625113,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11708,1,,,14608,,Zone of skin,N,50597,CHEMBL625114,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11709,1,,,14608,,Zone of skin,N,50597,CHEMBL874397,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11710,1,,,14608,,Spleen,N,50597,CHEMBL625115,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11711,1,,,14608,,Spleen,N,50597,CHEMBL625116,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11712,1,,,14608,,Spleen,N,50597,CHEMBL623932,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11713,1,,,14608,,Striatum,N,50597,CHEMBL623933,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11714,1,,,14608,,Striatum,N,50597,CHEMBL623934,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11715,1,,,14608,,Striatum,N,50597,CHEMBL623935,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,11716,1,,,14608,,Thyroid gland,N,50597,CHEMBL623936,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,11717,1,,,14608,,Thyroid gland,N,50597,CHEMBL623937,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,11718,1,,,14608,,Thyroid gland,N,50597,CHEMBL623938,BAO_0000218,2046.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11719,1,,,15383,,,N,50594,CHEMBL623939,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11720,1,,,15383,,,N,50594,CHEMBL623940,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11721,1,,,15383,,,N,50594,CHEMBL623941,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11722,1,,,15383,,,N,50594,CHEMBL627216,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11723,1,,,15383,,,N,50594,CHEMBL623942,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11724,1,,,15383,,Brain,N,50594,CHEMBL618793,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11725,1,,,15383,,Brain,N,50594,CHEMBL618794,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11726,1,,,15383,,Brain,N,50594,CHEMBL618795,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11727,1,,,15383,,,N,50594,CHEMBL618796,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11728,1,,,15383,,,N,50594,CHEMBL618797,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,11729,1,,,15383,,Kidney,N,50594,CHEMBL618798,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11730,1,,,15383,,Kidney,N,50594,CHEMBL618799,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11731,1,,,15383,,Kidney,N,50594,CHEMBL618800,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11732,1,,,15383,,Kidney,N,50594,CHEMBL618801,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11733,1,,,15383,,Kidney,N,50594,CHEMBL618802,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11734,1,,,15383,,Kidney,N,50594,CHEMBL618803,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,11735,1,,,15383,,Liver,N,50594,CHEMBL618804,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11736,1,,,15383,,Liver,N,50594,CHEMBL618805,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11737,1,,,15383,,Liver,N,50594,CHEMBL618806,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11738,1,,,15383,,Liver,N,50594,CHEMBL618807,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11739,1,,,15383,,Liver,N,50594,CHEMBL618808,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11740,1,,,15383,,Liver,N,50594,CHEMBL618809,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11741,1,,,15383,,Muscle tissue,N,50594,CHEMBL618810,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,11742,1,,,15383,,Muscle tissue,N,50594,CHEMBL618811,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11743,1,,,15383,,Muscle tissue,N,50594,CHEMBL875844,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11744,1,,,15383,,Muscle tissue,N,50594,CHEMBL618812,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11745,1,,,15383,,Muscle tissue,N,50594,CHEMBL618813,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11746,1,,,15383,,,N,50594,CHEMBL618814,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11747,1,,,15383,,,N,50594,CHEMBL618815,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11748,1,,,15383,,,N,50594,CHEMBL618816,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11749,1,,,15383,,,N,50594,CHEMBL618817,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11750,1,,,15383,,,N,50594,CHEMBL620544,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,11751,1,,,15341,,,N,50597,CHEMBL626230,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,11752,1,,,15341,,,N,50597,CHEMBL626231,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,11753,1,,,15341,,,N,50597,CHEMBL626232,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,11754,1,,,14906,,Plasma,N,50588,CHEMBL626233,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,11755,1,,,14906,,Plasma,N,50597,CHEMBL626234,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,11756,1,,,14906,,Plasma,N,50597,CHEMBL875341,BAO_0000218,1969.0
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,The maximum plasma concentration (100 mg/kg) administered orally in human,,11757,1,,,14215,,Plasma,N,50587,CHEMBL626235,BAO_0000218,1969.0
A,Autocuration,1,,,Callithrix,In vivo,,9481.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,11758,0,,,14215,,Plasma,U,22224,CHEMBL626236,BAO_0000218,1969.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,11759,0,,,14215,,Plasma,U,22224,CHEMBL626237,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,11760,1,,,14215,,Plasma,N,50588,CHEMBL626238,BAO_0000218,1969.0
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,The maximum plasma concentration (200 mg/kg) administered orally in human,,11761,1,,,14215,,Plasma,N,50587,CHEMBL622412,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,11762,1,,,14215,,Plasma,N,50597,CHEMBL623114,BAO_0000218,1969.0
A,Autocuration,1,,,Callithrix,In vivo,,9481.0,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,11763,0,,,14215,,Plasma,U,22224,CHEMBL623115,BAO_0000218,1969.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,11764,0,,,14215,,Plasma,U,22224,CHEMBL623116,BAO_0000218,1969.0
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,The maximum plasma concentration (30 mg/kg) administered orally in dog,,11765,0,,,14215,,Plasma,U,22224,CHEMBL623117,BAO_0000218,1969.0
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,The maximum plasma concentration (400 mg/kg) administered orally in human,,11766,1,,,14215,,Plasma,N,50587,CHEMBL623118,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,11767,1,,,14215,,Plasma,N,50597,CHEMBL623119,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma concentration (50 mg/kg) administered orally in rat,,11768,1,,,14215,,Plasma,N,50597,CHEMBL623120,BAO_0000218,1969.0
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,The maximum plasma concentration (800 mg/kg) administered orally in human,,11769,1,,,14215,,Plasma,N,50587,CHEMBL623286,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma concentration was measured on rats,,11770,1,,,14067,,Plasma,N,50597,CHEMBL623287,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The maximum plasma concentration was measured on rats after oral administration,,11771,1,,,12350,,Plasma,N,50597,CHEMBL623288,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma drug Cmax in rat (PO dose),,11772,1,,,14813,,Plasma,N,50597,CHEMBL623289,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,11773,0,,,12536,,,U,22224,CHEMBL623290,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,maximum Plasma concentration in Dog was determined after Peroral administration,,11774,1,,,14169,,Plasma,N,50588,CHEMBL623291,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,maximum Plasma concentration in Rats was determined after Peroral administration,,11775,1,,,14169,,Plasma,N,50597,CHEMBL623292,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,11776,1,,,15604,,Plasma,N,50588,CHEMBL623293,BAO_0000218,1969.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,11777,0,,,15604,,Plasma,U,22224,CHEMBL623294,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,11778,1,,,15604,,Plasma,N,50597,CHEMBL623295,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,maximum concentration was measured when administered through oral route in mice,,11779,1,,,14387,,,N,50594,CHEMBL623296,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,11780,1,,,15115,,,N,50594,CHEMBL875349,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,11781,0,,,15115,,,U,22224,CHEMBL623297,BAO_0000019,
A,Autocuration,1,,,Simiiformes,,,314293.0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,11782,0,,,15115,,,U,22224,CHEMBL623298,BAO_0000019,
A,Autocuration,1,,,Simiiformes,,,314293.0,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,11783,0,,,15115,,,U,22224,CHEMBL623299,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter was evaluated in rats,,11784,1,,,16359,,,N,50597,CHEMBL623300,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,11785,1,,,12829,,,N,50594,CHEMBL623301,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,11786,1,,,12829,,,N,50594,CHEMBL623302,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,11787,1,,,12829,,,N,50594,CHEMBL623303,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,11788,1,,,12829,,,N,50594,CHEMBL623304,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,11789,1,,,12829,,,N,50594,CHEMBL623305,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,11790,1,,,15137,,Plasma,N,50597,CHEMBL623306,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,11791,1,,,15137,,Plasma,N,50597,CHEMBL623307,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,11792,1,,,15137,,Plasma,N,50597,CHEMBL623308,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,11793,1,,,15137,,Plasma,N,50594,CHEMBL623309,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma Concentration after 120 min of oral administration to mice,,11794,1,,,13509,,,N,50594,CHEMBL623310,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma Concentration after 30 min of oral administration to mice,,11795,1,,,13509,,,N,50594,CHEMBL623311,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Plasma Concentration after 60 min of oral administration to mice,,11796,1,,,13509,,,N,100710,CHEMBL623312,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma Concentration after 60 min of oral administration to mice; Not determined,,11797,1,,,13509,,,N,50594,CHEMBL875350,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Plasma Concentration after 90 min of oral administration to mice,,11798,1,,,13509,,,N,50594,CHEMBL628635,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,11799,1,,,12064,,,N,50597,CHEMBL628636,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,11800,1,,,12064,,,N,50597,CHEMBL628637,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,11801,1,,,12064,,,N,50597,CHEMBL628058,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,11802,1,,,10677,,,N,50597,CHEMBL628059,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,11803,1,,,10677,,,N,50597,CHEMBL628060,BAO_0000218,
A,Autocuration,1,,,,,,,Distribution in the lung after 15 min of intravenous administration,,11804,0,,,8926,,,U,22224,CHEMBL628061,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the lung after 30 min of intravenous administration,,11805,0,,,8926,,,U,22224,CHEMBL628062,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the lung after 5 min of intravenous administration,,11806,0,,,8926,,,U,22224,CHEMBL628063,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the lung after 60 min of intravenous administration,,11807,0,,,8926,,,U,22224,CHEMBL628064,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the lung after 90 min of intravenous administration,,11808,0,,,8926,,,U,22224,CHEMBL628065,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution in the muscle after 120 min of intravenous administration,,11809,0,,,8926,,Muscle tissue,U,22224,CHEMBL628066,BAO_0000019,2385.0
A,Autocuration,1,,,,,,,Distribution in the muscle after 15 min of intravenous administration,,11810,0,,,8926,,Muscle tissue,U,22224,CHEMBL628067,BAO_0000019,2385.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution in the muscle after 30 min of intravenous administration,,11811,1,,,8926,,Muscle tissue,N,50594,CHEMBL874646,BAO_0000218,2385.0
A,Autocuration,1,,,,,,,Distribution in the muscle after 5 min of intravenous administration,,11812,0,,,8926,,Muscle tissue,U,22224,CHEMBL628068,BAO_0000019,2385.0
A,Autocuration,1,,,,,,,Distribution in the muscle after 60 min of intravenous administration,,11813,0,,,8926,,Muscle tissue,U,22224,CHEMBL628069,BAO_0000019,2385.0
A,Autocuration,1,,,,,,,Distribution in the muscle after 90 min of intravenous administration,,11814,0,,,8926,,Muscle tissue,U,22224,CHEMBL628070,BAO_0000019,2385.0
A,Autocuration,1,,,,,,,Distribution in the spleen after 120 min of intravenous administration,,11815,0,,,8926,,Spleen,U,22224,CHEMBL628071,BAO_0000019,2106.0
A,Autocuration,1,,,,,,,Distribution in the spleen after 15 min of intravenous administration,,11816,0,,,8926,,Spleen,U,22224,CHEMBL628072,BAO_0000019,2106.0
A,Autocuration,1,,,,,,,Distribution in the spleen after 30 min of intravenous administration,,11817,0,,,8926,,Spleen,U,22224,CHEMBL628073,BAO_0000019,2106.0
A,Autocuration,1,,,,,,,Distribution in the spleen after 5 min of intravenous administration,,11818,0,,,8926,,Spleen,U,22224,CHEMBL628074,BAO_0000019,2106.0
A,Autocuration,1,,,,,,,Distribution in the spleen after 60 min of intravenous administration,,11819,0,,,8926,,Spleen,U,22224,CHEMBL628075,BAO_0000019,2106.0
A,Autocuration,1,,,,,,,Distribution in the spleen after 90 min of intravenous administration,,11820,0,,,8926,,Spleen,U,22224,CHEMBL628076,BAO_0000019,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,11821,1,,,7570,,Adrenal cortex,N,50597,CHEMBL628077,BAO_0000218,1235.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,11822,1,,,7570,,Blood,N,50597,CHEMBL628078,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,11823,1,,,7570,,Liver,N,50597,CHEMBL628079,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,11824,1,,,7570,,Female gonad,N,50597,CHEMBL628080,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,11825,1,,,7570,,Thyroid gland,N,50597,CHEMBL628081,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,11826,1,,,7570,,Adrenal cortex,N,50597,CHEMBL628082,BAO_0000218,1235.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,11827,1,,,7570,,Blood,N,50597,CHEMBL874647,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,11828,1,,,7570,,Liver,N,50597,CHEMBL626406,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,11829,1,,,7570,,Female gonad,N,50597,CHEMBL626407,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,11830,1,,,7570,,Thyroid gland,N,50597,CHEMBL626408,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,11831,1,,,8608,,Blood,N,50597,CHEMBL626409,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,11832,1,,,8608,,Blood,N,50597,CHEMBL626410,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,11833,1,,,8608,,Blood,N,50597,CHEMBL626411,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,11834,1,,,8608,,Blood,N,50597,CHEMBL626412,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,11835,1,,,8608,,Blood,N,50597,CHEMBL626413,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,11836,1,,,8608,,Blood,N,50597,CHEMBL626414,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,11837,1,,,8608,,Blood,N,50597,CHEMBL626415,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,11838,1,,,8608,,Blood,N,50597,CHEMBL626416,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,11839,1,,,8608,,Blood,N,50597,CHEMBL627062,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,11840,1,,,8608,,Blood,N,50597,CHEMBL627063,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,11841,1,,,8608,,Blood,N,50597,CHEMBL627064,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,11842,1,,,8608,,Blood,N,50597,CHEMBL627227,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,11843,1,,,8608,,Blood,N,50597,CHEMBL627228,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,11844,1,,,8608,,Blood,N,50597,CHEMBL627229,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,11845,1,,,8608,,Blood,N,50597,CHEMBL625792,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,11846,1,,,8608,,Blood,N,50597,CHEMBL625793,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,11847,1,,,8608,,Blood,N,50597,CHEMBL625794,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,11848,1,,,8608,,Blood,N,50597,CHEMBL625795,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,11849,1,,,13792,,,N,50594,CHEMBL625796,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,11850,1,,,13376,,,N,50588,CHEMBL625797,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,11851,1,,,13376,,,N,50588,CHEMBL625798,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11852,0,,,14380,,,U,22224,CHEMBL875613,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,11853,0,,,14380,,,U,22224,CHEMBL625799,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,11854,0,,,14380,,,U,22224,CHEMBL625800,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,11855,0,,,14380,,,U,22224,CHEMBL625801,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,11856,0,,,14380,,,U,22224,CHEMBL625802,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,11857,0,,,14380,,,U,22224,CHEMBL625803,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,11858,0,,,14380,,,U,22224,CHEMBL625804,BAO_0000019,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,11859,0,,,14380,,,U,22224,CHEMBL622530,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,11860,1,,,13701,,,N,50594,CHEMBL622531,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,11861,1,,,13701,,,N,50594,CHEMBL622532,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,11862,1,,,13701,,,N,50594,CHEMBL623176,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,11863,1,,,13701,,,N,50594,CHEMBL623177,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,11864,1,,,13701,,,N,50594,CHEMBL623178,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,11865,1,,,13701,,,N,50594,CHEMBL623179,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,11866,1,,,13701,,,N,50594,CHEMBL623180,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,11867,1,,,13701,,,N,50594,CHEMBL623181,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,11868,1,,,13701,,,N,50594,CHEMBL624131,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,11869,1,,,13701,,,N,50594,CHEMBL624132,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,11870,1,,,13701,,,N,50594,CHEMBL624133,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,11871,1,,,13701,,,N,50594,CHEMBL624846,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,11872,1,,,13701,,,N,50594,CHEMBL624847,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,11873,1,,,13701,,,N,50594,CHEMBL624848,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,11874,1,,,13701,,,N,50594,CHEMBL625012,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,11875,1,,,13701,,,N,50594,CHEMBL625013,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,11876,1,,,13701,,,N,50594,CHEMBL625014,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,11877,1,,,13701,,,N,50594,CHEMBL625015,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,11878,1,,,13701,,,N,50594,CHEMBL625016,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,11879,1,,,13701,,,N,50594,CHEMBL625017,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,11880,1,,,13701,,,N,50594,CHEMBL625018,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,11881,1,,,13701,,,N,50594,CHEMBL625019,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,11882,1,,,13701,,,N,50594,CHEMBL625020,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,11883,1,,,13701,,,N,50594,CHEMBL625021,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,11884,1,,,14393,,,N,50597,CHEMBL625022,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,11885,1,,,14731,,,N,50594,CHEMBL625023,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,11886,1,,,14731,,,N,100710,CHEMBL625024,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,11887,1,,,14731,,,N,100710,CHEMBL627626,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,11888,0,,,13758,,Brain,U,22224,CHEMBL627627,BAO_0000218,955.0
A,Autocuration,1,,,,,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,11889,0,,,13758,,Serum,U,22224,CHEMBL627628,BAO_0000218,1977.0
A,Autocuration,1,,,,,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,11890,0,,,13758,,Brain,U,22224,CHEMBL627629,BAO_0000218,955.0
A,Autocuration,1,,,,,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,11891,0,,,13758,,Serum,U,22224,CHEMBL627630,BAO_0000218,1977.0
A,Autocuration,1,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,11892,0,,,16359,,,U,22224,CHEMBL627631,BAO_0000019,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,11893,0,,,16359,,,U,22224,CHEMBL629515,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11894,1,,,15383,,Spleen,N,50594,CHEMBL629516,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11895,1,,,15383,,Spleen,N,50594,CHEMBL629517,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11896,1,,,15383,,Spleen,N,50594,CHEMBL629518,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,11897,1,,,15383,,,N,50594,CHEMBL877499,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,11898,1,,,15383,,,N,50594,CHEMBL629519,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,11899,1,,,15383,,,N,50594,CHEMBL629520,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,11900,1,,,15383,,,N,50594,CHEMBL629521,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,11901,1,,,14439,,,N,50594,CHEMBL629522,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,11902,1,,,14439,,,N,50594,CHEMBL629523,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,11903,1,,,14439,,,N,50594,CHEMBL629524,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,11904,1,,,14439,,,N,50594,CHEMBL629525,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,11905,1,,,14439,,,N,50594,CHEMBL629526,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,11906,1,,,14439,,,N,50594,CHEMBL629527,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,11907,1,,,14439,,,N,50594,CHEMBL629528,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,11908,1,,,14439,,,N,50594,CHEMBL629529,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,11909,1,,,14439,,,N,50594,CHEMBL629530,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,11910,1,,,14439,,,N,50594,CHEMBL629531,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,11911,1,,,14439,,,N,50594,CHEMBL628656,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,11912,1,,,14439,,,N,50594,CHEMBL628657,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,11913,1,,,13751,,,N,50597,CHEMBL628658,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11914,1,,,13751,,,N,50597,CHEMBL628659,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,11915,1,,,13751,,,N,50597,CHEMBL877500,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11916,1,,,13751,,,N,50597,CHEMBL628660,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11917,1,,,13751,,,N,50597,CHEMBL628661,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11918,1,,,13751,,,N,50597,CHEMBL628662,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,11919,1,,,13751,,,N,50597,CHEMBL628663,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,11920,1,,,13751,,,N,50597,CHEMBL628664,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11921,1,,,13751,,Blood,N,50597,CHEMBL628665,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,11922,1,,,13751,,Blood,N,50597,CHEMBL628666,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11923,1,,,13751,,Blood,N,50597,CHEMBL628667,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11924,1,,,13751,,Blood,N,50597,CHEMBL628668,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11925,1,,,13751,,Blood,N,50597,CHEMBL628669,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,11926,1,,,13751,,Blood,N,50597,CHEMBL628670,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,11927,1,,,13751,,Blood,N,50597,CHEMBL628671,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11928,1,,,13751,,Bone,N,50597,CHEMBL628672,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11929,1,,,13751,,Bone,N,50597,CHEMBL630300,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11930,1,,,13751,,Bone,N,50597,CHEMBL629787,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11931,1,,,13751,,Bone,N,50597,CHEMBL629788,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,11932,1,,,13751,,Brain,N,50597,CHEMBL629789,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,11933,1,,,13751,,Brain,N,50597,CHEMBL629790,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,11934,1,,,13751,,Brain,N,50597,CHEMBL629791,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,11935,1,,,13751,,Brain,N,50597,CHEMBL629792,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,11936,1,,,13751,,Brain,N,50597,CHEMBL629793,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,11937,1,,,13751,,Brain,N,50597,CHEMBL629794,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,11938,1,,,10677,,,N,50597,CHEMBL874459,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,11939,1,,,10677,,,N,50597,CHEMBL629795,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,11940,1,,,10677,,,N,50597,CHEMBL629796,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,11941,1,,,10677,,,N,50597,CHEMBL629797,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,11942,1,,,10677,,,N,50597,CHEMBL629798,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11943,1,,,10911,,Adrenal gland,N,50597,CHEMBL629799,BAO_0000218,2369.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11944,1,,,10911,,Adrenal gland,N,50597,CHEMBL629800,BAO_0000218,2369.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11945,1,,,10911,,Adrenal gland,N,50597,CHEMBL629801,BAO_0000218,2369.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,11946,1,,,10911,,Adrenal gland,N,50597,CHEMBL629802,BAO_0000218,2369.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11947,1,,,10911,,Adrenal gland,N,50597,CHEMBL629803,BAO_0000218,2369.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11948,1,,,10911,,Blood,N,50597,CHEMBL629804,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11949,1,,,10911,,Blood,N,50597,CHEMBL629805,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,11950,1,,,10911,,Blood,N,50597,CHEMBL629806,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11951,1,,,10911,,Blood,N,50597,CHEMBL629807,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11952,1,,,10911,,Blood,N,50597,CHEMBL629808,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11953,1,,,10911,,Brain,N,50597,CHEMBL629809,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11954,1,,,10911,,Brain,N,50597,CHEMBL629810,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,11955,1,,,10911,,Brain,N,50597,CHEMBL629811,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11956,1,,,10911,,Brain,N,50597,CHEMBL629812,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,11957,1,,,10911,,Brain,N,50597,CHEMBL629813,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11958,1,,,10911,,Brain,N,50597,CHEMBL874460,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11959,1,,,10911,,,N,50597,CHEMBL629814,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11960,1,,,10911,,,N,50597,CHEMBL629815,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11961,1,,,10911,,,N,50597,CHEMBL629816,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11962,1,,,10911,,,N,50597,CHEMBL629817,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11963,1,,,10911,,Kidney,N,50597,CHEMBL626643,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11964,1,,,10911,,Kidney,N,50597,CHEMBL626644,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11965,1,,,10911,,Kidney,N,50597,CHEMBL626806,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11966,1,,,10911,,Kidney,N,50597,CHEMBL626807,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11967,1,,,10911,,Liver,N,50597,CHEMBL627261,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11968,1,,,10911,,Liver,N,50597,CHEMBL627262,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11969,1,,,10911,,Liver,N,50597,CHEMBL627263,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11970,1,,,10911,,Liver,N,50597,CHEMBL627264,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11971,1,,,10911,,Lung,N,50597,CHEMBL627265,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11972,1,,,10911,,Lung,N,50597,CHEMBL627266,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,11973,1,,,10911,,Lung,N,50597,CHEMBL627267,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,11974,1,,,10911,,Lung,N,50597,CHEMBL627268,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,11975,1,,,10911,,Muscle tissue,N,50597,CHEMBL627269,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,11976,1,,,10911,,Muscle tissue,N,50597,CHEMBL627270,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,11977,1,,,8608,,,N,50597,CHEMBL627271,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,11978,1,,,8608,,,N,50597,CHEMBL627946,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,11979,1,,,8608,,,N,50597,CHEMBL875472,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,11980,1,,,8608,,,N,50597,CHEMBL627947,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,11981,1,,,8608,,,N,50597,CHEMBL627948,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,11982,1,,,8608,,,N,50597,CHEMBL628113,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,11983,1,,,8608,,,N,50597,CHEMBL628114,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,11984,1,,,8608,,,N,50597,CHEMBL628115,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,11985,1,,,8608,,,N,50597,CHEMBL628116,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,11986,1,,,8608,,,N,50597,CHEMBL628117,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,11987,1,,,8608,,,N,50597,CHEMBL628118,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,11988,1,,,8608,,,N,50597,CHEMBL628119,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,11989,1,,,8608,,,N,50597,CHEMBL628120,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,11990,1,,,8608,,,N,50597,CHEMBL628121,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,11991,1,,,8608,,,N,50597,CHEMBL628122,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,11992,1,,,8608,,,N,50597,CHEMBL627297,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,11993,1,,,8608,,,N,50597,CHEMBL627298,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,11994,1,,,8608,,,N,50597,CHEMBL627299,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,11995,1,,,8608,,,N,50597,CHEMBL627300,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,11996,1,,,8608,,,N,50597,CHEMBL627301,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,11997,1,,,8608,,,N,50597,CHEMBL627302,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,11998,1,,,8608,,,N,50597,CHEMBL627303,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,11999,1,,,8608,,,N,50597,CHEMBL627304,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,12000,1,,,8608,,,N,50597,CHEMBL627305,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,12001,1,,,8608,,,N,50597,CHEMBL627306,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,12002,1,,,8608,,,N,50597,CHEMBL623982,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,12003,1,,,8608,,,N,50597,CHEMBL623983,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,12004,1,,,8608,,,N,50597,CHEMBL623984,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,12005,1,,,8608,,,N,50597,CHEMBL623985,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,12006,1,,,8608,,,N,50597,CHEMBL623986,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,12007,1,,,8608,,,N,50597,CHEMBL623987,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,12008,1,,,8608,,,N,50597,CHEMBL623988,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,12009,1,,,8608,,,N,50597,CHEMBL623989,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,12010,1,,,8608,,,N,50597,CHEMBL622215,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,12011,1,,,8608,,,N,50597,CHEMBL622216,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,12012,1,,,8608,,,N,50597,CHEMBL877481,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,12013,0,,,16359,,,U,22224,CHEMBL622217,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,12014,1,,,13701,,,N,50594,CHEMBL622218,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic profile AUC was evaluated in rats,,12015,1,,,14554,,,N,50597,CHEMBL622219,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic property (Area under curve),,12016,0,,,6241,,,U,22224,CHEMBL622220,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,12017,1,,,11537,,,N,50588,CHEMBL622221,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,12018,1,,,11537,,,N,50594,CHEMBL622222,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,12019,1,,,11537,,,N,50588,CHEMBL622223,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,12020,1,,,11537,,,N,50594,CHEMBL622224,BAO_0000218,
A,Autocuration,1,,,,,,,Plasma concentration (AUC) was determined,,12021,0,,,13118,,,U,22224,CHEMBL622225,BAO_0000019,
A,Autocuration,1,,,,,,,Plasma concentration (AUC) was determined; Not detectable,,12022,0,,,13118,,,U,22224,CHEMBL622226,BAO_0000019,
A,Intermediate,1,,,Cavia porcellus,,,10141.0,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,12023,1,,,9562,,,N,50512,CHEMBL624154,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,12024,1,,,10363,,,N,50597,CHEMBL624155,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,12025,1,,,10363,,,N,50597,CHEMBL624156,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,12026,1,,,10363,,,N,50597,CHEMBL624157,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,12027,1,,,10363,,,N,50597,CHEMBL624158,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,12028,1,,,12504,,,N,50597,CHEMBL624159,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,12029,1,,,12504,,,N,50597,CHEMBL624160,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,12030,1,,,12504,,,N,50597,CHEMBL624161,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,12031,1,,,12504,,,N,50597,CHEMBL624162,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,12032,1,,,13317,,,N,50588,CHEMBL624163,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,12033,1,,,15078,,,N,50597,CHEMBL624164,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The AUC(0-infinity) values in female wistar rats.,,12034,1,,,14941,,,N,50597,CHEMBL624165,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,12035,1,,,15078,,,N,50597,CHEMBL624166,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,12036,1,,,15078,,,N,50597,CHEMBL624167,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The AUC(0-t)values in female wistar rats.,,12037,1,,,14941,,,N,50597,CHEMBL624168,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The Area under the concentration time curve of compound was measured on rats,,12038,1,,,14067,,,N,50597,CHEMBL624169,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,The area under curve (100 mg/kg) administered orally in humans,,12039,1,,,14215,,,N,50587,CHEMBL624170,BAO_0000218,
A,Autocuration,1,,,Callithrix,,,9481.0,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,12040,0,,,14215,,,U,22224,CHEMBL624171,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,The area under curve (12.5 mg/kg) administered intravenously in monkey,,12041,0,,,14215,,,U,22224,CHEMBL624172,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,The area under curve (15 mg/kg) administered intravenously in dog,,12042,1,,,14215,,,N,50588,CHEMBL624173,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,The area under curve (200 mg/kg) administered orally in humans,,12043,1,,,14215,,,N,50587,CHEMBL877488,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The area under curve (25 mg/kg) administered intravenously in rat,,12044,1,,,14215,,,N,50597,CHEMBL624174,BAO_0000218,
A,Autocuration,1,,,Callithrix,,,9481.0,The area under curve (25 mg/kg) administered orally in marmoset,,12045,0,,,14215,,,U,22224,CHEMBL624175,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,The area under curve (25 mg/kg) administered orally in monkey,,12046,0,,,14215,,,U,22224,CHEMBL624176,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,The area under curve (30 mg/kg) administered orally in dog,,12047,1,,,14215,,,N,50588,CHEMBL624177,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,The area under curve (400 mg/kg) administered orally in humans,,12048,1,,,14215,,,N,50587,CHEMBL624178,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The area under curve (50 mg/kg) administered orally in fasted rat,,12049,1,,,14215,,,N,50597,CHEMBL624179,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The area under curve (50 mg/kg) administered orally in rat,,12050,1,,,14215,,,N,50597,CHEMBL627689,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,The area under curve (800 mg/kg) administered orally in humans,,12051,1,,,14215,,,N,50587,CHEMBL627690,BAO_0000218,
A,Autocuration,1,,,,,,,The compound was evaluated for area under the curve,,12052,0,,,11324,,,U,22224,CHEMBL627691,BAO_0000019,
A,Autocuration,1,,,Callithrix,,,9481.0,The compound was evaluated for area under the curve in marmosets,,12053,0,,,11324,,,U,22224,CHEMBL627692,BAO_0000019,
A,Autocuration,1,,,Callithrix,,,9481.0,The compound was evaluated for area under the curve in marmosets,,12054,0,,,11324,,,U,22224,CHEMBL627693,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,12055,1,,,13875,,,N,50597,CHEMBL627694,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,12056,1,,,13875,,,N,50597,CHEMBL627695,BAO_0000218,
A,Autocuration,1,,,,,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,12057,0,,,13875,,,U,22224,CHEMBL627696,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,12058,1,,,13875,,,N,50597,CHEMBL627697,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,12059,1,,,13875,,,N,50597,CHEMBL627698,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,12060,1,,,13875,,,N,50597,CHEMBL627699,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,12061,1,,,13807,,,N,50597,CHEMBL627700,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total drug exposure is determined after oral dosing in rats.,,12062,1,,,14127,,,N,50597,CHEMBL627701,BAO_0000218,
A,Autocuration,1,,,,,,,Total drug exposure (5 mg/kg) when administered intravenously,,12063,0,,,15116,,,U,22224,CHEMBL627702,BAO_0000218,
A,Autocuration,1,,,,,,,Total drug exposure (5 mg/kg) when administered orally,,12064,0,,,15116,,,U,22224,CHEMBL627703,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,12065,0,,,15604,,,U,22224,CHEMBL626873,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,12066,1,,,15604,,,N,50597,CHEMBL629583,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,12067,1,,,15604,,,N,50588,CHEMBL629584,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,12068,1,,,15604,,,N,50588,CHEMBL629585,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12069,1,,,13751,,Brain,N,50597,CHEMBL629586,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12070,1,,,13751,,Brain,N,50597,CHEMBL629587,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12071,1,,,13751,,,N,50597,CHEMBL629588,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12072,1,,,13751,,,N,50597,CHEMBL629589,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12073,1,,,13751,,,N,50597,CHEMBL629590,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12074,1,,,13751,,,N,50597,CHEMBL629591,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12075,1,,,13751,,,N,50597,CHEMBL629592,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12076,1,,,13751,,,N,50597,CHEMBL629593,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12077,1,,,13751,,,N,50597,CHEMBL629594,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12078,1,,,13751,,Heart,N,50597,CHEMBL629595,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12079,1,,,13751,,Heart,N,50597,CHEMBL630290,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12080,1,,,13751,,Heart,N,50597,CHEMBL627137,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12081,1,,,13751,,Heart,N,50597,CHEMBL627138,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12082,1,,,13751,,Heart,N,50597,CHEMBL627139,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12083,1,,,13751,,Heart,N,50597,CHEMBL627140,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12084,1,,,13751,,Heart,N,50597,CHEMBL627141,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12085,1,,,13751,,Kidney,N,50597,CHEMBL627142,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12086,1,,,13751,,Kidney,N,50597,CHEMBL627143,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12087,1,,,13751,,Kidney,N,50597,CHEMBL874449,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12088,1,,,13751,,Kidney,N,50597,CHEMBL627144,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12089,1,,,13751,,Kidney,N,50597,CHEMBL627145,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12090,1,,,13751,,Kidney,N,50597,CHEMBL627146,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12091,1,,,13751,,Kidney,N,50597,CHEMBL627147,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12092,1,,,13751,,Liver,N,50597,CHEMBL627148,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12093,1,,,13751,,Lung,N,50597,CHEMBL627149,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12094,1,,,13751,,Lung,N,50597,CHEMBL632160,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12095,1,,,13751,,Lung,N,50597,CHEMBL632161,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12096,1,,,13751,,Lung,N,50597,CHEMBL632162,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12097,1,,,13751,,Lung,N,50597,CHEMBL632163,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12098,1,,,13751,,Lung,N,50597,CHEMBL874469,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12099,1,,,13751,,Lung,N,50597,CHEMBL627182,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,12100,1,,,13751,,Muscle tissue,N,50597,CHEMBL627183,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12101,1,,,13751,,Muscle tissue,N,50597,CHEMBL627184,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12102,1,,,13751,,Muscle tissue,N,50597,CHEMBL627185,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12103,1,,,13751,,Muscle tissue,N,50597,CHEMBL627186,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12104,1,,,13751,,Muscle tissue,N,50597,CHEMBL627187,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12105,1,,,13751,,Muscle tissue,N,50597,CHEMBL627188,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12106,1,,,13751,,Muscle tissue,N,50597,CHEMBL627189,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12107,1,,,13751,,,N,50597,CHEMBL627190,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,12108,1,,,13751,,Liver,N,50597,CHEMBL627191,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,12109,1,,,13751,,Liver,N,50597,CHEMBL627192,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,12110,1,,,13751,,Liver,N,50597,CHEMBL627193,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,12111,1,,,10911,,Muscle tissue,N,50597,CHEMBL874590,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12112,1,,,10911,,Muscle tissue,N,50597,CHEMBL627194,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12113,1,,,10911,,Muscle tissue,N,50597,CHEMBL627195,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12114,1,,,10911,,Female gonad,N,50597,CHEMBL627196,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12115,1,,,10911,,Female gonad,N,50597,CHEMBL627197,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12116,1,,,10911,,Female gonad,N,50597,CHEMBL627198,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,12117,1,,,10911,,Female gonad,N,50597,CHEMBL627199,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12118,1,,,10911,,Female gonad,N,50597,CHEMBL627200,BAO_0000218,992.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12119,1,,,10911,,Plasma,N,50597,CHEMBL627201,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12120,1,,,10911,,Plasma,N,50597,CHEMBL627202,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12121,1,,,10911,,Plasma,N,50597,CHEMBL627203,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12122,1,,,10911,,Plasma,N,50597,CHEMBL627204,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12123,1,,,10911,,Spleen,N,50597,CHEMBL627205,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12124,1,,,10911,,Spleen,N,50597,CHEMBL627206,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12125,1,,,10911,,Spleen,N,50597,CHEMBL627207,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12126,1,,,10911,,Spleen,N,50597,CHEMBL627208,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12127,1,,,10911,,Thyroid gland,N,50597,CHEMBL627209,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12128,1,,,10911,,Thyroid gland,N,50597,CHEMBL627210,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12129,1,,,10911,,Thyroid gland,N,50597,CHEMBL627211,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12130,1,,,10911,,Thyroid gland,N,50597,CHEMBL627212,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,12131,1,,,10911,,Uterus,N,50597,CHEMBL627213,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,12132,1,,,10911,,Uterus,N,50597,CHEMBL626599,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,12133,1,,,10911,,Uterus,N,50597,CHEMBL626600,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,12134,1,,,10911,,Uterus,N,50597,CHEMBL626601,BAO_0000218,995.0
A,Autocuration,1,,,,,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,12135,0,,,8081,,,U,22224,CHEMBL627484,BAO_0000019,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,12136,1,,,17248,,Plasma,N,100710,CHEMBL627485,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,12137,1,,,17248,,Plasma,N,100710,CHEMBL628147,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,12138,1,,,17248,,Plasma,N,100710,CHEMBL628148,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,12139,1,,,17248,,Plasma,N,50588,CHEMBL628149,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,12140,1,,,17248,,Plasma,N,50588,CHEMBL628150,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,12141,1,,,17248,,Plasma,N,50588,CHEMBL628318,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,12142,1,,,17248,,Plasma,N,50588,CHEMBL628319,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,12143,1,,,15592,,,N,50588,CHEMBL875609,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,12144,0,,,7040,,,U,22224,CHEMBL628320,BAO_0000019,
A,Autocuration,1,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,12145,0,,,7040,,,U,22224,CHEMBL628321,BAO_0000019,
A,Autocuration,1,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,12146,0,,,7040,,,U,22224,CHEMBL628322,BAO_0000019,
A,Autocuration,1,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,12147,0,,,7040,,,U,22224,CHEMBL628323,BAO_0000019,
A,Autocuration,1,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,12148,0,,,7040,,,U,22224,CHEMBL628324,BAO_0000019,
A,Autocuration,1,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,12149,0,,,7040,,,U,22224,CHEMBL628325,BAO_0000019,
A,Autocuration,1,,,,,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,12150,0,,,7040,,,U,22224,CHEMBL628326,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,12151,1,,,9614,,Adrenal medulla,N,50588,CHEMBL628327,BAO_0000218,1236.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,12152,1,,,9614,,Adrenal medulla,N,50588,CHEMBL628328,BAO_0000218,1236.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in blood of dog 1, after administering intravenously",,12153,1,,,9614,,Blood,N,50588,CHEMBL628329,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,12154,1,,,8608,,Liver,N,50597,CHEMBL628330,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,12155,1,,,8608,,Liver,N,50597,CHEMBL628331,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,12156,1,,,8608,,Liver,N,50597,CHEMBL628332,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,12157,1,,,8608,,Liver,N,50597,CHEMBL628333,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,12158,1,,,8608,,Liver,N,50597,CHEMBL628334,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,12159,1,,,8608,,Liver,N,50597,CHEMBL628335,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,12160,1,,,8608,,Liver,N,50597,CHEMBL628336,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,12161,1,,,8608,,Liver,N,50597,CHEMBL628337,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,12162,1,,,8608,,Liver,N,50597,CHEMBL628338,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,12163,1,,,8608,,Liver,N,50597,CHEMBL875610,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,12164,1,,,8608,,Liver,N,50597,CHEMBL628339,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,12165,1,,,8608,,Liver,N,50597,CHEMBL628340,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,12166,1,,,8608,,Liver,N,50597,CHEMBL628341,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,12167,1,,,8608,,Liver,N,50597,CHEMBL622214,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,12168,1,,,8608,,Liver,N,50597,CHEMBL623167,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,12169,1,,,8608,,Liver,N,50597,CHEMBL623168,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,12170,1,,,8608,,Liver,N,50597,CHEMBL623169,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,12171,1,,,8608,,Liver,N,50597,CHEMBL623170,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,12172,1,,,8608,,Lung,N,50597,CHEMBL627224,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,12173,1,,,8608,,Lung,N,50597,CHEMBL875634,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,12174,1,,,8608,,Lung,N,50597,CHEMBL627225,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,12175,1,,,8608,,Lung,N,50597,CHEMBL627226,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,12176,1,,,8608,,Lung,N,50597,CHEMBL626083,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,12177,1,,,8608,,Lung,N,50597,CHEMBL626084,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,12178,1,,,8608,,Lung,N,50597,CHEMBL626085,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,12179,1,,,8608,,Lung,N,50597,CHEMBL626086,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,12180,1,,,8608,,Lung,N,50597,CHEMBL626087,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,12181,1,,,8608,,Lung,N,50597,CHEMBL626088,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,12182,1,,,8608,,Lung,N,50597,CHEMBL626089,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,12183,1,,,8608,,Lung,N,50597,CHEMBL626090,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,12184,1,,,8608,,Lung,N,50597,CHEMBL626091,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,12185,1,,,8608,,Lung,N,50597,CHEMBL626092,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,12186,1,,,8608,,Lung,N,50597,CHEMBL626093,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,12187,1,,,8608,,Lung,N,50597,CHEMBL626094,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,12188,1,,,8608,,Lung,N,50597,CHEMBL626095,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,12189,1,,,8608,,Lung,N,50597,CHEMBL626096,BAO_0000218,2048.0
A,Autocuration,1,,,Simiiformes,,,314293.0,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,12190,0,,,15604,,,U,22224,CHEMBL626097,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,12191,1,,,15604,,,N,50597,CHEMBL626098,BAO_0000218,
A,Autocuration,1,,,,,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,12192,0,,,1806,,Plasma,U,22224,CHEMBL626099,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,12193,0,,,1806,,Plasma,U,22224,CHEMBL626100,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,AUC 0-inf in dog,,12194,1,,,17237,,Plasma,N,50588,CHEMBL626101,BAO_0000218,1969.0
A,Intermediate,1,,,Cavia porcellus,,,10141.0,AUC 0-inf in guinea pig,,12195,1,,,17237,,Plasma,N,50512,CHEMBL626102,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,AUC 0-t in dog,,12196,1,,,17237,,Plasma,N,50588,CHEMBL626103,BAO_0000218,1969.0
A,Intermediate,1,,,Cavia porcellus,,,10141.0,AUC 0-t in guinea pig,,12197,1,,,17237,,Plasma,N,50512,CHEMBL628391,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for brain to plasma partition in rat,,12198,1,,,15194,,,N,50597,CHEMBL628392,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for brain to plasma partition in rat.,,12199,1,,,15194,,,N,50597,CHEMBL628393,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,12200,0,,,8787,,Blood,U,22224,CHEMBL628394,BAO_0000019,178.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,12201,1,,,17025,,,N,50588,CHEMBL628395,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,12202,0,,,17025,,,U,22224,CHEMBL628396,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,12203,1,,,17025,,,N,50592,CHEMBL628397,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,12204,1,,,17025,,,N,50597,CHEMBL628398,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,,,9544.0,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,12205,1,,,4236,,,N,50797,CHEMBL628399,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,12206,1,,,15343,,,N,50588,CHEMBL628400,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,12207,1,,,15343,,,N,50597,CHEMBL874907,BAO_0000218,
A,Autocuration,1,,,,,,,Area under curve of the compound was determined,,12208,0,,,17720,,,U,22224,CHEMBL628401,BAO_0000019,
A,Autocuration,1,,,Simiiformes,,,314293.0,AUC in monkeys at a dose of 1 mg/kg,,12209,0,,,17788,,Plasma,U,22224,CHEMBL628402,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,AUC in rats at a dose of 1 mg/kg,,12210,1,,,17788,,Plasma,N,50597,CHEMBL628403,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 2,,12211,0,,,8778,,,U,22224,CHEMBL628404,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 4,,12212,0,,,8778,,,U,22224,CHEMBL628405,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for the overall absorbance loss at pH of 7,,12213,0,,,8778,,,U,22224,CHEMBL628406,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for its absorption in the rats,,12214,1,,,2249,,,N,50597,CHEMBL628407,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,12215,1,,,8881,,Urine,N,50597,CHEMBL628408,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,12216,1,,,8881,,Urine,N,50597,CHEMBL629171,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,12217,1,,,8881,,Urine,N,50597,CHEMBL629172,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,12218,1,,,8881,,Urine,N,50597,CHEMBL629173,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum,,12219,1,,,15286,,,N,50597,CHEMBL629174,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 10-17,,12220,1,,,15286,,,N,50597,CHEMBL629175,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 10-18,,12221,1,,,15286,,,N,50597,CHEMBL629176,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 10-19,,12222,1,,,15286,,,N,50597,CHEMBL629177,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 12-15,,12223,1,,,15286,,,N,50597,CHEMBL629178,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 13-19,,12224,1,,,15286,,,N,50597,CHEMBL631869,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 14-17,,12225,1,,,15286,,,N,50597,CHEMBL631870,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 15-18,,12226,1,,,15286,,,N,50597,CHEMBL631871,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 2-5,,12227,1,,,15286,,,N,50597,CHEMBL631872,BAO_0000218,
A,Autocuration,1,,,,,,,In vitro percent permeability into rat ileum; Range is 23-42,,12228,0,,,15286,,Ileum,U,22224,CHEMBL875775,BAO_0000221,2116.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 28-36,,12229,1,,,15286,,,N,50597,CHEMBL631873,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 29-35,,12230,1,,,15286,,,N,50597,CHEMBL631874,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 46-66,,12231,1,,,15286,,,N,50597,CHEMBL631875,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 50-68,,12232,1,,,15286,,,N,50597,CHEMBL631876,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; Range is 78-81,,12233,1,,,15286,,,N,50597,CHEMBL631877,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,12234,1,,,15286,,,N,50597,CHEMBL631878,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; nd indicates not detected,,12235,1,,,15286,,,N,50597,CHEMBL631879,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; nt indicates not detected,,12236,1,,,15286,,,N,50597,CHEMBL631880,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro percent permeability into rat ileum; nt indicates not tested,,12237,1,,,15286,,,N,50597,CHEMBL631881,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for oral absorption in bile-duct cannulated rats,,12238,1,,,13770,,,N,50597,CHEMBL631882,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for oral absorption in bile-duct cannulated rats.,,12239,1,,,13770,,,N,50597,CHEMBL630749,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Oral absorption using Caco-2 cell monolayers.,,12240,1,,,5202,,,N,50587,CHEMBL630750,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Percent of the drug absorbed after administration to humans was determined,,12241,1,,,14920,,,N,50587,CHEMBL630253,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,12242,1,,,14103,,Plasma,N,50597,CHEMBL630254,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,12243,1,,,14103,,Plasma,N,50597,CHEMBL630255,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,12244,1,,,14103,,Plasma,N,50597,CHEMBL630256,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,12245,1,,,13751,,Liver,N,50597,CHEMBL875781,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,12246,1,,,13751,,Liver,N,50597,CHEMBL630257,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,12247,1,,,13751,,Liver,N,50597,CHEMBL630258,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,12248,1,,,15807,,,N,50597,CHEMBL630259,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,12249,1,,,15807,,Striatum,N,50597,CHEMBL630260,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,12250,1,,,15807,,Striatum,N,50597,CHEMBL630261,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,12251,1,,,14950,,,N,50597,CHEMBL630262,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,12252,1,,,14950,,,N,50597,CHEMBL630263,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,12253,1,,,14950,,,N,50597,CHEMBL630264,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,12254,1,,,14950,,,N,50597,CHEMBL630265,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,12255,1,,,14950,,,N,50597,CHEMBL630266,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,12256,1,,,14950,,Kidney,N,50597,CHEMBL630267,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,12257,1,,,14950,,Kidney,N,50597,CHEMBL630268,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,12258,1,,,14950,,,N,50597,CHEMBL630269,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,12259,1,,,14950,,,N,50597,CHEMBL630270,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,12260,1,,,14950,,Lung,N,50597,CHEMBL630141,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,12261,1,,,14950,,Lung,N,50597,CHEMBL630142,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,12262,1,,,14950,,Muscle tissue,N,50597,CHEMBL630143,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,12263,1,,,14950,,Muscle tissue,N,50597,CHEMBL630144,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,12264,1,,,14950,,Prostate gland,N,50597,CHEMBL630145,BAO_0000218,2367.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,12265,1,,,14950,,Prostate gland,N,50597,CHEMBL630146,BAO_0000218,2367.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,12266,1,,,14950,,,N,50597,CHEMBL630147,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,12267,1,,,14950,,,N,50597,CHEMBL630148,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,12268,1,,,14950,,,N,50597,CHEMBL630149,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,12269,1,,,14950,,Spleen,N,50597,CHEMBL630150,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,12270,1,,,14950,,Spleen,N,50597,CHEMBL630151,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,12271,1,,,14950,,Thyroid gland,N,50597,CHEMBL632031,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,12272,1,,,14950,,Thyroid gland,N,50597,CHEMBL632032,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,12273,1,,,14950,,,N,50597,CHEMBL632033,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,12274,1,,,14950,,,N,50597,CHEMBL632034,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,12275,1,,,14950,,Muscle tissue,N,50597,CHEMBL632035,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,12276,1,,,14950,,,N,50597,CHEMBL632036,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,12277,1,,,14950,,Thyroid gland,N,50597,CHEMBL632037,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,12278,1,,,8631,,Blood,N,50597,CHEMBL632038,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,12279,1,,,8631,,Blood,N,50597,CHEMBL632039,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,12280,1,,,8631,,Blood,N,50597,CHEMBL632040,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,12281,1,,,8631,,Blood,N,50597,CHEMBL632041,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in blood of dog 2, after administering intravenously",,12282,1,,,9614,,Blood,N,50588,CHEMBL632042,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,12283,1,,,9614,,,N,50588,CHEMBL632043,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,12284,1,,,9614,,,N,50588,CHEMBL632044,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in liver of dog 1, after administering intravenously",,12285,1,,,9614,,Liver,N,50588,CHEMBL632045,BAO_0000218,2107.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in liver of dog 2, after administering intravenously",,12286,1,,,9614,,Liver,N,50588,CHEMBL632046,BAO_0000218,2107.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in lung of dog 1, after administering intravenously",,12287,1,,,9614,,Lung,N,50588,CHEMBL632047,BAO_0000218,2048.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in lung of dog 2, after administering intravenously",,12288,1,,,9614,,Lung,N,50588,CHEMBL632048,BAO_0000218,2048.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in muscle of dog 1, after administering intravenously",,12289,1,,,9614,,Muscle tissue,N,50588,CHEMBL632049,BAO_0000218,2385.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in muscle of dog 2, after administering intravenously",,12290,1,,,9614,,Muscle tissue,N,50588,CHEMBL876418,BAO_0000218,2385.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in spleen of dog 1,after administering intravenously",,12291,1,,,9614,,Spleen,N,50588,CHEMBL632050,BAO_0000218,2106.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration of compound in spleen of dog 2, after administering intravenously",,12292,1,,,9614,,Spleen,N,50588,CHEMBL632051,BAO_0000218,2106.0
F,Autocuration,1,,,,,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,12293,0,,,10353,,,U,22224,CHEMBL632052,BAO_0000218,
F,Autocuration,1,,,,,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,12294,0,,,10353,,,U,22224,CHEMBL632053,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,12295,0,,,10353,,,U,22224,CHEMBL632054,BAO_0000218,
F,Autocuration,1,,,,,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,12296,0,,,10353,,,U,22224,CHEMBL632055,BAO_0000218,
F,Autocuration,1,,,,,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,12297,0,,,10353,,,U,22224,CHEMBL631181,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,12298,0,,,9196,,,U,22224,CHEMBL631182,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,12299,0,,,9196,,,U,22224,CHEMBL631183,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12300,0,,,9196,,,U,22224,CHEMBL631184,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12301,0,,,9196,,,U,22224,CHEMBL629774,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12302,0,,,9196,,,U,22224,CHEMBL629775,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12303,0,,,9196,,,U,22224,CHEMBL876549,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12304,0,,,9196,,,U,22224,CHEMBL628172,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,12305,0,,,9196,,,U,22224,CHEMBL628173,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,12306,0,,,9196,,,U,22224,CHEMBL628174,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,12307,0,,,9196,,,U,22224,CHEMBL628175,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,12308,0,,,9196,,,U,22224,CHEMBL628176,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,12309,0,,,9196,,,U,22224,CHEMBL628177,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12310,0,,,9196,,,U,22224,CHEMBL628178,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,12311,0,,,9196,,,U,22224,CHEMBL628179,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,12312,0,,,9196,,,U,22224,CHEMBL628180,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,12313,0,,,9196,,,U,22224,CHEMBL628181,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12314,0,,,9196,,,U,22224,CHEMBL628182,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12315,0,,,9196,,,U,22224,CHEMBL628183,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,12316,0,,,9196,,,U,22224,CHEMBL628184,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12317,0,,,9196,,,U,22224,CHEMBL628185,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12318,0,,,9196,,,U,22224,CHEMBL875617,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,12319,0,,,9196,,,U,22224,CHEMBL628186,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12320,0,,,9196,,,U,22224,CHEMBL628187,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,12321,0,,,9196,,,U,22224,CHEMBL628188,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,12322,0,,,9196,,,U,22224,CHEMBL628189,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,12323,0,,,9196,,,U,22224,CHEMBL628190,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,12324,0,,,9196,,,U,22224,CHEMBL628191,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,12325,0,,,9196,,,U,22224,CHEMBL626513,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,12326,1,,,8608,,Thyroid gland,N,50597,CHEMBL626514,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,12327,1,,,8608,,Thyroid gland,N,50597,CHEMBL626515,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,12328,1,,,8608,,Thyroid gland,N,50597,CHEMBL626516,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,12329,1,,,8608,,Thyroid gland,N,50597,CHEMBL626517,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,12330,1,,,8608,,Thyroid gland,N,50597,CHEMBL626518,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,12331,1,,,8608,,Thyroid gland,N,50597,CHEMBL626519,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,12332,1,,,8608,,Thyroid gland,N,50597,CHEMBL626520,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,12333,1,,,8608,,Thyroid gland,N,50597,CHEMBL626521,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,12334,1,,,8608,,Thyroid gland,N,50597,CHEMBL626522,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,12335,1,,,8608,,Thyroid gland,N,50597,CHEMBL626523,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,12336,1,,,8608,,Thyroid gland,N,50597,CHEMBL626524,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,12337,1,,,8608,,Thyroid gland,N,50597,CHEMBL626688,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,12338,1,,,8608,,Thyroid gland,N,50597,CHEMBL626689,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,12339,1,,,8608,,Thyroid gland,N,50597,CHEMBL626690,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,12340,1,,,8608,,Thyroid gland,N,50597,CHEMBL626691,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,12341,1,,,8608,,Thyroid gland,N,50597,CHEMBL627319,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,12342,1,,,8608,,Thyroid gland,N,50597,CHEMBL624052,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,12343,1,,,8608,,Thyroid gland,N,50597,CHEMBL624053,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12344,1,,,8085,,,N,50597,CHEMBL624054,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12345,1,,,8085,,,N,50597,CHEMBL624055,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12346,1,,,8085,,,N,50597,CHEMBL624056,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12347,1,,,8085,,Uterus,N,50597,CHEMBL624057,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12348,1,,,8085,,Uterus,N,50597,CHEMBL622281,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12349,1,,,8085,,Uterus,N,50597,CHEMBL622282,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12350,1,,,8085,,Uterus,N,50597,CHEMBL622283,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12351,1,,,8085,,Uterus,N,50597,CHEMBL622284,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12352,1,,,8085,,Uterus,N,50597,CHEMBL622285,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,12353,1,,,8085,,Uterus,N,50597,CHEMBL622286,BAO_0000218,995.0
P,Autocuration,1,,,,,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,12354,0,,,7657,,,U,22224,CHEMBL622287,BAO_0000100,
A,Intermediate,1,,,Mus musculus,,,10090.0,Partition coefficient (logD7.4),,12355,1,,,8935,,,N,50594,CHEMBL622288,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,12356,1,,,13792,,,N,50594,CHEMBL622289,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,12357,1,,,13792,,Brain,N,50594,CHEMBL622290,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,12358,1,,,13792,,,N,50594,CHEMBL622291,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,12359,1,,,13792,,Brain,N,50594,CHEMBL622292,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,12360,1,,,13792,,,N,50594,CHEMBL622293,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,12361,1,,,13792,,Brain,N,50594,CHEMBL622294,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,12362,1,,,13792,,,N,50594,CHEMBL622295,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,12363,1,,,13792,,Brain,N,50597,CHEMBL622296,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,12364,1,,,14103,,Plasma,N,50597,CHEMBL874409,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,12365,1,,,14103,,Plasma,N,50597,CHEMBL622297,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,12366,1,,,14103,,Plasma,N,50597,CHEMBL622298,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,12367,1,,,14103,,Plasma,N,50597,CHEMBL622299,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,12368,1,,,14103,,Plasma,N,50597,CHEMBL622300,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,12369,1,,,14103,,Plasma,N,50597,CHEMBL622301,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,12370,1,,,14103,,Plasma,N,50597,CHEMBL622302,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,12371,1,,,14103,,Plasma,N,50597,CHEMBL622303,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,12372,1,,,14103,,Plasma,N,50597,CHEMBL622304,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,12373,1,,,14103,,Plasma,N,50597,CHEMBL622305,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,12374,1,,,14103,,Plasma,N,50597,CHEMBL622306,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,12375,1,,,14103,,Plasma,N,50597,CHEMBL626864,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,12376,1,,,14103,,Plasma,N,50597,CHEMBL626865,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,12377,1,,,14103,,Plasma,N,50597,CHEMBL626866,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,12378,1,,,14103,,Plasma,N,50597,CHEMBL626867,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,12379,1,,,14103,,Plasma,N,50597,CHEMBL626868,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,12380,1,,,14103,,Plasma,N,50597,CHEMBL626869,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,12381,1,,,14103,,Plasma,N,50597,CHEMBL626870,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,12382,1,,,14103,,Plasma,N,50597,CHEMBL626871,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,12383,1,,,14103,,Plasma,N,50597,CHEMBL626872,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,12384,1,,,14103,,Plasma,N,50597,CHEMBL632185,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,12385,1,,,14103,,Plasma,N,50597,CHEMBL632186,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Amount of acetic acid produced by the compound,,12386,0,,,12904,,,U,22224,CHEMBL629310,BAO_0000019,
A,Autocuration,1,,,,,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,12387,0,,,12904,,,U,22224,CHEMBL629311,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Log of (Cbrain/Cblood) in rats,,12388,1,,,9663,,,N,50597,CHEMBL629312,BAO_0000218,
A,Autocuration,1,,,,,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,12389,0,,,7652,,,U,22224,CHEMBL629313,BAO_0000221,
A,Autocuration,1,,,,,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,12390,0,,,7652,,,U,22224,CHEMBL629314,BAO_0000221,
A,Autocuration,1,,,,,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,12391,0,,,7652,,,U,22224,CHEMBL629315,BAO_0000221,
B,Autocuration,1,,,,,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,12392,0,,,7652,,,U,22224,CHEMBL629316,BAO_0000219,
A,Autocuration,1,,,,,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,12393,0,,,7652,,,U,22224,CHEMBL629317,BAO_0000221,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,12394,0,,,7652,,,U,22224,CHEMBL629318,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,12395,0,,,7652,,,U,22224,CHEMBL877497,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,12396,0,,,7652,,,U,22224,CHEMBL629319,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,12397,0,,,7652,,,U,22224,CHEMBL629320,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,12398,0,,,7652,,,U,22224,CHEMBL629496,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,12399,0,,,7652,,,U,22224,CHEMBL629497,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,12400,0,,,7652,,,U,22224,CHEMBL629498,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,12401,0,,,7652,,,U,22224,CHEMBL629499,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,12402,0,,,7652,,,U,22224,CHEMBL629500,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,12403,0,,,7652,,,U,22224,CHEMBL629501,BAO_0000019,
A,Autocuration,1,,,,,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,12404,0,,,7652,,,U,22224,CHEMBL629502,BAO_0000019,
F,Autocuration,1,,,,In vivo,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,12405,0,,,8267,,,U,22224,CHEMBL629503,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,12406,1,,,8267,,,N,50588,CHEMBL629504,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,12407,0,,,14479,,,U,22224,CHEMBL629505,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for total body clearance,,12408,0,,,17515,,,U,22224,CHEMBL629506,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for volume of distribution at steady state,,12409,0,,,17515,,,U,22224,CHEMBL629507,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,12410,0,,,8142,,,U,22224,CHEMBL877498,BAO_0000019,
A,Autocuration,1,,,,,,,Percentage of the diamine which is monoprotonated at pH 7.4,,12411,0,,,14849,,,U,22224,CHEMBL629508,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,12412,0,,,7653,,,U,22224,CHEMBL629509,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,12413,1,,,8631,,Blood,N,50597,CHEMBL629510,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,12414,1,,,8631,,Blood,N,50597,CHEMBL629511,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12415,1,,,8631,,Blood,N,50597,CHEMBL629512,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12416,1,,,8631,,Blood,N,50597,CHEMBL629513,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,12417,1,,,8631,,Blood,N,50597,CHEMBL629514,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12418,1,,,8631,,Blood,N,50597,CHEMBL628447,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,12419,1,,,8631,,Blood,N,50597,CHEMBL628448,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,12420,1,,,8631,,Blood,N,50597,CHEMBL628449,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,12421,1,,,8631,,Blood,N,50597,CHEMBL631119,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,12422,1,,,8631,,Blood,N,50597,CHEMBL631120,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,12423,1,,,8631,,Blood,N,50597,CHEMBL631121,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,12424,1,,,8631,,Blood,N,50597,CHEMBL874458,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12425,1,,,8631,,Blood,N,50597,CHEMBL631122,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12426,1,,,8631,,Blood,N,50597,CHEMBL631123,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12427,1,,,8631,,Blood,N,50597,CHEMBL631124,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,12428,1,,,8631,,Blood,N,50597,CHEMBL631125,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12429,1,,,8631,,Blood,N,50597,CHEMBL631290,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12430,1,,,8631,,Blood,N,50597,CHEMBL631291,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12431,1,,,8631,,Blood,N,50597,CHEMBL631292,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,12432,1,,,8631,,Blood,N,50597,CHEMBL631293,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,12433,1,,,8631,,Blood,N,50597,CHEMBL631294,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,12434,1,,,8631,,Blood,N,50597,CHEMBL631295,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,12435,1,,,8631,,Blood,N,50597,CHEMBL631296,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,12436,1,,,8631,,Blood,N,50597,CHEMBL631297,BAO_0000218,178.0
A,Autocuration,1,,,,,,,Maximum biodistribution (Bmax) was determined.,,12437,0,,,10263,,,U,22224,CHEMBL631298,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,12438,1,,,12364,,,N,50594,CHEMBL631299,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,12439,1,,,12364,,,N,50594,CHEMBL631300,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,12440,1,,,12364,,,N,50594,CHEMBL631301,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,12441,1,,,12364,,,N,50594,CHEMBL630291,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,12442,0,,,14793,,,U,22224,CHEMBL630292,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,12443,0,,,14793,,,U,22224,CHEMBL630293,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,12444,0,,,14793,,,U,22224,CHEMBL630294,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,12445,0,,,14793,,,U,22224,CHEMBL630295,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,12446,0,,,14793,,,U,22224,CHEMBL630296,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,12447,0,,,14793,,,U,22224,CHEMBL626782,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,12448,0,,,14793,,,U,22224,CHEMBL626783,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,12449,0,,,14793,,,U,22224,CHEMBL626784,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,12450,0,,,14793,,,U,22224,CHEMBL626785,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,12451,0,,,14793,,,U,22224,CHEMBL626786,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12452,0,,,9196,,,U,22224,CHEMBL626787,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,12453,0,,,9196,,,U,22224,CHEMBL626788,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,12454,0,,,9196,,,U,22224,CHEMBL625927,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12455,1,,,8374,,Blood,N,50597,CHEMBL625928,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12456,1,,,8374,,Blood,N,50597,CHEMBL625929,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,12457,1,,,8374,,Blood,N,50597,CHEMBL625930,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,12458,1,,,8374,,Blood,N,50597,CHEMBL625931,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,12459,1,,,8374,,Blood,N,50597,CHEMBL627230,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12460,1,,,8374,,Blood,N,50597,CHEMBL627231,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12461,1,,,8374,,Blood,N,50597,CHEMBL627232,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,12462,1,,,8374,,Blood,N,50597,CHEMBL627233,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12463,1,,,8374,,Blood,N,50597,CHEMBL875470,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12464,1,,,8374,,Blood,N,50597,CHEMBL627234,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12465,1,,,8374,,Blood,N,50597,CHEMBL627235,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12466,1,,,8374,,Blood,N,50597,CHEMBL627236,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12467,1,,,8374,,Blood,N,50597,CHEMBL627237,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12468,1,,,8374,,Blood,N,50597,CHEMBL627238,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12469,1,,,8374,,Blood,N,50597,CHEMBL627239,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12470,1,,,8374,,Blood,N,50597,CHEMBL627240,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12471,1,,,8374,,Blood,N,50597,CHEMBL627241,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12472,1,,,8374,,Blood,N,50597,CHEMBL627242,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,12473,1,,,8374,,Blood,N,50597,CHEMBL627243,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12474,1,,,8374,,Blood,N,50597,CHEMBL627244,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12475,1,,,8374,,Blood,N,50597,CHEMBL627245,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12476,1,,,8374,,Blood,N,50597,CHEMBL627246,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12477,1,,,8374,,Blood,N,50597,CHEMBL627247,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12478,1,,,8374,,Blood,N,50597,CHEMBL627248,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12479,1,,,8374,,Blood,N,50597,CHEMBL627249,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12480,1,,,8374,,Blood,N,50597,CHEMBL625569,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12481,1,,,8374,,Blood,N,50597,CHEMBL625570,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12482,1,,,8374,,Blood,N,50597,CHEMBL625571,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12483,1,,,8374,,Blood,N,50597,CHEMBL625572,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12484,1,,,8374,,Blood,N,50597,CHEMBL625573,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,12485,1,,,8374,,Blood,N,50597,CHEMBL625574,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,12486,1,,,8374,,Blood,N,50597,CHEMBL626245,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12487,1,,,8374,,Blood,N,50597,CHEMBL626246,BAO_0000218,178.0
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12488,0,,,9196,,,U,22224,CHEMBL626247,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12489,0,,,9196,,,U,22224,CHEMBL626248,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,12490,0,,,9196,,,U,22224,CHEMBL626249,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12491,0,,,9196,,,U,22224,CHEMBL626420,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,12492,0,,,9196,,,U,22224,CHEMBL626421,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,12493,0,,,9196,,,U,22224,CHEMBL626422,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12494,0,,,9196,,,U,22224,CHEMBL626423,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12495,0,,,9196,,,U,22224,CHEMBL626424,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,12496,1,,,12023,,,N,50588,CHEMBL626425,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,12497,1,,,12023,,,N,50597,CHEMBL875476,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,12498,1,,,12023,,,N,100710,CHEMBL626426,BAO_0000218,
P,Autocuration,1,,,,,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,12499,0,,,10580,,,U,22224,CHEMBL626427,BAO_0000100,
P,Autocuration,1,,,,,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,12500,0,,,10580,,,U,22224,CHEMBL626428,BAO_0000100,
A,Autocuration,1,,,,,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,12501,0,,,16032,,,U,22224,CHEMBL626429,BAO_0000019,
A,Autocuration,1,,,,,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,12502,0,,,16032,,Urine,U,22224,CHEMBL625025,BAO_0000019,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12503,1,,,8594,,Blood,N,50597,CHEMBL625026,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12504,1,,,8594,,Blood,N,50597,CHEMBL625027,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12505,1,,,8594,,Blood,N,50597,CHEMBL874410,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12506,1,,,8594,,Blood,N,50597,CHEMBL625028,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12507,1,,,8594,,Blood,N,50597,CHEMBL625029,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12508,1,,,8594,,Blood,N,50597,CHEMBL625030,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12509,1,,,8594,,Blood,N,50597,CHEMBL625031,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12510,1,,,8594,,Blood,N,50597,CHEMBL625032,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12511,1,,,8594,,Blood,N,50597,CHEMBL625033,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12512,1,,,8594,,Blood,N,50597,CHEMBL625034,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12513,1,,,8594,,Heart,N,50597,CHEMBL624872,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12514,1,,,8594,,Heart,N,50597,CHEMBL624873,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12515,1,,,8594,,Heart,N,50597,CHEMBL624874,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12516,1,,,8594,,Heart,N,50597,CHEMBL624875,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12517,1,,,8594,,Heart,N,50597,CHEMBL624876,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12518,1,,,8594,,Heart,N,50597,CHEMBL624877,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12519,1,,,8594,,Heart,N,50597,CHEMBL624878,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12520,1,,,8594,,Heart,N,50597,CHEMBL624879,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12521,1,,,8594,,Heart,N,50597,CHEMBL624880,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,12522,1,,,8594,,Heart,N,50597,CHEMBL624881,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,12523,1,,,8594,,Heart,N,50597,CHEMBL624882,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12524,1,,,8594,,Kidney,N,50597,CHEMBL624883,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12525,1,,,8594,,Kidney,N,50597,CHEMBL624884,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12526,1,,,8594,,Kidney,N,50597,CHEMBL624885,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12527,1,,,8594,,Kidney,N,50597,CHEMBL624886,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12528,1,,,8594,,Kidney,N,50597,CHEMBL624887,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12529,1,,,8594,,Kidney,N,50597,CHEMBL624888,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12530,1,,,8594,,Kidney,N,50597,CHEMBL624889,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12531,1,,,8594,,Kidney,N,50597,CHEMBL624890,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12532,1,,,8594,,Kidney,N,50597,CHEMBL621964,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12533,1,,,8594,,Kidney,N,50597,CHEMBL621965,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12534,1,,,8594,,Liver,N,50597,CHEMBL621966,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12535,1,,,8594,,Liver,N,50597,CHEMBL621967,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12536,1,,,8594,,Liver,N,50597,CHEMBL622164,BAO_0000218,2107.0
A,Autocuration,1,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,12537,0,,,7653,,,U,22224,CHEMBL623097,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,12538,0,,,7653,,,U,22224,CHEMBL623098,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,12539,0,,,7653,,,U,22224,CHEMBL623099,BAO_0000019,
A,Autocuration,1,,,,,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,12540,0,,,7653,,,U,22224,CHEMBL623100,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,12541,1,,,9104,,,N,50597,CHEMBL628673,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,12542,1,,,9104,,,N,50597,CHEMBL628674,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,12543,1,,,9104,,,N,50597,CHEMBL628675,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,12544,1,,,9104,,,N,50597,CHEMBL627644,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,12545,1,,,9104,,,N,50597,CHEMBL627645,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,12546,1,,,9104,,,N,50597,CHEMBL627646,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,12547,1,,,9104,,,N,50597,CHEMBL627647,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,12548,1,,,9104,,,N,50597,CHEMBL627648,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Free level in rat plasma,,12549,1,,,12902,,,N,50597,CHEMBL627649,BAO_0000218,
A,Autocuration,1,,,,,,,Level reaching in blood plasma of rat or human was determined,,12550,0,,,6614,,,U,22224,CHEMBL628313,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Log (Cbrain/Cblood) in rats,,12551,1,,,9663,,,N,50597,CHEMBL628314,BAO_0000218,
A,Autocuration,1,,,,,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,12552,0,,,17658,,,U,22224,CHEMBL628315,BAO_0000019,
A,Autocuration,1,,,,,,,Mean percentage of compound transport through membrane; expressed as membrane transport,,12553,0,,,17658,,,U,22224,CHEMBL628316,BAO_0000019,
A,Autocuration,1,,,,,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,12554,0,,,14314,,,U,22224,CHEMBL628317,BAO_0000218,
A,Autocuration,1,,,,,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,12555,0,,,7385,,,U,22224,CHEMBL628473,BAO_0000019,
A,Autocuration,1,,,,,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,12556,0,,,7385,,,U,22224,CHEMBL628474,BAO_0000019,
A,Autocuration,1,,,,,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,12557,0,,,7385,,,U,22224,CHEMBL628475,BAO_0000019,
A,Autocuration,1,,,,,,,Net water uptake by a carrier mediated transport (%cm) mechanism,,12558,0,,,1329,,,U,22224,CHEMBL628476,BAO_0000019,
A,Autocuration,1,,,Simiiformes,,,314293.0,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,12559,0,,,12187,,,U,22224,CHEMBL628477,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,12560,1,,,12187,,,N,50506,CHEMBL628478,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,12561,1,,,12187,,,N,50506,CHEMBL628479,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,12562,0,,,12187,,,U,22224,CHEMBL628480,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,12563,0,,,12187,,,U,22224,CHEMBL628481,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,12564,1,,,12187,,,N,50597,CHEMBL628482,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,12565,1,,,12187,,,N,50597,CHEMBL628483,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,12566,1,,,9278,,Plasma,N,50597,CHEMBL628484,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,12567,1,,,9278,,Plasma,N,50597,CHEMBL628485,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,12568,1,,,9278,,Plasma,N,100710,CHEMBL628486,BAO_0000218,1969.0
A,Intermediate,1,,,Homo sapiens,,,9606.0,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,12569,1,,,9278,,Plasma,N,50587,CHEMBL628487,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,12570,1,,,9278,,Plasma,N,50597,CHEMBL628488,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,12571,1,,,9278,,Plasma,N,50597,CHEMBL628489,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,12572,1,,,9278,,Plasma,N,50597,CHEMBL628490,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12573,1,,,12186,,,N,100710,CHEMBL628491,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,,,9541.0,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12574,1,,,12186,,,N,100710,CHEMBL877507,BAO_0000218,
A,Autocuration,1,,,,,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12575,0,,,12186,,,U,22224,CHEMBL628492,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,12576,0,,,12041,,,U,22224,CHEMBL628493,BAO_0000019,
A,Autocuration,1,,,Simiiformes,,,314293.0,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,12577,0,,,12041,,,U,22224,CHEMBL628494,BAO_0000019,
A,Autocuration,1,,,Simiiformes,,,314293.0,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,12578,0,,,12041,,,U,22224,CHEMBL628495,BAO_0000019,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Permeability in Caco-2 assay at 10E-6,,12579,1,,,6737,,,N,50587,CHEMBL628496,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,12580,0,,,13758,,Brain,U,22224,CHEMBL628497,BAO_0000218,955.0
A,Autocuration,1,,,,,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,12581,0,,,13758,,Brain,U,22224,CHEMBL628498,BAO_0000218,955.0
A,Autocuration,1,,,,,,,Plasma protein binding was determined,,12582,0,,,5676,,,U,22224,CHEMBL628499,BAO_0000019,
A,Autocuration,1,,,,,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,12583,0,,,14793,,,U,22224,CHEMBL627656,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,12584,0,,,14793,,,U,22224,CHEMBL627657,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,12585,0,,,14793,,,U,22224,CHEMBL626808,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,12586,0,,,14793,,,U,22224,CHEMBL626809,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,12587,0,,,14793,,,U,22224,CHEMBL626810,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,12588,0,,,14793,,,U,22224,CHEMBL626811,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,12589,0,,,14793,,,U,22224,CHEMBL874465,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,12590,0,,,14793,,,U,22224,CHEMBL626812,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,12591,0,,,14793,,,U,22224,CHEMBL626813,BAO_0000218,
A,Autocuration,1,,,,,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,12592,0,,,14793,,,U,22224,CHEMBL626814,BAO_0000218,
A,Autocuration,1,,,,,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,12593,0,,,14000,,,U,22224,CHEMBL626815,BAO_0000019,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,12594,0,,,5948,,,U,22224,CHEMBL628566,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,12595,0,,,13824,,,U,22229,CHEMBL628567,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12596,0,,,10778,,,U,22229,CHEMBL628568,BAO_0000100,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,C max in dog,,12597,1,,,17237,,,N,50588,CHEMBL628569,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,C max in guinea pig,,12598,1,,,17237,,,N,50512,CHEMBL628570,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,C max value was evaluated,,12599,0,,,2809,,,U,22224,CHEMBL628571,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value after oral dose of 0.1 mg//kg,,12600,0,,,11954,,,U,22224,CHEMBL628572,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value after oral dose of 0.3 mg/kg,,12601,0,,,11954,,,U,22224,CHEMBL628573,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value after oral dose of 1 mg/kg,,12602,0,,,11954,,,U,22224,CHEMBL628574,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value after oral dose of 10 mg/kg,,12603,0,,,11954,,,U,22224,CHEMBL628575,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value after oral dose of 23.4 mg/kg,,12604,0,,,11954,,,U,22224,CHEMBL628576,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value after oral dose of 3 mg/kg,,12605,0,,,11954,,,U,22224,CHEMBL628577,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax value after oral dose of 3.87 mg/kg,,12606,0,,,11954,,,U,22224,CHEMBL628578,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Cmax value in female Beagle dogs,,12607,1,,,12768,,,N,50588,CHEMBL874466,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value in male rats,,12608,1,,,12768,,,N,50597,CHEMBL628579,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax value in rat plasma when administered 20 mg/kg perorally,,12609,1,,,12780,,Plasma,N,50597,CHEMBL628580,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,12610,1,,,15592,,Plasma,N,50588,CHEMBL628581,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,12611,1,,,15592,,Plasma,N,50588,CHEMBL628582,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,12612,1,,,17025,,,N,50588,CHEMBL628583,BAO_0000218,
A,Autocuration,1,,,Simiiformes,,,314293.0,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,12613,0,,,17025,,,U,22224,CHEMBL625782,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,12614,1,,,17025,,,N,50592,CHEMBL625783,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,12615,1,,,17025,,,N,50597,CHEMBL625784,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,,,9544.0,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,12616,1,,,4236,,Plasma,N,50797,CHEMBL625785,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,12617,1,,,15791,,,N,50597,CHEMBL625786,BAO_0000218,
A,Autocuration,1,,,,,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,12618,0,,,11149,,,U,22224,CHEMBL874467,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,12619,1,,,15592,,,N,50588,CHEMBL625787,BAO_0000218,
A,Intermediate,1,,,Human immunodeficiency virus,,,12721.0,cytotoxicity against HIV protease enzyme.,,12620,1,,,15778,,,N,50677,CHEMBL625964,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,12621,1,,,12745,,,N,50594,CHEMBL625965,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,12622,1,,,12745,,,N,50594,CHEMBL625966,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The plasma clearance in dog.,,12623,1,,,13941,,Plasma,N,50588,CHEMBL625967,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The plasma clearance in rat.,,12624,1,,,13941,,Plasma,N,50597,CHEMBL625968,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance from plasma in male Sprague-Dawley rats,,12625,1,,,16449,,Plasma,N,50597,CHEMBL625969,BAO_0000218,1969.0
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Clearance from plasma in male cynomolgus monkeys,,12626,1,,,16449,,Plasma,N,100710,CHEMBL625970,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,12627,1,,,14224,,Plasma,N,50588,CHEMBL625971,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Clearance of compound in dog plasma,,12628,1,,,14224,,Plasma,N,50588,CHEMBL625972,BAO_0000218,1969.0
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,Clearance of compound in human plasma,,12629,1,,,14224,,Plasma,N,50587,CHEMBL625973,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,12630,1,,,14317,,,N,50588,CHEMBL625974,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Clearance of compound when administered intravenously as an individual dose to a single dog.,,12631,1,,,14317,,,N,50588,CHEMBL625975,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,"Clearance (10 mg/kg, intravenously) in dog plasma",,12632,1,,,14224,,Plasma,N,50588,CHEMBL625976,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Clearance value in dog,,12633,1,,,17237,,,N,50588,CHEMBL625977,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,Clearance value in guinea pig,,12634,1,,,17237,,,N,50512,CHEMBL625978,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance values in rats after iv administration.,,12635,1,,,14187,,,N,50597,CHEMBL874468,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,12636,0,,,4806,,Plasma,U,22224,CHEMBL625421,BAO_0000218,1969.0
A,Intermediate,1,,,Oryctolagus cuniculus,In vivo,,9986.0,In vivo clearance (5 mg/kg) was determined in rabbits,,12637,1,,,15025,,,N,50592,CHEMBL625422,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma Clearance rate was determined for the compound in rats,,12638,1,,,13197,,,N,50597,CHEMBL625423,BAO_0000218,
A,Autocuration,1,,,Saimiri,In vivo,,9520.0,Plasma Clearance rate was determined for the compound in squirrel monkeys,,12639,0,,,13197,,,U,22224,CHEMBL625424,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance in rat,,12640,1,,,13960,,,N,50597,CHEMBL625425,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance of the compound,,12641,0,,,17820,,,U,22224,CHEMBL625426,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,12642,1,,,14706,,,N,50512,CHEMBL625427,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,12643,1,,,14706,,,N,50512,CHEMBL625428,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance was determined,,12644,0,,,6504,,,U,22224,CHEMBL625429,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,12645,1,,,14925,,,N,50588,CHEMBL625430,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance rate was determined for the compound in rats,,12646,1,,,13197,,,N,50597,CHEMBL625431,BAO_0000218,
A,Autocuration,1,,,Saimiri,In vivo,,9520.0,Plasma clearance rate was determined for the compound in squirrel monkeys,,12647,0,,,13197,,,U,22224,CHEMBL627307,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Slow clearance (CL) was determined,,12648,0,,,3437,,,U,22224,CHEMBL627308,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,12649,0,,,9196,,,U,22224,CHEMBL627309,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,12650,0,,,9196,,,U,22224,CHEMBL627310,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,12651,0,,,9196,,,U,22224,CHEMBL627311,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,12652,0,,,9196,,,U,22224,CHEMBL627312,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,12653,0,,,9196,,,U,22224,CHEMBL627313,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,12654,0,,,9196,,,U,22224,CHEMBL627314,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,12655,0,,,9196,,,U,22224,CHEMBL627315,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12656,0,,,9196,,,U,22224,CHEMBL627316,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,12657,0,,,9196,,,U,22224,CHEMBL627317,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,12658,0,,,9196,,,U,22224,CHEMBL627318,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,12659,0,,,9196,,,U,22224,CHEMBL627999,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,12660,0,,,9196,,,U,22224,CHEMBL628000,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,12661,0,,,9196,,,U,22224,CHEMBL628001,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,12662,0,,,9196,,,U,22224,CHEMBL628002,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,12663,0,,,9196,,,U,22224,CHEMBL625610,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,12664,0,,,9196,,,U,22224,CHEMBL625611,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,12665,0,,,9196,,,U,22224,CHEMBL625612,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,12666,0,,,9196,,,U,22224,CHEMBL625613,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,12667,0,,,9196,,,U,22224,CHEMBL875479,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,12668,0,,,9196,,,U,22224,CHEMBL625614,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,12669,0,,,9196,,,U,22224,CHEMBL625615,BAO_0000218,
A,Autocuration,1,,,,,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,12670,0,,,9196,,,U,22224,CHEMBL626302,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,12671,1,,,8374,,Blood,N,50597,CHEMBL626303,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,12672,1,,,8374,,Blood,N,50597,CHEMBL627420,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,12673,1,,,13477,,,N,50597,CHEMBL627421,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,12674,1,,,13477,,,N,50597,CHEMBL625695,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,12675,1,,,13477,,,N,50597,CHEMBL625696,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice brain was measured after 1 hr,,12676,1,,,10009,,Brain,N,50594,CHEMBL875606,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice brain was measured after 24 hr r,,12677,1,,,10009,,Brain,N,50594,CHEMBL625697,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice brain was measured after 2 hr,,12678,1,,,10009,,Brain,N,50594,CHEMBL625698,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice brain was measured after 3 hr,,12679,1,,,10009,,Brain,N,50594,CHEMBL625699,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice brain was measured after 6 hr,,12680,1,,,10009,,Brain,N,50594,CHEMBL625700,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice liver was measured after 1 hr,,12681,1,,,10009,,,N,50594,CHEMBL625701,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,12682,1,,,10009,,,N,50594,CHEMBL625702,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice liver was measured after 2 hr,,12683,1,,,10009,,,N,50594,CHEMBL625703,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice liver was measured after 3 hr,,12684,1,,,10009,,,N,50594,CHEMBL625704,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of compound in mice liver was measured after 6 hr,,12685,1,,,10009,,,N,50594,CHEMBL625705,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in dog adrenal medulla 30 min after administration.,,12686,1,,,8170,,Adrenal medulla,N,50588,CHEMBL625706,BAO_0000218,1236.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in dog adrenal medulla 72 hours after administration.,,12687,1,,,8170,,Adrenal medulla,N,50588,CHEMBL625707,BAO_0000218,1236.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog Ovary 24 hours after administration.,,12688,1,,,8170,,,N,50588,CHEMBL625708,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog Ovary 72 hours after administration.,,12689,1,,,8170,,,N,50588,CHEMBL625709,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog adipose 24 hours after administration.,,12690,1,,,8170,,,N,50588,CHEMBL624180,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog adipose 72 hours after administration.,,12691,1,,,8170,,,N,50588,CHEMBL624181,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog adrenal cortex 72 hours after administration.,,12692,1,,,8170,,Adrenal cortex,N,50588,CHEMBL624182,BAO_0000218,1235.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog adrenal cortex 72 hours after administration.,,12693,1,,,8170,,Adrenal cortex,N,50588,CHEMBL624183,BAO_0000218,1235.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12694,1,,,8594,,Liver,N,50597,CHEMBL624184,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12695,1,,,8594,,Liver,N,50597,CHEMBL877489,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12696,1,,,8594,,Liver,N,50597,CHEMBL624185,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12697,1,,,8594,,Liver,N,50597,CHEMBL624186,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12698,1,,,8594,,Liver,N,50597,CHEMBL624187,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12699,1,,,8594,,Liver,N,50597,CHEMBL624188,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12700,1,,,8594,,Lung,N,50597,CHEMBL624189,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12701,1,,,8594,,Lung,N,50597,CHEMBL624190,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12702,1,,,8594,,Lung,N,50597,CHEMBL624191,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12703,1,,,8594,,Lung,N,50597,CHEMBL624192,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12704,1,,,8594,,Lung,N,50597,CHEMBL624193,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12705,1,,,8594,,Lung,N,50597,CHEMBL624194,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12706,1,,,8594,,Lung,N,50597,CHEMBL624891,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12707,1,,,8594,,Lung,N,50597,CHEMBL624892,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12708,1,,,8594,,Lung,N,50597,CHEMBL624893,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12709,1,,,8594,,Lung,N,50597,CHEMBL627632,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12710,1,,,8594,,,N,50597,CHEMBL627633,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12711,1,,,8594,,,N,50597,CHEMBL627634,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12712,1,,,8594,,,N,50597,CHEMBL627635,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12713,1,,,8594,,,N,50597,CHEMBL627636,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12714,1,,,8594,,,N,50597,CHEMBL626816,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12715,1,,,8594,,,N,50597,CHEMBL626817,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12716,1,,,8594,,,N,50597,CHEMBL626818,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12717,1,,,8594,,,N,50597,CHEMBL626819,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12718,1,,,8594,,,N,50597,CHEMBL626820,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12719,1,,,8594,,,N,50597,CHEMBL626821,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,12720,1,,,8594,,Thyroid gland,N,50597,CHEMBL626822,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,12721,1,,,8594,,Thyroid gland,N,50597,CHEMBL626823,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,12722,1,,,8594,,Thyroid gland,N,50597,CHEMBL626824,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,12723,1,,,8594,,Thyroid gland,N,50597,CHEMBL626825,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,12724,1,,,8594,,Thyroid gland,N,50597,CHEMBL626826,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,12725,1,,,8594,,Thyroid gland,N,50597,CHEMBL626827,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,12726,1,,,8594,,Thyroid gland,N,50597,CHEMBL626828,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,12727,1,,,8594,,Thyroid gland,N,50597,CHEMBL626829,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12728,1,,,8594,,Thyroid gland,N,50597,CHEMBL626830,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12729,1,,,8594,,,N,50597,CHEMBL627150,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12730,1,,,8594,,,N,50597,CHEMBL627151,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,12731,1,,,8594,,,N,50597,CHEMBL627152,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,12732,1,,,8594,,,N,50597,CHEMBL627153,BAO_0000218,
A,Autocuration,1,,,,,,,Rate of acetate production by the compound was determined,,12733,0,,,12904,,,U,22224,CHEMBL627154,BAO_0000019,
A,Autocuration,1,,,,,,,Rate of acetate production by the compound was determined; Not determined,,12734,0,,,12904,,,U,22224,CHEMBL627155,BAO_0000019,
A,Autocuration,1,,,,,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,12735,0,,,3730,,,U,22224,CHEMBL627156,BAO_0000019,
A,Autocuration,1,,,,,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,12736,0,,,3627,,,U,22224,CHEMBL627157,BAO_0000019,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,12737,1,,,13799,,,N,50592,CHEMBL627158,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,12738,1,,,13799,,Plasma,N,50592,CHEMBL627159,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,12739,1,,,13799,,,N,50594,CHEMBL627160,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,12740,1,,,13799,,,N,50597,CHEMBL628540,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,12741,1,,,13799,,Plasma,N,50597,CHEMBL628541,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,12742,1,,,13799,,Plasma,N,50597,CHEMBL628542,BAO_0000218,1969.0
P,Autocuration,1,,,,,,,Solubility after at a pH 1.2,,12743,0,,,6629,,,U,22229,CHEMBL628543,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility after at pH 1.2,,12744,0,,,6629,,,U,22229,CHEMBL628544,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility after injection of water,,12745,0,,,6629,,,U,22229,CHEMBL628545,BAO_0000100,
A,Autocuration,1,,,,,,,Statistical significance of IC 50 values; Expressed as R value,,12746,0,,,14000,,,U,22224,CHEMBL628546,BAO_0000019,
A,Autocuration,1,,,,,,,Systemic availability with respect to methyldopa was determined,,12747,0,,,8267,,,U,22224,CHEMBL874455,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,12748,1,,,13799,,,N,50597,CHEMBL628547,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,12749,1,,,13799,,Plasma,N,50597,CHEMBL628548,BAO_0000218,1969.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,12750,1,,,7132,,Feces,N,50592,CHEMBL628549,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,12751,1,,,7132,,Feces,N,50592,CHEMBL628550,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,12752,1,,,7132,,Feces,N,50592,CHEMBL628551,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,12753,1,,,7132,,Urine,N,50592,CHEMBL628552,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,12754,1,,,7132,,Urine,N,50592,CHEMBL628553,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,12755,1,,,7132,,Urine,N,50592,CHEMBL628554,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,12756,1,,,7132,,Urine,N,50592,CHEMBL628555,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,12757,1,,,7132,,Urine,N,50592,CHEMBL628556,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,12758,1,,,7132,,Kidney,N,50592,CHEMBL628557,BAO_0000218,2113.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,12759,1,,,7132,,Feces,N,50592,CHEMBL628558,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,12760,1,,,7132,,Feces,N,50592,CHEMBL628559,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,12761,1,,,7132,,Feces,N,50592,CHEMBL628560,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,12762,1,,,7132,,Urine,N,50592,CHEMBL874456,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,12763,1,,,7132,,Feces,N,50592,CHEMBL628561,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,12764,1,,,7132,,Feces,N,50592,CHEMBL628562,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,12765,1,,,7132,,Urine,N,50592,CHEMBL628563,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,12766,1,,,7132,,Urine,N,50592,CHEMBL628564,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,12767,1,,,7132,,Urine,N,50592,CHEMBL628565,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,12768,1,,,7132,,Urine,N,50592,CHEMBL631248,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,12769,1,,,7132,,Urine,N,50592,CHEMBL631249,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,12770,1,,,7132,,Kidney,N,50592,CHEMBL627214,BAO_0000218,2113.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,12771,1,,,7132,,Feces,N,50592,CHEMBL874591,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,12772,1,,,7132,,Feces,N,50592,CHEMBL627215,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,12773,1,,,7132,,Feces,N,50592,CHEMBL625471,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,12774,1,,,7132,,,N,50592,CHEMBL625472,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,12775,1,,,7132,,,N,50592,CHEMBL625473,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,12776,1,,,13317,,,N,50588,CHEMBL625474,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,12777,1,,,15341,,,N,50588,CHEMBL625475,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,12778,1,,,15341,,,N,50597,CHEMBL625476,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,12779,1,,,15341,,,N,50597,CHEMBL625477,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,12780,1,,,15341,,,N,50597,CHEMBL625478,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,12781,1,,,12801,,esophageal tunica muscularis mucosae,N,50597,CHEMBL625479,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vitro,,10116.0,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,12782,1,,,12801,,esophageal tunica muscularis mucosae,N,50597,CHEMBL625480,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,12783,1,,,14856,,Plasma,N,50597,CHEMBL625481,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,12784,1,,,14062,,,N,50597,CHEMBL625482,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,12785,1,,,14062,,,N,50597,CHEMBL625483,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,12786,1,,,14062,,,N,50597,CHEMBL625484,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,12787,1,,,14062,,,N,50597,CHEMBL625485,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,12788,1,,,14346,,Plasma,N,50588,CHEMBL625486,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,12789,1,,,14346,,Plasma,N,50597,CHEMBL625487,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,12790,1,,,14346,,Plasma,N,50597,CHEMBL625488,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,12791,1,,,14346,,Plasma,N,50597,CHEMBL625489,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,12792,1,,,14346,,Plasma,N,50597,CHEMBL625490,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,12793,1,,,14346,,Plasma,N,50588,CHEMBL625491,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,12794,1,,,14346,,Plasma,N,50597,CHEMBL625492,BAO_0000218,1969.0
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,plasma clearance in human,,12795,1,,,15711,,Plasma,N,50587,CHEMBL625493,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,12796,1,,,14886,,,N,50597,CHEMBL625494,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,12797,1,,,14886,,,N,50597,CHEMBL625495,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,12798,1,,,14886,,,N,50597,CHEMBL625496,BAO_0000218,
P,Autocuration,1,,,,,,,1-Octanol/water partition coefficient measured at 7.4,,12799,0,,,4115,,,U,22229,CHEMBL625497,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12800,0,,,13733,,,U,22229,CHEMBL625498,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,12801,0,,,12102,,,U,22224,CHEMBL625499,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12802,0,,,12676,,,U,22229,CHEMBL625500,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12803,0,,,13733,,,U,22229,CHEMBL625501,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12804,0,,,13740,,,U,22229,CHEMBL625502,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,12805,0,,,12766,,,U,22229,CHEMBL625503,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12806,0,,,2764,,,U,22229,CHEMBL625504,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12807,0,,,12355,,,U,22229,CHEMBL625505,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient of the compound,,12808,0,,,11314,,,U,22229,CHEMBL625506,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,12809,0,,,12706,,,U,22224,CHEMBL625507,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12810,0,,,12645,,,U,22229,CHEMBL625508,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12811,0,,,13668,,,U,22229,CHEMBL625509,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12812,0,,,12819,,,U,22229,CHEMBL625510,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12813,0,,,13668,,,U,22229,CHEMBL883125,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12814,0,,,13017,,,U,22229,CHEMBL625511,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient of the compound,,12815,0,,,2448,,,U,22224,CHEMBL874650,BAO_0000019,
A,Autocuration,1,,,,,,,Partition coefficient of the compound,,12816,0,,,11526,,,U,22224,CHEMBL625512,BAO_0000019,
A,Autocuration,1,,,,,,,Partition coefficient of compound was determined,,12817,0,,,12426,,,U,22224,CHEMBL625513,BAO_0000019,
A,Autocuration,1,,,,,,,Partition coefficient was determined,,12818,0,,,2448,,,U,22224,CHEMBL625514,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12819,0,,,12001,,,U,22229,CHEMBL625515,BAO_0000100,
P,Autocuration,1,,,,,,,partition coefficient of compound was determined,,12820,0,,,12426,,,U,22229,CHEMBL625516,BAO_0000100,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The total body administered intravenously in dog,,12821,1,,,13204,,,N,50588,CHEMBL625517,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The total body administered intravenously in rats,,12822,1,,,13204,,,N,50597,CHEMBL625518,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Time taken for the administration to female NIH mice weighing 25-30 g.,,12823,1,,,13889,,,N,50594,CHEMBL625519,BAO_0000218,
A,Autocuration,1,,,,,,,Time taken for the administration,,12824,0,,,13889,,,U,22224,CHEMBL625520,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,12825,1,,,17025,,,N,50588,CHEMBL874651,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,12826,0,,,17025,,,U,22224,CHEMBL625521,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,12827,1,,,17025,,,N,50592,CHEMBL623171,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,12828,1,,,17025,,,N,50597,CHEMBL623853,BAO_0000218,
A,Autocuration,1,,,,,,,Plasma clearance for the compound was determined.,,12829,0,,,15067,,,U,22224,CHEMBL623854,BAO_0000019,
P,Autocuration,1,,,,,,,CLog P value of the compound,,12830,0,,,3091,,,U,22224,CHEMBL874405,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12831,0,,,15592,,,U,22229,CHEMBL623855,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12832,0,,,14738,,,U,22229,CHEMBL623856,BAO_0000100,
P,Autocuration,1,,,,,,,ClogP value of the compound; nd ='no data',,12833,0,,,14738,,,U,22224,CHEMBL623857,BAO_0000100,
P,Autocuration,1,,,,,,,ClogP value of the compound; nd ='not determined',,12834,0,,,14738,,,U,22224,CHEMBL623858,BAO_0000100,
P,Autocuration,1,,,,,,,CLog P was determined,,12835,0,,,6076,,,U,22224,CHEMBL623859,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12836,0,,,17840,,,U,22229,CHEMBL839829,BAO_0000100,
A,Autocuration,1,,,,,,,CLogP was calculated,,12837,0,,,13589,,,U,22224,CHEMBL623860,BAO_0000019,
A,Autocuration,1,,,,,,,CLogP value was determined,,12838,0,,,17655,,,U,22224,CHEMBL623861,BAO_0000019,
A,Autocuration,1,,,,,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,12839,0,,,5867,,,U,22224,CHEMBL623862,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12840,0,,,5867,,,U,22229,CHEMBL874406,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12841,0,,,10783,,,U,22229,CHEMBL623863,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12842,0,,,14849,,,U,22229,CHEMBL624021,BAO_0000100,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog adrenal medulla 24 hours after administration.,,12843,1,,,8170,,Adrenal medulla,N,50588,CHEMBL624022,BAO_0000218,1236.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog adrenal medulla 72 hours after administration.,,12844,1,,,8170,,Adrenal medulla,N,50588,CHEMBL624023,BAO_0000218,1236.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog bile 24 hours after administration.,,12845,1,,,8170,,,N,50588,CHEMBL624024,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog bile 72 hr after administration.,,12846,1,,,8170,,,N,50588,CHEMBL624025,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog blood 24 hours after administration.,,12847,1,,,8170,,,N,50588,CHEMBL624026,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog blood 72 hours after administration.,,12848,1,,,8170,,,N,50588,CHEMBL624027,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog heart 24 hours after administration.,,12849,1,,,8170,,,N,50588,CHEMBL624028,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog heart 72 hours after administration.,,12850,1,,,8170,,,N,50588,CHEMBL624029,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog kidney 24 hours after administration.,,12851,1,,,8170,,,N,50588,CHEMBL624030,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog kidney 72 hours after administration.,,12852,1,,,8170,,,N,50588,CHEMBL624031,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog large intestine 24 hours after administration.,,12853,1,,,8170,,Intestine,N,50588,CHEMBL624032,BAO_0000218,160.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog large intestine 72 hours after administration.,,12854,1,,,8170,,Intestine,N,50588,CHEMBL874407,BAO_0000218,160.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog liver 24 hours after administration.,,12855,1,,,8170,,,N,50588,CHEMBL624033,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog liver 72 hours after administration.,,12856,1,,,8170,,,N,50588,CHEMBL624034,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog lung 24 hours after administration.,,12857,1,,,8170,,,N,50588,CHEMBL624035,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog lung 72 hours after administration.,,12858,1,,,8170,,,N,50588,CHEMBL624036,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog muscle 24 hours after administration.,,12859,1,,,8170,,Muscle tissue,N,50588,CHEMBL624037,BAO_0000218,2385.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog muscle 72 hours after administration.,,12860,1,,,8170,,Muscle tissue,N,50588,CHEMBL624038,BAO_0000218,2385.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog pancreas 24 hours after administration.,,12861,1,,,8170,,,N,50588,CHEMBL624039,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog pancreas 72 hours after administration.,,12862,1,,,8170,,,N,50588,CHEMBL624040,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog small intestine 24 hours after administration.,,12863,1,,,8170,,Intestine,N,50588,CHEMBL624041,BAO_0000218,160.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog small intestine 72 hours after administration.,,12864,1,,,8170,,Intestine,N,50588,CHEMBL624042,BAO_0000218,160.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog spleen 24 hours after administration.,,12865,1,,,8170,,Spleen,N,50588,CHEMBL624043,BAO_0000218,2106.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog spleen 72 hours after administration.,,12866,1,,,8170,,Spleen,N,50588,CHEMBL624044,BAO_0000218,2106.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog stomach 24 hours after administration.,,12867,1,,,8170,,Stomach,N,50588,CHEMBL624045,BAO_0000218,945.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog stomach 72 hours after administration.,,12868,1,,,8170,,Stomach,N,50588,CHEMBL624046,BAO_0000218,945.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog thyroid 24 hours after administration.,,12869,1,,,8170,,Thyroid gland,N,50588,CHEMBL624047,BAO_0000218,2046.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog thyroid 72 hours after administration.,,12870,1,,,8170,,Thyroid gland,N,50588,CHEMBL624048,BAO_0000218,2046.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog urine 24 hours after administration.,,12871,1,,,8170,,Urine,N,50588,CHEMBL874408,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Distribution in female dog urine 72 hr after administration.,,12872,1,,,8170,,Urine,N,50588,CHEMBL624049,BAO_0000218,1088.0
A,Autocuration,1,,,,,,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,12873,0,,,14283,,Plasma,U,22224,CHEMBL624050,BAO_0000218,1969.0
A,Autocuration,1,,,,,,,Plasma concentration at 7 hr after intravenous dosing,,12874,0,,,5623,,,U,22224,CHEMBL624051,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,12875,1,,,13477,,,N,50597,CHEMBL623278,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,12876,1,,,13477,,,N,50597,CHEMBL623279,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,12877,1,,,13477,,,N,50597,CHEMBL623280,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,12878,1,,,13477,,,N,50597,CHEMBL623963,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,12879,1,,,13477,,,N,50597,CHEMBL623964,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,12880,1,,,13477,,,N,50597,CHEMBL623965,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,12881,1,,,13477,,,N,50597,CHEMBL623966,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,12882,1,,,13477,,,N,50597,CHEMBL874415,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,12883,1,,,13477,,,N,50597,CHEMBL623967,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,12884,1,,,13477,,,N,50597,CHEMBL623968,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,12885,1,,,13477,,,N,50597,CHEMBL623969,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,12886,1,,,13477,,,N,50597,CHEMBL628409,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,12887,1,,,13477,,,N,50597,CHEMBL628410,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,12888,1,,,13477,,,N,50597,CHEMBL628411,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,12889,1,,,13477,,,N,50597,CHEMBL628412,BAO_0000218,
A,Autocuration,1,,,,,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,12890,0,,,12553,,,U,22224,CHEMBL628413,BAO_0000019,
A,Autocuration,1,,,,,,,The concentration in plasmat; Not determined,,12891,0,,,14548,,Plasma,U,22224,CHEMBL628414,BAO_0000019,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue level at 10 mg/kg/po in wistar rats in blood,,12892,1,,,14393,,,N,50597,CHEMBL628415,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,12893,1,,,14393,,,N,50597,CHEMBL628416,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue level at 10 mg/kg/po in wistar rats in heart,,12894,1,,,14393,,,N,50597,CHEMBL628417,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue level at 10 mg/kg/po in wistar rats in liver,,12895,1,,,14393,,Liver,N,50597,CHEMBL874908,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue level at 10 mg/kg/po in wistar rats in plasma,,12896,1,,,14393,,,N,50597,CHEMBL628418,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,12897,1,,,14393,,Muscle tissue,N,50597,CHEMBL628419,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,12898,1,,,14393,,,N,50597,CHEMBL628420,BAO_0000218,
A,Autocuration,1,,,,,,,Water solubility at 37 degree C.,,12899,0,,,1629,,,U,22224,CHEMBL628421,BAO_0000019,
P,Autocuration,1,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,12900,0,,,8194,,,U,22229,CHEMBL626726,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,12901,0,,,8194,,,U,22229,CHEMBL626727,BAO_0000100,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12902,1,,,8594,,Blood,N,50597,CHEMBL626728,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12903,1,,,8594,,Blood,N,50597,CHEMBL626729,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12904,1,,,8594,,Blood,N,50597,CHEMBL626730,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12905,1,,,8594,,Blood,N,50597,CHEMBL626731,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12906,1,,,8594,,Blood,N,50597,CHEMBL626732,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12907,1,,,8594,,Heart,N,50597,CHEMBL626733,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12908,1,,,8594,,Heart,N,50597,CHEMBL626734,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12909,1,,,8594,,Heart,N,50597,CHEMBL626735,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12910,1,,,8594,,Heart,N,50597,CHEMBL874909,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12911,1,,,8594,,Heart,N,50597,CHEMBL626736,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12912,1,,,8594,,Kidney,N,50597,CHEMBL626737,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12913,1,,,8594,,Kidney,N,50597,CHEMBL630999,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12914,1,,,8594,,Kidney,N,50597,CHEMBL631000,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12915,1,,,8594,,Kidney,N,50597,CHEMBL631001,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12916,1,,,8594,,Kidney,N,50597,CHEMBL631002,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12917,1,,,8594,,Liver,N,50597,CHEMBL631003,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12918,1,,,8594,,Liver,N,50597,CHEMBL631004,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12919,1,,,8594,,Liver,N,50597,CHEMBL631005,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12920,1,,,8594,,Liver,N,50597,CHEMBL631006,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12921,1,,,8594,,Liver,N,50597,CHEMBL631007,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12922,1,,,8594,,Lung,N,50597,CHEMBL631008,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12923,1,,,8594,,Lung,N,50597,CHEMBL631009,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12924,1,,,8594,,Lung,N,50597,CHEMBL631010,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12925,1,,,8594,,Lung,N,50597,CHEMBL631011,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12926,1,,,8594,,Lung,N,50597,CHEMBL631012,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,12927,1,,,8594,,Thyroid gland,N,50597,CHEMBL630271,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,12928,1,,,8594,,Thyroid gland,N,50597,CHEMBL630272,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,12929,1,,,8594,,Thyroid gland,N,50597,CHEMBL630273,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,12930,1,,,8594,,Thyroid gland,N,50597,CHEMBL630274,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,12931,1,,,8594,,Thyroid gland,N,50597,CHEMBL630275,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,12932,1,,,8594,,,N,50597,CHEMBL875782,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,12933,1,,,8594,,,N,50597,CHEMBL630276,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,12934,1,,,8594,,,N,50597,CHEMBL630277,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,12935,1,,,8594,,,N,50597,CHEMBL630278,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,12936,1,,,8594,,,N,50597,CHEMBL630279,BAO_0000218,
A,Autocuration,1,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,12937,0,,,8151,,,U,22224,CHEMBL630280,BAO_0000019,
A,Autocuration,1,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,12938,0,,,8151,,,U,22224,CHEMBL630281,BAO_0000019,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,12939,1,,,7132,,,N,50592,CHEMBL630282,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,12940,1,,,7132,,,N,50592,CHEMBL630283,BAO_0000218,
A,Autocuration,1,,,,,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,12941,0,,,5797,,,U,22224,CHEMBL630284,BAO_0000019,
A,Autocuration,1,,,,,,,Alkylating activity was determined,,12942,0,,,7849,,,U,22224,CHEMBL630285,BAO_0000019,
A,Autocuration,1,,Microsomes,,,,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,12943,0,,,14220,,,U,22224,CHEMBL630286,BAO_0000251,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,12944,1,,,8650,,,N,50592,CHEMBL630069,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,12945,1,,,8650,,,N,50592,CHEMBL630070,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,12946,1,,,8650,,,N,50592,CHEMBL630071,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,12947,1,,,8650,,,N,50592,CHEMBL630072,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,12948,1,,,8650,,,N,50592,CHEMBL875110,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for antidiuretic activity in rats,,12949,1,,,7116,,,N,50597,CHEMBL630073,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was tested for inactivation kinetic values,,12950,0,,,14131,,,U,22224,CHEMBL630074,BAO_0000019,
A,Autocuration,1,,,,In vivo,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,12951,0,,,7415,,,U,22224,CHEMBL630075,BAO_0000218,
A,Autocuration,1,,,,,,,Dissociation rate calculated from the first-order equation using the t1/2 value,,12952,0,,,13178,,,U,22224,CHEMBL630076,BAO_0000019,
P,Autocuration,1,,,,,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,12953,0,,,8815,,,U,22229,CHEMBL630077,BAO_0000100,
P,Autocuration,1,,,,,,,Aqueous solubility was measured,,12954,0,,,1450,,,U,22229,CHEMBL630078,BAO_0000100,
P,Autocuration,1,,,,,,,Aqueous solubility was measured at a pH 4,,12955,0,,,1450,,,U,22229,CHEMBL630079,BAO_0000100,
P,Autocuration,1,,,,,,,Aqueous solubility (pH 7),,12956,0,,,1450,,,U,22229,CHEMBL630080,BAO_0000100,
P,Autocuration,1,,,,,,,Aqueous solubility was measured at a pH 9,,12957,0,,,1450,,,U,22229,CHEMBL630081,BAO_0000100,
A,Autocuration,1,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,12958,0,,,12711,,,U,22224,CHEMBL630082,BAO_0000019,
A,Autocuration,1,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12959,0,,,12711,,,U,22224,CHEMBL630083,BAO_0000019,
A,Autocuration,1,,,,,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12960,0,,,12711,,,U,22224,CHEMBL630084,BAO_0000019,
P,Autocuration,1,,,,,,,Aqueous solubility of the compound,,12961,0,,,15032,,,U,22229,CHEMBL629198,BAO_0000100,
P,Autocuration,1,,,,,,,Aqueous solubility at 37 degree Celsius at pH 7.38,,12962,0,,,9964,,,U,22229,CHEMBL629199,BAO_0000100,
P,Autocuration,1,,,,,,,Aqueous solubility in pH 7.4 phosphate buffer,,12963,0,,,14962,,,U,22229,CHEMBL629200,BAO_0000100,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,12964,1,,,12487,,,N,50588,CHEMBL629201,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,12965,1,,,12487,,,N,50588,CHEMBL629202,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,12966,1,,,10026,,,N,50587,CHEMBL875111,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,12967,1,,,10026,,,N,50587,CHEMBL629203,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,12968,1,,,10026,,,N,50587,CHEMBL629204,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,12969,1,,,10026,,,N,50587,CHEMBL629205,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,12970,1,,,10026,,,N,50587,CHEMBL629206,BAO_0000218,
A,Autocuration,1,,,,,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,12971,0,,,10026,,,U,22224,CHEMBL631185,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for the average bile flow rat in rats,,12972,1,,,7415,,,N,50597,CHEMBL631186,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,12973,1,,,17025,,,N,50592,CHEMBL631187,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,12974,1,,,17025,,,N,50592,CHEMBL631188,BAO_0000218,
A,Autocuration,1,,,,,,,Average half life period was determined,,12975,0,,,10184,,,U,22224,CHEMBL876419,BAO_0000019,
A,Autocuration,1,,,,,,,Average half life period was determined,,12976,0,,,10184,,,U,22224,CHEMBL631189,BAO_0000019,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,12977,1,,,8613,,,N,50602,CHEMBL631190,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,12978,1,,,8613,,,N,50602,CHEMBL631191,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,12979,1,,,8613,,,N,50602,CHEMBL631192,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,12980,1,,,8613,,,N,50602,CHEMBL632400,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,12981,1,,,8613,,,N,50602,CHEMBL630564,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,12982,1,,,8613,,,N,50602,CHEMBL630565,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,12983,1,,,8613,,,N,50602,CHEMBL630566,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,12984,1,,,8613,,,N,50602,CHEMBL631229,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,12985,1,,,8613,,,N,50602,CHEMBL631230,BAO_0000218,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12986,0,,,6030,,,U,22229,CHEMBL876428,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12987,0,,,6147,,,U,22229,CHEMBL631231,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (MacLogP),,12988,0,,,14556,,,U,22229,CHEMBL631232,BAO_0000100,
A,Autocuration,1,,,,,,,Hydrophilicity was determined,,12989,0,,,768,,,U,22224,CHEMBL631233,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12990,0,,,14452,,,U,22229,CHEMBL631234,BAO_0000100,
A,Autocuration,1,,,,,,,Increased absorption was determined,,12991,0,,,5237,,,U,22224,CHEMBL883126,BAO_0000019,
P,Autocuration,1,,,,,,,Lipophilicity value was evaluated,,12992,0,,,14378,,,U,22224,CHEMBL631235,BAO_0000100,
P,Autocuration,1,,,,,,,Log P value of the compound.,,12993,0,,,14418,,,U,22224,CHEMBL631236,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient of compound was determined,,12994,0,,,5249,,,U,22224,CHEMBL631237,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12995,0,,,14621,,,U,22229,CHEMBL631238,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12996,0,,,12542,,,U,22229,CHEMBL876429,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient was measured by medchem software; Not calculated,,12997,0,,,12542,,,U,22224,CHEMBL631414,BAO_0000019,
P,Autocuration,1,,,,,,,Partition coefficient was measured by octanol-water using standard shake-flask method,,12998,0,,,12542,,,U,22224,CHEMBL631415,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,12999,0,,,15462,,,U,22229,CHEMBL631416,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,13000,0,,,14884,,,U,22224,CHEMBL631417,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13001,0,,,16526,,,U,22229,CHEMBL631418,BAO_0000100,
P,Autocuration,1,,,,,,,The Octanol/Water partition coefficient CLogP,,13002,0,,,13693,,,U,22229,CHEMBL631419,BAO_0000100,
A,Autocuration,1,,,,,,,The pharmacokinetic parameter C Log p was reported,,13003,0,,,13693,,,U,22224,CHEMBL631420,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13004,0,,,13779,,,U,22229,CHEMBL631421,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13005,0,,,14772,,,U,22229,CHEMBL631422,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13006,0,,,14393,,,U,22229,CHEMBL631423,BAO_0000100,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,13007,1,,,14793,,Plasma,N,50597,CHEMBL876430,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,13008,1,,,14793,,Plasma,N,50597,CHEMBL631424,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was administered intravenously in dog to evaluate plasma clearance values,,13009,1,,,13744,,Plasma,N,50588,CHEMBL631425,BAO_0000218,1969.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Compound was administered intravenously in monkey to evaluate plasma clearance values,,13010,0,,,13744,,Plasma,U,22224,CHEMBL631426,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Compound was administered intravenously in mouse to evaluate plasma clearance values,,13011,1,,,13744,,Plasma,N,50594,CHEMBL631427,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,13012,1,,,13207,,Plasma,N,50588,CHEMBL631428,BAO_0000218,1969.0
A,Intermediate,1,,Microsomes,Macaca mulatta,In vitro,,9544.0,Intrinsic clearance in Rhesus liver microsome,,13013,1,,,5669,,Liver,N,50797,CHEMBL631429,BAO_0000218,2107.0
A,Intermediate,1,,Microsomes,Canis lupus familiaris,In vitro,,9615.0,Intrinsic clearance in dog liver microsome,,13014,1,,,5669,,Liver,N,50588,CHEMBL631430,BAO_0000218,2107.0
A,Intermediate,1,,Microsomes,Rattus norvegicus,In vitro,,10116.0,Intrinsic clearance in rat liver microsome,,13015,1,,,5669,,Liver,N,50597,CHEMBL631431,BAO_0000218,2107.0
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Low plasma clearance was calculated in rhesus monkey,,13016,1,,,4853,,Plasma,N,50797,CHEMBL631432,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,13017,1,,,16452,,,N,50588,CHEMBL631433,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance after intravenous dose of 0.3 mg/kg,,13018,0,,,11954,,,U,22224,CHEMBL631434,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance after intravenous dose of 1 mg/kg,,13019,0,,,11954,,,U,22224,CHEMBL631435,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance after intravenous dose of 3 mg/kg,,13020,0,,,11954,,,U,22224,CHEMBL631436,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance after intravenous dose of 3.87 mg/kg,,13021,0,,,11954,,,U,22224,CHEMBL631437,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after peroral administration at 10 mpk in Rat,,13022,1,,,5669,,,N,50597,CHEMBL631438,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Plasma clearance after peroral administration at 10 mpk in Rhesus,,13023,1,,,5669,,,N,50797,CHEMBL876431,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Plasma clearance after peroral administration at 10 mpk in dog,,13024,1,,,5669,,,N,50588,CHEMBL631439,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,13025,1,,,13662,,,N,50597,CHEMBL631440,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,13026,0,,,8272,,,U,22224,CHEMBL631441,BAO_0000019,
A,Autocuration,1,,,,,,,Critical Micellar concentration was determined,,13027,0,,,13410,,,U,22224,CHEMBL631442,BAO_0000019,
A,Autocuration,1,,,,,,,Critical Micellar concentration of the compound. was determined,,13028,0,,,13410,,,U,22224,CHEMBL626525,BAO_0000019,
A,Autocuration,1,,,,,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,13029,0,,,12628,,,U,22224,CHEMBL627168,BAO_0000019,
A,Autocuration,1,,,,,,,Critical micellar concentration was measured in water by the dye solubilization method,,13030,0,,,9675,,,U,22224,CHEMBL875618,BAO_0000019,
B,Autocuration,1,,,,,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,13031,0,,,12628,,,U,22224,CHEMBL626612,BAO_0000019,
A,Autocuration,1,,,,,,,CMR value (relative to BAY K 8644),,13032,0,,,12766,,,U,22224,CHEMBL626613,BAO_0000019,
A,Autocuration,1,,,,,,,Carbamoylating activity was determined,,13033,0,,,7849,,,U,22224,CHEMBL626614,BAO_0000019,
A,Autocuration,1,,,Simiiformes,,,314293.0,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,13034,0,,,12187,,,U,22224,CHEMBL626615,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,13035,0,,,2040,,,U,22224,CHEMBL626616,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,13036,0,,,2040,,,U,22224,CHEMBL626617,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,13037,1,,,14180,,Plasma,N,50588,CHEMBL626618,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,13038,1,,,14180,,Plasma,N,50597,CHEMBL626619,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,"Clearance rate at 0.46 mg/kg, iv, in dogs",,13039,1,,,14474,,,N,50588,CHEMBL626620,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Clearance rate at 5.5 mg/kg, iv, in rat",,13040,1,,,14474,,,N,50597,CHEMBL626621,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,13041,1,,,14548,,,N,100710,CHEMBL626622,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,13042,1,,,14548,,,N,100710,CHEMBL626623,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,13043,1,,,14548,,,N,50588,CHEMBL626624,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,13044,1,,,14548,,,N,50597,CHEMBL626625,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,Ex vivo,,10116.0,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,13045,1,,,6125,,Liver,N,50597,CHEMBL626626,BAO_0000218,2107.0
A,Autocuration,1,,,,In vivo,,,Tested for the total clearance of the compound,,13046,0,,,6874,,,U,22224,CHEMBL626627,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,13047,1,,,15343,,,N,50588,CHEMBL626628,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Total body clearance was determined,,13048,0,,,6236,,,U,22224,CHEMBL626629,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,13049,1,,,11510,,,N,50597,CHEMBL626630,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,13050,1,,,11510,,,N,50597,CHEMBL626631,BAO_0000218,
P,Autocuration,1,,,,,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,13051,0,,,8194,,,U,22229,CHEMBL626632,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,13052,0,,,8194,,,U,22229,CHEMBL626633,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,13053,0,,,8194,,,U,22229,CHEMBL626634,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,13054,0,,,8194,,,U,22229,CHEMBL626635,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,13055,0,,,8194,,,U,22229,CHEMBL626636,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,13056,0,,,8194,,,U,22229,CHEMBL626637,BAO_0000100,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,13057,1,,,13273,,,N,50339,CHEMBL626638,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,13058,1,,,13273,,,N,50339,CHEMBL626639,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,13059,1,,,13273,,,N,50339,CHEMBL626640,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,13060,1,,,13273,,,N,50339,CHEMBL626641,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,13061,1,,,13273,,,N,50339,CHEMBL627272,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,13062,1,,,13273,,,N,50339,CHEMBL627273,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,13063,1,,,13273,,,N,50339,CHEMBL627441,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,13064,1,,,13273,,,N,50339,CHEMBL628355,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,13065,1,,,13273,,,N,50339,CHEMBL628356,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,13066,1,,,13273,,,N,50339,CHEMBL628357,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,13067,1,,,13273,,,N,50339,CHEMBL628358,BAO_0000218,
A,Intermediate,1,,,Pneumocystis carinii,,,4754.0,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,13068,1,,,13273,,,N,50339,CHEMBL622307,BAO_0000218,
A,Autocuration,1,,,,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,13069,0,,,13118,,,U,22224,CHEMBL622527,BAO_0000019,
A,Autocuration,1,,,,,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,13070,0,,,13118,,,U,22224,CHEMBL622528,BAO_0000019,
A,Autocuration,1,,,,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,13071,0,,,13118,,,U,22224,CHEMBL622529,BAO_0000019,
A,Autocuration,1,,,,,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,13072,0,,,13118,,,U,22224,CHEMBL622992,BAO_0000019,
A,Autocuration,1,,,,,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,13073,0,,,13118,,,U,22224,CHEMBL622993,BAO_0000019,
A,Autocuration,1,,,,,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,13074,0,,,13118,,,U,22224,CHEMBL622994,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,13075,1,,,10633,,,N,50597,CHEMBL622995,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,13076,1,,,10633,,,N,50597,CHEMBL622996,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,13077,1,,,10633,,,N,50597,CHEMBL622997,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,13078,1,,,10633,,,N,50597,CHEMBL622998,BAO_0000218,
A,Autocuration,1,,,,,,,Cp max following ip administration at 1 mg/kg,,13079,0,,,5767,,,U,22224,CHEMBL622999,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma was reported at 0.5 hour,,13080,0,,,3302,,Plasma,U,22224,CHEMBL623000,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Maximum concentration in plasma was reported at 2 hour,,13081,0,,,3302,,Plasma,U,22224,CHEMBL623001,BAO_0000218,1969.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,13082,1,,,12467,,,N,50594,CHEMBL623002,BAO_0000218,
P,Autocuration,1,,,,,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,13083,0,,,11778,,,U,22229,CHEMBL623003,BAO_0000100,
A,Autocuration,1,,,,,,,Steady state concentration was evaluated,,13084,0,,,4321,,,U,22224,CHEMBL623004,BAO_0000019,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,13085,0,,,14884,,,U,22224,CHEMBL623005,BAO_0000019,
A,Autocuration,1,,,,,,,Partition coefficient (logD7.4),,13086,0,,,15234,,,U,22224,CHEMBL623006,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,13087,1,,,14198,,Liver,N,50597,CHEMBL623007,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,13088,1,,,14198,,Bone,N,50597,CHEMBL623008,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,13089,1,,,14198,,Cerebellum,N,50597,CHEMBL876654,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,13090,1,,,14198,,,N,50597,CHEMBL623009,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,13091,1,,,14198,,,N,50597,CHEMBL623010,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,13092,1,,,14198,,Heart,N,50597,CHEMBL623011,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,13093,1,,,14198,,Intestine,N,50597,CHEMBL623012,BAO_0000218,160.0
A,Autocuration,1,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,13094,0,,,8151,,,U,22224,CHEMBL623013,BAO_0000019,
A,Autocuration,1,,,,,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,13095,0,,,8151,,,U,22224,CHEMBL623014,BAO_0000019,
A,Autocuration,1,,,,,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,13096,0,,,8151,,Urine,U,22224,CHEMBL623015,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,13097,0,,,8151,,Urine,U,22224,CHEMBL623016,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,13098,0,,,8151,,Urine,U,22224,CHEMBL624858,BAO_0000019,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,13099,1,,,8151,,,N,50597,CHEMBL624859,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,13100,1,,,8151,,,N,50597,CHEMBL624860,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,13101,1,,,8151,,,N,50597,CHEMBL624861,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,13102,1,,,8151,,,N,50597,CHEMBL624862,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,13103,1,,,8151,,,N,50597,CHEMBL624863,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,13104,1,,,8151,,,N,50597,CHEMBL876655,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,13105,1,,,6996,,,N,50588,CHEMBL624864,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,13106,1,,,6996,,,N,50588,CHEMBL624865,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,13107,1,,,6996,,,N,50588,CHEMBL624866,BAO_0000218,
F,Expert,1,,,Canis lupus familiaris,,,9615.0,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,13108,1,,,6996,,,N,50588,CHEMBL624867,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,13109,1,,,6996,,,N,50588,CHEMBL624868,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,13110,1,,,6996,,,N,50588,CHEMBL628450,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,13111,1,,,6996,,,N,50588,CHEMBL628451,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,13112,1,,,6996,,,N,50588,CHEMBL628452,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,13113,1,,,6996,,,N,50588,CHEMBL628453,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,13114,1,,,6996,,,N,50588,CHEMBL628454,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,13115,1,,,6996,,,N,50588,CHEMBL628455,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,13116,1,,,6996,,,N,50588,CHEMBL628456,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,13117,1,,,6996,,,N,50588,CHEMBL628457,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,13118,1,,,6996,,,N,50588,CHEMBL877505,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,13119,1,,,6996,,,N,50588,CHEMBL628458,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,13120,1,,,6996,,,N,50588,CHEMBL628459,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,13121,1,,,6996,,,N,50588,CHEMBL628460,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,13122,1,,,6996,,,N,50588,CHEMBL628461,BAO_0000218,
B,Autocuration,1,,,,,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,13123,0,,,6996,,,U,22224,CHEMBL628462,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13124,1,,,6996,,,N,50588,CHEMBL628463,BAO_0000218,
F,Expert,1,,,Rattus norvegicus,,,10116.0,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,13125,1,,,6996,,,N,50597,CHEMBL625666,BAO_0000218,
B,Autocuration,1,,,,,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13126,0,,,6996,,,U,22224,CHEMBL625667,BAO_0000218,
A,Expert,1,,,Rattus norvegicus,,,10116.0,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13127,1,,,6996,,,N,50597,CHEMBL625668,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,13128,1,,,6996,,,N,50597,CHEMBL625669,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,13129,0,,,7114,,,U,22224,CHEMBL625670,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,13130,1,,,7114,,,N,50597,CHEMBL625671,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,13131,1,,,8613,,,N,50602,CHEMBL625672,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,13132,1,,,8613,,,N,50602,CHEMBL625673,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,13133,1,,,8613,,,N,50602,CHEMBL625674,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,13134,1,,,8613,,,N,50602,CHEMBL625675,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,13135,1,,,8613,,,N,50602,CHEMBL627637,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,13136,1,,,8613,,,N,50602,CHEMBL627638,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,13137,1,,,8613,,,N,50602,CHEMBL627639,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,13138,1,,,8613,,,N,50602,CHEMBL627640,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,13139,1,,,8613,,,N,50602,CHEMBL627641,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,13140,1,,,8613,,,N,50602,CHEMBL627642,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,13141,1,,,8613,,,N,50602,CHEMBL877506,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,13142,1,,,8613,,,N,50594,CHEMBL627275,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,13143,1,,,11219,,,N,50506,CHEMBL627643,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,13144,1,,,11219,,,N,50506,CHEMBL631246,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,13145,1,,,11219,,,N,50506,CHEMBL631247,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,13146,1,,,11219,,,N,50506,CHEMBL629532,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,13147,1,,,11219,,,N,50506,CHEMBL629533,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,13148,1,,,11219,,,N,50506,CHEMBL629534,BAO_0000218,
A,Intermediate,1,,,Mustela putorius furo,,,9669.0,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,13149,1,,,11219,,,N,50506,CHEMBL629535,BAO_0000218,
A,Autocuration,1,,,,,,,Pharmacokinetic parameter :drug bound to plasma was reported,,13150,0,,,14837,,,U,22224,CHEMBL625932,BAO_0000019,
A,Autocuration,1,,,,,,,compound was evaluated for drug bound in plasma,,13151,0,,,14837,,,U,22224,CHEMBL625933,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,13152,1,,,15343,,,N,50597,CHEMBL625934,BAO_0000218,
A,Autocuration,1,,,Eutheria,,,9347.0,Bioavailability,,13153,0,,,13761,,,U,22224,CHEMBL625935,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,13154,1,,,14810,,,N,50597,CHEMBL625936,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,13155,1,,,14810,,,N,50597,CHEMBL625937,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,13156,1,,,13249,,,N,50588,CHEMBL625938,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,13157,1,,,9267,,Bile,N,50597,CHEMBL625939,BAO_0000218,1970.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,13158,1,,,9267,,Bile,N,50597,CHEMBL625940,BAO_0000218,1970.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,13159,1,,,9267,,Bile,N,50597,CHEMBL874464,BAO_0000218,1970.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,13160,1,,,9267,,Bile,N,50597,CHEMBL625941,BAO_0000218,1970.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,13161,1,,,9267,,Bile,N,50597,CHEMBL625942,BAO_0000218,1970.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,13162,1,,,9267,,Bile,N,50597,CHEMBL625943,BAO_0000218,1970.0
A,Intermediate,1,,,Homo sapiens,,,9606.0,In vitro protein binding in human serum at 5 ug/ml,,13163,1,,,15549,,Serum,N,50587,CHEMBL625944,BAO_0000218,1977.0
A,Autocuration,1,,,,,,,Serum protein binding ability was measured,,13164,0,,,10929,,,U,22224,CHEMBL625945,BAO_0000019,
A,Autocuration,1,,,,,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,13165,0,,,15444,,,U,22224,CHEMBL625946,BAO_0000019,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Oral bioavailability in dog,,13166,0,,,12860,,,U,22224,CHEMBL625947,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,13167,1,,,12170,,,N,50597,CHEMBL625948,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,13168,0,,,15173,,,U,22224,CHEMBL625949,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,13169,0,,,15173,,,U,22224,CHEMBL625950,BAO_0000218,
A,Autocuration,1,,,Eutheria,In vivo,,9347.0,Oral bioavailability (dose 15 mg/kg i.v.),,13170,0,,,15173,,,U,22224,CHEMBL625951,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,13171,0,,,15173,,,U,22224,CHEMBL625952,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,13172,0,,,15173,,,U,22224,CHEMBL625953,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,13173,0,,,15173,,,U,22224,CHEMBL625954,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,13174,0,,,15173,,,U,22224,CHEMBL882959,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,13175,1,,,11767,,,N,50588,CHEMBL625955,BAO_0000218,
A,Autocuration,1,,,Mustela putorius furo,In vivo,,9669.0,Bioavailability in ferret,,13176,0,,,11219,,,U,22224,CHEMBL625956,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,13177,1,,,12186,,,N,100710,CHEMBL625957,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,13178,1,,,11510,,,N,50597,CHEMBL625958,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,13179,1,,,11510,,,N,50597,CHEMBL625959,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,13180,1,,,11510,,,N,50597,CHEMBL626642,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,13181,1,,,11510,,,N,50597,CHEMBL631330,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,13182,1,,,11510,,,N,50597,CHEMBL631331,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,13183,1,,,11510,,,N,50597,CHEMBL631332,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,13184,1,,,11510,,,N,50597,CHEMBL631333,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,13185,1,,,11510,,,N,50597,CHEMBL632018,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,13186,1,,,11510,,,N,50597,CHEMBL632019,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,13187,1,,,11510,,,N,50597,CHEMBL632020,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,13188,1,,,11510,,,N,50597,CHEMBL632021,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,13189,1,,,11510,,,N,50597,CHEMBL632022,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,13190,1,,,11510,,,N,50597,CHEMBL632023,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,13191,1,,,11510,,,N,50597,CHEMBL632024,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,13192,1,,,11510,,,N,50597,CHEMBL874472,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,13193,1,,,11510,,,N,50597,CHEMBL632025,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,13194,1,,,11510,,,N,50597,CHEMBL632026,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,13195,1,,,11510,,,N,50597,CHEMBL632027,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,13196,1,,,11510,,,N,50597,CHEMBL632028,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,13197,1,,,11510,,,N,50597,CHEMBL626430,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,13198,1,,,11510,,,N,50597,CHEMBL626431,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,13199,1,,,11510,,,N,50597,CHEMBL626432,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,13200,1,,,11510,,,N,50597,CHEMBL626433,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,13201,1,,,11510,,,N,50597,CHEMBL626434,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,13202,1,,,11510,,,N,50597,CHEMBL627280,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,13203,1,,,11510,,,N,50597,CHEMBL627281,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,13204,1,,,11510,,,N,50597,CHEMBL627282,BAO_0000218,
A,Autocuration,1,,,,,,,Total body clearance was measured at given dose,,13205,0,,,7199,,,U,22224,CHEMBL627283,BAO_0000019,
A,Autocuration,1,,,,,,,Total body clearance was measured at given dose.,,13206,0,,,7199,,,U,22224,CHEMBL627284,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Metabolic clearance from the body in rat,,13207,1,,,7095,,,N,50597,CHEMBL627285,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Renal clearance from the body,,13208,0,,,7095,,,U,22224,CHEMBL627286,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Renal clearance from the body in rat,,13209,1,,,7095,,,N,50597,CHEMBL875477,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,13210,1,,,12528,,,N,50597,CHEMBL627287,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,13211,1,,,12528,,,N,50588,CHEMBL627288,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total clearance from the body in rat,,13212,1,,,7095,,,N,50597,CHEMBL627289,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance into cortex from rat plasma or PBS,,13213,1,,,14223,,Plasma,N,50597,CHEMBL627290,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,13214,0,,,13569,,,U,22224,CHEMBL627291,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,13215,0,,,13569,,,U,22224,CHEMBL627292,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,13216,0,,,13569,,,U,22224,CHEMBL627293,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,13217,0,,,13569,,,U,22224,CHEMBL627294,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,13218,0,,,13569,,,U,22224,CHEMBL875478,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Clearance was determined,,13219,0,,,13979,,,U,22224,CHEMBL627295,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,13220,1,,,14315,,,N,50594,CHEMBL627296,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,In vivo,,9986.0,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,13221,1,,,14315,,,N,50592,CHEMBL626119,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,13222,1,,,14315,,,N,50597,CHEMBL626120,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance in rat after iv dose (100 ug/kg),,13223,1,,,12174,,,N,50597,CHEMBL626121,BAO_0000218,
A,Autocuration,1,,,Cavia porcellus,In vivo,,10141.0,Clearance in guinea pig,,13224,0,,,12797,,,U,22224,CHEMBL626122,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for clearance in rat,,13225,1,,,12797,,,N,50597,CHEMBL626123,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for the clearance in dog,,13226,1,,,12797,,,N,50588,CHEMBL623456,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for the clearance in rat,,13227,1,,,12797,,,N,50597,CHEMBL623457,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested in vivo for clearance after iv administration in the rat,,13228,1,,,11500,,,N,50597,CHEMBL623458,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,IV clearance determined at an iv dose of 14 mg/kg,,13229,0,,,15173,,,U,22224,CHEMBL623459,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,IV clearance determined at an iv dose of 15.2 mg/kg,,13230,0,,,15173,,,U,22224,CHEMBL875484,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,IV clearance determined at an iv dose of 15 mg/kg,,13231,0,,,15173,,,U,22224,CHEMBL623460,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,IV clearance determined at an peroral dose of 30 mg/kg.,,13232,0,,,15173,,,U,22224,CHEMBL623461,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,13233,0,,,15173,,,U,22224,CHEMBL623462,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,13234,0,,,15173,,,U,22224,CHEMBL627386,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,13235,1,,,14198,,Kidney,N,50597,CHEMBL627387,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,13236,1,,,14198,,Liver,N,50597,CHEMBL627388,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,13237,1,,,14198,,Lung,N,50597,CHEMBL627389,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,13238,1,,,14198,,Muscle tissue,N,50597,CHEMBL627390,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,13239,1,,,14198,,Plasma,N,50597,CHEMBL627391,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,13240,1,,,14198,,,N,50597,CHEMBL627392,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,13241,1,,,14198,,Spleen,N,50597,CHEMBL627393,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,13242,1,,,14198,,Trachea,N,50597,CHEMBL627394,BAO_0000218,3126.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,13243,1,,,14198,,Bone,N,50597,CHEMBL627395,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,13244,1,,,14198,,Cerebellum,N,50597,CHEMBL875485,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,13245,1,,,14198,,,N,50597,CHEMBL627396,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,13246,1,,,14198,,,N,50597,CHEMBL627397,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,13247,1,,,14198,,Heart,N,50597,CHEMBL627398,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,13248,1,,,14198,,Bone,N,50597,CHEMBL627399,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,13249,1,,,14198,,Kidney,N,50597,CHEMBL627400,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,13250,1,,,14198,,Liver,N,50597,CHEMBL627401,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,13251,1,,,14198,,Lung,N,50597,CHEMBL627402,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,13252,1,,,14198,,Muscle tissue,N,50597,CHEMBL627403,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,13253,1,,,14198,,Plasma,N,50597,CHEMBL627404,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,13254,1,,,14198,,,N,50597,CHEMBL623101,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,13255,1,,,14198,,Spleen,N,50597,CHEMBL877480,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,13256,1,,,14198,,Trachea,N,50597,CHEMBL623102,BAO_0000218,3126.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,13257,1,,,14198,,Bone,N,50597,CHEMBL623103,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,13258,1,,,14198,,Cerebellum,N,50597,CHEMBL623104,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,13259,1,,,14198,,,N,50597,CHEMBL623105,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,13260,1,,,14198,,,N,50597,CHEMBL623106,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,13261,1,,,14198,,Heart,N,50597,CHEMBL623107,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,13262,1,,,14198,,Intestine,N,50597,CHEMBL623108,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,13263,1,,,14198,,Kidney,N,50597,CHEMBL623109,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,13264,1,,,14198,,Liver,N,50597,CHEMBL623110,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,13265,1,,,14198,,Lung,N,50597,CHEMBL623111,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,13266,1,,,14198,,Muscle tissue,N,50597,CHEMBL625060,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,13267,1,,,14198,,Plasma,N,50597,CHEMBL625061,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,13268,1,,,14198,,,N,50597,CHEMBL625062,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,13269,1,,,14198,,Spleen,N,50597,CHEMBL625063,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,13270,1,,,14198,,Trachea,N,50597,CHEMBL625064,BAO_0000218,3126.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,13271,1,,,14198,,Bone,N,50597,CHEMBL625065,BAO_0000218,10000001.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,13272,1,,,14198,,Cerebellum,N,50597,CHEMBL625066,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,13273,1,,,14198,,,N,50597,CHEMBL625067,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,13274,1,,,14198,,,N,50597,CHEMBL625068,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,13275,1,,,14198,,Heart,N,50597,CHEMBL622159,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,13276,1,,,14198,,Intestine,N,50597,CHEMBL622160,BAO_0000218,160.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,13277,1,,,14198,,Kidney,N,50597,CHEMBL622161,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,13278,1,,,14198,,Lung,N,50597,CHEMBL622162,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,13279,1,,,14198,,Muscle tissue,N,50597,CHEMBL622163,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,13280,1,,,14198,,Plasma,N,50597,CHEMBL622313,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,13281,1,,,14198,,,N,50597,CHEMBL622314,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,13282,1,,,14198,,Spleen,N,50597,CHEMBL622315,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,13283,1,,,14198,,Trachea,N,50597,CHEMBL622316,BAO_0000218,3126.0
A,Intermediate,1,,,Escherichia coli,,,562.0,Normal diffusion coefficient in water for Escherichia coli,,13284,1,,,15599,,,N,50212,CHEMBL877486,BAO_0000218,
A,Autocuration,1,,,,,,,Average max percent decrease in RVR (renal vascular resistance) was determined,,13285,0,,,8204,,,U,22224,CHEMBL622317,BAO_0000019,
A,Autocuration,1,,,,,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,13286,0,,,8204,,,U,22224,CHEMBL622318,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,13287,0,,,6154,,,U,22224,CHEMBL622319,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,13288,0,,,6154,,,U,22224,CHEMBL622320,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,13289,0,,,6154,,,U,22224,CHEMBL622321,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,13290,0,,,6154,,,U,22224,CHEMBL622322,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,13291,0,,,7114,,,U,22224,CHEMBL622323,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,13292,1,,,7114,,,N,50597,CHEMBL622324,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,13293,1,,,8133,,Urine,N,50588,CHEMBL622325,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,13294,1,,,8133,,Urine,N,50588,CHEMBL622326,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,13295,1,,,8133,,Urine,N,50588,CHEMBL877487,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,13296,1,,,8133,,Urine,N,50588,CHEMBL622327,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,13297,1,,,8133,,Urine,N,50588,CHEMBL622328,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,13298,1,,,8133,,Urine,N,50588,CHEMBL622329,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,13299,1,,,8133,,Urine,N,50588,CHEMBL622330,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,13300,1,,,8133,,Urine,N,50588,CHEMBL622331,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,13301,1,,,8133,,Urine,N,50588,CHEMBL622332,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,13302,1,,,8133,,Urine,N,50588,CHEMBL622333,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,13303,0,,,8133,,Urine,U,22224,CHEMBL627658,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,13304,0,,,8133,,Urine,U,22224,CHEMBL630428,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,13305,0,,,8133,,Urine,U,22224,CHEMBL630429,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,13306,0,,,8133,,Urine,U,22224,CHEMBL630430,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,13307,0,,,8133,,Urine,U,22224,CHEMBL630431,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,13308,1,,,8133,,Urine,N,50597,CHEMBL630432,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,13309,1,,,8133,,Urine,N,50597,CHEMBL630433,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,13310,1,,,8133,,Urine,N,50597,CHEMBL630434,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,13311,1,,,8133,,Urine,N,50597,CHEMBL629372,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,13312,1,,,8133,,Urine,N,50597,CHEMBL629553,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,13313,1,,,8133,,Urine,N,50597,CHEMBL629554,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,13314,1,,,8133,,Urine,N,50597,CHEMBL874447,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,13315,1,,,8133,,Urine,N,50597,CHEMBL629555,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,13316,1,,,8133,,Urine,N,50597,CHEMBL629556,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,13317,1,,,8133,,Urine,N,50597,CHEMBL629557,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,13318,1,,,8133,,Urine,N,50597,CHEMBL629558,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,13319,1,,,8133,,Urine,N,50597,CHEMBL629559,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,13320,1,,,8133,,Urine,N,50597,CHEMBL629560,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,13321,1,,,8133,,Urine,N,50588,CHEMBL629561,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,13322,1,,,8133,,Urine,N,50588,CHEMBL629562,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,13323,1,,,8133,,Urine,N,50588,CHEMBL629563,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,13324,1,,,8133,,Urine,N,50588,CHEMBL629564,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,13325,1,,,8133,,Urine,N,50588,CHEMBL629565,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,13326,1,,,8133,,Urine,N,50588,CHEMBL629566,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,13327,1,,,8133,,Urine,N,50588,CHEMBL629567,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,13328,1,,,8133,,Urine,N,50588,CHEMBL629568,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,13329,1,,,8133,,Urine,N,50588,CHEMBL629569,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,13330,1,,,8133,,Urine,N,50588,CHEMBL629570,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,13331,0,,,8133,,Urine,U,22224,CHEMBL629571,BAO_0000218,1088.0
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,13332,0,,,12170,,,U,22224,CHEMBL629572,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,13333,0,,,12170,,,U,22224,CHEMBL629573,BAO_0000218,
A,Autocuration,1,,,Eutheria,In vivo,,9347.0,Bioavailability (dose 20 mg/kg),,13334,0,,,4985,,,U,22224,CHEMBL629574,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability in dog,,13335,0,,,15145,,,U,22224,CHEMBL629575,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (Sprague-Dawley) (male),,13336,0,,,14080,,,U,22224,CHEMBL874448,BAO_0000218,
A,Autocuration,1,,,Primates,In vivo,,9443.0,Bioavailability in monkey (dose 10 mg/kg i.d.),,13337,0,,,11219,,,U,22224,CHEMBL629576,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,13338,0,,,15145,,,U,22224,CHEMBL629577,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,13339,0,,,15145,,,U,22224,CHEMBL629578,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability in dog (dose 3.0 mg/kg p.o.),,13340,0,,,1202,,,U,22224,CHEMBL629579,BAO_0000218,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,13341,0,,,1202,,,U,22224,CHEMBL882958,BAO_0000218,
A,Intermediate,1,,,Pan troglodytes,In vivo,,9598.0,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,13342,1,,,1202,,,N,50505,CHEMBL629580,BAO_0000218,
A,Autocuration,1,,,Eutheria,In vivo,,9347.0,Bioavailability,,13343,0,,,4026,,,U,22224,CHEMBL629581,BAO_0000218,
A,Autocuration,1,,,Saimiri,In vivo,,9520.0,Bioavailability in squirrel monkey,,13344,0,,,1492,,,U,22224,CHEMBL629582,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Bioavailability was evaluated in dog,,13345,1,,,12793,,,N,50588,CHEMBL628522,BAO_0000218,
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Bioavailability was evaluated in hamster,,13346,1,,,12793,,,N,100712,CHEMBL625432,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat,,13347,0,,,12793,,,U,22224,CHEMBL625433,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,13348,1,,,14793,,Plasma,N,50597,CHEMBL625434,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,13349,1,,,14793,,Plasma,N,50597,CHEMBL625435,BAO_0000218,1969.0
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 10 mg/kg p.o.),,13350,0,,,14793,,,U,22224,CHEMBL625436,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Bioavailability was measured in cynomolgus monkeys.,,13351,1,,,14731,,,N,100710,CHEMBL874588,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Bioavailability was measured in nude mice.,,13352,1,,,14731,,,N,50594,CHEMBL625437,BAO_0000218,
A,Autocuration,1,,,Mustela putorius furo,In vivo,,9669.0,Bioavailability in ferret (dose 10 mg/kg i.d.),,13353,0,,,12187,,,U,22224,CHEMBL625438,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,13354,0,,,12187,,,U,22224,CHEMBL625439,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,13355,0,,,12187,,,U,22224,CHEMBL625440,BAO_0000218,
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,13356,0,,,12187,,,U,22224,CHEMBL625441,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Bioavailability in rat (dose 10 mg/kg i.d.),,13357,0,,,12187,,,U,22224,CHEMBL625442,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,13358,1,,,12187,,,N,50597,CHEMBL625443,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Bioavailability was determined; extremely poor,,13359,0,,,17431,,,U,22224,CHEMBL625444,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,% bioavailability in mice after oral administration of prodrug,,13360,1,,,13318,,,N,50594,CHEMBL625445,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,13361,1,,,9025,,,N,50588,CHEMBL625446,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,13362,1,,,9025,,,N,50588,CHEMBL882960,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,13363,1,,,9025,,,N,50588,CHEMBL625447,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,13364,1,,,9025,,,N,50588,CHEMBL625448,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,13365,1,,,9025,,,N,50588,CHEMBL625449,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,13366,1,,,9025,,,N,50588,CHEMBL874589,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,13367,1,,,9025,,,N,50588,CHEMBL625450,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,13368,1,,,9025,,,N,50588,CHEMBL625451,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,13369,1,,,9025,,,N,50588,CHEMBL626584,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,13370,1,,,9025,,,N,50588,CHEMBL626585,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,13371,1,,,9025,,,N,50588,CHEMBL626586,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,13372,1,,,9025,,,N,50588,CHEMBL626587,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,13373,1,,,9025,,,N,50588,CHEMBL626588,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,13374,1,,,9025,,,N,50588,CHEMBL626589,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,13375,1,,,9025,,,N,50588,CHEMBL626590,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,13376,1,,,9025,,,N,50588,CHEMBL626591,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,13377,1,,,9025,,,N,50588,CHEMBL627181,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,13378,1,,,9025,,,N,50588,CHEMBL628083,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,IV clearance determined at an peroral dose of 15 mg/kg.,,13379,0,,,15173,,,U,22224,CHEMBL628084,BAO_0000218,
F,Expert,1,,,Hymenolepis nana,In vivo,,102285.0,Mouse oral clearance was measured against Hymenolepiasis nana.,,13380,1,,,7732,,,N,50064,CHEMBL628085,BAO_0000218,
F,Expert,1,,,Heligmosomoides polygyrus,In vivo,,6339.0,Mouse oral clearance was measured against Nematospiroides dubius,,13381,1,,,7732,,,N,50545,CHEMBL628086,BAO_0000218,
F,Autocuration,1,,,,In vivo,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,13382,0,,,7732,,,U,22224,CHEMBL628087,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Mouse oral clearance was measured against N. nana; NT is Not Tested,,13383,1,,,7732,,,N,50594,CHEMBL628088,BAO_0000218,
B,Autocuration,1,,,,In vivo,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,13384,0,,,7732,,,U,22224,CHEMBL628089,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,13385,0,,,8328,,,U,22224,CHEMBL628090,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,13386,0,,,8328,,,U,22224,CHEMBL628091,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,13387,0,,,8328,,,U,22224,CHEMBL628092,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,13388,0,,,8328,,,U,22224,CHEMBL628093,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,13389,0,,,8328,,,U,22224,CHEMBL875607,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,13390,0,,,8328,,,U,22224,CHEMBL625710,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,13391,0,,,8328,,,U,22224,CHEMBL625711,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,13392,0,,,8328,,,U,22224,CHEMBL625712,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,13393,0,,,8328,,,U,22224,CHEMBL625713,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,13394,1,,,13376,,,N,50588,CHEMBL625714,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,13395,1,,,13477,,,N,50797,CHEMBL625715,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,13396,1,,,13477,,,N,50597,CHEMBL625716,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,13397,1,,,13477,,,N,50597,CHEMBL625717,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance was determined for the compound in rats,,13398,1,,,13313,,,N,50597,CHEMBL625718,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,13399,1,,,12504,,,N,50597,CHEMBL625719,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,13400,1,,,12504,,,N,50597,CHEMBL625720,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,13401,1,,,12504,,,N,50597,CHEMBL625721,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,13402,1,,,12504,,,N,50597,CHEMBL625722,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,13403,1,,,13129,,,N,50597,CHEMBL625723,BAO_0000218,
A,Intermediate,1,,,Heligmosomoides polygyrus,In vivo,,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,13404,1,,,7732,,,N,50545,CHEMBL625724,BAO_0000218,
A,Intermediate,1,,,Heligmosomoides polygyrus,In vivo,,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,13405,1,,,7732,,,N,50545,CHEMBL625725,BAO_0000218,
A,Intermediate,1,,,Heligmosomoides polygyrus,In vivo,,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,13406,1,,,7732,,,N,50545,CHEMBL625726,BAO_0000218,
A,Intermediate,1,,,Heligmosomoides polygyrus,In vivo,,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,13407,1,,,7732,,,N,50545,CHEMBL875608,BAO_0000218,
A,Intermediate,1,,,Heligmosomoides polygyrus,In vivo,,6339.0,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,13408,1,,,7732,,,N,50545,CHEMBL625727,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,13409,0,,,9278,,Urine,U,22224,CHEMBL625728,BAO_0000218,1088.0
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,13410,0,,,9278,,,U,22224,CHEMBL625729,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,13411,0,,,9278,,,U,22224,CHEMBL625730,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,13412,0,,,9278,,Urine,U,22224,CHEMBL625731,BAO_0000218,1088.0
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Urinary clearance was determined in rat at 25 mg/kg os dosage,,13413,0,,,9278,,Urine,U,22224,CHEMBL626417,BAO_0000218,1088.0
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,Urinary clearance was determined at 100 mg/kg oral dosage in human,,13414,1,,,9278,,Urine,N,50587,CHEMBL626418,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,13415,1,,,9278,,Urine,N,50588,CHEMBL626419,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,13416,1,,,5932,,Plasma,N,50588,CHEMBL626592,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,13417,1,,,5932,,Plasma,N,50597,CHEMBL626593,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,13418,1,,,5182,,,N,50597,CHEMBL626594,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Clearance rate in dogs,,13419,1,,,10499,,,N,50588,CHEMBL625035,BAO_0000218,
A,Autocuration,1,,,,In vitro,,,Compound was measured for intrinsic clearance,,13420,0,,,6051,,,U,22224,CHEMBL625036,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13421,0,,,17508,,,U,22229,CHEMBL625037,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13422,0,,,6228,,,U,22229,CHEMBL625038,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13423,0,,,6231,,,U,22229,CHEMBL625039,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13424,0,,,17740,,,U,22229,CHEMBL625040,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13425,0,,,6495,,,U,22229,CHEMBL625041,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13426,0,,,2171,,,U,22229,CHEMBL625042,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient of the compound,,13427,0,,,3255,,,U,22224,CHEMBL874411,BAO_0000019,
A,Autocuration,1,,,,,,,Permeability,,13428,0,,,6821,,,U,22224,CHEMBL625043,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13429,0,,,2685,,,U,22229,CHEMBL625044,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient (logD),,13430,0,,,17584,,,U,22224,CHEMBL625045,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13431,0,,,13824,,,U,22229,CHEMBL625046,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13432,0,,,13824,,,U,22229,CHEMBL625047,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13433,0,,,16479,,,U,22229,CHEMBL625048,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13434,0,,,11997,,,U,22229,CHEMBL625049,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated logarithm of partition coefficient (P) was determined,,13435,0,,,2988,,,U,22229,CHEMBL625050,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13436,0,,,931,,,U,22229,CHEMBL625051,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13437,0,,,4381,,,U,22229,CHEMBL874412,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13438,0,,,4397,,,U,22229,CHEMBL625052,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13439,0,,,5889,,,U,22229,CHEMBL625053,BAO_0000100,
A,Autocuration,1,,,,,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,13440,0,,,6154,,,U,22224,CHEMBL623250,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,13441,0,,,6154,,,U,22224,CHEMBL623251,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,13442,0,,,6154,,,U,22224,CHEMBL623252,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,13443,0,,,6154,,,U,22224,CHEMBL623253,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,13444,0,,,6154,,,U,22224,CHEMBL623254,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,13445,0,,,6154,,,U,22224,CHEMBL623255,BAO_0000019,
A,Autocuration,1,,,,,,,Percent degradation of compound at a pH of 1 over a 18 hr period,,13446,0,,,6887,,,U,22224,CHEMBL626831,BAO_0000019,
A,Autocuration,1,,,,,,,Percent degradation of compound at pH of 1 over an 18 hr period,,13447,0,,,6887,,,U,22224,CHEMBL877494,BAO_0000019,
A,Autocuration,1,,,,,,,Delta Logarithm of Partition Coefficient value was determined.,,13448,0,,,14116,,,U,22224,CHEMBL626832,BAO_0000019,
A,Autocuration,1,,,,,,,Delta logPoct-cyc,,13449,0,,,11137,,,U,22224,CHEMBL626833,BAO_0000019,
P,Autocuration,1,,,,,,,Lipophilicity estimated on reversed phase TLC,,13450,0,,,7230,,,U,22224,CHEMBL626834,BAO_0000100,
A,Autocuration,1,,,,,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,13451,0,,,15741,,,U,22224,CHEMBL626835,BAO_0000019,
A,Autocuration,1,,,,,,,Delta logPoct-cyc,,13452,0,,,9663,,,U,22224,CHEMBL626836,BAO_0000019,
P,Autocuration,1,,,,,,,Change in logarithm of partition coefficient of the compound,,13453,0,,,9663,,,U,22229,CHEMBL626837,BAO_0000100,
A,Autocuration,1,,,,,,,Delta logD (pH 6.5),,13454,0,,,13807,,,U,22224,CHEMBL626838,BAO_0000019,
P,Autocuration,1,,,,,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,13455,0,,,13807,,,U,22224,CHEMBL626839,BAO_0000100,
A,Autocuration,1,,,,,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,13456,0,,,17425,,,U,22224,CHEMBL626840,BAO_0000019,
A,Autocuration,1,,,,,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,13457,0,,,12143,,,U,22224,CHEMBL626841,BAO_0000019,
A,Autocuration,1,,,,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,13458,0,,,12608,,,U,22224,CHEMBL626842,BAO_0000219,
A,Autocuration,1,,,,,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,13459,0,,,12608,,,U,22224,CHEMBL626843,BAO_0000219,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,13460,1,,,8649,,,N,50597,CHEMBL626844,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of deuterium retained was reported after normal workup in rats,,13461,1,,,8649,,,N,50597,CHEMBL877495,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,13462,1,,,8649,,,N,50597,CHEMBL626845,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,13463,1,,,8649,,,N,50597,CHEMBL626846,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,13464,1,,,8649,,,N,50597,CHEMBL626847,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,13465,1,,,8649,,,N,50597,CHEMBL628677,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,13466,1,,,8649,,,N,50597,CHEMBL628678,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was subjected to electrochemical oxidation,,13467,0,,,9659,,,U,22224,CHEMBL628679,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was subjected to photochemical oxidation,,13468,0,,,9659,,,U,22224,CHEMBL628680,BAO_0000019,
A,Autocuration,1,,,,,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,13469,0,,,9659,,,U,22224,CHEMBL628681,BAO_0000019,
A,Autocuration,1,,,,,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,13470,0,,,9659,,,U,22224,CHEMBL628682,BAO_0000019,
A,Autocuration,1,,,,,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,13471,0,,,9659,,,U,22224,CHEMBL628683,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent diffusion through fuzzy rat skin after 48 h of incubation,,13472,1,,,9607,,,N,50597,CHEMBL628684,BAO_0000218,
P,Autocuration,1,,,,,,,Dissociation constant (pKa),,13473,0,,,7057,,,U,22229,CHEMBL877501,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant value of the compound; ND means not determined.,,13474,0,,,7057,,,U,22224,CHEMBL628685,BAO_0000100,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,13475,1,,,7911,,Blood,N,50597,CHEMBL628686,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13476,1,,,7911,,Blood,N,50597,CHEMBL628687,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,13477,1,,,7911,,,N,50597,CHEMBL628688,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13478,1,,,7911,,,N,50597,CHEMBL628689,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,13479,1,,,7911,,Liver,N,50597,CHEMBL628690,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,13480,1,,,7911,,Liver,N,50597,CHEMBL629363,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,13481,1,,,7911,,Spleen,N,50597,CHEMBL629364,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13482,1,,,7911,,Spleen,N,50597,CHEMBL629365,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,13483,1,,,7911,,,N,50597,CHEMBL629366,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,13484,1,,,7911,,Urine,N,50597,CHEMBL629367,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,13485,1,,,7911,,Feces,N,50597,CHEMBL629368,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,13486,1,,,7911,,Urine,N,50597,CHEMBL877502,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,13487,1,,,13792,,Cerebellum,N,50594,CHEMBL629369,BAO_0000218,2037.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,13488,1,,,13792,,Brain,N,50594,CHEMBL629370,BAO_0000218,955.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,13489,0,,,8133,,Urine,U,22224,CHEMBL629371,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,13490,0,,,8133,,Urine,U,22224,CHEMBL626276,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,13491,0,,,8133,,Urine,U,22224,CHEMBL626277,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,13492,0,,,8133,,Urine,U,22224,CHEMBL631250,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,13493,1,,,8133,,Urine,N,50597,CHEMBL631251,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,13494,1,,,8133,,Urine,N,50597,CHEMBL631252,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,13495,1,,,8133,,Urine,N,50597,CHEMBL631253,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,13496,1,,,8133,,Urine,N,50597,CHEMBL631254,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,13497,1,,,8133,,Urine,N,50597,CHEMBL631255,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,13498,1,,,8133,,Urine,N,50597,CHEMBL631256,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,13499,1,,,8133,,Urine,N,50597,CHEMBL631257,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,13500,1,,,8133,,Urine,N,50597,CHEMBL628009,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,13501,1,,,8133,,Urine,N,50597,CHEMBL628010,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,13502,1,,,8133,,Urine,N,50597,CHEMBL628011,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,13503,1,,,8133,,Urine,N,50597,CHEMBL628012,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,13504,1,,,8133,,Urine,N,50597,CHEMBL628013,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,13505,1,,,8133,,Urine,N,50597,CHEMBL628014,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,13506,1,,,8133,,Urine,N,50588,CHEMBL628015,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,13507,1,,,8133,,Urine,N,50588,CHEMBL628016,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,13508,1,,,8133,,Urine,N,50588,CHEMBL874461,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,13509,1,,,8133,,Urine,N,50588,CHEMBL628017,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,13510,1,,,8133,,Urine,N,50588,CHEMBL628018,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,13511,1,,,8133,,Urine,N,50588,CHEMBL628019,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,13512,1,,,8133,,Urine,N,50588,CHEMBL628020,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,13513,1,,,8133,,Urine,N,50588,CHEMBL628021,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,13514,1,,,8133,,Urine,N,50588,CHEMBL628022,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,13515,1,,,8133,,Urine,N,50588,CHEMBL628023,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,13516,0,,,8133,,Urine,U,22224,CHEMBL628024,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,13517,0,,,8133,,Urine,U,22224,CHEMBL628025,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,13518,0,,,8133,,Urine,U,22224,CHEMBL628026,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,13519,0,,,8133,,Urine,U,22224,CHEMBL628027,BAO_0000218,1088.0
A,Autocuration,1,,,Simiiformes,,,314293.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,13520,0,,,8133,,Urine,U,22224,CHEMBL628028,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,13521,1,,,8133,,Urine,N,50597,CHEMBL628029,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,13522,1,,,8133,,Urine,N,50597,CHEMBL628030,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,13523,1,,,8133,,Urine,N,50597,CHEMBL628031,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,13524,1,,,8133,,Urine,N,50597,CHEMBL628032,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,13525,1,,,8133,,Urine,N,50597,CHEMBL628033,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,13526,1,,,8133,,Urine,N,50597,CHEMBL628034,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,13527,1,,,8133,,Urine,N,50597,CHEMBL628035,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,13528,1,,,8133,,Urine,N,50597,CHEMBL628036,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,13529,1,,,8133,,Urine,N,50597,CHEMBL874462,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,13530,1,,,9025,,,N,50588,CHEMBL628037,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,13531,1,,,9025,,,N,50588,CHEMBL628123,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,13532,1,,,9025,,,N,50588,CHEMBL628124,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,13533,1,,,9025,,,N,50588,CHEMBL628125,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,13534,1,,,9025,,,N,50588,CHEMBL628126,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,13535,1,,,9025,,,N,50588,CHEMBL628127,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,13536,1,,,9025,,,N,50588,CHEMBL628128,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,13537,1,,,9025,,,N,50588,CHEMBL628129,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,13538,1,,,9025,,,N,50588,CHEMBL628130,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,13539,1,,,9025,,,N,50588,CHEMBL628131,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,13540,1,,,9025,,,N,50588,CHEMBL628132,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,13541,1,,,9025,,,N,50588,CHEMBL628133,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,13542,1,,,9025,,,N,50588,CHEMBL628134,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,13543,1,,,9025,,,N,50588,CHEMBL628135,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,13544,1,,,9025,,,N,50588,CHEMBL628136,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,13545,1,,,9025,,,N,50588,CHEMBL628137,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,13546,1,,,9025,,,N,50588,CHEMBL628138,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,13547,1,,,9025,,,N,50588,CHEMBL628139,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,13548,1,,,9025,,,N,50588,CHEMBL628140,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,13549,1,,,9025,,,N,50588,CHEMBL628141,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,13550,1,,,9025,,,N,50588,CHEMBL628142,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,13551,1,,,9025,,,N,50588,CHEMBL628143,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,13552,1,,,9025,,,N,50588,CHEMBL628144,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,13553,1,,,9025,,,N,50588,CHEMBL628145,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,13554,1,,,9025,,,N,50588,CHEMBL628146,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,13555,1,,,9025,,,N,50588,CHEMBL625355,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,13556,1,,,9025,,,N,50588,CHEMBL625356,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,13557,1,,,9025,,,N,50588,CHEMBL625357,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,13558,1,,,9025,,,N,50588,CHEMBL625527,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,13559,1,,,9025,,,N,50588,CHEMBL875473,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,13560,1,,,9025,,,N,50588,CHEMBL625528,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,13561,1,,,9025,,,N,50597,CHEMBL626304,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,13562,1,,,9025,,Artery,N,50588,CHEMBL624138,BAO_0000218,1637.0
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13563,0,,,6448,,,U,22229,CHEMBL624139,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13564,0,,,17221,,,U,22229,CHEMBL624140,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13565,0,,,6545,,,U,22229,CHEMBL624141,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13566,0,,,577,,,U,22229,CHEMBL624142,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13567,0,,,6285,,,U,22229,CHEMBL624143,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13568,0,,,6500,,,U,22229,CHEMBL624144,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13569,0,,,6716,,,U,22229,CHEMBL624145,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13570,0,,,13658,,,U,22229,CHEMBL624146,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13571,0,,,6549,,,U,22229,CHEMBL624147,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (MacLogP),,13572,0,,,14685,,,U,22229,CHEMBL883123,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,13573,0,,,6893,,,U,22224,CHEMBL624148,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter was determined,,13574,0,,,3687,,,U,22224,CHEMBL874416,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13575,0,,,4207,,,U,22229,CHEMBL624149,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13576,0,,,4626,,,U,22229,CHEMBL624150,BAO_0000100,
P,Autocuration,1,,,,,,,Lipophilicity was determined,,13577,0,,,1021,,,U,22224,CHEMBL624151,BAO_0000100,
P,Autocuration,1,,,,,,,Lipophilicity was determined,,13578,0,,,3777,,,U,22224,CHEMBL624152,BAO_0000100,
P,Autocuration,1,,,,,,,Lipophilicity was determined,,13579,0,,,17533,,,U,22224,CHEMBL622139,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13580,0,,,6524,,,U,22229,CHEMBL622140,BAO_0000100,
P,Autocuration,1,,,,,,,Lipophilicity was determined,,13581,0,,,17533,,,U,22224,CHEMBL622141,BAO_0000100,
P,Autocuration,1,,,,,,,Lipophilicity in octanol-water,,13582,0,,,6480,,,U,22224,CHEMBL622142,BAO_0000100,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13583,0,,,17606,,,U,22229,CHEMBL622143,BAO_0000100,
P,Autocuration,1,,,,,,,Octanol-water partition coefficient was determined,,13584,0,,,6863,,,U,22229,CHEMBL622144,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,13585,0,,,1356,,,U,22224,CHEMBL877473,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13586,0,,,3326,,,U,22229,CHEMBL622145,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient was determined; ND means not determined,,13587,0,,,1356,,,U,22224,CHEMBL622146,BAO_0000019,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP),,13588,0,,,12984,,,U,22229,CHEMBL622147,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient of the compound,,13589,0,,,17363,,,U,22224,CHEMBL622148,BAO_0000019,
A,Autocuration,1,,,,,,,Permeability was determined,,13590,0,,,6827,,,U,22224,CHEMBL883124,BAO_0000019,
P,Autocuration,1,,,,,,,The compound was evaluated for the partition coefficient,,13591,0,,,261,,,U,22229,CHEMBL622149,BAO_0000100,
A,Autocuration,1,,,,,,,Partition coefficient (logP),,13592,0,,,2685,,,U,22224,CHEMBL622150,BAO_0000019,
P,Autocuration,1,,,,,,,The lipophilicity was reported,,13593,0,,,414,,,U,22224,CHEMBL622151,BAO_0000100,
P,Autocuration,1,,,,,,,logarithm of the octanol-water partition coefficient for the compound,,13594,0,,,15769,,,U,22229,CHEMBL622152,BAO_0000100,
A,Autocuration,1,,,,,,,Clogp value was determined,,13595,0,,,17248,,,U,22224,CHEMBL622153,BAO_0000019,
A,Autocuration,1,,,,In vivo,,,Clp at a dose of 1.5 mg/kg,,13596,0,,,16935,,,U,22224,CHEMBL877474,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Clp at a dose of 2.0 mg/kg,,13597,0,,,16935,,,U,22224,CHEMBL622154,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,"Clp, plasma clearance at a dose of 10 mg/kg",,13598,0,,,14832,,Plasma,U,22224,CHEMBL622155,BAO_0000218,1969.0
A,Autocuration,1,,,,In vivo,,,"Clp, plasma clearance at a dose of 50 mg/kg",,13599,0,,,14832,,Plasma,U,22224,CHEMBL622156,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for plasma clearance in rat,,13600,1,,,2399,,Plasma,N,50597,CHEMBL622157,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Compound was tested for plasma clearance in rat; Not determined,,13601,1,,,2399,,Plasma,N,50597,CHEMBL622158,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,13602,1,,,6227,,,N,50597,CHEMBL622807,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,13603,1,,,6227,,,N,50797,CHEMBL622808,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,13604,0,,,5623,,,U,22224,CHEMBL622809,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Plasma clearance determined,,13605,0,,,4854,,,U,22224,CHEMBL622810,BAO_0000218,
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Plasma clearance after iv administration at 3 mg/kg in hamster,,13606,1,,,4493,,,N,100712,CHEMBL876653,BAO_0000218,
A,Intermediate,1,,,Cricetinae,In vivo,,10026.0,Plasma clearance after iv administration at 4 mg/kg in hamster,,13607,1,,,4493,,,N,100712,CHEMBL622811,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Rate of clearance in rat was determined,,13608,1,,,14956,,,N,50597,CHEMBL622986,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,13609,1,,,15372,,Plasma,N,50597,CHEMBL622987,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,13610,1,,,15372,,Plasma,N,50597,CHEMBL622988,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,13611,1,,,15372,,Plasma,N,50597,CHEMBL622989,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,13612,1,,,15372,,Plasma,N,50597,CHEMBL622990,BAO_0000218,1969.0
A,Autocuration,1,,,Simiiformes,In vivo,,314293.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,13613,0,,,15604,,Plasma,U,22224,CHEMBL622991,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,13614,1,,,15604,,Plasma,N,50597,CHEMBL622227,BAO_0000218,1969.0
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,13615,1,,,15604,,Plasma,N,50588,CHEMBL622228,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Clpl value in rat,,13616,1,,,14964,,,N,50597,CHEMBL622229,BAO_0000218,
A,Intermediate,1,,,Cavia porcellus,In vivo,,10141.0,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,13617,1,,,15240,,,N,50512,CHEMBL622230,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,13618,1,,,16449,,,N,50597,CHEMBL622231,BAO_0000218,
A,Intermediate,1,,,Macaca fascicularis,In vivo,,9541.0,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,13619,1,,,16449,,,N,100710,CHEMBL622232,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,13620,0,,,12902,,,U,22224,CHEMBL622233,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,13621,0,,,12902,,,U,22224,CHEMBL622234,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,13622,0,,,12902,,,U,22224,CHEMBL622235,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,13623,0,,,12902,,,U,22224,CHEMBL622236,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,13624,0,,,12902,,,U,22224,CHEMBL622237,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,13625,0,,,12902,,,U,22224,CHEMBL877482,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,13626,0,,,12902,,,U,22224,CHEMBL622238,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,13627,0,,,12902,,,U,22224,CHEMBL622239,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax was calculated as maximum concentration reached in the blood,,13628,0,,,11149,,Blood,U,22224,CHEMBL622240,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,13629,0,,,11149,,Blood,U,22224,CHEMBL622241,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was determine after peroral administration at 10 mpk in Rat,,13630,1,,,5669,,,N,50597,CHEMBL631013,BAO_0000218,
A,Intermediate,1,,,Macaca mulatta,In vivo,,9544.0,Cmax was determine after peroral administration at 10 mpk in Rhesus,,13631,1,,,5669,,,N,50797,CHEMBL631014,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Cmax was determine after peroral administration at 10 mpk in dog,,13632,1,,,5669,,,N,50588,CHEMBL631015,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was determine after peroral administration at 160 mpk in Rat,,13633,1,,,5669,,,N,50597,CHEMBL631016,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was determine after peroral administration at 20 mpk in Rat,,13634,1,,,5669,,,N,50597,CHEMBL631017,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Cmax was determine after peroral administration at 50 mpk in Rat,,13635,1,,,5669,,,N,50597,CHEMBL631018,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Cmax was determined,,13636,0,,,4236,,,U,22224,CHEMBL631019,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,13637,1,,,13792,,Brain,N,50594,CHEMBL875761,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,13638,1,,,13792,,Brain,N,50594,CHEMBL631020,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,13639,1,,,13792,,Brain,N,50594,CHEMBL631669,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,13640,1,,,13792,,Brain,N,50594,CHEMBL631670,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,13641,1,,,13792,,Striatum,N,50594,CHEMBL631671,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,13642,1,,,8418,,Blood,N,50597,CHEMBL631672,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,13643,1,,,8418,,Blood,N,50597,CHEMBL631673,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,13644,1,,,8418,,Blood,N,50597,CHEMBL631856,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,13645,1,,,8418,,Blood,N,50597,CHEMBL631857,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,13646,1,,,8418,,Blood,N,50597,CHEMBL631858,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,13647,1,,,8418,,Blood,N,50597,CHEMBL631859,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,13648,1,,,8418,,Blood,N,50597,CHEMBL631860,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,13649,1,,,8418,,Blood,N,50597,CHEMBL631861,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,13650,1,,,8418,,Blood,N,50597,CHEMBL631862,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,13651,1,,,8418,,Blood,N,50597,CHEMBL631863,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,13652,1,,,8418,,Blood,N,50597,CHEMBL631864,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,13653,1,,,8418,,Blood,N,50597,CHEMBL631865,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,13654,1,,,8418,,Blood,N,50597,CHEMBL631866,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,13655,1,,,8418,,Blood,N,50597,CHEMBL629360,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,13656,1,,,8418,,Blood,N,50597,CHEMBL629361,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,13657,1,,,8418,,Blood,N,50597,CHEMBL629362,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,13658,1,,,8418,,Blood,N,50597,CHEMBL630740,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,13659,1,,,8418,,Blood,N,50597,CHEMBL630741,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,13660,1,,,8418,,Blood,N,50597,CHEMBL630742,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,13661,1,,,8418,,,N,50597,CHEMBL630743,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,13662,1,,,8418,,,N,50597,CHEMBL630744,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,13663,1,,,8418,,,N,50597,CHEMBL630745,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,13664,1,,,8418,,,N,50597,CHEMBL630746,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,13665,1,,,8418,,,N,50597,CHEMBL630747,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,13666,1,,,8418,,,N,50597,CHEMBL630748,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,13667,1,,,8418,,,N,50597,CHEMBL632056,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,13668,1,,,8418,,,N,50597,CHEMBL632057,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,13669,1,,,8418,,,N,50597,CHEMBL632058,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,13670,1,,,8418,,,N,50597,CHEMBL632059,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,13671,1,,,8418,,,N,50597,CHEMBL632060,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,13672,1,,,8418,,,N,50597,CHEMBL632061,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,13673,1,,,8418,,,N,50597,CHEMBL629207,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,13674,1,,,8418,,,N,50597,CHEMBL629208,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,13675,1,,,8418,,,N,50597,CHEMBL629209,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,13676,1,,,8418,,,N,50597,CHEMBL629210,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,13677,1,,,8418,,,N,50597,CHEMBL629211,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,13678,1,,,8418,,,N,50597,CHEMBL629212,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,13679,1,,,8418,,,N,50597,CHEMBL629213,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,13680,1,,,8133,,Urine,N,50597,CHEMBL629214,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,13681,1,,,8133,,Urine,N,50597,CHEMBL629215,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,13682,1,,,8133,,Urine,N,50597,CHEMBL635154,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,13683,1,,,6996,,,N,50597,CHEMBL629216,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,13684,1,,,6996,,,N,50597,CHEMBL629217,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,13685,1,,,6996,,,N,50597,CHEMBL629218,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,13686,1,,,6996,,,N,50597,CHEMBL629219,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,13687,1,,,6996,,,N,50597,CHEMBL629220,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,13688,1,,,6996,,,N,50597,CHEMBL629221,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,13689,1,,,6996,,,N,50597,CHEMBL631127,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,13690,1,,,6996,,,N,50597,CHEMBL631128,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,13691,1,,,6996,,,N,50597,CHEMBL631129,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,13692,1,,,6996,,,N,50597,CHEMBL631130,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,13693,1,,,6996,,,N,50597,CHEMBL631131,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,13694,1,,,6996,,,N,50597,CHEMBL631132,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,13695,1,,,6996,,,N,50597,CHEMBL631133,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,13696,1,,,6996,,,N,50597,CHEMBL631134,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,13697,1,,,6996,,,N,50597,CHEMBL875120,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,13698,1,,,6996,,,N,50597,CHEMBL631135,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,13699,1,,,6996,,,N,50597,CHEMBL631136,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,13700,1,,,6996,,,N,50597,CHEMBL631137,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,13701,1,,,6996,,,N,50597,CHEMBL631138,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,13702,1,,,6996,,,N,50597,CHEMBL631139,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,13703,1,,,6996,,,N,50597,CHEMBL631140,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,13704,1,,,6996,,,N,50597,CHEMBL631141,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,13705,1,,,6996,,,N,50597,CHEMBL631142,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,13706,1,,,6996,,,N,50597,CHEMBL631143,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,13707,1,,,6996,,,N,50597,CHEMBL631144,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,13708,1,,,6996,,,N,50588,CHEMBL631145,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,13709,1,,,6996,,,N,50588,CHEMBL631146,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,13710,1,,,6996,,,N,50588,CHEMBL631147,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,13711,1,,,6996,,,N,50588,CHEMBL631148,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,13712,1,,,6996,,,N,50588,CHEMBL631149,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,13713,1,,,6996,,,N,50588,CHEMBL631150,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,13714,1,,,6996,,,N,50588,CHEMBL631151,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,13715,1,,,6996,,,N,50588,CHEMBL631152,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,13716,1,,,6996,,,N,50588,CHEMBL631443,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,13717,1,,,6996,,,N,50588,CHEMBL631444,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,13718,1,,,6996,,,N,50588,CHEMBL631445,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,13719,1,,,6996,,,N,50588,CHEMBL631446,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,13720,1,,,6996,,,N,50588,CHEMBL631447,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,13721,1,,,6996,,,N,50588,CHEMBL631448,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,13722,1,,,6996,,,N,50588,CHEMBL631449,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,13723,1,,,6996,,,N,50588,CHEMBL631450,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,13724,1,,,6996,,,N,50588,CHEMBL629724,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13725,1,,,9716,,Zone of skin,N,50594,CHEMBL629725,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13726,1,,,9716,,Zone of skin,N,50594,CHEMBL629726,BAO_0000218,14.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13727,1,,,9716,,Spleen,N,50594,CHEMBL629727,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13728,1,,,9716,,Spleen,N,50594,CHEMBL630404,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13729,1,,,9716,,Spleen,N,50594,CHEMBL630405,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13730,1,,,9716,,Spleen,N,50594,CHEMBL630406,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13731,1,,,9716,,Stomach,N,50594,CHEMBL630407,BAO_0000218,945.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13732,1,,,9716,,Stomach,N,50594,CHEMBL630573,BAO_0000218,945.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13733,1,,,9716,,Stomach,N,50594,CHEMBL630574,BAO_0000218,945.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13734,1,,,9716,,Stomach,N,50594,CHEMBL630575,BAO_0000218,945.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13735,1,,,9716,,,N,50594,CHEMBL630576,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13736,1,,,9716,,,N,50594,CHEMBL630577,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13737,1,,,9716,,,N,50594,CHEMBL630578,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,13738,1,,,9716,,,N,50594,CHEMBL630579,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,13739,1,,,12192,,Kidney,N,50594,CHEMBL630580,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,13740,1,,,12192,,Kidney,N,50594,CHEMBL630581,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,13741,1,,,12192,,Kidney,N,50594,CHEMBL630582,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,13742,1,,,12192,,,N,50594,CHEMBL630583,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,13743,1,,,12192,,,N,50594,CHEMBL630584,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,13744,1,,,12192,,,N,50594,CHEMBL630585,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,13745,1,,,12192,,,N,50594,CHEMBL630586,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,13746,1,,,12192,,,N,50594,CHEMBL630587,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,13747,1,,,12192,,,N,50594,CHEMBL630588,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,13748,1,,,12192,,,N,50594,CHEMBL630589,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,13749,1,,,12192,,,N,50594,CHEMBL630590,BAO_0000218,
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in feces at 24 h,,13750,0,,,12192,,Feces,U,22224,CHEMBL630591,BAO_0000019,1988.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,13751,0,,,12192,,Feces,U,22224,CHEMBL630592,BAO_0000019,1988.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,13752,0,,,12192,,,U,22224,CHEMBL630593,BAO_0000019,
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,13753,0,,,12192,,,U,22224,CHEMBL630594,BAO_0000019,
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,13754,0,,,12192,,Urine,U,22224,CHEMBL630595,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,13755,0,,,12192,,Urine,U,22224,CHEMBL630596,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,13756,0,,,12192,,Urine,U,22224,CHEMBL630597,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,13757,0,,,12192,,Urine,U,22224,CHEMBL630598,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,13758,0,,,12192,,Urine,U,22224,CHEMBL630599,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,13759,0,,,12192,,Urine,U,22224,CHEMBL630600,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,13760,0,,,12192,,Urine,U,22224,CHEMBL630601,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,13761,0,,,12192,,Urine,U,22224,CHEMBL630602,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,13762,0,,,12192,,Urine,U,22224,CHEMBL630603,BAO_0000019,1088.0
A,Autocuration,1,,,,,,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,13763,0,,,12192,,Urine,U,22224,CHEMBL630604,BAO_0000019,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13764,1,,,12017,,Blood,N,50597,CHEMBL624869,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13765,1,,,12017,,Blood,N,50597,CHEMBL624870,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13766,1,,,12017,,Blood,N,50597,CHEMBL623189,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13767,1,,,12017,,Blood,N,50597,CHEMBL623190,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13768,1,,,12017,,Blood,N,50597,CHEMBL623191,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13769,1,,,12017,,,N,50597,CHEMBL623192,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13770,1,,,12017,,,N,50597,CHEMBL623193,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13771,1,,,12017,,,N,50597,CHEMBL623194,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13772,1,,,12017,,,N,50597,CHEMBL623195,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13773,1,,,12017,,,N,50597,CHEMBL623196,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,13774,1,,,11836,,,N,50597,CHEMBL623197,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,13775,1,,,11836,,,N,50597,CHEMBL623198,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,13776,1,,,11836,,,N,50597,CHEMBL623199,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,13777,1,,,11836,,Muscle tissue,N,50597,CHEMBL623200,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,13778,1,,,11836,,Muscle tissue,N,50597,CHEMBL623201,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,13779,1,,,11836,,Muscle tissue,N,50597,CHEMBL623202,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,13780,1,,,11836,,Muscle tissue,N,50597,CHEMBL623203,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,13781,1,,,11836,,Muscle tissue,N,50597,CHEMBL623204,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,13782,1,,,11836,,Muscle tissue,N,50597,CHEMBL623205,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,13783,1,,,11836,,Muscle tissue,N,50597,CHEMBL623206,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,13784,1,,,11836,,Muscle tissue,N,50597,CHEMBL623207,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,13785,1,,,11836,,Muscle tissue,N,50597,CHEMBL623208,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,13786,1,,,11836,,Muscle tissue,N,50597,CHEMBL623209,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,13787,1,,,11836,,Muscle tissue,N,50597,CHEMBL623210,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,13788,1,,,11836,,,N,50597,CHEMBL623211,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,13789,1,,,11836,,Uterus,N,50597,CHEMBL623212,BAO_0000218,995.0
A,Autocuration,1,,,,,,,Tested in vitro for intrinsic activity relative to quinpirole,,13790,0,,,12640,,,U,22224,CHEMBL623213,BAO_0000019,
A,Autocuration,1,,,,,,,"Relative ion enhancement, determined in pulsed ultrafiltration",,13791,0,,,14218,,,U,22224,CHEMBL623214,BAO_0000019,
A,Autocuration,1,,,,,,,% ionization at the pH 7.4 at 37 degree Centigrade,,13792,0,,,11296,,,U,22224,CHEMBL623215,BAO_0000019,
A,Autocuration,1,,,,,,,Percentage ionization was measured,,13793,0,,,10929,,,U,22224,CHEMBL623216,BAO_0000019,
A,Intermediate,1,,,Bos taurus,,,9913.0,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,13794,1,,,13841,,,N,50591,CHEMBL623217,BAO_0000218,
A,Autocuration,1,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,13795,0,,,10431,,,U,22224,CHEMBL623218,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,13796,0,,,10431,,,U,22224,CHEMBL623913,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,13797,0,,,10431,,,U,22224,CHEMBL623914,BAO_0000019,
P,Autocuration,1,,,,,,,Compound was evaluated for the partition coefficient in octanol/water,,13798,0,,,8826,,,U,22229,CHEMBL623915,BAO_0000100,
P,Autocuration,1,,,,,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,13799,0,,,8826,,,U,22229,CHEMBL624080,BAO_0000100,
A,Autocuration,1,,,,,,,Equilibrium constant measured by the pulse radiolysis at pH 7,,13800,0,,,9884,,,U,22224,CHEMBL624081,BAO_0000019,
A,Intermediate,1,,,Homo sapiens,,,9606.0,In vitro hydrolytic rate constant determined in human blood,,13801,1,,,9827,,,N,50587,CHEMBL624082,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,13802,1,,,10009,,,N,50587,CHEMBL625054,BAO_0000218,
A,Autocuration,1,,,,,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,13803,0,,,10009,,,U,22224,CHEMBL877485,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,13804,1,,,10009,,,N,50594,CHEMBL625055,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,13805,1,,,10009,,,N,50594,CHEMBL625056,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,In vitro oxidation of compound in presence of human plasma,,13806,1,,,10009,,,N,50587,CHEMBL625057,BAO_0000218,
A,Autocuration,1,,,,,,,In vitro oxidation of compound in presence of hydrogen peroxide,,13807,0,,,10009,,,U,22224,CHEMBL625058,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro oxidation of compound in presence of mouse brain homogenate,,13808,1,,,10009,,,N,50594,CHEMBL625059,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro oxidation of compound in presence of mouse liver homogenate,,13809,1,,,10009,,,N,50594,CHEMBL629536,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,13810,1,,,11510,,,N,50597,CHEMBL629537,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,13811,1,,,11510,,,N,50597,CHEMBL629538,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,13812,1,,,11510,,,N,50597,CHEMBL629539,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,13813,1,,,11510,,,N,50597,CHEMBL874445,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,13814,1,,,11510,,,N,50597,CHEMBL629540,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,13815,1,,,11510,,,N,50597,CHEMBL629541,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,13816,1,,,11510,,,N,50597,CHEMBL629542,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,13817,1,,,11510,,,N,50597,CHEMBL630243,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,13818,1,,,11510,,,N,50597,CHEMBL630244,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,13819,1,,,11510,,,N,50597,CHEMBL630245,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,13820,1,,,11510,,,N,50597,CHEMBL630246,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,13821,1,,,11510,,,N,50597,CHEMBL630247,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,13822,1,,,11510,,,N,50597,CHEMBL630248,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood at 240 minutes after dose administration.,,13823,1,,,13100,,Blood,N,50597,CHEMBL630249,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood at 30 minutes after dose administration.,,13824,1,,,13100,,Blood,N,50597,CHEMBL630250,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood at 360 minutes after dose administration.,,13825,1,,,13100,,Blood,N,50597,CHEMBL630251,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood at 3 hr after dose administration.,,13826,1,,,13100,,Blood,N,50597,CHEMBL630252,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood at 60 minutes after dose administration.,,13827,1,,,13100,,Blood,N,50597,CHEMBL630408,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,13828,1,,,13100,,Cerebellum,N,50597,CHEMBL630409,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,13829,1,,,13100,,Cerebellum,N,50597,CHEMBL874446,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,13830,1,,,13100,,Cerebellum,N,50597,CHEMBL630410,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,13831,1,,,13100,,Cerebellum,N,50597,CHEMBL630411,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,13832,1,,,13100,,Cerebellum,N,50597,CHEMBL630412,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,13833,1,,,13100,,Cerebellum,N,50597,CHEMBL630413,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 3 hr after dose administration.,,13834,1,,,13100,,Cerebellum,N,50597,CHEMBL630414,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,13835,1,,,13100,,Cerebellum,N,50597,CHEMBL630415,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 120 minutes after dose administration.,,13836,1,,,13100,,,N,50597,CHEMBL630416,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 1440 minutes after dose administration.,,13837,1,,,13100,,,N,50597,CHEMBL630417,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 15 minutes after dose administration.,,13838,1,,,13100,,,N,50597,CHEMBL630418,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 240 minutes after dose administration.,,13839,1,,,13100,,,N,50597,CHEMBL630419,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 30 minutes after dose administration.,,13840,1,,,13100,,,N,50597,CHEMBL630420,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 360 minutes after dose administration.,,13841,1,,,13100,,,N,50597,CHEMBL630421,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 3 hr after dose administration.,,13842,1,,,13100,,,N,50597,CHEMBL630422,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat cortex at 60 minutes after dose administration.,,13843,1,,,13100,,,N,50597,CHEMBL630423,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart at 120 minutes after dose administration.,,13844,1,,,13100,,Heart,N,50597,CHEMBL630424,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart at 15 minutes after dose administration.,,13845,1,,,13100,,Heart,N,50597,CHEMBL630425,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart at 240 minutes after dose administration.,,13846,1,,,13100,,Heart,N,50597,CHEMBL629462,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart at 30 minutes after dose administration.,,13847,1,,,13100,,Heart,N,50597,CHEMBL630426,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart at 360 minutes after dose administration.,,13848,1,,,13100,,Heart,N,50597,CHEMBL630427,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart at 3 hr after dose administration.,,13849,1,,,13100,,Heart,N,50597,CHEMBL625877,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart at 60 minutes after dose administration.,,13850,1,,,13100,,Heart,N,50597,CHEMBL625878,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,13851,1,,,13100,,Hippocampus,N,50597,CHEMBL625879,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,13852,1,,,13100,,Hippocampus,N,50597,CHEMBL625880,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,13853,1,,,13100,,Hippocampus,N,50597,CHEMBL625881,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,13854,1,,,13100,,Hippocampus,N,50597,CHEMBL625882,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,13855,1,,,13100,,Hippocampus,N,50597,CHEMBL625883,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney at 120 minutes after dose administration.,,13856,1,,,13100,,Kidney,N,50597,CHEMBL625884,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney at 1440 minutes after dose administration.,,13857,1,,,13100,,Kidney,N,50597,CHEMBL625885,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney at 15 minutes after dose administration.,,13858,1,,,13100,,Kidney,N,50597,CHEMBL628649,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney at 240 minutes after dose administration.,,13859,1,,,13100,,Kidney,N,50597,CHEMBL628650,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney at 30 minutes after dose administration.,,13860,1,,,13100,,Kidney,N,50597,CHEMBL628651,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney at 360 minutes after dose administration.,,13861,1,,,13100,,Kidney,N,50597,CHEMBL628652,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney at 60 minutes after dose administration.,,13862,1,,,13100,,Kidney,N,50597,CHEMBL628653,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver at 120 minutes after dose administration.,,13863,1,,,13100,,Liver,N,50597,CHEMBL628654,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver at 1440 minutes after dose administration.,,13864,1,,,13100,,Liver,N,50597,CHEMBL628655,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver at 15 minutes after dose administration.,,13865,1,,,13100,,Liver,N,50597,CHEMBL625238,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver at 240 minutes after dose administration.,,13866,1,,,13100,,Liver,N,50597,CHEMBL625239,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver at 30 minutes after dose administration.,,13867,1,,,13100,,Liver,N,50597,CHEMBL625240,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver at 360 minutes after dose administration.,,13868,1,,,13100,,Liver,N,50597,CHEMBL625241,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver at 60 minutes after dose administration.,,13869,1,,,13100,,Liver,N,50597,CHEMBL625242,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung at 120 minutes after dose administration.,,13870,1,,,13100,,Lung,N,50597,CHEMBL874587,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung at 1440 minutes after dose administration.,,13871,1,,,13100,,Lung,N,50597,CHEMBL625405,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung at 15 minutes after dose administration.,,13872,1,,,13100,,Lung,N,50597,CHEMBL625406,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung at 240 minutes after dose administration.,,13873,1,,,13100,,Lung,N,50597,CHEMBL625407,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung at 30 minutes after dose administration.,,13874,1,,,13100,,Lung,N,50597,CHEMBL625408,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung at 360 minutes after dose administration.,,13875,1,,,13100,,Lung,N,50597,CHEMBL625409,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,13876,1,,,12361,,Thoracic aorta,N,50597,CHEMBL625410,BAO_0000218,1515.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,13877,1,,,12361,,Thoracic aorta,N,50597,CHEMBL625411,BAO_0000218,1515.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,13878,1,,,12361,,Thoracic aorta,N,50597,CHEMBL625412,BAO_0000218,1515.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,13879,1,,,12361,,Thoracic aorta,N,50597,CHEMBL625413,BAO_0000218,1515.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,13880,1,,,12361,,Thoracic aorta,N,50597,CHEMBL625414,BAO_0000218,1515.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,13881,1,,,12361,,Thoracic aorta,N,50597,CHEMBL625415,BAO_0000218,1515.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,13882,1,,,12361,,Thoracic aorta,N,50597,CHEMBL625416,BAO_0000218,1515.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,13883,1,,,12712,,Urine,N,50597,CHEMBL625417,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,13884,1,,,7415,,Feces,N,50597,CHEMBL625418,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,13885,1,,,7415,,Urine,N,50597,CHEMBL625419,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,13886,1,,,7415,,,N,50597,CHEMBL625420,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,13887,1,,,7415,,,N,50597,CHEMBL626996,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,13888,1,,,7415,,Feces,N,50597,CHEMBL626997,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,13889,1,,,7415,,Urine,N,50597,CHEMBL626998,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,13890,1,,,7415,,,N,50597,CHEMBL626999,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,13891,1,,,8050,,,N,50594,CHEMBL627000,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,13892,1,,,8050,,,N,50594,CHEMBL627001,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,13893,1,,,8050,,,N,50594,CHEMBL627002,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,13894,1,,,8050,,,N,50594,CHEMBL627003,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,13895,1,,,8050,,Urine,N,50594,CHEMBL627004,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,13896,1,,,8050,,Urine,N,50594,CHEMBL627005,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,13897,1,,,8050,,Urine,N,50594,CHEMBL874594,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,13898,1,,,8050,,Urine,N,50594,CHEMBL627006,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,13899,1,,,8050,,Urine,N,50594,CHEMBL627007,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,13900,1,,,8050,,Urine,N,50594,CHEMBL627884,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,13901,1,,,8050,,Urine,N,50594,CHEMBL627885,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,13902,1,,,8050,,Urine,N,50594,CHEMBL627886,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,13903,1,,,8050,,Urine,N,50594,CHEMBL627887,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,13904,1,,,8050,,Urine,N,50594,CHEMBL627888,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,13905,1,,,8050,,Urine,N,50594,CHEMBL628057,BAO_0000218,1088.0
A,Intermediate,1,,,Mus musculus,,,10090.0,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,13906,1,,,8050,,Urine,N,50594,CHEMBL627405,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,13907,1,,,12582,,Urine,N,50588,CHEMBL627406,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,13908,1,,,12582,,Urine,N,50588,CHEMBL627407,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,13909,1,,,12582,,Urine,N,50588,CHEMBL627408,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,13910,1,,,12582,,Urine,N,50588,CHEMBL627409,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,13911,1,,,12582,,Urine,N,50588,CHEMBL875486,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,13912,1,,,12582,,Urine,N,50588,CHEMBL627410,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,13913,1,,,12582,,Urine,N,50588,CHEMBL627411,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,13914,1,,,12582,,Urine,N,50588,CHEMBL627412,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,13915,1,,,12582,,Urine,N,50588,CHEMBL627413,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,13916,1,,,12582,,Urine,N,50588,CHEMBL627414,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,13917,1,,,12582,,Urine,N,50588,CHEMBL627415,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,13918,1,,,12582,,Urine,N,50588,CHEMBL627416,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,13919,1,,,12582,,Urine,N,50588,CHEMBL627417,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,13920,1,,,12582,,Urine,N,50588,CHEMBL627418,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,13921,1,,,12582,,Urine,N,50588,CHEMBL627419,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,13922,1,,,12582,,Urine,N,50588,CHEMBL627320,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,13923,1,,,12582,,Urine,N,50588,CHEMBL627321,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13924,1,,,12017,,Kidney,N,50597,CHEMBL627322,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13925,1,,,12017,,Kidney,N,50597,CHEMBL627323,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13926,1,,,12017,,Kidney,N,50597,CHEMBL627491,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13927,1,,,12017,,Kidney,N,50597,CHEMBL627492,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13928,1,,,12017,,Kidney,N,50597,CHEMBL627493,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13929,1,,,12017,,Liver,N,50597,CHEMBL627494,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13930,1,,,12017,,Liver,N,50597,CHEMBL627495,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13931,1,,,12017,,Liver,N,50597,CHEMBL627496,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13932,1,,,12017,,Liver,N,50597,CHEMBL627497,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13933,1,,,12017,,Liver,N,50597,CHEMBL627498,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13934,1,,,12017,,Lung,N,50597,CHEMBL627499,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13935,1,,,12017,,Lung,N,50597,CHEMBL627500,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13936,1,,,12017,,Lung,N,50597,CHEMBL627501,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13937,1,,,12017,,Lung,N,50597,CHEMBL625616,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13938,1,,,12017,,Lung,N,50597,CHEMBL625617,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13939,1,,,12017,,Muscle tissue,N,50597,CHEMBL625618,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13940,1,,,12017,,Muscle tissue,N,50597,CHEMBL625619,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13941,1,,,12017,,Muscle tissue,N,50597,CHEMBL625620,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13942,1,,,12017,,Muscle tissue,N,50597,CHEMBL625621,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13943,1,,,12017,,Muscle tissue,N,50597,CHEMBL625622,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13944,1,,,12017,,Spleen,N,50597,CHEMBL625788,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13945,1,,,12017,,Spleen,N,50597,CHEMBL625789,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13946,1,,,12017,,Spleen,N,50597,CHEMBL625790,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13947,1,,,12017,,Spleen,N,50597,CHEMBL625791,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13948,1,,,12017,,Spleen,N,50597,CHEMBL622334,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13949,1,,,12017,,Thyroid gland,N,50597,CHEMBL622335,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13950,1,,,12017,,Thyroid gland,N,50597,CHEMBL622336,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13951,1,,,12017,,Thyroid gland,N,50597,CHEMBL622337,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13952,1,,,12017,,Thyroid gland,N,50597,CHEMBL622338,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13953,1,,,12017,,Thyroid gland,N,50597,CHEMBL622339,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13954,1,,,12017,,,N,50597,CHEMBL624153,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13955,1,,,12017,,,N,50597,CHEMBL628430,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,13956,1,,,12017,,,N,50597,CHEMBL628431,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13957,1,,,12017,,,N,50597,CHEMBL628432,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,13958,1,,,12017,,,N,50597,CHEMBL628433,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13959,1,,,12017,,Spleen,N,50597,CHEMBL628434,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13960,1,,,12017,,Spleen,N,50597,CHEMBL626789,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,13961,1,,,12017,,Spleen,N,50597,CHEMBL626790,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13962,1,,,12017,,Spleen,N,50597,CHEMBL626791,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13963,1,,,12017,,Spleen,N,50597,CHEMBL626792,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,13964,1,,,12017,,Spleen,N,50597,CHEMBL626793,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,13965,1,,,11510,,,N,50597,CHEMBL627436,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,13966,1,,,11510,,,N,50597,CHEMBL627437,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,13967,1,,,11510,,,N,50597,CHEMBL627438,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,13968,1,,,11510,,,N,50597,CHEMBL627439,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,13969,1,,,11510,,,N,50597,CHEMBL627440,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,13970,1,,,11510,,,N,50597,CHEMBL627602,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,13971,1,,,11510,,,N,50597,CHEMBL627603,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,13972,1,,,11510,,,N,50597,CHEMBL627604,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,13973,1,,,11510,,,N,50597,CHEMBL627605,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,13974,1,,,11510,,,N,50597,CHEMBL627606,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,13975,1,,,11510,,,N,50597,CHEMBL627607,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,13976,1,,,11510,,,N,50597,CHEMBL627608,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,13977,1,,,11510,,,N,50597,CHEMBL627609,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,13978,1,,,11510,,,N,50597,CHEMBL627610,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,13979,1,,,11510,,,N,50597,CHEMBL627611,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,13980,1,,,11510,,,N,50597,CHEMBL627612,BAO_0000218,
P,Autocuration,1,,,,,,,Octanol:water partition coefficient is evaluated,,13981,0,,,8362,,,U,22229,CHEMBL627613,BAO_0000100,
P,Autocuration,1,,,,,,,Partition coefficient in 1-octanol/water system,,13982,0,,,8257,,,U,22224,CHEMBL627614,BAO_0000100,
P,Autocuration,1,,,,,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,13983,0,,,8257,,,U,22224,CHEMBL627615,BAO_0000100,
P,Autocuration,1,,,,,,,Partition coefficient in octanol/water system was determined,,13984,0,,,9468,,,U,22224,CHEMBL627616,BAO_0000100,
P,Autocuration,1,,,,,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,13985,0,,,9468,,,U,22224,CHEMBL627617,BAO_0000100,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,13986,0,,,10568,,,U,22224,CHEMBL627618,BAO_0000019,
A,Autocuration,1,,,,,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,13987,0,,,10568,,,U,22224,CHEMBL627619,BAO_0000019,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant of the compound,,13988,0,,,15359,,,U,22224,CHEMBL627620,BAO_0000019,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant with 1-min time point,,13989,0,,,15359,,,U,22224,CHEMBL627621,BAO_0000019,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant without 1-min time point,,13990,0,,,15359,,,U,22224,CHEMBL627622,BAO_0000019,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,13991,0,,,10431,,,U,22224,CHEMBL627623,BAO_0000019,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,13992,0,,,10431,,,U,22224,CHEMBL627624,BAO_0000019,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,13993,0,,,10431,,,U,22224,CHEMBL627625,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,13994,0,,,15704,,,U,22224,CHEMBL628523,BAO_0000019,
A,Autocuration,1,,,,,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,13995,0,,,15287,,,U,22224,CHEMBL628524,BAO_0000019,
A,Autocuration,1,,,,,,,The efflux rate constant of the compound,,13996,0,,,7516,,,U,22224,CHEMBL628525,BAO_0000019,
A,Autocuration,1,,,,,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,13997,0,,,12973,,,U,22224,CHEMBL625732,BAO_0000019,
A,Autocuration,1,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,13998,0,,,12973,,,U,22224,CHEMBL625733,BAO_0000019,
F,Autocuration,1,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,13999,0,,,12973,,,U,22224,CHEMBL625734,BAO_0000019,
A,Autocuration,1,,,,,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,14000,0,,,12973,,,U,22224,CHEMBL625913,BAO_0000019,
A,Autocuration,1,,,,,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,14001,0,,,8696,,,U,22224,CHEMBL625914,BAO_0000019,
A,Autocuration,1,,,,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,14002,0,,,15052,,,U,22224,CHEMBL625915,BAO_0000019,
A,Autocuration,1,,,,,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,14003,0,,,15052,,,U,22224,CHEMBL625916,BAO_0000019,
A,Autocuration,1,,,,,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,14004,0,,,10503,,,U,22224,CHEMBL625917,BAO_0000019,
A,Autocuration,1,,,,,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14005,0,,,8354,,,U,22224,CHEMBL625918,BAO_0000019,
A,Autocuration,1,,,,,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14006,0,,,8354,,,U,22224,CHEMBL625919,BAO_0000019,
A,Autocuration,1,,,,,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14007,0,,,8354,,,U,22224,CHEMBL625920,BAO_0000019,
A,Autocuration,1,,,,,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14008,0,,,8354,,,U,22224,CHEMBL874453,BAO_0000019,
A,Autocuration,1,,,,,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,14009,0,,,8354,,,U,22224,CHEMBL625921,BAO_0000019,
A,Autocuration,1,,,,,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,14010,0,,,10503,,,U,22224,CHEMBL625922,BAO_0000019,
A,Autocuration,1,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14011,0,,,8354,,,U,22224,CHEMBL625923,BAO_0000019,
A,Autocuration,1,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14012,0,,,8354,,,U,22224,CHEMBL625924,BAO_0000019,
A,Autocuration,1,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14013,0,,,8354,,,U,22224,CHEMBL625925,BAO_0000019,
A,Autocuration,1,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14014,0,,,8354,,,U,22224,CHEMBL625926,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung at 60 minutes after dose administration.,,14015,1,,,13100,,Lung,N,50597,CHEMBL627704,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,14016,1,,,13100,,,N,50597,CHEMBL627705,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,14017,1,,,13100,,,N,50597,CHEMBL627706,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,14018,1,,,13100,,,N,50597,CHEMBL627707,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,14019,1,,,13100,,,N,50597,CHEMBL627708,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,14020,1,,,13100,,,N,50597,CHEMBL628361,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,14021,1,,,13100,,,N,50597,CHEMBL628362,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 120 minutes after dose administration.,,14022,1,,,13100,,Striatum,N,50597,CHEMBL628363,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 1440 minutes after dose administration.,,14023,1,,,13100,,Striatum,N,50597,CHEMBL628364,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 15 minutes after dose administration.,,14024,1,,,13100,,Striatum,N,50597,CHEMBL628365,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 240 minutes after dose administration.,,14025,1,,,13100,,Striatum,N,50597,CHEMBL874454,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 30 minutes after dose administration.,,14026,1,,,13100,,Striatum,N,50597,CHEMBL628531,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 360 minutes after dose administration.,,14027,1,,,13100,,Striatum,N,50597,CHEMBL628532,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 3 hr after dose administration.,,14028,1,,,13100,,Striatum,N,50597,CHEMBL628533,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat striatum at 60 minutes after dose administration.,,14029,1,,,13100,,Striatum,N,50597,CHEMBL628534,BAO_0000218,2435.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat thyroid at 120 minutes after dose administration.,,14030,1,,,13100,,Thyroid gland,N,50597,CHEMBL628535,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,14031,1,,,13100,,Thyroid gland,N,50597,CHEMBL628536,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat thyroid at 15 minutes after dose administration.,,14032,1,,,13100,,Thyroid gland,N,50597,CHEMBL628537,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat thyroid at 240 minutes after dose administration.,,14033,1,,,13100,,Thyroid gland,N,50597,CHEMBL628538,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat thyroid at 30 minutes after dose administration.,,14034,1,,,13100,,Thyroid gland,N,50597,CHEMBL628539,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat thyroid at 360 minutes after dose administration.,,14035,1,,,13100,,Thyroid gland,N,50597,CHEMBL630297,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat thyroid at 60 minutes after dose administration.,,14036,1,,,13100,,Thyroid gland,N,50597,CHEMBL630298,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,14037,1,,,13100,,Brain,N,50597,CHEMBL630299,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,14038,1,,,13100,,Brain,N,50597,CHEMBL628094,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,14039,1,,,13100,,Brain,N,50597,CHEMBL628095,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,14040,1,,,13100,,Brain,N,50597,CHEMBL874648,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,14041,1,,,13100,,Brain,N,50597,CHEMBL628096,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,14042,1,,,13100,,Brain,N,50597,CHEMBL628097,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,14043,1,,,13100,,Brain,N,50597,CHEMBL628098,BAO_0000218,955.0
A,Autocuration,1,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,14044,0,,,13331,,,U,22224,CHEMBL628099,BAO_0000019,
A,Autocuration,1,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,14045,0,,,13331,,,U,22224,CHEMBL628100,BAO_0000019,
A,Autocuration,1,,,,,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,14046,0,,,13331,,,U,22224,CHEMBL628101,BAO_0000019,
A,Autocuration,1,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,14047,0,,,13331,,,U,22224,CHEMBL628102,BAO_0000019,
A,Autocuration,1,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,14048,0,,,13331,,,U,22224,CHEMBL628103,BAO_0000019,
A,Autocuration,1,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,14049,0,,,13331,,,U,22224,CHEMBL628104,BAO_0000019,
A,Autocuration,1,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,14050,0,,,13331,,,U,22224,CHEMBL628105,BAO_0000019,
A,Autocuration,1,,,,,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,14051,0,,,13331,,,U,22224,CHEMBL628106,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,14052,1,,,10086,,Urine,N,50597,CHEMBL628107,BAO_0000218,1088.0
F,Autocuration,1,,,,,,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,14053,0,,,10086,,Urine,U,22224,CHEMBL628108,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,14054,1,,,10086,,Urine,N,50597,CHEMBL628109,BAO_0000218,1088.0
F,Autocuration,1,,,,,,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,14055,0,,,10086,,Urine,U,22224,CHEMBL625299,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,14056,1,,,10086,,Urine,N,50597,CHEMBL625300,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,14057,1,,,10086,,Urine,N,50597,CHEMBL625301,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,14058,1,,,10086,,Urine,N,50597,CHEMBL625302,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,14059,1,,,10086,,Urine,N,50597,CHEMBL874649,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,14060,1,,,13248,,,N,50597,CHEMBL625303,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,14061,1,,,13248,,,N,50597,CHEMBL625463,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,In vitro metabolism in human liver microsomes,,14062,1,,,14527,,Liver,N,50587,CHEMBL625464,BAO_0000218,2107.0
A,Intermediate,1,,,Homo sapiens,,,9606.0,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,14063,1,,,3008,,,N,50587,CHEMBL625465,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,14064,1,,,12582,,Urine,N,50588,CHEMBL625466,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,14065,1,,,12582,,Urine,N,50588,CHEMBL625467,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,14066,1,,,12582,,Urine,N,50597,CHEMBL625468,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,14067,1,,,12582,,Urine,N,50597,CHEMBL625469,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,14068,1,,,12582,,Urine,N,50597,CHEMBL625470,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,14069,1,,,12582,,Urine,N,50597,CHEMBL632418,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,14070,1,,,12582,,Urine,N,50597,CHEMBL627250,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,14071,1,,,12582,,Urine,N,50597,CHEMBL627251,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,14072,1,,,12582,,Urine,N,50597,CHEMBL627252,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,14073,1,,,12582,,Urine,N,50597,CHEMBL627253,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,14074,1,,,12582,,Urine,N,50597,CHEMBL627254,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,14075,1,,,12582,,Urine,N,50597,CHEMBL875471,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,14076,1,,,12582,,Urine,N,50597,CHEMBL627255,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,14077,1,,,12582,,Urine,N,50597,CHEMBL627256,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,14078,1,,,12582,,Urine,N,50597,CHEMBL627257,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,14079,1,,,12582,,Urine,N,50597,CHEMBL627258,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,14080,1,,,12582,,Urine,N,50597,CHEMBL627259,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,14081,1,,,12582,,Urine,N,50597,CHEMBL627260,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,14082,1,,,12582,,Urine,N,50597,CHEMBL623256,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,14083,1,,,12582,,Urine,N,50597,CHEMBL874413,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,14084,1,,,12582,,Urine,N,50597,CHEMBL623257,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,14085,1,,,12582,,Urine,N,50597,CHEMBL623258,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,14086,1,,,12582,,Urine,N,50597,CHEMBL623259,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,14087,1,,,12582,,Urine,N,50597,CHEMBL623260,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,14088,1,,,12582,,Urine,N,50597,CHEMBL623261,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,14089,1,,,12582,,Urine,N,50597,CHEMBL623262,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,14090,1,,,12582,,Urine,N,50597,CHEMBL623263,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,14091,1,,,12582,,Urine,N,50597,CHEMBL623264,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,14092,1,,,12582,,Urine,N,50597,CHEMBL623265,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,14093,1,,,12582,,Urine,N,50597,CHEMBL623266,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,14094,1,,,12582,,Urine,N,50597,CHEMBL623267,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,14095,1,,,12582,,Urine,N,50597,CHEMBL623268,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,14096,1,,,12582,,Urine,N,50597,CHEMBL623269,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,14097,1,,,12582,,Urine,N,50597,CHEMBL623270,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,14098,1,,,12582,,Urine,N,50597,CHEMBL623271,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,14099,1,,,12582,,Urine,N,50597,CHEMBL623272,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,14100,1,,,12582,,Urine,N,50597,CHEMBL623273,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,14101,1,,,12582,,Urine,N,50597,CHEMBL623274,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,14102,1,,,12582,,Urine,N,50597,CHEMBL874414,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,14103,1,,,12582,,Urine,N,50597,CHEMBL623275,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,14104,1,,,12582,,Urine,N,50597,CHEMBL629150,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,14105,1,,,12582,,Urine,N,50597,CHEMBL623276,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,14106,1,,,12582,,Urine,N,50597,CHEMBL623277,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,14107,1,,,12582,,Urine,N,50597,CHEMBL623112,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,14108,1,,,12582,,Urine,N,50597,CHEMBL623113,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,14109,1,,,12582,,Urine,N,50597,CHEMBL623800,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,14110,1,,,12582,,Urine,N,50597,CHEMBL623801,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,14111,1,,,12017,,Spleen,N,50597,CHEMBL623802,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14112,1,,,12017,,Uterus,N,50597,CHEMBL623803,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14113,1,,,12017,,Uterus,N,50597,CHEMBL623970,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14114,1,,,12017,,Uterus,N,50597,CHEMBL623971,BAO_0000218,995.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,14115,1,,,14045,,Blood,N,50597,CHEMBL623972,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,14116,1,,,14045,,Blood,N,50597,CHEMBL623973,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,14117,1,,,14045,,Blood,N,50597,CHEMBL623974,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,14118,1,,,14045,,Blood,N,50597,CHEMBL623975,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,14119,1,,,14045,,Brain,N,50597,CHEMBL623976,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,14120,1,,,14045,,Brain,N,50597,CHEMBL623977,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,14121,1,,,14045,,Brain,N,50597,CHEMBL623978,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,14122,1,,,14045,,Brain,N,50597,CHEMBL623979,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,14123,1,,,14045,,,N,50597,CHEMBL623980,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,14124,1,,,14045,,,N,50597,CHEMBL623981,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,14125,1,,,14045,,,N,50597,CHEMBL626278,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,14126,1,,,14045,,,N,50597,CHEMBL626279,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in mice bladder plus excreted urine was determined,,14127,1,,,14045,,,N,50594,CHEMBL626280,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse blood, 10 minutes post injection",,14128,1,,,14045,,,N,50594,CHEMBL626281,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse blood, 30 minutes post injection",,14129,1,,,14045,,,N,50594,CHEMBL626282,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse blood, 5 minutes post injection",,14130,1,,,14045,,,N,50594,CHEMBL626283,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse blood, 60 minutes post injection",,14131,1,,,14045,,,N,50594,CHEMBL626284,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse brain, 10 minutes post injection",,14132,1,,,14045,,Brain,N,50594,CHEMBL626285,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse brain, 30 minutes post injection",,14133,1,,,14045,,Brain,N,50594,CHEMBL626286,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse brain, 5 minutes post injection",,14134,1,,,14045,,Brain,N,50594,CHEMBL626287,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse brain, 60 minutes post injection",,14135,1,,,14045,,Brain,N,50594,CHEMBL626288,BAO_0000218,955.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse heart, 10 minutes post injection",,14136,1,,,14045,,,N,50594,CHEMBL626289,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse heart, 30 minutes post injection",,14137,1,,,14045,,,N,50594,CHEMBL626290,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse heart, 5 minutes post injection",,14138,1,,,14045,,,N,50594,CHEMBL626291,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse heart, 60 minutes post injection",,14139,1,,,14045,,,N,50594,CHEMBL839888,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,14140,1,,,14045,,Intestine,N,50594,CHEMBL626292,BAO_0000218,160.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,14141,1,,,14045,,Intestine,N,50594,CHEMBL626293,BAO_0000218,160.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,14142,1,,,14045,,Intestine,N,50594,CHEMBL626294,BAO_0000218,160.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,14143,1,,,14045,,Intestine,N,50594,CHEMBL626295,BAO_0000218,160.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse liver, 10 minutes post injection",,14144,1,,,14045,,Liver,N,50594,CHEMBL627659,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,14145,1,,,14045,,Liver,N,50594,CHEMBL627660,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse liver, 5 minutes post injection",,14146,1,,,14045,,Liver,N,50594,CHEMBL627661,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in mice liver at 60 minutes of post injection,,14147,1,,,14045,,Liver,N,50594,CHEMBL627662,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in mice lungs at 10 min of post injection,,14148,1,,,14045,,Lung,N,50594,CHEMBL627663,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mouse lung, 30 minutes post injection",,14149,1,,,14045,,,N,50594,CHEMBL627664,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,"Percentage biodistribution in mousee lung, 5 minutes post injection",,14150,1,,,14045,,,N,50594,CHEMBL627665,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in mice lungs at 60 min of post injection,,14151,1,,,14045,,Lung,N,50594,CHEMBL627666,BAO_0000218,2048.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Percentage biodistribution in mouse spleen,,14152,1,,,14045,,Spleen,N,50594,CHEMBL627667,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Percentage biodistribution in mouse stomach,,14153,1,,,14045,,Stomach,N,50594,CHEMBL627668,BAO_0000218,945.0
A,Intermediate,1,,,Mus musculus,,,10090.0,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,14154,1,,,11745,,Urine,N,50594,CHEMBL627669,BAO_0000218,1088.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,14155,0,,,13257,,Urinary bladder,U,22224,CHEMBL627670,BAO_0000218,1255.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,14156,0,,,13257,,Blood,U,22224,CHEMBL627671,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,14157,0,,,13257,,Bone element,U,22224,CHEMBL627672,BAO_0000218,1474.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,14158,0,,,13257,,,U,22224,CHEMBL627673,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,14159,0,,,13257,,Kidney,U,22224,CHEMBL627674,BAO_0000218,2113.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,14160,0,,,13257,,Liver,U,22224,CHEMBL627675,BAO_0000218,2107.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,14161,0,,,13257,,Lung,U,22224,CHEMBL627676,BAO_0000218,2048.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,14162,0,,,13257,,Muscle tissue,U,22224,CHEMBL627677,BAO_0000218,2385.0
A,Autocuration,1,,,,,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,14163,0,,,8354,,,U,22224,CHEMBL627678,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Affinity for protein binding expressed as association constant in fresh rat serum,,14164,1,,,7095,,Serum,N,50597,CHEMBL627679,BAO_0000218,1977.0
A,Autocuration,1,,,,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,14165,0,,,12185,,,U,22224,CHEMBL627680,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,14166,0,,,12185,,,U,22224,CHEMBL627681,BAO_0000019,
A,Autocuration,1,,,,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,14167,0,,,12185,,,U,22224,CHEMBL627682,BAO_0000019,
A,Autocuration,1,,,,,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,14168,0,,,12185,,,U,22224,CHEMBL627683,BAO_0000019,
A,Autocuration,1,,,,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,14169,0,,,12686,,,U,22224,CHEMBL627684,BAO_0000019,
A,Autocuration,1,,,,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,14170,0,,,12686,,,U,22224,CHEMBL874441,BAO_0000019,
A,Autocuration,1,,,,,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,14171,0,,,12686,,,U,22224,CHEMBL627685,BAO_0000019,
A,Autocuration,1,,,,,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,14172,0,,,12686,,,U,22224,CHEMBL627686,BAO_0000019,
A,Autocuration,1,,,,,,,Apparent rate constant Koff for inactivation of dTMP synthase.,,14173,0,,,8057,,,U,22224,CHEMBL627687,BAO_0000019,
A,Autocuration,1,,,,,,,The irreversible inhibitor activity by second order rate equation.,,14174,0,,,15778,,,U,22224,CHEMBL627688,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,14175,1,,,12375,,,N,50597,CHEMBL628038,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,14176,1,,,12375,,,N,50597,CHEMBL628039,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,14177,1,,,12375,,,N,50597,CHEMBL628040,BAO_0000218,
A,Autocuration,1,,,,,,,Dissociation rate calculated from the first-order equation using t1/2 value,,14178,0,,,13588,,,U,22224,CHEMBL628041,BAO_0000019,
A,Autocuration,1,,,,,,,The compound was tested for Binding constant against DNA,,14179,0,,,15039,,,U,22224,CHEMBL630226,BAO_0000019,
A,Autocuration,1,,,,,,,First order rate constant for cyclization of the compound,,14180,0,,,9500,,,U,22224,CHEMBL628042,BAO_0000019,
A,Autocuration,1,,,,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,14181,0,,,10014,,,U,22224,CHEMBL625232,BAO_0000019,
A,Autocuration,1,,,,,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,14182,0,,,10014,,,U,22224,CHEMBL625233,BAO_0000019,
A,Autocuration,1,,,,,,,Hydrolysis rate constant was determined,,14183,0,,,568,,,U,22224,CHEMBL625979,BAO_0000019,
A,Autocuration,1,,,,,,,Observed first order rate constant,,14184,0,,,10026,,,U,22224,CHEMBL625980,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,14185,0,,,10281,,,U,22224,CHEMBL625981,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,14186,0,,,10281,,,U,22224,CHEMBL625982,BAO_0000019,
A,Autocuration,1,,,,,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,14187,0,,,9680,,,U,22224,CHEMBL625983,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14188,0,,,13028,,,U,22224,CHEMBL625984,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14189,0,,,13028,,,U,22224,CHEMBL625985,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14190,0,,,13028,,,U,22224,CHEMBL625986,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14191,0,,,13028,,,U,22224,CHEMBL625987,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14192,0,,,13028,,,U,22224,CHEMBL625988,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14193,0,,,13028,,,U,22224,CHEMBL625989,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14194,0,,,13028,,,U,22224,CHEMBL625990,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14195,0,,,13028,,,U,22224,CHEMBL625991,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14196,0,,,13028,,,U,22224,CHEMBL625992,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14197,0,,,13028,,,U,22224,CHEMBL625993,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14198,0,,,13028,,,U,22224,CHEMBL631973,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14199,0,,,13028,,,U,22224,CHEMBL632143,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14200,0,,,13028,,,U,22224,CHEMBL632144,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14201,0,,,13028,,,U,22224,CHEMBL632145,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14202,0,,,13028,,,U,22224,CHEMBL632146,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14203,0,,,13028,,,U,22224,CHEMBL632147,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14204,0,,,13028,,,U,22224,CHEMBL632148,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14205,0,,,13028,,,U,22224,CHEMBL632149,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14206,0,,,13028,,,U,22224,CHEMBL632150,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14207,0,,,13028,,,U,22224,CHEMBL632151,BAO_0000019,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,14208,1,,,3008,,,N,50587,CHEMBL632152,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,14209,1,,,4509,,,N,50587,CHEMBL632153,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,,,9606.0,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,14210,1,,,4509,,,N,50587,CHEMBL632154,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,14211,1,,,8613,,,N,50602,CHEMBL632155,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,14212,1,,,8613,,,N,50602,CHEMBL632156,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,14213,1,,,8613,,,N,50602,CHEMBL632157,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,14214,1,,,8613,,,N,50602,CHEMBL632158,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,14215,1,,,8613,,,N,50602,CHEMBL632159,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,14216,1,,,8613,,,N,50602,CHEMBL626305,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,14217,1,,,8613,,,N,50602,CHEMBL626306,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,14218,1,,,8613,,,N,50602,CHEMBL626307,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,14219,1,,,8613,,,N,50602,CHEMBL626308,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,14220,1,,,8613,,,N,50602,CHEMBL626479,BAO_0000218,
A,Intermediate,1,,,Human herpesvirus 1,,,10298.0,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,14221,1,,,8613,,,N,50602,CHEMBL626480,BAO_0000218,
P,Autocuration,1,,,,,,,Calculated partition coefficient (clogP) (MlogP),,14222,0,,,6021,,,U,22229,CHEMBL626481,BAO_0000100,
A,Autocuration,1,,,,,,,Equipotent potent ratio relative to carbachol (nicotinic activity),,14223,0,,,9348,,,U,22224,CHEMBL626482,BAO_0000019,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,14224,1,,,15592,,,N,50588,CHEMBL626483,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,14225,1,,,15592,,,N,50588,CHEMBL626484,BAO_0000218,
P,Autocuration,1,,,,,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,14226,0,,,15592,,,U,22229,CHEMBL626485,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,14227,0,,,15592,,,U,22229,CHEMBL626486,BAO_0000100,
P,Autocuration,1,,,,,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,14228,0,,,15592,,,U,22229,CHEMBL626487,BAO_0000100,
A,Intermediate,1,,,Canis lupus familiaris,In vivo,,9615.0,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,14229,1,,,15592,,Plasma,N,50588,CHEMBL626488,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,14230,1,,,7095,,Serum,N,50597,CHEMBL626489,BAO_0000218,1977.0
A,Autocuration,1,,,,,,,Area under the MAP curve measured over 5 min; ND means Not determined,,14231,0,,,16618,,,U,22224,CHEMBL626490,BAO_0000019,
P,Autocuration,1,,,,,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,14232,0,,,16835,,,U,22224,CHEMBL626491,BAO_0000100,
P,Autocuration,1,,,,,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,14233,0,,,15284,,,U,22229,CHEMBL626492,BAO_0000100,
A,Autocuration,1,,,,,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,14234,0,,,15750,,,U,22224,CHEMBL626493,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,14235,1,,,16618,,,N,50597,CHEMBL626494,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Half life after oral tested,,14236,0,,,16618,,,U,22224,CHEMBL626495,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Half life was determined in plasma of rat; NT indicates not tested,,14237,1,,,15812,,Plasma,N,50597,CHEMBL626496,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,14238,1,,,16618,,,N,50597,CHEMBL626497,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,Oral bioavailability after oral tested,,14239,0,,,16618,,,U,22224,CHEMBL626498,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,14240,1,,,13098,,,N,50597,CHEMBL626499,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,14241,1,,,13098,,,N,50597,CHEMBL626500,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,half life was determined in plasma of rat; NT indicates not tested,,14242,1,,,15812,,Plasma,N,50597,CHEMBL626501,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,half life was determined in plasma of rat; NT means not tested,,14243,1,,,15812,,Plasma,N,50597,CHEMBL626502,BAO_0000218,1969.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,14244,1,,,11510,,,N,50597,CHEMBL626503,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,14245,1,,,11510,,,N,50597,CHEMBL626504,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,14246,1,,,11510,,,N,50597,CHEMBL626505,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,14247,1,,,11510,,,N,50597,CHEMBL626506,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,14248,1,,,11510,,,N,50597,CHEMBL626507,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,14249,1,,,11510,,,N,50597,CHEMBL626508,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,14250,1,,,11510,,,N,50597,CHEMBL626509,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,14251,1,,,11510,,,N,50597,CHEMBL875480,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,14252,1,,,11510,,,N,50597,CHEMBL626510,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,14253,1,,,11510,,,N,50597,CHEMBL626511,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,14254,1,,,11510,,,N,50597,CHEMBL626512,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,14255,1,,,11510,,,N,50597,CHEMBL628208,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,14256,1,,,11510,,,N,50597,CHEMBL628209,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,14257,1,,,11510,,,N,50597,CHEMBL628210,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,14258,1,,,11510,,,N,50597,CHEMBL628211,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,14259,1,,,11510,,,N,50597,CHEMBL628212,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,14260,1,,,11510,,,N,50597,CHEMBL628213,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,14261,1,,,12582,,Urine,N,50597,CHEMBL628214,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,14262,1,,,12582,,Urine,N,50597,CHEMBL628215,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,14263,1,,,12582,,Urine,N,50597,CHEMBL628216,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,14264,1,,,12582,,Urine,N,50597,CHEMBL626595,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,14265,1,,,12582,,Urine,N,50597,CHEMBL626596,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,14266,1,,,12582,,Urine,N,50597,CHEMBL626597,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,14267,1,,,12582,,Urine,N,50597,CHEMBL626598,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,14268,1,,,12582,,Urine,N,50597,CHEMBL622242,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,14269,1,,,12582,,Urine,N,50597,CHEMBL622243,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,14270,1,,,12582,,Urine,N,50597,CHEMBL622244,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,14271,1,,,12582,,Urine,N,50597,CHEMBL622245,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,14272,1,,,12582,,Urine,N,50597,CHEMBL622246,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,14273,1,,,12582,,Urine,N,50597,CHEMBL622247,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,14274,1,,,12582,,Urine,N,50597,CHEMBL622248,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,14275,1,,,12582,,Urine,N,50597,CHEMBL877483,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,14276,1,,,12582,,Urine,N,50597,CHEMBL622249,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,14277,1,,,12582,,Urine,N,50588,CHEMBL622250,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,14278,1,,,12582,,Urine,N,50588,CHEMBL622251,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,14279,1,,,12582,,Urine,N,50588,CHEMBL622252,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,14280,1,,,12582,,Urine,N,50588,CHEMBL622253,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,14281,1,,,12582,,Urine,N,50588,CHEMBL622254,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,14282,1,,,12582,,Urine,N,50588,CHEMBL622255,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,14283,1,,,12582,,Urine,N,50588,CHEMBL622256,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,14284,1,,,12582,,Urine,N,50588,CHEMBL622257,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,14285,1,,,12582,,Urine,N,50588,CHEMBL622258,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,14286,1,,,12582,,Urine,N,50588,CHEMBL622259,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,14287,1,,,12582,,Urine,N,50588,CHEMBL622927,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,14288,1,,,12582,,Urine,N,50588,CHEMBL622928,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,14289,1,,,12582,,Urine,N,50588,CHEMBL622929,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,14290,1,,,12582,,Urine,N,50588,CHEMBL623182,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,14291,1,,,12582,,Urine,N,50588,CHEMBL623183,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,14292,1,,,12582,,Urine,N,50597,CHEMBL623184,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,14293,1,,,12582,,Urine,N,50597,CHEMBL623185,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,14294,1,,,12582,,Urine,N,50597,CHEMBL877484,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,14295,1,,,12582,,Urine,N,50597,CHEMBL627274,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,14296,1,,,12582,,Urine,N,50597,CHEMBL623186,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,14297,1,,,12582,,Urine,N,50597,CHEMBL623187,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,14298,1,,,12582,,Urine,N,50597,CHEMBL623188,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,14299,1,,,12582,,Urine,N,50597,CHEMBL628055,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,14300,1,,,12582,,Urine,N,50597,CHEMBL628056,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,14301,1,,,12582,,Urine,N,50597,CHEMBL628200,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,14302,1,,,12582,,Urine,N,50597,CHEMBL628201,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,14303,1,,,12582,,Urine,N,50597,CHEMBL628202,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,14304,1,,,12582,,Urine,N,50597,CHEMBL628203,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,14305,1,,,12582,,Urine,N,50597,CHEMBL628204,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,14306,1,,,12582,,Urine,N,50597,CHEMBL628205,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,14307,1,,,12582,,Urine,N,50597,CHEMBL628206,BAO_0000218,1088.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,14308,0,,,13257,,Prostate gland,U,22224,CHEMBL628207,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,14309,0,,,13257,,Prostate gland,U,22224,CHEMBL627220,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,14310,0,,,13257,,Muscle tissue,U,22224,CHEMBL627221,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,14311,0,,,13257,,Prostate gland,U,22224,CHEMBL627222,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,14312,0,,,13257,,,U,22224,CHEMBL627223,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,14313,0,,,13257,,Muscle tissue,U,22224,CHEMBL632062,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,14314,0,,,13257,,Spleen,U,22224,CHEMBL632063,BAO_0000218,2106.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,14315,0,,,13257,,Urinary bladder,U,22224,CHEMBL632064,BAO_0000218,1255.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,14316,0,,,13257,,Blood,U,22224,CHEMBL632065,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,14317,0,,,13257,,Bone element,U,22224,CHEMBL632066,BAO_0000218,1474.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,14318,0,,,13257,,,U,22224,CHEMBL632067,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,14319,0,,,13257,,Kidney,U,22224,CHEMBL629188,BAO_0000218,2113.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,14320,0,,,13257,,Liver,U,22224,CHEMBL629189,BAO_0000218,2107.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,14321,0,,,13257,,Lung,U,22224,CHEMBL629190,BAO_0000218,2048.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,14322,0,,,13257,,Muscle tissue,U,22224,CHEMBL629191,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,14323,0,,,13257,,Prostate gland,U,22224,CHEMBL629192,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,14324,0,,,13257,,Muscle tissue,U,22224,CHEMBL629193,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,14325,0,,,13257,,Prostate gland,U,22224,CHEMBL629194,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,14326,0,,,13257,,,U,22224,CHEMBL629195,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,14327,0,,,13257,,Muscle tissue,U,22224,CHEMBL629373,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,14328,0,,,13257,,Spleen,U,22224,CHEMBL629374,BAO_0000218,2106.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,14329,0,,,13257,,Prostate gland,U,22224,CHEMBL629375,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,14330,0,,,13257,,Urinary bladder,U,22224,CHEMBL629376,BAO_0000218,1255.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,14331,0,,,13257,,Blood,U,22224,CHEMBL629377,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,14332,0,,,13257,,Bone element,U,22224,CHEMBL629378,BAO_0000218,1474.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,14333,0,,,13257,,,U,22224,CHEMBL629379,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,14334,0,,,13257,,Kidney,U,22224,CHEMBL629151,BAO_0000218,2113.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,14335,0,,,13257,,Liver,U,22224,CHEMBL629152,BAO_0000218,2107.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,14336,0,,,13257,,Lung,U,22224,CHEMBL629153,BAO_0000218,2048.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,14337,0,,,13257,,Muscle tissue,U,22224,CHEMBL629154,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,14338,0,,,13257,,Prostate gland,U,22224,CHEMBL629155,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,14339,0,,,13257,,Prostate gland,U,22224,CHEMBL629156,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,14340,0,,,13257,,Muscle tissue,U,22224,CHEMBL629157,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,14341,0,,,13257,,Prostate gland,U,22224,CHEMBL629158,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,14342,0,,,13257,,,U,22224,CHEMBL629159,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,14343,0,,,13257,,Muscle tissue,U,22224,CHEMBL629160,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,14344,0,,,13257,,Spleen,U,22224,CHEMBL629161,BAO_0000218,2106.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,14345,0,,,13257,,Urinary bladder,U,22224,CHEMBL629162,BAO_0000218,1255.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,14346,0,,,13257,,Blood,U,22224,CHEMBL629163,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,14347,0,,,13257,,Bone element,U,22224,CHEMBL629164,BAO_0000218,1474.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,14348,0,,,13257,,,U,22224,CHEMBL629165,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,14349,0,,,13257,,Liver,U,22224,CHEMBL629166,BAO_0000218,2107.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,14350,0,,,13257,,Lung,U,22224,CHEMBL629167,BAO_0000218,2048.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,14351,0,,,13257,,Muscle tissue,U,22224,CHEMBL629168,BAO_0000218,2385.0
A,Autocuration,1,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,14352,0,,,2193,,,U,22224,CHEMBL629169,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,14353,0,,,2193,,,U,22224,CHEMBL629170,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,14354,0,,,2193,,,U,22224,CHEMBL631153,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,14355,0,,,2193,,,U,22224,CHEMBL875121,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,14356,0,,,2193,,,U,22224,CHEMBL631154,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,14357,0,,,2193,,,U,22224,CHEMBL631155,BAO_0000019,
A,Autocuration,1,,,,,,,Hydrolysis rate constant was determined,,14358,0,,,568,,,U,22224,CHEMBL631156,BAO_0000019,
A,Autocuration,1,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,14359,0,,,9680,,,U,22224,CHEMBL631157,BAO_0000019,
A,Autocuration,1,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,14360,0,,,9680,,,U,22224,CHEMBL631158,BAO_0000019,
A,Autocuration,1,,,,,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,14361,0,,,9680,,,U,22224,CHEMBL631159,BAO_0000019,
A,Autocuration,1,,,,,,,Observed second order rate constant,,14362,0,,,10026,,,U,22224,CHEMBL631160,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,14363,0,,,10281,,,U,22224,CHEMBL631161,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,14364,0,,,10014,,,U,22224,CHEMBL631162,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,14365,0,,,10014,,,U,22224,CHEMBL630313,BAO_0000019,
A,Autocuration,1,,,,,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,14366,0,,,9680,,,U,22224,CHEMBL630314,BAO_0000019,
A,Autocuration,1,,,,,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,14367,0,,,9680,,,U,22224,CHEMBL630315,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14368,0,,,13028,,,U,22224,CHEMBL630316,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14369,0,,,13028,,,U,22224,CHEMBL630986,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,14370,0,,,13028,,,U,22224,CHEMBL630987,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,14371,0,,,13028,,,U,22224,CHEMBL630988,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14372,0,,,13028,,,U,22224,CHEMBL630989,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14373,0,,,13028,,,U,22224,CHEMBL630990,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14374,0,,,13028,,,U,22224,CHEMBL630991,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14375,0,,,13028,,,U,22224,CHEMBL630992,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14376,0,,,13028,,,U,22224,CHEMBL630993,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,14377,0,,,13028,,,U,22224,CHEMBL630994,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,14378,1,,,10014,,,N,50597,CHEMBL630995,BAO_0000218,
A,Autocuration,1,,,,,,,Association constant for compound at 31 degree C was determined,,14379,0,,,9962,,,U,22224,CHEMBL629252,BAO_0000019,
A,Autocuration,1,,,,,,,Calculated antagonist equilibrium dissociation constant of the compound,,14380,0,,,12029,,,U,22224,CHEMBL629253,BAO_0000019,
A,Autocuration,1,,,,,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,14381,0,,,12029,,,U,22224,CHEMBL629944,BAO_0000019,
A,Intermediate,1,,,Cavia porcellus,,,10141.0,Dissociation constants vs LTE4 on guinea pig trachea,,14382,1,,,10583,,Trachea,N,50512,CHEMBL629945,BAO_0000218,3126.0
A,Autocuration,1,,,,,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,14383,0,,,568,,,U,22224,CHEMBL629946,BAO_0000019,
A,Autocuration,1,,,,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,14384,0,,,568,,,U,22224,CHEMBL629947,BAO_0000019,
A,Autocuration,1,,,,,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,14385,0,,,568,,,U,22224,CHEMBL629948,BAO_0000019,
A,Autocuration,1,,,,,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,14386,0,,,568,,,U,22224,CHEMBL856024,BAO_0000019,
A,Autocuration,1,,,,,,,Affinity constant KD value was derived from TMP,,14387,0,,,7493,,,U,22224,CHEMBL629949,BAO_0000019,
A,Autocuration,1,,,,,,,Apparent dissociation (binding) rate constant was evaluated,,14388,0,,,8371,,,U,22224,CHEMBL629950,BAO_0000019,
P,Autocuration,1,,,,,,,Dissociation constant (KD) of the compound,,14389,0,,,13114,,,U,22224,CHEMBL630127,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,14390,0,,,15515,,,U,22224,CHEMBL630128,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant from ESR titration experiments,,14391,0,,,522,,,U,22224,CHEMBL630129,BAO_0000100,
,Autocuration,1,,,,,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,14392,0,,,13888,,,U,22224,CHEMBL630130,BAO_0000019,
P,Autocuration,1,,,,,,,Dissociation constant was evaluated.,,14393,0,,,2616,,,U,22224,CHEMBL875234,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant was reported,,14394,0,,,3798,,,U,22224,CHEMBL630131,BAO_0000100,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Dissociation constant was determined in rat pituitary cells.,,14395,1,,,8731,,,N,50597,CHEMBL630132,BAO_0000218,
A,Autocuration,1,,,,,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,14396,0,,,11892,,,U,22224,CHEMBL630133,BAO_0000019,
A,Autocuration,1,,,,,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,14397,0,,,11892,,,U,22224,CHEMBL630134,BAO_0000019,
A,Autocuration,1,,,,,,,Equilibrium dissociation constant of the compound,,14398,0,,,2582,,,U,22224,CHEMBL630135,BAO_0000019,
A,Autocuration,1,,,,,,,Equilibrium dissociation constant was determined,,14399,0,,,11892,,,U,22224,CHEMBL630136,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic constant KD was evaluated,,14400,0,,,13396,,,U,22224,CHEMBL630137,BAO_0000019,
A,Autocuration,1,,,,,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,14401,0,,,603,,,U,22224,CHEMBL630138,BAO_0000019,
A,Autocuration,1,,,,,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,14402,0,,,15673,,,U,22224,CHEMBL630139,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant for hydrolysis in aqueous acetone.,,14403,0,,,10368,,,U,22224,CHEMBL630140,BAO_0000019,
A,Autocuration,1,,,,,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,14404,0,,,14228,,,U,22224,CHEMBL875235,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,14405,1,,,11510,,,N,50597,CHEMBL876439,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,14406,1,,,11510,,,N,50597,CHEMBL630605,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,14407,1,,,11510,,,N,50597,CHEMBL630606,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,14408,1,,,11510,,,N,50597,CHEMBL630607,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,14409,1,,,11510,,,N,50597,CHEMBL630608,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,14410,1,,,11510,,,N,50597,CHEMBL630609,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,14411,1,,,11510,,,N,50597,CHEMBL630610,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,14412,1,,,11510,,,N,50597,CHEMBL630611,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,14413,1,,,11510,,,N,50597,CHEMBL629552,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,14414,1,,,11510,,,N,50597,CHEMBL629733,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,14415,1,,,11510,,,N,50597,CHEMBL629734,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,14416,1,,,11510,,,N,50597,CHEMBL629735,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,14417,1,,,11510,,,N,50597,CHEMBL629736,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,14418,1,,,11510,,,N,50597,CHEMBL629737,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,14419,1,,,11510,,,N,50597,CHEMBL629738,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,14420,1,,,11510,,,N,50597,CHEMBL629739,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,14421,1,,,11510,,,N,50597,CHEMBL629740,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,14422,1,,,11510,,,N,50597,CHEMBL629741,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,14423,1,,,11510,,,N,50597,CHEMBL629742,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,14424,1,,,11510,,,N,50597,CHEMBL629743,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,14425,1,,,11510,,,N,50597,CHEMBL629744,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,14426,1,,,11510,,,N,50597,CHEMBL629745,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,14427,1,,,11510,,,N,50597,CHEMBL629746,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,14428,1,,,11510,,,N,50597,CHEMBL629747,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,14429,1,,,11510,,,N,50597,CHEMBL629748,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,14430,1,,,11510,,,N,50597,CHEMBL629749,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,14431,1,,,11510,,,N,50597,CHEMBL629750,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,14432,1,,,11510,,,N,50597,CHEMBL629751,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,14433,1,,,11510,,,N,50597,CHEMBL629752,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,14434,1,,,11510,,,N,50597,CHEMBL629753,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,14435,1,,,11510,,,N,50597,CHEMBL629754,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,14436,1,,,11510,,,N,50597,CHEMBL629755,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,14437,1,,,11510,,,N,50597,CHEMBL629756,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,14438,1,,,11510,,,N,50597,CHEMBL629757,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,14439,1,,,11510,,,N,50597,CHEMBL629758,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,14440,1,,,11510,,,N,50597,CHEMBL629759,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,14441,1,,,11510,,,N,50597,CHEMBL629760,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,14442,1,,,11510,,,N,50597,CHEMBL876443,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,14443,1,,,8310,,,N,50588,CHEMBL629761,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,14444,1,,,8310,,,N,50588,CHEMBL629762,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14445,1,,,8310,,,N,50594,CHEMBL629763,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,14446,1,,,8310,,,N,50594,CHEMBL629764,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,14447,1,,,8310,,,N,50594,CHEMBL629765,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,14448,1,,,8310,,,N,50594,CHEMBL629766,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14449,1,,,8310,,,N,50594,CHEMBL629767,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,14450,1,,,8310,,,N,50588,CHEMBL629768,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,14451,1,,,8310,,,N,50594,CHEMBL629769,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,14452,1,,,8310,,,N,50588,CHEMBL629770,BAO_0000218,
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,14453,1,,,8310,,,N,50588,CHEMBL629771,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14454,1,,,8310,,,N,50594,CHEMBL629772,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,14455,1,,,8310,,,N,50594,CHEMBL629773,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,14456,1,,,8310,,,N,50594,CHEMBL625455,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,14457,1,,,8310,,,N,50594,CHEMBL625456,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,14458,1,,,8310,,,N,50594,CHEMBL625457,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,14459,1,,,12582,,Urine,N,50597,CHEMBL625458,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,14460,1,,,12582,,Urine,N,50597,CHEMBL625459,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,14461,1,,,12582,,Urine,N,50597,CHEMBL875483,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,14462,1,,,12582,,Urine,N,50597,CHEMBL634779,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,14463,1,,,12582,,Urine,N,50597,CHEMBL625460,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,14464,1,,,12582,,Urine,N,50597,CHEMBL626117,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,14465,1,,,12582,,Urine,N,50597,CHEMBL626118,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,14466,1,,,12582,,Urine,N,50597,CHEMBL628342,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,14467,1,,,12582,,Urine,N,50597,CHEMBL628343,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,14468,1,,,12582,,Urine,N,50597,CHEMBL628344,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,14469,1,,,12582,,Urine,N,50597,CHEMBL628345,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,14470,1,,,12582,,Urine,N,50597,CHEMBL628346,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,14471,1,,,12582,,Urine,N,50597,CHEMBL628347,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,14472,1,,,12582,,Urine,N,50597,CHEMBL628348,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,14473,1,,,12582,,Urine,N,50597,CHEMBL628349,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,14474,1,,,12582,,Urine,N,50597,CHEMBL875611,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,14475,1,,,12582,,Urine,N,50597,CHEMBL628350,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,14476,1,,,12582,,Urine,N,50597,CHEMBL628351,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,14477,1,,,12582,,Urine,N,50597,CHEMBL628352,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,14478,1,,,12582,,Urine,N,50597,CHEMBL628353,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,14479,1,,,12582,,Urine,N,50597,CHEMBL628354,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,14480,1,,,12582,,Urine,N,50597,CHEMBL626667,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,14481,1,,,12582,,Urine,N,50597,CHEMBL626668,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,14482,1,,,12582,,Urine,N,50597,CHEMBL626669,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,14483,1,,,12582,,Urine,N,50597,CHEMBL626670,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,14484,1,,,12582,,Urine,N,50597,CHEMBL626671,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,14485,1,,,12582,,Urine,N,50597,CHEMBL626672,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,14486,1,,,12582,,Urine,N,50597,CHEMBL626673,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,14487,1,,,12582,,Urine,N,50597,CHEMBL626674,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,14488,1,,,12582,,Urine,N,50597,CHEMBL626675,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,14489,1,,,12582,,Urine,N,50597,CHEMBL626676,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,14490,1,,,12582,,Urine,N,50597,CHEMBL626677,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,14491,1,,,12582,,Urine,N,50597,CHEMBL626678,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,14492,1,,,12582,,Urine,N,50597,CHEMBL626679,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,14493,1,,,12582,,Urine,N,50597,CHEMBL875612,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,14494,1,,,12582,,Urine,N,50597,CHEMBL626680,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,14495,1,,,12582,,Urine,N,50597,CHEMBL626681,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,14496,1,,,12582,,Urine,N,50597,CHEMBL626682,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,14497,1,,,12582,,Urine,N,50597,CHEMBL626683,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,14498,1,,,12582,,Urine,N,50597,CHEMBL626684,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,14499,1,,,12582,,Urine,N,50597,CHEMBL626685,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,14500,1,,,12582,,Urine,N,50597,CHEMBL626686,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,14501,1,,,12582,,Urine,N,50597,CHEMBL626687,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,14502,1,,,12582,,Urine,N,50597,CHEMBL624978,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,14503,1,,,12582,,Urine,N,50597,CHEMBL624979,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,14504,1,,,12582,,Urine,N,50597,CHEMBL624980,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,14505,1,,,12582,,Urine,N,50597,CHEMBL624981,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,14506,1,,,12582,,Urine,N,50588,CHEMBL624982,BAO_0000218,1088.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,14507,0,,,13257,,Prostate gland,U,22224,CHEMBL627564,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,14508,0,,,13257,,Prostate gland,U,22224,CHEMBL627565,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,14509,0,,,13257,,,U,22224,CHEMBL627566,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,14510,0,,,13257,,Muscle tissue,U,22224,CHEMBL627567,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,14511,0,,,13257,,Spleen,U,22224,CHEMBL627568,BAO_0000218,2106.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,14512,0,,,13257,,Kidney,U,22224,CHEMBL627569,BAO_0000218,2113.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,14513,0,,,13257,,Urinary bladder,U,22224,CHEMBL627570,BAO_0000218,1255.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,14514,0,,,13257,,Blood,U,22224,CHEMBL627571,BAO_0000218,178.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,14515,0,,,13257,,Bone element,U,22224,CHEMBL627572,BAO_0000218,1474.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,14516,0,,,13257,,,U,22224,CHEMBL627573,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,14517,0,,,13257,,Kidney,U,22224,CHEMBL627574,BAO_0000218,2113.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,14518,0,,,13257,,Liver,U,22224,CHEMBL627575,BAO_0000218,2107.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,14519,0,,,13257,,Lung,U,22224,CHEMBL627576,BAO_0000218,2048.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,14520,0,,,13257,,Muscle tissue,U,22224,CHEMBL627577,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,14521,0,,,13257,,Prostate gland,U,22224,CHEMBL627578,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,14522,0,,,13257,,Prostate gland,U,22224,CHEMBL627579,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,14523,0,,,13257,,Muscle tissue,U,22224,CHEMBL627580,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,14524,0,,,13257,,Prostate gland,U,22224,CHEMBL627581,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,14525,0,,,13257,,,U,22224,CHEMBL627582,BAO_0000218,
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,14526,0,,,13257,,Muscle tissue,U,22224,CHEMBL627583,BAO_0000218,2385.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,14527,0,,,13257,,Spleen,U,22224,CHEMBL627584,BAO_0000218,2106.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,14528,0,,,13257,,Prostate gland,U,22224,CHEMBL627585,BAO_0000218,2367.0
A,Autocuration,1,,,,In vivo,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,14529,0,,,13257,,Muscle tissue,U,22224,CHEMBL627586,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,14530,1,,,15413,,,N,50597,CHEMBL627587,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,14531,1,,,15413,,,N,50597,CHEMBL627588,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,14532,1,,,15413,,,N,50597,CHEMBL628250,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,14533,1,,,15413,,,N,50597,CHEMBL628251,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,14534,1,,,15413,,Hippocampus,N,50597,CHEMBL628252,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,14535,1,,,15413,,Hippocampus,N,50597,CHEMBL628253,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,14536,1,,,15413,,Hypothalamus,N,50597,CHEMBL628254,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,14537,1,,,15413,,Hypothalamus,N,50597,CHEMBL877493,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,14538,1,,,15413,,,N,50597,CHEMBL628255,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,14539,1,,,15413,,,N,50597,CHEMBL628256,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,14540,1,,,15413,,Hippocampus,N,50597,CHEMBL628257,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,14541,1,,,15413,,Hypothalamus,N,50597,CHEMBL628258,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,14542,1,,,15413,,,N,50597,CHEMBL628259,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,14543,1,,,15413,,,N,50597,CHEMBL628429,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,14544,1,,,15413,,Hippocampus,N,50597,CHEMBL626862,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,14545,1,,,15413,,Hypothalamus,N,50597,CHEMBL626863,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,14546,1,,,15413,,Cerebellum,N,50597,CHEMBL625886,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,14547,1,,,15413,,Cerebellum,N,50597,CHEMBL625887,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,14548,1,,,15413,,,N,50597,CHEMBL625888,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,14549,1,,,15413,,,N,50597,CHEMBL625889,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,14550,1,,,15413,,Hippocampus,N,50597,CHEMBL625890,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,14551,1,,,15413,,Hippocampus,N,50597,CHEMBL625891,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,14552,1,,,15413,,Hypothalamus,N,50597,CHEMBL625892,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,14553,1,,,15413,,Hypothalamus,N,50597,CHEMBL625893,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,14554,1,,,15413,,Cerebellum,N,50597,CHEMBL625894,BAO_0000218,2037.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,14555,1,,,15413,,,N,50597,CHEMBL625895,BAO_0000218,
A,Autocuration,1,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,14556,0,,,12404,,,U,22224,CHEMBL625896,BAO_0000019,
A,Autocuration,1,,,,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,14557,0,,,568,,,U,22224,CHEMBL625897,BAO_0000019,
A,Autocuration,1,,,,,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,14558,0,,,568,,,U,22224,CHEMBL625898,BAO_0000019,
A,Autocuration,1,,,,,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,14559,0,,,568,,,U,22224,CHEMBL625899,BAO_0000019,
A,Autocuration,1,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,14560,0,,,12404,,,U,22224,CHEMBL626124,BAO_0000019,
A,Intermediate,1,,,Escherichia coli,,,562.0,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,14561,1,,,7624,,,N,50212,CHEMBL628500,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,14562,1,,,7624,,,N,50597,CHEMBL857856,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,14563,1,,,7624,,,N,50597,CHEMBL628501,BAO_0000218,
A,Autocuration,1,,,,,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,14564,0,,,4643,,,U,22224,CHEMBL628502,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,14565,0,,,11532,,,U,22224,CHEMBL628503,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,14566,0,,,11018,,,U,22224,CHEMBL628504,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,14567,0,,,2276,,,U,22224,CHEMBL628505,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,14568,0,,,2276,,,U,22224,CHEMBL874452,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,14569,0,,,2276,,,U,22224,CHEMBL628506,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,14570,0,,,2276,,,U,22224,CHEMBL628507,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,14571,0,,,2276,,,U,22224,CHEMBL628508,BAO_0000019,
A,Autocuration,1,,,,,,,Michaelis constant (KM) was evaluated,,14572,0,,,8949,,,U,22224,CHEMBL628509,BAO_0000019,
A,Autocuration,1,,,,,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,14573,0,,,12404,,,U,22224,CHEMBL628510,BAO_0000019,
B,Autocuration,1,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,14574,0,,,7625,,,U,22224,CHEMBL628511,BAO_0000019,
B,Autocuration,1,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,14575,0,,,7625,,,U,22224,CHEMBL628512,BAO_0000019,
B,Autocuration,1,,,,,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,14576,0,,,7625,,,U,22224,CHEMBL628513,BAO_0000019,
B,Autocuration,1,,,,,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,14577,0,,,7625,,,U,22224,CHEMBL628514,BAO_0000019,
A,Autocuration,1,,,,,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,14578,0,,,12908,,,U,22224,CHEMBL628515,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,14579,0,,,10368,,,U,22224,CHEMBL628516,BAO_0000019,
A,Autocuration,1,,,,,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,14580,0,,,13108,,,U,22224,CHEMBL628517,BAO_0000019,
A,Autocuration,1,,,,,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,14581,0,,,13108,,,U,22224,CHEMBL628518,BAO_0000019,
A,Autocuration,1,,,,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,14582,0,,,15217,,,U,22224,CHEMBL628519,BAO_0000019,
A,Autocuration,1,,,,,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,14583,0,,,15217,,,U,22224,CHEMBL628520,BAO_0000019,
A,Autocuration,1,,,,,,,Binding constant was determined,,14584,0,,,10933,,,U,22224,CHEMBL628521,BAO_0000019,
A,Autocuration,1,,,,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,14585,0,,,2363,,,U,22224,CHEMBL630443,BAO_0000019,
A,Autocuration,1,,,,,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,14586,0,,,2363,,,U,22224,CHEMBL630444,BAO_0000019,
A,Autocuration,1,,,,,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,14587,0,,,2276,,,U,22224,CHEMBL857732,BAO_0000019,
P,Autocuration,1,,,,,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,14588,0,,,14915,,,U,22224,CHEMBL630445,BAO_0000100,
A,Autocuration,1,,,,,,,Catalytic rate constant of the compound,,14589,0,,,8847,,,U,22224,CHEMBL630446,BAO_0000019,
B,Autocuration,1,,,,,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,14590,0,,,15357,,,U,22224,CHEMBL630447,BAO_0000019,
A,Autocuration,1,,,,,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,14591,0,,,2869,,,U,22224,CHEMBL630448,BAO_0000019,
A,Autocuration,1,,,,,,,Catalytic rate constant against phospholipase A2 was determined,,14592,0,,,3484,,,U,22224,CHEMBL630449,BAO_0000019,
A,Autocuration,1,,,,,,,"Compound was evaluated for catalytic constant, Kcat",,14593,0,,,1373,,,U,22224,CHEMBL630450,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,14594,0,,,8142,,,U,22224,CHEMBL630451,BAO_0000019,
A,Autocuration,1,,,,,,,Kcat calculated from 0.693/T1/2,,14595,0,,,14131,,,U,22224,CHEMBL630452,BAO_0000019,
A,Autocuration,1,,,,,,,Kcat was determined,,14596,0,,,17269,,,U,22224,CHEMBL630453,BAO_0000019,
A,Autocuration,1,,,,,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,14597,0,,,3485,,,U,22224,CHEMBL630454,BAO_0000019,
A,Autocuration,1,,,,,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,14598,0,,,3485,,,U,22224,CHEMBL630455,BAO_0000019,
A,Autocuration,1,,,,,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,14599,0,,,3485,,,U,22224,CHEMBL631487,BAO_0000019,
A,Autocuration,1,,,,,,,Kcat value was determined,,14600,0,,,5962,,,U,22224,CHEMBL631488,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,14601,0,,,3133,,,U,22224,CHEMBL876440,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,14602,0,,,3133,,,U,22224,CHEMBL631489,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,14603,0,,,2276,,,U,22224,CHEMBL857742,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,14604,0,,,2276,,,U,22224,CHEMBL631490,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,14605,0,,,2276,,,U,22224,CHEMBL631491,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,14606,0,,,2276,,,U,22224,CHEMBL631492,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,14607,0,,,2276,,,U,22224,CHEMBL631493,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter for rate of conversion to PABA was determined,,14608,0,,,4892,,,U,22224,CHEMBL631494,BAO_0000019,
A,Autocuration,1,,,,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,14609,0,,,3133,,,U,22224,CHEMBL631495,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,14610,1,,,11488,,Feces,N,50597,CHEMBL631496,BAO_0000218,1988.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,14611,1,,,11488,,Urine,N,50597,CHEMBL631497,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,14612,1,,,11488,,Urine,N,50597,CHEMBL631498,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,14613,1,,,11488,,Urine,N,50597,CHEMBL629776,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,14614,1,,,11488,,Urine,N,50597,CHEMBL629777,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,14615,1,,,11488,,Urine,N,50597,CHEMBL629778,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,14616,1,,,11488,,,N,50597,CHEMBL630456,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,14617,1,,,11488,,,N,50597,CHEMBL630457,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,14618,1,,,11488,,,N,50597,CHEMBL630458,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,14619,1,,,11488,,,N,50597,CHEMBL630459,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,14620,1,,,11488,,,N,50597,CHEMBL630460,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,14621,1,,,11488,,,N,50597,CHEMBL876550,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,14622,1,,,11488,,,N,50597,CHEMBL630461,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,14623,1,,,11488,,,N,50597,CHEMBL630462,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,14624,1,,,11488,,,N,50597,CHEMBL630463,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,14625,1,,,11488,,,N,50597,CHEMBL630464,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,14626,1,,,11488,,,N,50597,CHEMBL630465,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,14627,1,,,11488,,,N,50597,CHEMBL630466,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,14628,1,,,11488,,,N,50597,CHEMBL630467,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,14629,1,,,11488,,,N,50597,CHEMBL630633,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,14630,1,,,11488,,,N,50597,CHEMBL630634,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,14631,1,,,11488,,,N,50597,CHEMBL630635,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,14632,1,,,11488,,,N,50597,CHEMBL630636,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,14633,1,,,11488,,,N,50597,CHEMBL630637,BAO_0000218,
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,14634,1,,,7132,,Feces,N,50592,CHEMBL630638,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,14635,1,,,7132,,Feces,N,50592,CHEMBL630639,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,14636,1,,,7132,,Feces,N,50592,CHEMBL630640,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,14637,1,,,7132,,Feces,N,50592,CHEMBL876551,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,14638,1,,,7132,,Urine,N,50592,CHEMBL630641,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,14639,1,,,7132,,Urine,N,50592,CHEMBL630642,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,14640,1,,,7132,,Urine,N,50592,CHEMBL630643,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,14641,1,,,7132,,Urine,N,50592,CHEMBL630644,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,14642,1,,,7132,,Urine,N,50592,CHEMBL630645,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,14643,1,,,7132,,Feces,N,50592,CHEMBL625599,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,14644,1,,,7132,,Feces,N,50592,CHEMBL625600,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,14645,1,,,7132,,Feces,N,50592,CHEMBL625601,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,14646,1,,,7132,,Feces,N,50592,CHEMBL625602,BAO_0000218,1988.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,14647,1,,,7132,,Urine,N,50592,CHEMBL627470,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,14648,1,,,7132,,Urine,N,50592,CHEMBL627471,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,14649,1,,,7132,,Urine,N,50592,CHEMBL627472,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,14650,1,,,7132,,Urine,N,50592,CHEMBL627473,BAO_0000218,1088.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,14651,1,,,7132,,Urine,N,50592,CHEMBL627474,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14652,1,,,13925,,Blood,N,50597,CHEMBL627475,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14653,1,,,13925,,Blood,N,50597,CHEMBL627476,BAO_0000218,178.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,14654,1,,,12582,,Urine,N,50588,CHEMBL627477,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,14655,1,,,12582,,Urine,N,50588,CHEMBL627478,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,14656,1,,,12582,,Urine,N,50588,CHEMBL627479,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,14657,1,,,12582,,Urine,N,50588,CHEMBL627480,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,14658,1,,,12582,,Urine,N,50588,CHEMBL627481,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,14659,1,,,12582,,Urine,N,50588,CHEMBL627482,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,14660,1,,,12582,,Urine,N,50588,CHEMBL627483,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,14661,1,,,12582,,Urine,N,50588,CHEMBL875636,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,14662,1,,,12582,,Urine,N,50588,CHEMBL625764,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,14663,1,,,12582,,Urine,N,50588,CHEMBL625765,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,14664,1,,,12582,,Urine,N,50588,CHEMBL625766,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,14665,1,,,12582,,Urine,N,50588,CHEMBL625767,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,14666,1,,,12582,,Urine,N,50588,CHEMBL625768,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,14667,1,,,12582,,Urine,N,50588,CHEMBL625769,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,14668,1,,,12582,,Urine,N,50588,CHEMBL625770,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,14669,1,,,12582,,Urine,N,50588,CHEMBL625771,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,14670,1,,,12582,,Urine,N,50588,CHEMBL625772,BAO_0000218,1088.0
A,Intermediate,1,,,Canis lupus familiaris,,,9615.0,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,14671,1,,,12582,,Urine,N,50588,CHEMBL625773,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,14672,1,,,12582,,Urine,N,50597,CHEMBL625774,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,14673,1,,,12582,,Urine,N,50597,CHEMBL625775,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,14674,1,,,12582,,Urine,N,50597,CHEMBL625776,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,14675,1,,,12582,,Urine,N,50597,CHEMBL625777,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,14676,1,,,12582,,Urine,N,50597,CHEMBL625778,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,14677,1,,,12582,,Urine,N,50597,CHEMBL625779,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,14678,1,,,12582,,Urine,N,50597,CHEMBL625780,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,14679,1,,,12582,,Urine,N,50597,CHEMBL625781,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,14680,1,,,12582,,Urine,N,50597,CHEMBL875637,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,14681,1,,,12582,,Urine,N,50597,CHEMBL626473,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,14682,1,,,12582,,Urine,N,50597,CHEMBL626474,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,14683,1,,,12582,,Urine,N,50597,CHEMBL626475,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,14684,1,,,12582,,Urine,N,50597,CHEMBL626476,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,14685,1,,,12582,,Urine,N,50597,CHEMBL634397,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,14686,1,,,12582,,Urine,N,50597,CHEMBL626477,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,14687,1,,,12582,,Urine,N,50597,CHEMBL631069,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,14688,1,,,12582,,Urine,N,50597,CHEMBL631070,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,14689,1,,,12582,,Urine,N,50597,CHEMBL631071,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,14690,1,,,12582,,Urine,N,50597,CHEMBL631072,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,14691,1,,,12582,,Urine,N,50597,CHEMBL631073,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,14692,1,,,12582,,Urine,N,50597,CHEMBL631074,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,14693,1,,,12582,,Urine,N,50597,CHEMBL631075,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,14694,1,,,12582,,Urine,N,50597,CHEMBL631725,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,14695,1,,,12582,,Urine,N,50597,CHEMBL631726,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,14696,1,,,12582,,Urine,N,50597,CHEMBL631727,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,14697,1,,,12582,,Urine,N,50597,CHEMBL631728,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,14698,1,,,12582,,Urine,N,50597,CHEMBL631729,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,14699,1,,,12582,,Urine,N,50597,CHEMBL631730,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,14700,1,,,12582,,Urine,N,50597,CHEMBL631731,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,14701,1,,,12582,,Urine,N,50597,CHEMBL631910,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,14702,1,,,15413,,Hippocampus,N,50597,CHEMBL631911,BAO_0000218,10000000.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,14703,1,,,15413,,Hypothalamus,N,50597,CHEMBL631912,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,14704,1,,,15413,,Hypothalamus,N,50597,CHEMBL631913,BAO_0000218,1898.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14705,1,,,12017,,Blood,N,50597,CHEMBL631914,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14706,1,,,12017,,Blood,N,50597,CHEMBL631915,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14707,1,,,12017,,Blood,N,50597,CHEMBL875778,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14708,1,,,12017,,Blood,N,50597,CHEMBL631916,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14709,1,,,12017,,Blood,N,50597,CHEMBL631917,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14710,1,,,12017,,Blood,N,50597,CHEMBL631918,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14711,1,,,12017,,Blood,N,50597,CHEMBL631919,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14712,1,,,12017,,Blood,N,50597,CHEMBL631920,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14713,1,,,12017,,Blood,N,50597,CHEMBL631921,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14714,1,,,12017,,Blood,N,50597,CHEMBL631922,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14715,1,,,12017,,Blood,N,50597,CHEMBL631923,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14716,1,,,12017,,,N,50597,CHEMBL631924,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14717,1,,,12017,,,N,50597,CHEMBL630234,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14718,1,,,12017,,,N,50597,CHEMBL630235,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14719,1,,,12017,,,N,50597,CHEMBL630236,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14720,1,,,12017,,,N,50597,CHEMBL630237,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14721,1,,,12017,,,N,50597,CHEMBL630238,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14722,1,,,12017,,,N,50597,CHEMBL630239,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14723,1,,,12017,,,N,50597,CHEMBL630303,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14724,1,,,12017,,,N,50597,CHEMBL630304,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14725,1,,,12017,,,N,50597,CHEMBL630305,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14726,1,,,12017,,Kidney,N,50597,CHEMBL630306,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14727,1,,,12017,,Kidney,N,50597,CHEMBL630307,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14728,1,,,12017,,Kidney,N,50597,CHEMBL630308,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14729,1,,,12017,,Kidney,N,50597,CHEMBL630309,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14730,1,,,12017,,Kidney,N,50597,CHEMBL629309,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14731,1,,,12017,,Kidney,N,50597,CHEMBL629993,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14732,1,,,12017,,Kidney,N,50597,CHEMBL629994,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14733,1,,,12017,,Kidney,N,50597,CHEMBL629995,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14734,1,,,12017,,Kidney,N,50597,CHEMBL631993,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14735,1,,,12017,,Kidney,N,50597,CHEMBL631994,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14736,1,,,12017,,Kidney,N,50597,CHEMBL631995,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14737,1,,,12017,,Liver,N,50597,CHEMBL631996,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14738,1,,,12017,,Liver,N,50597,CHEMBL631997,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14739,1,,,12017,,Liver,N,50597,CHEMBL631998,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14740,1,,,12017,,Liver,N,50597,CHEMBL631999,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14741,1,,,12017,,Liver,N,50597,CHEMBL632000,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14742,1,,,12017,,Liver,N,50597,CHEMBL632001,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14743,1,,,12017,,Liver,N,50597,CHEMBL874424,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14744,1,,,12017,,Liver,N,50597,CHEMBL632002,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14745,1,,,12017,,Liver,N,50597,CHEMBL632003,BAO_0000218,2107.0
A,Autocuration,1,,,,,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,14746,0,,,3133,,,U,22224,CHEMBL632004,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,14747,0,,,2742,,,U,22224,CHEMBL632005,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,14748,0,,,2742,,,U,22224,CHEMBL632006,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,14749,0,,,2742,,,U,22224,CHEMBL632007,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,14750,0,,,2742,,,U,22224,CHEMBL632008,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,14751,0,,,2742,,,U,22224,CHEMBL632009,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,14752,0,,,2742,,,U,22224,CHEMBL632010,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,14753,0,,,2742,,,U,22224,CHEMBL857750,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,14754,0,,,2742,,,U,22224,CHEMBL632011,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14755,0,,,2276,,,U,22224,CHEMBL632012,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14756,0,,,2276,,,U,22224,CHEMBL632013,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,14757,0,,,2276,,,U,22224,CHEMBL632014,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14758,0,,,2276,,,U,22224,CHEMBL629622,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,14759,0,,,2276,,,U,22224,CHEMBL629623,BAO_0000019,
A,Autocuration,1,,,,,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,14760,0,,,2276,,,U,22224,CHEMBL629624,BAO_0000019,
A,Autocuration,1,,,,,,,Ratio of Kcat to that of Km was determined,,14761,0,,,17269,,,U,22224,CHEMBL629625,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,14762,0,,,2276,,,U,22224,CHEMBL629626,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,14763,0,,,2276,,,U,22224,CHEMBL629627,BAO_0000019,
A,Autocuration,1,,,,,,,"Compound was evaluated for constant, Kd",,14764,0,,,15917,,,U,22224,CHEMBL629628,BAO_0000019,
A,Autocuration,1,,,,,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,14765,0,,,10933,,,U,22224,CHEMBL629629,BAO_0000019,
A,Autocuration,1,,,,,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,14766,0,,,10933,,,U,22224,CHEMBL629630,BAO_0000019,
A,Autocuration,1,,,,,,,Dissociation Constant of compound determined,,14767,0,,,14293,,,U,22224,CHEMBL856030,BAO_0000019,
B,Autocuration,1,,,,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,14768,0,,,6698,,,U,22224,CHEMBL629631,BAO_0000019,
B,Autocuration,1,,,,,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,14769,0,,,6698,,,U,22224,CHEMBL629632,BAO_0000019,
P,Autocuration,1,,,,,,,Dissociation constant of compound with Fructose was determined,,14770,0,,,4318,,,U,22224,CHEMBL629633,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant of compound with Fructose was determined; Not determined,,14771,0,,,4318,,,U,22224,CHEMBL629634,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant of compound with Lactulose was determined,,14772,0,,,4318,,,U,22224,CHEMBL629635,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant of compound with Lactulose was determined; Not determined,,14773,0,,,4318,,,U,22224,CHEMBL629636,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant of the Compound,,14774,0,,,14959,,,U,22224,CHEMBL629637,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant by non-linear regression analysis,,14775,0,,,5913,,,U,22224,CHEMBL629638,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant was determined,,14776,0,,,14218,,,U,22224,CHEMBL629639,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,14777,0,,,10689,,,U,22224,CHEMBL629640,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant was determined,,14778,0,,,13925,,,U,22224,CHEMBL629641,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant was determined,,14779,0,,,16359,,,U,22224,CHEMBL631344,BAO_0000100,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,14780,1,,,10944,,Muscle tissue,N,50597,CHEMBL631345,BAO_0000218,2385.0
A,Autocuration,1,,,,,,,The dissociation constant determined by fluorescence displacement assay,,14781,0,,,11080,,,U,22224,CHEMBL631346,BAO_0000019,
A,Autocuration,1,,,,,,,kd value surface plasmon resonance (SPR) method,,14782,0,,,17805,,,U,22224,CHEMBL631524,BAO_0000019,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,14783,1,,,10944,,Muscle tissue,N,50597,CHEMBL631525,BAO_0000218,2385.0
F,Autocuration,1,,,,,,,First dissociation constant of the binding of compound to V30M TTR,,14784,0,,,16645,,,U,22224,CHEMBL631526,BAO_0000019,
F,Autocuration,1,,,,,,,Second dissociation constant of the binding of compound to V30M TTR,,14785,0,,,16645,,,U,22224,CHEMBL631527,BAO_0000019,
A,Autocuration,1,,,,,,,"Compound was evaluated for equilibrium constant, Ke",,14786,0,,,7793,,,U,22224,CHEMBL631528,BAO_0000019,
A,Autocuration,1,,,,,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,14787,0,,,12199,,Hypothalamus,U,22224,CHEMBL631529,BAO_0000019,1898.0
A,Autocuration,1,,,,,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,14788,0,,,12199,,Hypothalamus,U,22224,CHEMBL631530,BAO_0000019,1898.0
A,Autocuration,1,,,,,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,14789,0,,,9680,,,U,22224,CHEMBL631531,BAO_0000019,
A,Autocuration,1,,,,,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,14790,0,,,9680,,,U,22224,CHEMBL631532,BAO_0000019,
A,Autocuration,1,,,,,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,14791,0,,,9680,,,U,22224,CHEMBL631533,BAO_0000019,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14792,1,,,13758,,,N,50594,CHEMBL876552,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,14793,1,,,13758,,,N,50594,CHEMBL631534,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14794,1,,,13758,,,N,50594,CHEMBL631535,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14795,1,,,13758,,,N,50594,CHEMBL631536,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,14796,1,,,13758,,,N,50594,CHEMBL631537,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,14797,1,,,13758,,,N,50594,CHEMBL631538,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,14798,1,,,13758,,,N,50594,CHEMBL631539,BAO_0000218,
A,Intermediate,1,,,Mus musculus,,,10090.0,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,14799,1,,,13758,,,N,50594,CHEMBL631540,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14800,1,,,14393,,,N,50597,CHEMBL625637,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14801,1,,,14393,,,N,50597,CHEMBL625638,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,14802,1,,,15078,,,N,50597,CHEMBL625639,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14803,1,,,13925,,Brain,N,50597,CHEMBL625640,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14804,1,,,13925,,Brain,N,50597,CHEMBL625641,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14805,1,,,13925,,Heart,N,50597,CHEMBL625642,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14806,1,,,13925,,Heart,N,50597,CHEMBL625643,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14807,1,,,13925,,Kidney,N,50597,CHEMBL625644,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14808,1,,,13925,,Kidney,N,50597,CHEMBL625645,BAO_0000218,2113.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14809,1,,,13925,,Liver,N,50597,CHEMBL625646,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14810,1,,,13925,,Liver,N,50597,CHEMBL625647,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14811,1,,,13925,,Lung,N,50597,CHEMBL625648,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,14812,1,,,13925,,Lung,N,50597,CHEMBL625649,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14813,1,,,13925,,Muscle tissue,N,50597,CHEMBL625650,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14814,1,,,13925,,Muscle tissue,N,50597,CHEMBL625651,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14815,1,,,13925,,Zone of skin,N,50597,CHEMBL625652,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14816,1,,,13925,,Zone of skin,N,50597,CHEMBL625653,BAO_0000218,14.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14817,1,,,13925,,Spleen,N,50597,CHEMBL625654,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,14818,1,,,13925,,Spleen,N,50597,CHEMBL625655,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat blood after 15 minutes of administration,,14819,1,,,9712,,Blood,N,50597,CHEMBL625656,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat blood after 2 minutes of administration,,14820,1,,,9712,,Blood,N,50597,CHEMBL625657,BAO_0000218,178.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat brain after 15 minutes of administration,,14821,1,,,9712,,Brain,N,50597,CHEMBL625658,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat brain after 2 minutes of administration,,14822,1,,,9712,,Brain,N,50597,CHEMBL625659,BAO_0000218,955.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat heart after 15 minutes of administration,,14823,1,,,9712,,Heart,N,50597,CHEMBL625660,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat heart after 2 minutes of administration,,14824,1,,,9712,,Heart,N,50597,CHEMBL625661,BAO_0000218,948.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat liver after 15 minutes of administration,,14825,1,,,9712,,Liver,N,50597,CHEMBL625662,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat liver after 2 minutes of administration,,14826,1,,,9712,,Liver,N,50597,CHEMBL625663,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat lung after 15 minutes of administration,,14827,1,,,9712,,Lung,N,50597,CHEMBL875621,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat lung after 2 minutes of administration,,14828,1,,,9712,,Lung,N,50597,CHEMBL628382,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat muscle after 15 minutes of administration,,14829,1,,,9712,,Muscle tissue,N,50597,CHEMBL628383,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution of Compound in rat muscle after 2 minutes of administration,,14830,1,,,9712,,Muscle tissue,N,50597,CHEMBL628384,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,14831,1,,,13925,,,N,50597,CHEMBL628385,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,14832,1,,,13925,,,N,50597,CHEMBL875753,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,14833,1,,,13925,,,N,50597,CHEMBL628386,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat blood 2 minutes after intravenous injection,,14834,1,,,6941,,,N,50597,CHEMBL628387,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat blood 2 hr after intravenous injection,,14835,1,,,6941,,,N,50597,CHEMBL628388,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat blood 30 minutes after intravenous injection,,14836,1,,,6941,,,N,50597,CHEMBL628389,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat blood 30 min after intravenous injection,,14837,1,,,6941,,,N,50597,CHEMBL632756,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat brain 2 minutes after intravenous injection,,14838,1,,,6941,,,N,50597,CHEMBL628390,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat brain 2 hr after intravenous injection,,14839,1,,,6941,,,N,50597,CHEMBL631811,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat brain 30 minutes after intravenous injection,,14840,1,,,6941,,,N,50597,CHEMBL631812,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat heart 2 minutes after intravenous injection,,14841,1,,,6941,,,N,50597,CHEMBL631813,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat heart 2 hr after intravenous injection,,14842,1,,,6941,,,N,50597,CHEMBL631814,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat heart 30 minutes after intravenous injection,,14843,1,,,6941,,,N,50597,CHEMBL631815,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat kidney 2 minutes after intravenous injection,,14844,1,,,6941,,,N,50597,CHEMBL631816,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat kidney 2 hr after intravenous injection,,14845,1,,,6941,,,N,50597,CHEMBL875758,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat kidney 30 minutes after intravenous injection,,14846,1,,,6941,,,N,50597,CHEMBL631817,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat liver 2 minutes after intravenous injection,,14847,1,,,6941,,Liver,N,50597,CHEMBL631818,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat liver 2 hr after intravenous injection,,14848,1,,,6941,,Liver,N,50597,CHEMBL631819,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat liver 30 minutes after intravenous injection,,14849,1,,,6941,,Liver,N,50597,CHEMBL631820,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat lung 2 minutes after intravenous injection,,14850,1,,,6941,,,N,50597,CHEMBL631821,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat lung 2 hr after intravenous injection,,14851,1,,,6941,,,N,50597,CHEMBL631822,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat lung 30 minutes after intravenous injection,,14852,1,,,6941,,,N,50597,CHEMBL631823,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat muscle 2 minutes after intravenous injection,,14853,1,,,6941,,Muscle tissue,N,50597,CHEMBL631824,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat muscle 2 hr after intravenous injection,,14854,1,,,6941,,Muscle tissue,N,50597,CHEMBL631825,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Organ distribution in rat muscle 30 minutes after intravenous injection,,14855,1,,,6941,,Muscle tissue,N,50597,CHEMBL631826,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,14856,1,,,14439,,,N,50594,CHEMBL631827,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,14857,1,,,14439,,,N,50594,CHEMBL631828,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,14858,1,,,14439,,,N,50594,CHEMBL631829,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,14859,1,,,12582,,Urine,N,50597,CHEMBL875759,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,14860,1,,,12582,,Urine,N,50597,CHEMBL631830,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,14861,1,,,12582,,Urine,N,50597,CHEMBL631831,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,14862,1,,,12582,,Urine,N,50597,CHEMBL631832,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,14863,1,,,12582,,Urine,N,50597,CHEMBL631833,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,14864,1,,,12582,,Urine,N,50597,CHEMBL631834,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,14865,1,,,12582,,Urine,N,50597,CHEMBL631835,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,14866,1,,,12582,,Urine,N,50597,CHEMBL631836,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,14867,1,,,12582,,Urine,N,50597,CHEMBL631837,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,14868,1,,,12582,,Urine,N,50597,CHEMBL631838,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,14869,1,,,12582,,Urine,N,50597,CHEMBL631839,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,14870,1,,,12582,,Urine,N,50597,CHEMBL631840,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,14871,1,,,12582,,Urine,N,50597,CHEMBL631841,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,14872,1,,,12582,,Urine,N,50597,CHEMBL631842,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,14873,1,,,12582,,Urine,N,50597,CHEMBL631843,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,14874,1,,,12582,,Urine,N,50597,CHEMBL631844,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,14875,1,,,12582,,Urine,N,50597,CHEMBL631845,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,14876,1,,,12582,,Urine,N,50597,CHEMBL631846,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,14877,1,,,12582,,Urine,N,50597,CHEMBL875760,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,14878,1,,,12582,,Urine,N,50597,CHEMBL632199,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,14879,1,,,12582,,Urine,N,50597,CHEMBL631847,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,14880,1,,,12582,,Urine,N,50597,CHEMBL631848,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,14881,1,,,12582,,Urine,N,50597,CHEMBL628707,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,14882,1,,,12582,,Urine,N,50597,CHEMBL628708,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,14883,1,,,12582,,Urine,N,50597,CHEMBL628709,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,14884,1,,,12582,,Urine,N,50597,CHEMBL628710,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,14885,1,,,12582,,Urine,N,50597,CHEMBL628711,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,14886,1,,,12582,,Urine,N,50597,CHEMBL628712,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,14887,1,,,12582,,Urine,N,50597,CHEMBL628713,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,14888,1,,,12582,,Urine,N,50597,CHEMBL628714,BAO_0000218,1088.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,14889,1,,,7415,,,N,50597,CHEMBL628715,BAO_0000218,
A,Autocuration,1,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,14890,0,,,7313,,,U,22224,CHEMBL629179,BAO_0000019,
A,Autocuration,1,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,14891,0,,,7313,,,U,22224,CHEMBL629180,BAO_0000019,
A,Autocuration,1,,,,,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,14892,0,,,7313,,,U,22224,CHEMBL875108,BAO_0000019,
A,Autocuration,1,,,,,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,14893,0,,,7570,,Adrenal cortex,U,22224,CHEMBL629181,BAO_0000019,1235.0
A,Autocuration,1,,,,,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,14894,0,,,7570,,Adrenal cortex,U,22224,CHEMBL629182,BAO_0000019,1235.0
A,Autocuration,1,,,,,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,14895,0,,,7570,,,U,22224,CHEMBL629183,BAO_0000019,
A,Autocuration,1,,,,,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,14896,0,,,7570,,,U,22224,CHEMBL629184,BAO_0000019,
A,Autocuration,1,,,,,,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,14897,0,,,7570,,Adrenal cortex,U,22224,CHEMBL629185,BAO_0000019,1235.0
A,Autocuration,1,,,,,,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,14898,0,,,7570,,Adrenal cortex,U,22224,CHEMBL629186,BAO_0000019,1235.0
A,Autocuration,1,,,,,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,14899,0,,,7570,,,U,22224,CHEMBL629187,BAO_0000019,
A,Autocuration,1,,,,,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,14900,0,,,7570,,,U,22224,CHEMBL629887,BAO_0000019,
A,Autocuration,1,,,,,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,14901,0,,,7570,,,U,22224,CHEMBL629888,BAO_0000019,
A,Autocuration,1,,,,,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,14902,0,,,7570,,,U,22224,CHEMBL629889,BAO_0000019,
A,Autocuration,1,,,,,,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,14903,0,,,7570,,Adrenal cortex,U,22224,CHEMBL629890,BAO_0000019,1235.0
A,Autocuration,1,,,,,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,14904,0,,,7570,,,U,22224,CHEMBL629891,BAO_0000019,
A,Autocuration,1,,,,,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,14905,0,,,7570,,,U,22224,CHEMBL629892,BAO_0000019,
A,Autocuration,1,,,,,,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,14906,0,,,7570,,Adrenal cortex,U,22224,CHEMBL629893,BAO_0000019,1235.0
A,Autocuration,1,,,,,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,14907,0,,,7570,,,U,22224,CHEMBL629894,BAO_0000019,
A,Autocuration,1,,,,,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,14908,0,,,7570,,,U,22224,CHEMBL629895,BAO_0000019,
A,Autocuration,1,,,Canis lupus familiaris,In vivo,,9615.0,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,14909,0,,,14122,,,U,22224,CHEMBL875109,BAO_0000218,
A,Autocuration,1,,,Macaca fascicularis,In vivo,,9541.0,Absolute bioavailability in male cynomolgus monkeys,,14910,0,,,16449,,,U,22224,CHEMBL629896,BAO_0000218,
A,Autocuration,1,,,Rattus norvegicus,In vivo,,10116.0,Absolute bioavailability in maleSprague-Dawley rats,,14911,0,,,16449,,,U,22224,CHEMBL629897,BAO_0000218,
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14912,1,,,12017,,Liver,N,50597,CHEMBL629898,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14913,1,,,12017,,Liver,N,50597,CHEMBL630057,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14914,1,,,12017,,Liver,N,50597,CHEMBL630058,BAO_0000218,2107.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14915,1,,,12017,,Lung,N,50597,CHEMBL630059,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14916,1,,,12017,,Lung,N,50597,CHEMBL630060,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14917,1,,,12017,,Lung,N,50597,CHEMBL630061,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14918,1,,,12017,,Lung,N,50597,CHEMBL630062,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14919,1,,,12017,,Lung,N,50597,CHEMBL630063,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14920,1,,,12017,,Lung,N,50597,CHEMBL630064,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14921,1,,,12017,,Lung,N,50597,CHEMBL630065,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14922,1,,,12017,,Lung,N,50597,CHEMBL630066,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14923,1,,,12017,,Lung,N,50597,CHEMBL630067,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14924,1,,,12017,,Lung,N,50597,CHEMBL630068,BAO_0000218,2048.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14925,1,,,12017,,Muscle tissue,N,50597,CHEMBL631113,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14926,1,,,12017,,Muscle tissue,N,50597,CHEMBL631114,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14927,1,,,12017,,Muscle tissue,N,50597,CHEMBL631115,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14928,1,,,12017,,Muscle tissue,N,50597,CHEMBL631116,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14929,1,,,12017,,Muscle tissue,N,50597,CHEMBL630528,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14930,1,,,12017,,Muscle tissue,N,50597,CHEMBL630529,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14931,1,,,12017,,Muscle tissue,N,50597,CHEMBL630530,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14932,1,,,12017,,Muscle tissue,N,50597,CHEMBL630531,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14933,1,,,12017,,Muscle tissue,N,50597,CHEMBL630532,BAO_0000218,2385.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14934,1,,,12017,,Muscle tissue,N,50597,CHEMBL630533,BAO_0000218,2385.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice blood after 120 hr,,14935,1,,,15045,,Blood,N,50594,CHEMBL630534,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice blood after 24 hr,,14936,1,,,15045,,Blood,N,50594,CHEMBL630535,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice blood after 4 hr,,14937,1,,,15045,,Blood,N,50594,CHEMBL630536,BAO_0000218,178.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice bone after 120 hr,,14938,1,,,15045,,Bone,N,50594,CHEMBL630537,BAO_0000218,10000001.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice bone after 24 hr,,14939,1,,,15045,,Bone,N,50594,CHEMBL630538,BAO_0000218,10000001.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice bone after 4 hr,,14940,1,,,15045,,Bone,N,50594,CHEMBL630539,BAO_0000218,10000001.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice heart after 120 hr,,14941,1,,,15045,,Heart,N,50594,CHEMBL630540,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice heart after 24 hr,,14942,1,,,15045,,Heart,N,50594,CHEMBL630541,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice heart after 4 hr,,14943,1,,,15045,,Heart,N,50594,CHEMBL630542,BAO_0000218,948.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice kidney after 120 hr,,14944,1,,,15045,,Kidney,N,50594,CHEMBL630543,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice kidney after 24 hr,,14945,1,,,15045,,Kidney,N,50594,CHEMBL630544,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice kidney after 4 hr,,14946,1,,,15045,,Kidney,N,50594,CHEMBL630545,BAO_0000218,2113.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice liver after 120 hr,,14947,1,,,15045,,Liver,N,50594,CHEMBL630546,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice liver after 24 hr,,14948,1,,,15045,,Liver,N,50594,CHEMBL630547,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice liver after 4 hr,,14949,1,,,15045,,Liver,N,50594,CHEMBL630548,BAO_0000218,2107.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice spleen after 120 hr,,14950,1,,,15045,,Spleen,N,50594,CHEMBL630549,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice spleen after 24 hr,,14951,1,,,15045,,Spleen,N,50594,CHEMBL630550,BAO_0000218,2106.0
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in normal mice spleen after 4 hr,,14952,1,,,15045,,Spleen,N,50594,CHEMBL876426,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14953,1,,,12017,,Spleen,N,50597,CHEMBL630551,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14954,1,,,12017,,Spleen,N,50597,CHEMBL630552,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14955,1,,,12017,,Spleen,N,50597,CHEMBL630553,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14956,1,,,12017,,Spleen,N,50597,CHEMBL630554,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14957,1,,,12017,,Spleen,N,50597,CHEMBL630555,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14958,1,,,12017,,Spleen,N,50597,CHEMBL630556,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14959,1,,,12017,,Spleen,N,50597,CHEMBL630557,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,14960,1,,,12017,,Spleen,N,50597,CHEMBL630558,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14961,1,,,12017,,Spleen,N,50597,CHEMBL630559,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14962,1,,,12017,,Spleen,N,50597,CHEMBL630560,BAO_0000218,2106.0
A,Intermediate,1,,,Rattus norvegicus,In vivo,,10116.0,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,14963,1,,,12017,,Thyroid gland,N,50597,CHEMBL876427,BAO_0000218,2046.0
A,Intermediate,1,,,Rattus norvegicus,,,10116.0,The Kel values in female wistar rats.,,14964,1,,,14941,,,N,50597,CHEMBL630561,BAO_0000218,
A,Autocuration,1,,,,,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,14965,0,,,4646,,,U,22224,CHEMBL630562,BAO_0000019,
A,Autocuration,1,,,,,,,Hydrolysis rate constant of the compound,,14966,0,,,8847,,,U,22224,CHEMBL630563,BAO_0000019,
P,Autocuration,1,,,,,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,14967,0,,,11778,,,U,22229,CHEMBL629673,BAO_0000100,
A,Autocuration,1,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,14968,0,,,2363,,,U,22224,CHEMBL629674,BAO_0000019,
A,Autocuration,1,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,14969,0,,,2363,,,U,22224,CHEMBL629675,BAO_0000019,
A,Autocuration,1,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,14970,0,,,2363,,,U,22224,CHEMBL629676,BAO_0000019,
A,Autocuration,1,,,,,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,14971,0,,,2363,,,U,22224,CHEMBL629677,BAO_0000019,
A,Autocuration,1,,,,,,,Apparent inactivation rate constant was evaluated,,14972,0,,,8371,,,U,22224,CHEMBL629678,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,14973,0,,,14883,,,U,22224,CHEMBL629679,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,14974,0,,,14883,,,U,22224,CHEMBL629680,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,14975,0,,,4643,,,U,22224,CHEMBL629681,BAO_0000019,
A,Autocuration,1,,,,,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,14976,0,,,3519,,,U,22224,CHEMBL629682,BAO_0000019,
A,Autocuration,1,,,,,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,14977,0,,,10600,,,U,22224,CHEMBL629683,BAO_0000019,
F,Autocuration,1,,,,,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,14978,0,,,8501,,,U,22224,CHEMBL629684,BAO_0000019,
P,Autocuration,1,,,,,,,Dissociation constant was determined,,14979,0,,,8505,,,U,22224,CHEMBL629685,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant was determined,,14980,0,,,9778,,,U,22224,CHEMBL629686,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant at pH 7.4,,14981,0,,,9778,,,U,22224,CHEMBL872932,BAO_0000100,
P,Autocuration,1,,,,,,,Dissociation constant in presence of 1 mM dithiothreitol,,14982,0,,,9778,,,U,22224,CHEMBL629687,BAO_0000100,
A,Autocuration,1,,,,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,14983,0,,,13007,,,U,22224,CHEMBL872931,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,14984,0,,,13007,,,U,22224,CHEMBL628151,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,14985,0,,,13007,,,U,22224,CHEMBL628152,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,14986,0,,,13007,,,U,22224,CHEMBL628153,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic constant for aromatization of androstenedione,,14987,0,,,11482,,,U,22224,CHEMBL628154,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic constant for aromatization of testosterone,,14988,0,,,11482,,,U,22224,CHEMBL628155,BAO_0000019,
A,Autocuration,1,,,,,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,14989,0,,,2303,,,U,22224,CHEMBL628156,BAO_0000019,
A,Autocuration,1,,,,,,,Local inhibition constant was determined,,14990,0,,,11964,,,U,22224,CHEMBL628157,BAO_0000019,
A,Intermediate,1,,,Saccharomyces cerevisiae,,,4932.0,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,14991,1,,,3140,,,N,50347,CHEMBL857533,BAO_0000218,
P,Autocuration,1,,,,,,,Dissociation constant value of the compound,,14992,0,,,10650,,,U,22224,CHEMBL628158,BAO_0000100,
A,Autocuration,1,,,,,,,In vitro permeability through cornea without epithelium,,14993,0,,,4667,,Cornea,U,22224,CHEMBL628159,BAO_0000019,964.0
A,Autocuration,1,,,,,,,In vitro permeability through intact cornea,,14994,0,,,4667,,Cornea,U,22224,CHEMBL875616,BAO_0000019,964.0
A,Intermediate,1,,,Oryctolagus cuniculus,,,9986.0,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,14995,1,,,9199,,Cornea,N,50592,CHEMBL628160,BAO_0000218,964.0
A,Autocuration,1,,,,,,,Rate of enzyme inactivation for the compound was determined,,14996,0,,,11966,,,U,22224,CHEMBL628161,BAO_0000019,
A,Autocuration,1,,,,,,,In vitro permeability through cornea without epithelium,,14997,0,,,4667,,Cornea,U,22224,CHEMBL628162,BAO_0000019,964.0
A,Autocuration,1,,,,,,,In vitro permeability through intact cornea,,14998,0,,,4667,,Cornea,U,22224,CHEMBL628163,BAO_0000019,964.0
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,14999,0,,,8354,,,U,22224,CHEMBL628164,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15000,0,,,8354,,,U,22224,CHEMBL628165,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15001,0,,,8354,,,U,22224,CHEMBL628166,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15002,0,,,8354,,,U,22224,CHEMBL628167,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15003,0,,,8354,,,U,22224,CHEMBL628168,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15004,0,,,8354,,,U,22224,CHEMBL628169,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15005,0,,,8354,,,U,22224,CHEMBL628170,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15006,0,,,8354,,,U,22224,CHEMBL628171,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15007,0,,,8354,,,U,22224,CHEMBL627434,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15008,0,,,8354,,,U,22224,CHEMBL627435,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15009,0,,,8354,,,U,22224,CHEMBL628110,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15010,0,,,8354,,,U,22224,CHEMBL628111,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15011,0,,,8354,,,U,22224,CHEMBL628112,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15012,0,,,8354,,,U,22224,CHEMBL628260,BAO_0000019,
A,Autocuration,1,,,,,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,15013,0,,,8354,,,U,22224,CHEMBL628261,BAO_0000019,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,15014,1,,,14439,,,N,50594,CHEMBL628262,BAO_0000218,
A,Intermediate,1,,,Homo sapiens,In vivo,,9606.0,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,15015,1,,,14439,,,N,50587,CHEMBL628263,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,15016,1,,,14439,,,N,50594,CHEMBL628264,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,15017,1,,,14439,,,N,50594,CHEMBL628265,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,15018,1,,,14439,,,N,50594,CHEMBL628266,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,15019,1,,,14439,,,N,50594,CHEMBL628267,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,15020,1,,,14439,,,N,50594,CHEMBL628268,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,15021,1,,,14439,,,N,50594,CHEMBL628269,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,15022,1,,,14439,,,N,50594,CHEMBL628270,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,15023,1,,,14439,,,N,50594,CHEMBL628271,BAO_0000218,
A,Intermediate,1,,,Mus musculus,In vivo,,10090.0,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,15024,1,,,14439,,,N,50594,CHEMBL628272,BAO_0000218,
